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ABSTRACT 
Most of the research concerned with the economics of health systems has focussed on 
allocative efficiency. Specifically, much effort has been devoted to the development 
and application of techniques of economic evaluation. The consideration of technical 
efficiency has figured less prominently in the search for 'solutions' to the problems of 
health systems. Those working on the economic evaluation of health care interventions 
have adopted the assumption that interventions are being, or will be, produced in a 
technically efficient manner. 
The aim of this thesis is to challenge this assumption and illustrate the potential 
implications of assuming technical efficiency when allocating scarce resources. Two 
case studies from Bangladesh are presented: vaccination services in Dhaka City and 
primary health care in rural Bangladesh. The specific objectives of this thesis are to: 
estimate the cost of these services using standard costing methods; and analyse the same 
data sets using parametric (stochastic frontier analysis) and non-parametric (data 
envelopment analysis) techniques in order to identify whether, and to what degree, the 
services were being delivered efficiently. 
Applying efficiency measurement techniques illustrated that standard costing methods 
disguise a high degree of inefficiency. By investigating production practices, costs 
related to inefficiencies can be identified and addressed. The thesis illustrates that if 
something is deemed worth doing then it should be carried out in a way which ensures 
the optimum use of scarce resources. An exclusive focus on switching resources from 
less cost-effective to more cost-effective activities will not realise the full benefits in 
terms of improved allocative efficiency if providers on the ground are not producing 
services at lowest cost. Recommendations are made for policy-makers on how 
technical efficiency can be improved. Recommendations for future research are also 
made. 
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Chapter 1 
INTRODUCTION 
This thesis explores whether, and to what degree, health care is delivered efficiently. It 
compares and contrasts different efficiency measurement techniques, and applies them 
to the delivery of primary health care in urban and rural Bangladesh. It considers the 
impact an assumption of technical efficiency may have on the interpretation of cost-
effectiveness ratios. And finally, it provides recommendations to policy-makers before 
presenting an agenda for future research. 
Resources are scarcest in low- and middle-income countries such as Bangladesh, thus 
their inefficient use exacts a much higher penalty in terms of foregone health benefits in 
these settings than it does in high-income countries. It is essential that resources are 
used as efficiently as possible. 
1.1 Introduction 
In recent years, most of the research concerned with the economics of health systems in 
low- and middle-income countries has focussed on aspects of allocative efficiency. 
Specifically, a desire to enhance the allocative efficiency of health systems has led to 
much effort being devoted to the development and application of the techniques of 
economic evaluation, and in particular cost-effectiveness analysisl (CEA), which aim to 
allow comparison among alternative health interventions (e.g. Jamison et a1. 1993; 
Jamison et a1. 2006). The consideration of technical efficiency, however, has figured 
1 It should be noted that in practice, there has been a blurring of the distinctions between CEA and cost-
utility analysis (CUA), with the latter seen as an extension of the former (Musgrove 2000). Hence, the 
cost-effectiveness literature often encompasses both these approaches. Indeed, use of the term CEA in 
this thesis will encompass both approaches. 
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less prominently in the search for 'solutions' to the problems of health systems in low-
and middle-income countries. In the best traditions of economics, those working on the 
economic evaluation of health care interventions have tended to adopt the assumption 
that the interventions they are examining are being, or will be, produced in a technically 
efficient manner (Hensher 2001). 
1.2 Case studies, and thesis aim and objectives 
The overall aim of the thesis is to contribute to the methodological development of cost, 
and more broadly cost-effectiveness, analysis of health care programmes by exploring 
whether, and to what degree, health care is delivered in a technically efficient manner. 
Two case studies were chosen from projects described below. The first uses data from 
the delivery of vaccination services in Dhaka City. Data were collected from a sample 
of 132 vaccination delivery units. The second case study uses data collected from 36 
health centres in rural Bangladesh. More details on these case studies are provided in 
Chapters 5, 6 and 8. It should be noted that while immunisation is an integral 
component of primary health care in Bangladesh, it is not routinely delivered through 
rural health centres in Bangladesh (although they are used on a regular basis as outreach 
sites). Therefore, although the case studies both consider aspects of primary health care, 
they unfortunately do not cover the same activities2• However, the decision to include 
both case studies was largely influenced by the candidate's upgrading committee 
meeting in March 2003. The committee urged the candidate to supplement his early 
collaborative work on the efficiency of vaccination services in Dhaka (see below) to 
2 Data were available from nine sub-district hospitals that are responsible for organising and delivering 
vaccination services in rural Bangladesh (see Chapter 5), collected as part of project fun~d by the UK 
Department for International Development (DFID) described below. However, for reasons described in 
Chapter 3, nine facilities is an insufficient sample size for the purpose of this thesis. 
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ensure the work included in this thesis was substantially his own. However, as is 
described in more detail in the section 1.4 below, "Responsibility for completion of 
work included in the thesis", that earlier collaborative work has also been significantly 
revised by the candidate. 
Using these two case studies from Bangladesh, the specific objectives are to: 
1. Describe the empirical evidence on the efficiency of health care programmes in low-
and middle-income countries and regions; 
2. Estimate the cost of delivering vaccination services among a sample of vaccination 
delivery units in Dhaka City; 
3. Estimate the cost of delivering primary health care among a sample of health centres 
in rural Bangladesh; 
4. Estimate the efficiency of delivering these services using data envelopment analysis 
and stochastic frontier analysis; 
5. Describe the variation in efficiency among the units and to explore some of the 
causes of this variation; 
6. On the basis of these findings, describe the potential implications of inefficiency in 
the delivery of health care programmes; 
7. On the basis of these findings, make recommendations on how policy-makers in 
Bangladesh and elsewhere could improve efficiency, and make recommendations on 
\ 
further research relevant to health care efficiency issues. 
The thesis draws from two independent, yet related, projects of which the candidate was 
a co-investigator. The first project's aim was to estimate the cost-effectiveness of the 
measles vaccine of the national immunisation programme in Dhaka, Bangladesh. The 
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data were collected in 1999, and analysed and written up in 2000 (Walker et al. 2000). 
The study was funded by the World Health Organization (WHO) (grant number 
HQ/98/454419 011638) with contributions to salaries and fieldwork costs from 
ICDDR,B: Centre for Health and Population Research (lCDDR,B) and the London 
School of Hygiene and Tropical Medicine (LSHTM). The second project's aim was to 
evaluate the cost-effectiveness of introducing vaccines against hepatitis b, Haemophilus 
injluenzae type b and rotavirus versus the status quo of the current programme at 
existing, and higher, coverage rates in Bangladesh and Peru. The data were collected 
during 2002-2003, and analysed and written up during 2004-2005. The study was 
funded by DFID (grant number R 7842) with contributions to salaries and fieldwork 
costs from WHO, ICDDR,B and LSHTM. 
Neither of these studies had as an objective the application of parametric and non-
parametric efficiency measurement techniques, such as stochastic frontier analysis 
(SF A) and data envelopment analysis (DEA). Rather, they sought to identify the cost-
effectiveness of different vaccination programmes. The implications of this are 
discussed in Chapter 10. However, it is important to note that the aim of this thesis is 
not to examine in detail the methodological underpinnings of parametric and non-
parametric efficiency measurement techniques. Rather, it is to use these techniques to 
critique the underlying assumptions of technical and scale efficiency in economic 
evaluation. Of course, this does not mean that such techniques are not without their 
own problems and Chapter 3 provides a summary of the main criticisms. However, the 
focus of this thesis is on using these techniques to critique economic evaluation rather 
than vice versa. 
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1.3 Contribution of thesis 
It is anticipated that this thesis will add to the cost-effectiveness literature by providing 
an insight into the importance of failing to consider technical and scale efficiency. This 
study will assess the extent to which incorporating technical efficiency considerations 
can potentially alter the decision on whether or not to adopt a new technology and / or 
expand an existing technology. This should provide decision-makers with a clearer 
indication of the extent to which results generated in one setting are transferable 
between settings, transferable with adjustment or not transferable at all. 
1.4 Responsibility for completion of work included in this thesis 
All the work included in this thesis derives from the two studies described above and 
the candidate recognises the contributions of all who were employed to work on the 
projects. 
Early versions of Chapters 6 and 7 have been published elsewhere by Khan et al. 
(2004)3 and Valdmanis et al. (2003)4. In terms ofthe candidate's contributions to each 
of the papers, they were as follows. For the Khan et al. (2004) paper, the candidate: 
• wrote the original proposal from which the paper derivess; 
• designed the data collection tools; 
• supervised data collection (Suhaila Khan supervised data collection, entry and 
cleaning locally); 
• performed the analysis in collaboration with Suhaila Khan; 
3 Khan MM, Khan SH, Walker D, Fox-Rushby J, Cutts F, Akramuzzaman SM (2004) Cost of delivering 
child immunization services in urban Bangladesh: a study based on facility-level surveys. Journal of 
Health. Population and Nutrition 22(4): 404-412. See Appendix 1 for a pdf copy of this paper. 
4 Valdmanis V, Walker D, Fox-Rushby JA (2003) Are vaccination sites in Bangladesh scale efficient? 
International Journal of Technology Assessment in Health Care 19(4): 692-697. See Appendix 2 for a 
rdf copy of this paper. 
WHO grant number HQ/98/454419 011638 
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• drafted the paper in collaboration with Suhaila Khan. 
Felicity Cutts and Julia Fox-Rushby were principal investigators at LSHTM, and 
Mahmud Khan and Syed Md. Akramuzzaman were principal investigators at ICDDR,B, 
and they reviewed the article critically for final approval. All authors responded to the 
referees' comments. 
Chapter 6 represents a substantially revised version of the paper. In particular, the 
candidate re-cleaned the data set, resulting in the loss of 22 vaccination delivery units 
due to missing and / or questionable data. Examiners of this thesis may wish to 
compare Chapter 6 with the Khan et al. (2004) article which can be found in Appendix 
1. 
For the Valdmanis et al. (2003) article, the candidate6: 
• contributed to the conceptualisation of the problem statement along with Vivian 
Valdmanis; 
• contributed substantive knowledge regarding the delivery of vaccination services in 
Dhaka, which enabled Vivian Valdmanis to design the DEA model; 
• contributed to the interpretation of the results; 
• contributed to the drafting of the article. 
All authors reviewed the article critically for final approval, and all authors responded to 
the referees. 
6 Note, this paper derives from the same original proposal (Walker et al. 2000). Thus many of the points 
raised above with respect to the Khan et al. (2004) paper apply here. The list here focuses on points of 
relevance to the secondary analysis performed of the same data using DEA. 
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Chapter 7 represents a significantly revised version of the paper. In particular, the 
candidate used the re-cleaned data set, resulting in the loss of seven vaccination delivery 
units due to missing and / or questionable data. Furthermore, the candidate included a 
further two DEA model specifications, and introduced the SF As. Therefore, the 
methods, results and discussion sections are substantially revised. In essence, Chapter 6 
bears little resemblance to the paper Valdmanis et al. (2003). The examiners of this 
thesis are welcome to compare Chapter 7 with the Valdmanis et al. (2003) article which 
can be found in Appendix 2. 
With respect to Chapters 8 and 9, the candidate: 
• wrote the original proposal from which the paper derives 7; 
• designed the data collection tools; 
• supervised data collection, entry and cleaning; 
• performed all analyses. 
Colin Sanderson and Julia Fox-Rushby were principal investigators of the project at 
LSHTM, and Shahadat Hossain, Nazme Sabina were principal investigators at 
ICDDR,B. The candidate gratefully acknowledges the contributions these individuals 
made during the data collection period, particularly Shahadat Hossain and Nazme 
Sabina. While the analyses presented in Chapters 8 and 9 are thus based on data 
collected through a joint project, they fell outside of the project's aims and objectives, 
and the candidate is thus fully responsible for what is presented herewith. 
7 DFID grant number R7842. 
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1.5 Outline of thesis 
Chapter 2 provides an overview of the concepts of efficiency and economic evaluation. 
It describes the role of CEA in the health sector. The chapter concludes by discussing 
the assumption of technical efficiency underlying CEA, and begins to consider the 
impact these assumptions may have on the interpretation of cost-effectiveness ratios, 
and thus how decisions of how to allocate resources. 
Chapter 3 describes SF A and DEA, the main parametric and non-parametric efficiency 
measurement techniques. However, it begins with a brief introduction to the efficiency 
concepts developed by Farrell (1957). This chapter also compares and contrasts the 
strengths and weaknesses of the two approaches. The final section discusses some 
methodological challenges of measuring efficiency in the health sector, e.g. adjusting 
for case mix, allowing for variation in technical quality and knowledge of input prices. 
The literature review presented in Chapter 4, examines the evidence-base on the 
efficiency of health care services in low- and middle-income countries. It identifies the 
range of methods used, models specified, results and recommendations. The literature 
review identifies a number of key gaps and unanswered questions concerning the 
measurement of efficiency in low- and middle-income settings. 
Chapter 5 provides background and context in which the two case studies examined in 
this thesis are operating in Bangladesh. It provides an overview of general health status 
indicators, a description of the Ministry of Health and Family Welfare, which has 
overall responsibility for health sector policy and planning in Bangladesh, a summary of 
health care services, both government and non-government, in urban and rural 
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Bangladesh, alongside an examination of health care expenditure. It concludes by 
summarising the health policy and planning framework in place in Bangladesh and 
gives a description of recent health sector reform programmes. 
Chapters 6 and 8 estimate the costs of delivering vaccination services and primary 
health care in urban and rural Bangladesh respectively, using standard costing methods. 
The chapters describe the variation in unit costs observed among 110 vaccination 
delivery units and 34 health centres respectively. The same data are examined by using 
DEA and SFA in chapters 7 and 9. The different techniques are compared and 
contrasted in order to assess the stability of the findings. In addition, analyses are 
performed to identify whether selected environmental variables explain some of the 
variation in efficiency observed in the sample data. These chapters also discuss some of 
the policy implications of the findings, focussing in particular on the potential savings 
were technical efficiency improved. And in order to guide mangers of these services, it 
also provides targets for efficiency improvements. Some suggestions are provided on 
how these targets might be met. 
Chapter lOis divided into two main sections. The first section discusses 
methodological issues, in particular limitations of the data, analysis and interpretation. 
The second section discusses the main findings of the thesis. This section focuses in 
particular on the implications of the findings on the practice of economic evaluation. 
The concluding chapter reflects on what has been presented in the preceding ten 
chapters and draws lessons from the theoretical and empirical information. It discusses 
the generalisability of the findings within and beyond Bangladesh. It makes 
2S 
recommendations on how policy-makers in Bangladesh and elsewhere could best 
approach the issue of inefficiency within the health sector. Finally, areas for future 
research are outlined. 
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Chapter 2 
EFFICIENCY AND ECONOMIC EVALUATION 
By way of background, the first section provides an overview of the concepts of 
efficiencl. The second section describes the role of CEA in the health sector. The 
third section describes the assumption of technical efficiency underlying CEA, drawing 
upon a selective review of key methodological guidelines. The fourth section concludes 
the chapter. 
2.1 Concepts of efficiency 
It is widely agreed that, given the scarcity of health care resources, it is important that 
services be produced efficiently. However, it is not always clear what is meant by 
efficient. Economists use a number of concepts of efficiencl. Thus, as Culyer (1992) 
states, "The term 'efficient' ... needs unpacking, since much confusion about what it is 
abounds". The basic premise underlying the concept of efficiency is that no output can 
be produced without resources (inputs) and that these resources are limited in supply. 
From this, it follows that there is a limit to the volume of output that can be produced. 
At the most basic level, there is a desire to ensure that the existing inputs are not capable 
of producing more services. Therefore all definitions of efficiency basically follow 
from avoidance of waste. The presence of waste obviously implies some persons could 
be made better off without using more resources. The two main concepts to consider 
8 Methods for measuring efficiency are reviewed in Chapter 3. 
9 A summary of arguments concerning economists' general confusion about efficiency can be found in 
the Reinhardt (2003). 
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are technical and allocative efficiencylO. It will be illustrated that the definitions are 
applied in different ways depending on whether the unit of analysis is a finn II or health 
system. 
2.1.1 Concepts of efficiency applied to finns 
2.1.1.1 Technical efficiency 
In order to measure efficiency, a norm must be specified. The norm set for measuring 
technical efficiency is that the minimum amount of resources should be used to produce a 
given level of output or, alternatively, the maximum amount of output should be produced 
for a given level of resource use. If more resources than necessary are used to produce a 
given amount of output, this implies a waste of resources and therefore inefficiency. Thus, 
the difference in the amount of output that could have been produced from a given amount 
of resources and the amount of output that was actually produced can be used as a measure 
of technical inefficiency. Technical inefficiency is therefore a matter of degree depending 
upon how much unnecessary resources have been used. Central to the measurement of 
technical efficiency is the notion of the isoquantl2 . 
This is illustrated in Figure 1 for a simple production process that uses only two inputs, 
Xa and Xb (for example, these inputs could be doctor- and nurse-hours worked, or 
doctor-hours and drugs). Any point along the isoquant QQ represents a technically 
efficient way of combining various quantities of inputs Xa and ~ to produce the same 
10 Some textbooks use the terms productive or operational efficiency instead of technical efficiency and 
the term price or economic efficiency instead of allocative efficiency. The terminology used in this thesis 
conforms to that used most often in recent production economics literature (e.g. Fare et aI. 1994). 
II The term decision-making unit is sometimes used to describe a productive entity in instances when the 
term 'firm' may not be entirely appropriate, e.g. when comparing the performance of public vaccination 
sites, the units are really parts of a fmn rather than fmns themselves. 
12 An isoquant represents all the possible combinations of inputs, which permit production of the same 
quantity of health care output - iso meaning 'same' and quant meaning 'quantity'. The output 
counterpart to the isoquant is the production possibilities frontier, which depicts the various combinations 
of inputs that could be used to produce a given level of output. 
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amount of output Q. For example, while points 1 and 2 differ in the combination of Xa 
and Xb (production at 1 is more intensive in Xb than at 2), both permit production of the 
same quantity Q. Points 1 and 2, like all other points on the isoquant QQ are technically 
efficient because it is not possible to produce Q with smaller quantities of either Xa or 
Xb, as depicted by the line (there is no room for further gain in technical efficiency). 
Point 3, like all points to the left of the isoquant, is infeasible, i.e. any reduction in the 
amounts of Xa and Xb from the amounts represented by the isoquant necessarily 
translates into a reduction in Q. In contrast, point 4, like all points to the right of the 
isoquant, constitutes a technically inefficient way of producing Q, i.e. technical 
efficiency can be improved by moving production from 4 to 2, thereby reducing the 
amount of Xa from Xa4 to Xa2. In effect, one modus operandi is considered more 
technically efficient than another, if it either produces the same quantity of output using 
fewer inputs, or produces a greater quantity of outputs using the same resources. 
Figure 1: An example of technical efficiency 
o 
Q 
technically 
infeasible area 
3 
technically 
inefficient area 
2 
Xa4 
4 
Q 
Xa 
It is important to note, that it is assumed here that technical quality of care also remains 
constant along the isoquant. Thus, not only does any combination of inputs Xa and Xb 
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along the curve pennit production of quantity Q of medical care output, but also, any 
such combination delivers medical care of constant technical quality, i.e., with the same 
effect on patients' health status (see Chapter 3 for a discussion of the implications of 
this assumption). 
2.1.1.2 Allocative efficiency 
An allocatively efficient finn will combine these inputs in a cost-minimising manner to 
produce a given level of output, with price ratios being the nonns for judging allocative 
efficiency. 3 . With factor input prices given, resources used in production should be 
combined so as to reflect the corresponding ratio of different factor input prices. A mix 
of resource use that deviates from the corresponding ratio of given factor input prices is 
taken as a measure of allocative inefficiency. Any deviation in the mix of resource use 
from observed price ratios is measurable, and hence, allocative inefficiency becomes a 
matter of degree, just like technical inefficiency. Although there may be many 
technically efficient alternatives to produce a given quantity Q, there is only one 
allocatively efficient way of doing so. 
Figure 2 helps to illustrate the fundamental difference and relationship between 
technical and allocative efficiency. Suppose that the unit prices of inputs Xa and Xb are 
Wa and Wb respectively. If a health facility is allocated a budget B., then B. represents 
the facility's budget constraint. The constraint is given by the ~uation: B. = (Xa * Wa) 
+ (Xb * Wb). Any point along the budget constraint line, such as points 1 and 3, 
consumes the whole budget B.. However, point 1 is preferable to 3 because at 1 
13 However, using prices as the criteria for measuring economic efficiency is based on the asswnption that 
firms have no influence on the price. Rather, prices are determined in the market as the outcome of 
competitive bidding between a large number of consumers and firms. Clearly this may Dot apply in the health 
sector. 
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quantity Q is produced, whereas at point 3 the smaller quantity Q" is produced. 
Furthermore, of all the technically efficient points along the frontier QQ, point 1 is the 
most allocatively efficient way of producing quantity Q. Point 2 is as technically 
efficient as 1, but is less allocatively efficient, since production at 2 requires a budget of 
B2, higher than B\. Graphically, the allocatively efficient point (point 1) corresponds to 
the tangency between the budget constraint and the isoquant. Thus, technical efficiency 
is a necessary but not sufficient condition for allocative efficiency. In general, two 
types of circumstances, discussed above, can lead to allocative inefficiency: technical 
inefficiency and technically efficient production that uses a mix of inputs that is not cost 
minimising. 14 
Figure 2: An example of allocative efficiency 
o Xa 
Finally, when taken together, technical efficiency and allocative efficiency determine 
the degree of economic, or overall, efficiency. Thus, if a firm uses its resources in a 
technically and allocatively efficient way, then it can be said to have achieved economic 
14 There is a third cause of economic inefficiency, referred to as social economic inefficiency that can 
arise when the input prices faced by facility managers (e.g. personnel wages or pharmaceutical products) 
depart from social (or shadow) prices. 
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efficiency. Alternatively, to the extent that either technical or allocative inefficiency is 
present, the firm will be operating at less than total economic efficiency. 
2.1.2 Concepts of efficiency applied to health systems 
As described above, allocative efficiency is traditionally used to describe the optimal, 
i.e. cost-minimising, mix of inputs to a production process given their respective prices. 
However, as interventions are inputs to the production of health, allocative efficiency 
can be viewed as choosing the optimal mix of interventions for any given level of 
expenditure (Tan-Torres Edejer et al. 2003). Technical efficiency is thus viewed as 
minimising the cost of delivering an intervention, referred to above as allocative 
efficiency, which perhaps illustrates a cause of some of the confusion among 
economists noted by Reinhardt (2003). As stated previously, technical efficiency 
traditionally describes a situation where the minimum quantity of inputs is used to 
produce a given level of output, or conversely, the maximum quantity of output is 
produced given available inputs, i.e. the cost of producing these levels of output might 
not be minimised (see Figure 2). However, it is implicitly assumed when viewing 
technical efficiency as minimising the cost of delivering an intervention that this 
traditional definition has been met - indeed, the achievement of allocative efficiency in 
the traditional sense requires technical efficiency to be met. Given that CEA generally 
deals with interventions as the unit of analysis rather than a health facility or health 
system, it is perhaps not surprising that the terms cost-effectiveness and technical 
efficiency have been viewed as synonymous by some economists. Thus, as Tan-Torres 
Edejer et al. (2003) state 
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" inefficiencies in the production of health may derive from two sources: 
problems with technical efficiency - how an intervention is delivered - and 
problems with allocative inefficiency - which set of interventions is provided". 
2.2 Role of cost-effectiveness analysis in the health sector 
CEA is a form of economic evaluation. The different forms of economic evaluation are 
cost-minimisation analysis (CMA), CVA and cost-benefit analysis (CBA). The basic 
task of any economic evaluation is to identify, measure, value and compare, the costs 
and consequences of the alternatives being considered (Drummond et al. 1997). The 
various evaluation techniques estimate costs in a similar fashion, but differ in the 
measurement of health outcomes (see Box 1). Costs refer to the value of opportunities, 
or benefits foregone, from not employing resources elsewhere. Benefits are gauged by 
the consequences of a health programme on people's well-being or health status. The 
different ways of measuring benefits lead to a trade-off between the scope for potential 
use and the practicality of various evaluation techniques. 
As illustrated above, when the unit of analysis is an intervention, as it generally is when 
performing an economic evaluation, allocative efficiency can be viewed as choosing the 
optimal mix of interventions for a given level of expenditure - optimal in the sense that 
they maximise health gain. In this broader definition of efficiency, different health care 
interventions with different objectives and outcomes must be compared, e.g. malaria 
versus tuberculosis control, or more generally, how should the Ministry of Health's 
budget be distributed between programmes? It thus follows that, while interventions 
may have different objectives and outcomes of interest, these must be converted into 
commensurable units if the optimal mix is to be defined. For this reason, CVA, which 
uses more complex measures of outcomes, can be used to assess allocative efficiency 
within the health sector. However, this form of economic evaluation is still restricted to 
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comparisons of programmes within the health sector, so strictly speaking only deals 
with quasi-allocative assessments. 
Box 1: Different types of economic evaluation 
Cost-minimisation analysis: compares two or more interventions that have identical 
outcomes (e.g. number of cases treated) are assessed to see which provides the cheapest 
way of delivering the same outcome. 
Cost-effectiveness analysis: measures the outcome of interventions in terms of 'natural 
units' e.g. for national immunisation programmes, this could be the number of disease 
cases averted. 
Cost-utility analysis: these evaluations use a measure of utility reflecting people's 
preferences. The outcomes are then expressed in terms of measures such as quality-
adjusted life-years or disability-adjusted life-years (DALYs). 
Cost-benefit analysis: expresses outcomes (e.g. the number of lives saved) in terms of 
monetary units. 
In theory, CBA has the widest scope of the four types of analysis because outcomes are 
monetised enabling inter-sectoral comparisons, i.e. in principle it can address how a 
government budget should be distributed between different ministries. In practice 
however, the valuation of health benefits is difficult and thus preference for CEA over 
other types of analysis for evaluating health care programmes has emerged since the late 
1970s in both developed and developing countries (Elixhauser et al. 93; Elixhauser et al. 
98; Stone et al. 2005; Walker and Fox-Rushby, 2000; Warner and Hutton 1980). 
On the other hand, all of the different types of economic evaluation can be used to 
assess technical efficiency, which, can be viewed as maximising the achievement of a 
34 
given objective within a given budget when the unit of analysis is an interventionl 5, e.g. 
vaccination of children through fixed, outreach or mobile clinics. 
As noted above, a perceived strength of CEA is that it can help identify technically 
efficient alternatives. Thus the next section describes in more detail the micro-
economic assumption of technical efficiency underlying economic evaluation. In doing 
so, it reviews the extent to which a selection of influential economic evaluation 
guidelines provide appropriate direction to analysts for identifying technically efficient 
interventions, and by definition, allocatively efficient health systems. 
2.3 The assumption of technical efficiency in economic evaluation 
It has been noted that CEA guidelines fail to explicitly consider the concept of technical 
efficiency (Donaldson et al. 2002), with perhaps the notable exception of the recent 
publication of the World Health Organization's generalised cost-effectiveness analysis 
(GCEA) guidelines, which conversely, explicitly states that the GCEA guidelines do not 
consider technical efficiency: 
The main objective of this type of economic evaluation [GCEA] is to provide 
policy makers with information on the relative cost-effectiveness of a given set 
of interventions. Thus it addresses issues of allocative efficiency of scarce 
health care resources. Technical efficiency is assumed in this type of analysis. 
(Italics mine) (Baltussen et al. 2002) 
Worryingly, the authors wrote this after stating that, "It is not useful for policy makers 
to know the cost-effectiveness of inefficient interventions" (Baltussen et al. 2002). 
However, this could have something to do with the fact that the tenns cost-effectiveness 
IS Or alternatively, the ability to produce a given output at the lowest possible cost. 
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and technical efficiency have been used interchangeably by some economists, again 
suggesting that technical efficiency is assumed rather than assessed (Donaldson 1990). 
As noted above, the 'cost' in cost-effectiveness refers to the value of opportunities, or 
benefits foregone, from not employing resources elsewhere. This requires that costs 
reflect overall, or economic, efficiency. Thus, if some of the resources used do not 
contribute to the improvement of health outcomes, these resources should be identified 
and excluded in the costing of the health care programme; including these costs would 
mean that the costs reported no longer reflect opportunity costs. Unfortunately, 
National Institute for Clinical Excellence (NICE) (2001) guidelines offer little advice on 
how analysts should measure opportunity costs. As Birch and Gafui (2002) point out 
when offering a critique of previous NICE guidelines: 
" ... a general problem that underlies many aspects of the guidelines relates to the 
limited attention given to the concept of opportunity cost '" the solution to the 
problem of using market prices that do not reflect opportunity costs is to use 
other data which also do not reflect opportunity costs ... ". 
Rather than provide a more appropriate definition of opportunity costs, the most recent 
guidelines from NICE state that they prefer unit costs to reflect the financial costs to the 
National Health Service and Personal Social Services, rather than the opportunity costs. 
If the aim of economic evaluations is to move resource use towards technical and 
allocative efficiency, opportunity costs are required. Thus the NICE position appears to 
be inconsistent with economic theory. Using financial costs in economic evaluations 
and decision-making may lead to inefficient resource allocation. 
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If costs vary because some centres are inefficient whereas others are relatively efficient, 
then it is inappropriate to use costs that are representative of all the centres concerned. 
Some centres may be producing the health care programmes concerned in an efficient 
manner, whereas in other centres, resources may be wasted. If the costs included are to 
represent opportunity costs then the costs from the efficient centres are those that are 
relevant. 
An economic evaluation should ideally be able to recognise departures from allocative 
efficiency. However, there is little evidence to suggest that the guiding principles for 
economic evaluation consider technical efficiency. If the costs used do not represent 
opportunity costs, because they incorporate inefficiency in the provision of health care 
programmes, then the study may produce misleading estimates of the relative cost-
effectiveness of each health care programme. The issue of how to ensure that the costs 
used in economic evaluations approximate opportunity costs is not addressed by many 
of the guidelines including the recent methodological guidance issued by NICE and 
WHO (NICE 2001; Tan-Torres Edejer 2003). 
2.4 Summary 
• Technical efficiency traditionally describes when the minimum quantity of inputs is 
used to produce a given level of output, or conversely, the maximum quantity of 
output is produced given available inputs; 
• Allocative efficiency is traditionally used to describe the optimal mix of inputs to a 
production process given their respective prices; 
• However, as interventions are inputs to the production of health, allocative 
efficiency can be viewed as choosing the optimal mix of interventions for any given 
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level of expenditure, and technical efficiency can thus be viewed as minimising the 
cost of delivering an intervention; 
• However, it is implicitly assumed when viewing technical efficiency as minimising 
the cost of delivering an intervention that this traditional definition has been met; 
• CEA is a form of economic evaluation. The other forms of economic evaluation are 
CMA, CUA and CBA. The basic task of any economic evaluation is to identify, 
measure, value and compare, the costs and consequences of the alternatives being 
considered; 
• CEA fails to explicitly consider technical efficiency, assuming instead that the cost 
of providing a particular level of service is minimised; 
• Failing to account for differing levels of technical, and therefore by definition 
allocative, efficiency among providers or health systems in different countries could 
have significant implications for the validity of the results ofCEAs; 
• This thesis will use parametric and non-parametric efficiency measurement 
technqiues, described in the next chapter, to challenge this assumption and to 
explore the implications of it. 
The next chapter presents DEA and SF A, two alternative approaches for measuring 
efficiency. 
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Chapter 3 
AL TERNATIVE METHODS FOR MEASURING EFFICIENCY IN 
THE HEALTH SECTOR 
This chapter presents the methods of two alternative approaches for measunng 
efficiency; DEA and SFA. However, it begins with a brief introduction to the efficiency 
concepts developed by Farrell (1957).16 The primary purpose of this first section is to 
outline a number of commonly used efficiency measures and to discuss how they can be 
calculated relative to a given technology, which is generally represented by some form 
of frontier function. The second section introduces the basic DEA models, namely the 
constant returns to scale (eRS) and variable returns to scale (VRS) models. This 
section also considers how allowance for environmental variables can be made. The 
third section provides an overview of stochastic frontier modelling, and again considers 
how allowance for environmental variables can be made. In addition, this section 
describes the maximum likelihood estimation procedure used in SF A, reviews 
alternative functional forms and presents methods for hypothesis testing. The fourth 
section considers appropriate sample sizes and the dimensionality issue, which are 
aspects relevant to both approaches. The fifth section compares and contrasts the 
strengths and weaknesses of the two approaches. The final section discusses some 
methodological challenges of measuring efficiency in the health sector, e.g. adjusting 
for case mix, allowing for variation in technical quality and knowledge of input prices. 
16 A more detailed treatment is provided by Lovell (1993) and Fare et al. (1994). 
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3.1 Introduction 
The consideration of efficiency measurement to a large extent began with Farrell 
(1957), who drew upon the work of Debreu (1951) and Koopmans (1951) to define a 
simple measure of firm efficiency which could account for mUltiple inputs. Farrell 
(1957) proposed that the efficiency of a firm consists of two components: technical 
efficiency, which reflects the ability of a firm to obtain maximal output from a given set 
of inputs, and allocative efficiency, which reflects the ability of a firm to use the inputs 
in optimal proportions given their respective prices and the production technology. 
These two measures are then combined to provide a measure of total economic 
efficiency 1 7 • 
3.1.1 Input-orientated measures 
Farrell illustrated his ideas using a simple example involving firms which use two 
inputs (xa and Xb) to produce a single output (y), under the assumption of CRS (which 
allows the technology to be represented using unit isoquantsI8). Knowledge of the unit 
isoquants of fully efficient firms 19, represented by QQ in Figure 3, permits the 
measurement of technical efficiency. If a given firm uses quantities of inputs, defined 
by the point P, to produce a unit of output, the technical inefficiency of that firm could 
be represented by the distance QP, which is the amount by which all inputs could be 
proportionally reduced without a reduction in output. This is usually expressed in 
percentage terms by the ratio QP / OP, which represents the percentage by which all 
inputs need to be reduced to achieve technically efficient production. The technical 
17 Farrell used the tenn price efficiency instead of allocative efficiency, and the tenn overall efficiency 
instead of economic efficiency. 
18 A finn is said to exhibit CRS if an increase in the proportion of inputs by one unit will result in a one 
unit increase in the proportion of outputs. 
19 This is not known in practice and thus must be estimated from observations on a sample of fums in the 
industry under consideration. 
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efficiency (TE) of a firm is most commonly measured by the ratio OQ / OP, which is 
equal to one minus QP / OP. It will take a value between zero and one, and hence 
provide an indicator of the degree of technical efficiency of the firm. A value of one 
indicates the firm is fully technically efficient. For example, the point Q is technically 
efficient because it lies on the isoquant. 
Figure 3: Technical and allocative efficiency 
Q 
o Xa 
If the input price ratio, represented by the slope of the isocost line, AA, in Figure 3, is 
also known, allocative efficiency can also be calculated. The allocative efficiency (AE) 
of the firm operating at P is defined as the ratio AE = OR / OQ, because the distance RQ 
represents the reduction in production costs that would occur if production were to 
occur at the allocatively (and technically) efficient point Q', instead of at the technically 
efficient, but allocatively inefficient, point Q. 
The total economic efficiency (EE) is defined as the ratio EE = OR / OP, where the 
distance RP can also be interpreted in terms of a cost reduction. The product of 
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technical and allocative efficiency provides the measure of overall or economic 
efficiency: 
Note that all three measures are bounded by zero and one. 
These efficiency measures assume that the production function is known. In practice 
this is not the case, and the efficient isoquants must be estimated from sample data. 
Farrell (1957) suggested the use of either a non-parametric piece-wise-linear convex 
isoquant, constructed such that no observed point lies to the left or below it (e.g. DEA), 
or a parametric function, such as the Cobb-Douglas20 form, fitted to the data (e.g. SF A), 
again such that no observed point lies to the left or below it. 
3.1.2 Output-orientated measures 
The above input-orientated technical efficiency measure addresses the question: "By 
how much can input quantities be proportionally reduced without changing the output 
quantities produced?". One could alternatively ask the question: "By how much can 
output quantities be proportionally expanded without altering the input quantities 
used?". This gives output-orientated measures as opposed to the input-orientated 
measures discussed above. 
20 The Cobb-Douglas function is a particular type of production function, of the form output (measured in 
appropriate units) = L· • K(l-a), where L is units of labour used, K is units of capital used, and a is a value 
between 0 and 1 (Varian 1992). Such a function has two particularly interesting properties: it exhibits 
CRS (that is, a given percentage change in both inputs will produce the same percentage change in the 
output) and diminishing returns to a single factor (that is, if one factor is increased by equal successive 
amounts while the other is held constant, the amount of additional output produced by each additional 
unit of the variable factor will gradually decline). Although these characteristics are not universally true 
for all situations, they are fairly representative of a large number of cases. 
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One can illustrate output-orientated measures by considering the case where production 
involves two outputs (yl and y2) and a single input (xl). If the input quantity is fixed at 
a particular level, the technology can be represented by a production possibilities 
frontier in two dimensions. This example is depicted in Figure 4 where the line ZZ is 
the production possibilities frontier and the point A corresponds to an inefficient firm. 
Note that an inefficient firm operating at point A lies below the frontier, because ZZ 
represents the upper bound of production possibilities. 
Figure 4: Technical and allocative efficiency from an output orientation 
o 
Ya 
The Farrell output-orientated efficiency measures (see Hire et al. 1994) are defined as 
follows. In Figure 4, the distance AB represents technical inefficiency, i.e. the amount 
by which outputs could be increased without requiring extra input. Hence a measure of 
output-orientated technical efficiency is the ratio TE = OA / OB. If price information is 
available then the isorevenue line DD' can be shown, and allocative efficiency is 
defined to be AE = OB / OC, which has a revenue increasing interpretation. Finally, 
overall or economic efficiency is defined as the product of these two measures: 
EE = (OA / OC) = (OA / OB) x (OB / OC) = TE x AE. 
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Again, all these three measures are bounded by zero and one. The output- and input-
orientated measures are equivalent measures of technical efficiency only when CRS 
exists (Coelli et al. 1998). It is important to note that technical efficiency has been 
measured along a ray from the origin to the observed production point. Hence these 
measures hold the relative proportions of inputs (or outputs) constant. One advantage of 
these radial efficiency measures is that they are unit invariant, i.e. changing the units of 
measurement does not change the value of the efficiency measure. 
3.2 Data envelopment analysis 
3.2.1 The constant returns to scale model 
DEA involves the use of linear programming methods to construct a non-parametric 
piece-wise surface, or frontier, over the data. Efficiency measures are then calculated 
relative to this surface. A comprehensive review of the methodology is presented by 
Cooper et al. (2003). 
The piece-wise-linear convex hull approach to frontier estimation, proposed by Farrell 
(1957), did not receive wide attention until the paper by Charnes, Cooper and Rhodes 
(1978), in which the term DEA was first used. Since then there has been a large number 
of papers which have extended and applied the DEA methodology (Hollingsworth 
2003; Worthington 2004). 
Charnes et al. (1978) proposed a model which had an input-orientation and assumed 
CRS. Subsequent papers have considered alternative sets of assumptions, such as 
Banker et al. (1984), in which a VRS model was proposed. The VRS model is 
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discussed in the next sub-section, but here a description of the input-orientated eRS 
model is provided. 
Some notation is required to begin with. Assume there are data on K inputs and M 
outputs for each of N firms. For the i-th firm these are represented by the column 
vectors Xi and Yi respectively. The KxN input matrix, X, and the MxN output matrix, Y, 
represent the data for all the firms. 
miIla", e 
subject to YA~Yi 
XA~ eXi 
A~O 
where e is a scalar and A is a Nxl vector of constants. The value of e obtained will be 
the efficiency score for the i-th firm. It will satisfy e ~ 1, with a value of 1 indicating a 
point on the frontier and hence a technically efficient firm, according to the Farrell 
(1957) definition. The linear programming problem must be solved N times, once for 
each firm in the sample. A value of e is then obtained for each firm. Essentially, the 
above linear programming problem takes the i-th firm and then seeks to radially 
contract the input vector, Xi, as far as possible, while still remaining within the feasible 
input set. 
3.2.1.1 Slacks, peers and targets 
The piece-wise linear form of the non-parametric frontier in DEA can cause a few 
difficulties in efficiency measurement. Problem arise because of the sections of the 
piece-wise linear frontier which run parallel to the axes which do not occur in most 
parametric functions. To illustrate the problem see Figure 5 below, where the units 
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using input combinations C and D are the two efficient units which define the frontier, 
and firms A and B are inefficient units. The Farrell (1957) measure of technical 
efficiency gives the efficiency of firms A and B as OA' / OA and OB' / OB respectively. 
However, it is questionable as to whether the point A' is an efficient point because the 
amount of input Xb used could be reduced (by the amount CA') and still produce the 
same quantity Q. This is known as input slack in the literature, although some authors 
use the term input excess (Coelli et al. 1998). The related concept of output slack also 
occurs. 
In DEA, health centres which obtain an efficiency score of one (1.00) are regarded as 
(relatively) efficient, while those with scores less than one are classified as (relatively) 
inefficient. An input-orientated specification illustrates the level of radial contraction of 
inputs necessary for an 'inefficient' health centre to become 'efficient'. This level is 
established on the basis of efficient health centres that have been found to operate under 
similar technology. These efficient health centres are known as peers, with which a 
relatively inefficient health centre is compared (Coelli et al. 1998). Every efficient 
health centre is peer at least once, for itself, but may be act as a peer for other inefficient 
health centres. A score of zero denotes that the health centre was not efficient in that 
particular specification. On the other hand, a score of one indicates that the health 
centre has a unique combination of input(s) and output(s) compared to other health 
centres in the sample. DEA studies also refer to targets as well peers. These concepts 
are illustrated below in Figure 5. It should be noted, for example, that unit B could 
possibly reduce the consumption of both inputs to the point B' without reducing output. 
This projected point lies on a line joining points C and D. Firms C and D are therefore 
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referred to as the peers of firm B. Furthermore, the targets of firm B are the coordinates 
of the efficient projection point B' . 
Figure 5: Efficiency measurement and input slacks 
B 
Q 
o Xa 
3.2.2 The variable returns to scale model and scale efficiencies 
The CRS assumption is only appropriate when all firms are operating at an optimal 
scale. In reality there are usually reasons to suspect that a firm may not be operating at 
optimal scale (Jacobs and Baladi 1996; Elbasha and Messonnier 2004). The use of the 
CRS specification when not all firms are operating at the optimal scale, results in 
measures of technical efficiency which are confounded by scale efficiency. Therefore, 
Banker, et al. (1984) suggested an extension of the CRS DEA model to account for 
VRS situations. The use of the VRS specification permits the calculation of technical 
efficiency devoid of these scale efficiency effects. 
The CRS linear programming model can be modified to account for VRS by adding the 
convexity constraint N 1 'A. = 1 to provide: 
minaA 9 
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subject to YI.::::Yi 
XI.:::: SXi 
Nl 'I. = 1 
1.::::0 
where N I is an Nx I vector of ones. This approach fonns a convex hull of intersecting 
planes which envelope the data points more tightly than the CRS conical hull, and thus 
provides technical efficiency scores which are greater than or equal to those obtained 
using the CRS model (Coelli et al. 1998). 
The convexity constraint (NI 'I. = I) essentially ensures that an inefficient finn is only 
benchmarked against finns of a similar size. That is, the projected point (for that finn) 
on the DEA frontier will be a convex combination of observed finns. This convexity 
restriction is not imposed in the CRS case. Hence in a CRS DEA, a finn may be 
benchmarked against finns which are substantially larger (or smaller) than it. In this 
instance the I.-weights will sum to a value greater than (or less than) one. 
If it is considered that the technology exhibits VRS, then it is possible to obtain a scale 
efficiency measure for each finn. This is achieved by conducting both a CRS and a 
VRS DEA. The technical efficiency scores obtained from the CRS DEA are then 
decomposed into two components, one due to scale inefficiency and the other due to 
'pure' technical inefficiency. If there is a difference in the CRS and VRS technical 
efficiency scores for a particular finn, then this indicates that the finn has scale 
inefficiency. Scale inefficiency (SE) can be calculated by dividing the CRS technical 
efficiency (TEcRS) score by the VRS technical efficiency TEvRS score, where all these 
measures are bounded by zero and one: 
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SE = TEcRS 
TEVRS 
One shortcoming of this measure of scale efficiency is that the value does not indicate 
whether the firm is operating in an area of increasing or decreasing returns to scale21 • 
This can be determined by running an additional DEA problem with non-increasing 
returns to scale (NIRS) imposed. This is carried out by altering the DEA model 
presented above by substituting the Nl 'A. = 1 restriction with Nl 'A. ~ 1, to provide: 
mins).. e 
subject to YA. 2: Yi 
Nl'A.~ 1 
The constraint NI 'A. ~ 1 ensures that the i-th firm will not be benchmarked against firms 
which are substantially larger than it, but may be compared with firms smaller than it. 
3.2.3 Adjusting for the environment 
The results of DEA may be misleading because of the favourable or unfavourable 
environments in which some firms operate, such that there will always be some inherent 
inefficiency. Fried et aI. (2002) recently summarised the existing approaches to 
incorporating environmental effects in DEA. These approaches can be grouped 
somewhat loosely into one-stage models and two-stage models. Single-stage 
approaches were developed by Banker and Morey (1986a; 1986b) for non-discretionary 
21 A f1fJD is said to exhibit eRS when a unit increase in inputs yields a proportionate unit increase in 
output. Increasing returns occur if a unit increase in input yields a proportionately larger increase in 
output, and decreasing returns when a unit increase in input yields a proportionately smaller increase in 
output. 
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environmental variables (such as quasi-fixed inputs and / or outputs whose magnitudes 
are temporarily constrained by contractual arrangements), and also for categorical 
environmental variables (such as fonn of ownership, e.g. government, private, etc.). 
The approach to non-discretionary variables is to include them together with the inputs 
and outputs, but to restrict the optimisation to either inputs or outputs. An obvious 
requirement is that the direction of the impact on producer perfonnance of each non-
discretionary variable must be known in advance. The approach to categorical variables 
is to restrict the comparison set to other producers in the same or higher (or the same or 
lower) categories. This of course requires that the categories be nested, and reduces the 
size of the comparison set for most producers, thereby reducing the discriminatory 
power of the model. Both approaches are purely detenninistic, and so are incapable of 
incorporating the effect of statistical noise on producer perfonnance. A more detailed 
commentary on the two single-stage approaches is provided by Cooper et al. (2003). 
The typical two-stage approach follows a first stage DEA exercise based on inputs and 
outputs with a second stage regression analysis seeking to explain variation in first stage 
efficiency scores in terms of a vector of observable environmental variables. Timmer 
(1971) pioneered this approach, and several subsequent studies have improved upon 
Timmer's second stage by using limited dependent variable regression techniques 
(because efficiency scores are bounded, and frequently achieve their upper bound). For 
example McCarty and Yaisawarng (1993) went a step further, by using the second stage 
regression residuals to adjust the first stage efficiency scores. Pastor (1995) suggested a 
novel variation on the two-stage approach by proposing a double DEA fonnat. In the 
first stage he applied either input-oriented DBA to the inputs and environmental 
variables or output-oriented DEA to the outputs and environmental variables. He then 
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replaced either the inputs or the outputs by their radial projections, in order to eliminate 
the effect of the environmental variables. In the second stage he again applied DEA to 
an expanded data set consisting of the originally efficient observations, the originally 
inefficient observations, and the radial projections of the originally inefficient 
observations. A comparison of the second stage efficiency scores of the originally 
inefficient observations with those of the radial projections of the originally inefficient 
observations reveals the impact of the environmental variables on producer 
performance. 
It is also possible to extend the basic two-stage approach, as Fried et al. (1999) have 
done. In their approach an initial DEA evaluation is followed by a second stage tobit 
regression analysis to obtain predictions of the impacts of the environmental variables 
on the first stage performance evaluations. In the third stage, the original data are 
adjusted to account for these environmental impacts, and the DEA evaluation is 
repeated. The virtue of this approach is that the second stage is stochastic. The 
shortcoming of this approach is that the data adjustment accounts for environmental 
impacts, but not for the impact of statistical noise. 
Coelli et al. (1998) recommend the two-stage approach because it has the advantages 
that it can accommodate more than one variable, and continuous and categorical 
variables. It does not make prior assumptions regarding the direction of the influence of 
the categorical variable and it is possible to conduct hypothesis tests to see if the 
variables have a significant influence upon efficiencies. And finally, the method is 
relatively easy to calculate and therefore transparent. 
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3.3 Stochastic frontier analysis 
The following review of stochastic frontier modelling and efficiency measurement is 
brief. The purpose of this section is to provide an introduction to the method. More 
detailed examinations can be found in Kumbhakar and Lovell (2000). It is important to 
recall that Farrell (1957) proposed a measure of the efficiency of a firm that consists of 
two components: technical efficiency, which reflects the ability of a firm to obtain 
maximal output from a given set of inputs, and allocative efficiency, which reflects the 
ability of a firm to use the inputs in optimal proportions, given their respective prices. 
These two measures are then combined to provide a measure of total economic 
efficiency. These efficiency measures assume that the production function of fully 
efficient firms is known. However, because the production function is never known in 
practice, Farrell (1957) suggested that the function be estimated from sample data using 
either a non-parametric piece-wise linear technique or a parametric function, such as the 
Cobb-Douglas form. The first suggestion was taken up by Chames et al. (1978), 
resulting in the development of the DEA approach reviewed above. The latter 
parametric approach was followed up by Aigner et al. (1977), subsequently resulting in 
the development of the stochastic frontier model. 
Aigner and Chu (1968) considered the estimation of a parametric frontier production 
function of Cobb-Douglas form, using data on a sample of N firms. The model is 
defined by: 
In(Yi) = Xif3-Ui i = 1,2, ... , n 
where: 
In(Yi) is the logarithm of the (scalar) output for the i-th firm 
(1.1) 
S2 
Xi is the (K + 1 )-row vector, whose first element is "1" and the remaining elements are 
the logarithms of the K-input quantities used by the i-th finn 
~=(~O'~l' ... , ~K)' is a (K + 1 )-column vector of unknown parameters to be estimated 
Ui is a non-negative random variable, associated with technical inefficiency In 
production of finns in the industry involved. 
The ratio of the observed output for the i-th finn, relative to the potential output, defined 
by the frontier function, given the input vector, Xi. is used to define the technical 
efficiency of the i-th finn: 
TEi = yi = exp(xif3 -w) = exp(-w) 
exp(xif3) exp(xif3) (1.2) 
This measure is an output-orientated Farrell measure of technical efficiency, which 
takes a value between zero and one. It indicates the magnitude of the output of the i-th 
finn relative to the output that could be produced by a fully-efficient finn using the 
same input vector. The technical efficiency, defined by equation (1.2), can be estimated 
by the ratio of the observed output, Yi. to the estimated value of the frontier output, 
N 
exp( Xi~), obtained by estimating ~ using linear programming, where ~ u; is minimised, 
i=1 
subjectto the constraints Ui~O, i=1, 2, ... , N. 
Afriat (1972) specified a model similar to that of equation (1.1), except that the UiS were 
assumed to have a gamma22 distribution and the parameters of the model were estimated 
22 A distribution used for continuous random variables which are constrained to be greater or equal to O. It 
is characterised by two parameters: shape and scale. The gamma distribution is often used to model data 
which are positively skewed (Everitt 1995). 
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using the maximum-likelihood (ML) method23 . Richmond (1974) noted that the 
parameters of Afriat's model could also be estimated using a method that has become 
known as correct least-squares (COLS). This method uses the ordinary least-squares 
(OLS) estimators, which are unbiased for the slope parameters, but the (negatively 
biased) OLS estimator of the intercept parameter, Po, is adjusted up, using the sample 
moments of the error distribution, obtained from the OLS residuals. Schmidt (1976) 
highlighted that the linear and quadratic programming estimators, proposed by Aigner 
and Chu (1968), are ML estimators if the UjS are distributed as exponential or half-
normal random variables, respectively. 
One of the primary criticisms of the above deterministic24 frontier model is that no 
account is taken of the possible influence of measurement errors and other 'noise' upon 
the frontier. All deviations from the frontier are assumed to be the result of technical 
inefficiency. Aigner et al. (1977) and Meeusen and van den Broeck (1977) 
independently proposed the stochastic frontier production function, as the solution of 
the 'noise' problem, in which an additional random error, vi, is added to the non-
negative random variable, Uj, in equation (1.1) to provide: 
In{Yi) = XiP + Vi - Ui , i = 1, ... , n (1.3) 
23 This method is a general method of finding estimated values of parameters. It yields values for the 
unknown parameters, which maximise the probability of obtaining the observed values. The estimation 
process involves considering the observed data values as constants and the parameter to be estimated as a 
variable, and then using differentiation to find the value of the parameter that maximises the likelihood 
function. First a likelihood function is set up which expresses the probability of the observed data as a 
function of the unknown parameters. The ML estimators of these parameters are chosen to be those 
values, which maximise this function. The resulting estimators are those, which agree most closely with 
the observed data. This method works best for large samples, where it tends to produce estimators with 
the smallest possible variance. The ML estimators are often biased in small samples (Everitt 1995). 
24 The term deterministic is used because, in the frontier model of equation (1.1), the observed output Yio 
is bounded above by the non-stochastic, i.e. deterministic quantity exp(xi~)' Thus, the models of Aigner 
and Chu (1968), Afriat (1972) and Schmidt (1976) are examples of deterministic frontiers. 
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The random error, Vi, accounts for measurement error and other random factors, such as 
the epidemics, the effects of weather and strikes on the value of the output variables, 
together with the combined effects of unspecified input variables in the production 
function. Aigner, Lovell and Schmidt (1977) assumed that the ViS were independent and 
identically distributed normal random variables with mean zero and constant variance, 
a/, independent of the UjS, which were assumed to be independent and identically 
distributed exponential or half-normal random variables. 
The model, defined by equation (1.3), is termed the stochastic frontier production 
function because the output values are bounded above by the stochastic (random) 
variable, exp(xi~+Vi). The random error, Vi, can be positive or negative and so the 
stochastic frontier outputs vary about the deterministic part of the frontier model, 
exp(xi~). 
The basic features of the stochastic frontier model are illustrated in Figure 6. The 
input(s) are represented on the horizontal axis and the outputs on the vertical axis. The 
deterministic component of the frontier model, y = exp(x~), is drawn assuming that 
diminishing returns to scale apply. The observed outputs and inputs for two firms, i and 
j, are presented on the graph. The i-th firm uses the level of inputs, Xi. to produce the 
output(s) Yi. The observed input-output value is indicated by the point marked with • 
above the value of Xi. The value of the stochastic frontier output, Yi*=exp(xi~+Vi)' is 
marked by the point X above the production function because the random error, Vi. is 
positive. Similarly, the j-th firm uses the level of inputs, Xj, and produces the output(s}, 
yj. However, the frontier output, yj*=exp(xj~+Vj), is below the production because the 
random error, Vj, is negative. Of course, the stochastic frontier outputs, Yi* and yj*, are 
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not observed because the random errors, Vi and Vj, are not observable. However, the 
deterministic part of the stochastic frontier model is seen to lie between the stochastic 
frontier outputs. 
Figure 6: The stochastic frontier production frontier 
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This stochastic frontier model permits the estimation of standard errors and tests of 
hypotheses using traditional maximum-likelihood methods. 
3.3.1 Maximum likelihood estimation 
The parameters of the stochastic frontier production function, defined by equation (1.3), 
can be estimated using either the ML method or using a variant of the COLS method 
suggested by Richmond (1974). However, Coelli et a1. (1998) state that the ML 
estimator should be given preference to the COLS estimator because it was found to 
perform better in a Monte Carlo experiment (Coelli 1995). 
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Aigner et a1. (1977) derived the log-likelihood function for the model defined by 
equation (1.3), in which the UiS are assumed to be independent and identically 
distributed truncations (at zero) of a N(O, ( 2) random variable, independent of the ViS 
which are assumed to be independent and identically distributed N(O, 0/). Aigner et a1. 
(1977) expressed the likelihood function in terms of the two variance parameters, Os 2=a2 
+ 0/ and f..=o/ov. Battese and Corra (1997) suggested that the parameter, 'Y=a2 10/, be 
used because it has a value between zero and one, whereas the A.-parameter could be any 
non-negative value. 
Battese and Corra (1977) showed that the log-likelihood function, in terms of this 
parameterisation is equal to: 
N N N 1 N 
In(L) = --In(n 12) --log(O';) + ~)n[1-¢(Z;)]--2 L(lny; - X;p)2 (1.4) 
2 2 ;=) 20's ;=) 
where zi = (!ny, - x,p) ~ r ; and "'(.j is the distribution function of the standard 
Oi 1-y 
normal random variable. 
The ML estimates of p, os2and 'Y are obtained by finding the maximum of the log-
likelihood function, defined in equation (1.4). The ML estimators are consistent and 
asyrnptomatically efficient (Aigner et a1. 1977). 
The computer programme, Frontier Version 4.1 (Coelli 1996b), can be used to obtain 
the ML estimates for the parameters of this mode12s• The programme follows a three-
step estimation procedure: 
25 If starting values are specified in the instruction file. the programme will skip the first two steps of the 
procedure. 
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1. The first step involves calculating the OLS estimators of ~ and 0/. These are 
unbiased estimators of the parameters in equation (1.3), with the exception of the 
intercept, ~o and 0/; 
2. In the second step, the likelihood function is evaluated for a number of y between 
zero and one (this is referred to a 'grid search'). In these calculations, the OLS 
estimates of ~o and os2 are adjusted according to the corrected ordinary least squares 
formula presented in Coelli (1995). The OLS estimates are used for the remaining 
parameters in ~; 
3. The final step uses the best estimates (that is, those corresponding to the largest log-
likelihood value) from the second step as starting values in a Davidon-Flectcher-
Powell iterative maximisation routine which obtains the ML estimates when the 
likelihood function attains its global maximum. 
3.3.2 Alternative functional forms 
The model presented dealt with the case of the half-normal distribution for the technical 
inefficiency effects, because it has been most frequently assumed in empirical 
applications (Coelli et al. 1998). Its simplicity is an attractive feature. A logarithmic 
transformation provides a model which is linear in the logarithms of the inputs and, 
hence, the Cobb-Douglas form is easy to estimate. However, a common criticism of the 
stochastic frontier method is that there is no a priori justification for the selection of any 
particular distributional form for the technical inefficiency effects, Uj. The half-normal 
distribution is an arbitrary selection. As this distribution has a mode at zero, it implies 
that there is the highest probability that the inefficiency effects are in the neighbourhood 
of zero. This, in turn, implies relatively high technical efficiency. In practice, it may be 
possible to have a few very efficient firms, but a lot of quite inefficient firms. 
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A few researchers have attempted to address this criticism by specifying a more general 
distribution form, such as the truncated-normal (Stevenson 1980) distribution for the 
technical inefficiency effects. The truncated normal distribution is a generalisation of 
the half-normal distribution. It is obtained by the truncation at zero of the normal 
distribution with mean, J.l, and variance, (J2. If J.l is pre-assigned to be zero, then the 
distribution is the half-normal. 
A translog26 production frontier assuming a truncated normal distribution 
In(Yi) = xifi + Vi - Ui , i = 1, ... , n (1.6) 
where: 
In(yj), Xj, f3 and Vj are as defined above, and Uj has truncated normal distribution. 
3.3.3 Tests of hypotheses 
For the frontier model defined by equation (1.3), the null hypothesis that there are no 
technical inefficiency effects in the model, can be conducted by testing the null and 
alternative, Ho: (J2=0 versus HI: ~>0.z7 This hypothesis can be tested using a number 
of different statistical tests. The Wald statistic involves the ratio of the ML estimator 
for (J2 to its estimated standard error. This statistic, or a slight variant of it, has been 
explicitly or implicitly conducted in almost every empirical analysis involving the 
stochastic frontier model since the first application by Aigner et al. (1977) (Coelli et al. 
1998). In many cases one of the equivalent sets of hypotheses, Ho: A=O versus HI: "->1, 
or Ho:y=O versus HI :y>O, is considered depending upon the parameterisation used in the 
26 The transcendental logarithmic function allows a wide range of non-linear models to be expressed in 
linear form. It includes the logarithm of every explanatory variable, as well as their products and cross-
r,roducts (Coelli et a1.1998). 
7 ci is the variance of the normal distribution which is truncated at zero to obtain the distribution of Uj. If 
this variance is zero, then all the UjS are zero, implying that all firms are fully efficient. 
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estimation of the stochastic frontier model. In this thesis, the Battese and Corra (1977) 
parameterisation is adopted, thus the hypotheses involving y are considered. 
For the Wald test, the ratio of the estimates for y to its estimated standard error is 
calculated. If Ho:y=O is true, this statistic is asymptotically distributed as a standard 
normal random variable. The test must be performed as a one-sided test because y 
cannot take negative values. However Coelli (1995) suggested that the one-sided 
generalised likelihood-ratio test should be performed when ML estimation is involved. 
This is because the Wald test has very poor size (i.e. probability of a Type I error) 
properties, whereas the one-sided generalised likelihood-ratio test has the correct size 
properties (Coelli 1995). 
The generalised likelihood-ratio test requires the estimation of the model under both the 
null and alternate hypotheses. Under the null hypothesis, Ho:Y=O, the model is 
equivalent to the traditional average response function, without the technical 
inefficiency effect, Uj. The test statistic is calculated as: 
LR = -2{ln[I(H 0)/ L(HI)]} = -2{ln[L(H 0)] -In[L(HI)]} (1.5) 
where L(Ho) and L(HI) are the values of the likelihood function under the null and 
alternative hypotheses Ho and HI respectively. 
If Ho is true, this test statistic is usually assumed to be asymptotically distributed as a 
chi-squared random variable with degrees of freedom equal to the number of restrictions 
involved (in this instance one). The calculation of the critical value of this one-sided 
generalised likelihood-ratio test of Ho:y=O versus HI :y>O is as follows. The critical 
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value of a test of size a is equal to the value x/ (2a), where this is the value which is 
exceeded by the X\2 random variable with probability equal to 2a. Thus the one-sided 
generalised likelihood-ratio (LR) test of size a is: "Reject Ho:y=O in favour ofH\:r>O if 
LR exceeds X\2 (2a)". Thus the critical value for a test of size u=O.05 is 2.71 rather than 
3.84 (Coelli et al. 1998) 
The one-sided likelihood test to test the null hypothesis that there are no technical 
inefficiency effects in the half-normal model can be extended for use in the truncated-
normal model. If the null hypothesis, that there are no technical inefficiency effects in 
the model, is true, then the generalised likelihood-ratio statistic is asymptotically 
distributed as a mixture of chi-square distributions. The crucial value for this mixed 
chi-square distribution is 5.138 for a 5% level of significance. 
3.3.4 Adjusting for the environment 
A number of empirical studies (e.g. Pitt and Lee 1981) have estimated stochastic 
frontiers and predicted firm-level efficiencies using these estimated functions, and then 
regressed the predicted efficiencies upon firm-specific variables (such as managerial 
experience and ownership characteristics) in an attempt to identify some of the reasons 
for differences in predicted efficiencies between firms in an industry. This has long 
been recognised as a useful exercise, but the two-stage estimation procedure has also 
been considered to be one which is inconsistent in it's assumptions regarding the 
independence of the inefficiency effects in the two estimation stages. The two-stage 
estimation procedure is unlikely to provide estimates which are as efficient as those that 
could be obtained using a single-stage estimation procedure. 
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3.4 Dimensionality and sample size considerations 
An issue in the choice of approach is sample size. One of the most problematic issues 
in DEA is the specification of the inputs and outputs to be included in the analysis. 
Careful reflection on the production process is usually sufficient to identify the main 
dimensions. The omission of variables may have an adverse effect on the efficiency 
estimates, but the number of variables cannot be increased without constraint. 
Increasing the number of dimensions used in the characterisation of production reduces 
the discriminatory power of the analysis, increasing measured efficiency and the 
number of firms identified as fully efficient (Coelli et aI. 1998). DEA is therefore 
subject to an effect analogous to the loss of degrees of freedom in econometric analysis. 
The relationship between the number of dimensions in the DEA problem and the 
discriminatory power of the analysis arises because of the flexibility in the weights used 
in making efficiency comparisons. DEA adopts the weights for each firm that maximise 
each firm's relative performance. As the number of dimensions is increased, the 
opportunity to differentiate one firm from the others also increases. A firm may 
therefore be deemed efficient, because of the lack of comparator observations. Such 
differentiated firms will be judged efficient, but will rarely be identified as a peer 
observation of other firms in the sample 
Thus, a simple method suggested for identifying the loss of discriminatory power in 
DEA is to count the number of firms for which each efficient observation is identified 
as a peer. Boussofiane et al. (1991) argue that the minimum number of firms identified 
as efficient increases with the number of dimensions and will be approximately equal to 
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the product of the number of inputs and outputs included, identifying the minimum 
sample size required for the analysis. 
Rules of thumb commonly used with DEA suggest that the number of observations in 
the data set should be at least two to three times the sum of the number of input and 
output variables (Drake and Howcroft 1994; Cooper et a1. 2003). There is an alternative 
expression by Dyson et al (2001), which states that the number of observations should 
be at least twice the product of the number of inputs and outputs. Avkiran (2002) 
suggests a further rule of thumb, which states that a sample is large enough if the 
number of fully efficient firms does not exceed one third of the sample. Thus, it is 
important to note that where a sample is small, it is possible that a high proportion of 
firms will be classed as efficient, some of which would not otherwise be considered 
efficient if a larger sample was used. Reducing the sample size will tend to inflate the 
average efficiency score as it creates fewer comparable organisations and improves the 
likelihood of any entity being placed on the frontier 'by default'. 
Nevertheless, non-parametric methods are preferable for studies with small sample sizes 
because parametric methods are based on econometric techniques. Employing 
econometric methods on a small sample may not correctly separate random noise from 
inefficiency, which is one of the main advantages of SF A over DEA. Because SF A is 
based on regression methods, it requires a minimum sample size (usually at least, 30) to 
get significant results (Altman 1991). 
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In conclusion, it is difficult to define a clear-cut sample size below which inferences 
become problematic as this will ultimately depend on the quality and nature of the data, 
the number of explanatory variables and the estimation procedure being followed. 
3.5 Strengths and weaknesses of both approaches 
The following are the main strengths of DEA (Charnes et a1. 1995; Coelli et a1. 1998; 
Cooper et a1. 2003; Fried et a1. 1993): 
• it gives a measure of efficiency that is empirically obtainable in a given scenario 
(e.g. given available resources and institutional set-up), as firms are directly 
compared against a peer or combination of peers. Hence one can compare the 
efficiency of individual facilities against realistic benchmarks; 
• DEA does not impose a specified functional form to model and calculate the efficiency 
of a firm. Therefore, unlike the stochastic frontier models, DEA has the advantage of 
having few assumptions about the shape or form of the production and cost frontiers 
(which can cause model mis-specification and hence misleading results), as well as 
the distribution of the error terms; 
• DEA accommodates mUltiple inputs and outputs in a single measure of efficiency, and 
can address efficiency issues directly instead of using average relationships. 
Consequently, DEA can pinpoint inefficient health care facilities from large 
samples, and indicate the extent of cost savings and efficiency gains from a shift to 
efficient production. 
However, there have also been criticisms levied against this technique. Coelli et a1. 
(1998) note the following limitations or possible problems, of DEA (which 
paradoxically are often the same characteristics that make DEA a useful tool): 
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• measurement error, outliers and other 'noise' may influence the shape and position 
of the frontier, and therefore influence the results; 
• when few observations and many inputs and / or outputs are included many of the 
firms will appear on the DEA frontier Equally, the exclusion of an important input 
or output can result in biased results; 
• the addition of an extra firm in a DEA cannot result in an increase in the TE scores 
of the existing firms. Similarly, the addition of an extra input or output in a DEA 
model cannot result in a reduction in the TE scores; 
• the efficiency scores obtained are only relative to the best firms in the sample. The 
inclusion of extra firms may reduce efficiency scores; 
• comparing the mean efficiency scores from two studies only reflects the dispersion 
of efficiencies of one sample relative to the other; 
• treating inputs and / or outputs as homogenous commodities when they are 
heterogeneous may bias results; 
• not accounting for environmental differences may give misleading indications of 
relative managerial competence. 
To this list can be added: 
• DEA is good at estimating 'relative' efficiency of a firm but it converges very 
slowly to 'absolute' efficiency (Cooper et al. 2003). In other words, it identifies 
how well a firm is performing in comparison to its peers but not compared to a 
'theoretical maximum'; 
• because it gives a relative measure of efficiency it has the potential of justifying 
inefficiency, i.e. even those that appear to be efficient in the sample might actually be 
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inefficient in absolute tenns (in the engineering sense) (Hollingsworth et al. 1999). 
This problem can, however, be minimised by using a large sample and data set; 
• it is not prescriptive in what to do about inefficiencies, it only suggests where costs 
can be saved without reducing output (Shennan 1984). This is because the measure 
of inefficiency is based on the most efficient health facility in the group, which may 
itselfbe inefficient; 
• because DBA is a non-parametric technique, statistical hypothesis tests are difficult to 
perform Fried et al. (1993). 
The stochastic frontier model also, however, has problems. The main criticism is that 
there is generally no a priori justification for the selection of any particular 
distributional form for the UjS. Of the list of possible pitfalls in DBA presented above, 
most are applicable, in varying degrees, to SF A. In addition, SF A has a few specific 
problems of its own (Coelli et al. 1998; Kumbhakar and Lovell 2000), namely: 
• the selection of a distributional form for the inefficiency effects is arbitrary. 
Therefore general distributions, such as the truncated-normal, are considered best; 
• the stochastic frontier approach is only well-developed for single-output 
technologies, unless it is possible to aggregate output into a single measure. 
However, stochastic frontiers also have some advantages relative to DBA (Coelli et al. 
1998; Kumbhakar and Lovell 2000): 
• DBA assumes all deviations from the frontier are due to inefficiency. If any 'noise' 
is present, e.g. due to measurement error, weather, strikes or epidemics, then this 
may influence the placement of the DBA frontier (and hence the measurement of 
efficiencies) more than would be the case with the stochastic frontier approach; 
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• statistical tests of hypotheses regarding the existence of inefficiency and also 
regarding the structure of the production technology can be perfonned in a SF A. 
Therefore, on balance, Coelli et al. (1998) believe SF A is likely to be more appropriate 
than DEA where data are heavily influenced by measurement error. However, in the 
non-profit service sector, where: 
• random influences are less of an issue; 
• multiple-output production is important; 
• prices are difficult to define; 
• behavioural assumptions, such as cost minimisation, are difficult to justify, 
the DEA approach may often be the optimal choice. But ultimately, the selection of the 
appropriate method should be made on a case-by-case basis. 
3.6 Issues in the measurement of efficiency in the production of health services 
In this section, some of the methodological difficulties involved in efficiency analyses 
are reviewed including adjusting for case mix; allowing for variation in technical 
quality; and knowledge of input prices. 
3.6.1 Efficiency and case mix 
Case mix is an important, yet hard to define, concept through which researchers attempt 
to define output. Available definitions involve some or all of the following terms: 
facilities (or services) available; intermediate and final services provided; complexity of 
the cases treated; and patient characteristics (for example, age and gender)28. 
Everything else being constant, it would be expected that efficient providers dealing 
28 Health related groups (HRGs) and diagnostic related groups (DRGs) are examples of systems 
developed to better reflect case mix. 
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with different case mix to use different levels of inputs. For example, a facility with a 
greater proportion of complex cases should be expected to use more resources in 
providing health services to care for those cases, than an otherwise identical facility 
treating a set of patients with fewer severe cases. 
Unless case mIX IS considered, comparative studies of technical and allocative 
efficiency among several providers are likely to be misleading and wrong. To illustrate 
this point, consider in Figure 7 the case of two providers, A and B, with B treating high 
severity patients, such as children with severe dehydration from diarrhoea, and A 
treating low severity patients, like children with mild dehydration from diarrhoea. Note, 
the number of children treated by providers A and B are assumed to be identical. 
Figure 7: Case mix and efficiency 
o Xal Xa2 
output=Q 
quality = H 
severity = high 
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A quality=H 
severity = low 
Xa 
Highly dehydrated children may need to remain hospitalised for several days, often 
receive intravenous feeding and rehydration, and require close attention by the facility 
staff. Children with mild dehydration on the other hand, can be sent home with 
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instructions to the parents on using oral rehydration salts and the appropriate treatment 
for diarrhoea. 
Suppose that provider A perfonned at point I to treat high severity cases while provider 
B perfonned at point 2 to treat milder cases. If case severity was not considered, the 
uninfonned researcher would wrongly conclude that provider A, the one with the lowest 
input use, is the more technically and allocatively efficient. If case mix were 
considered, however, the researcher would observe that the provider consuming the 
greatest amount of resources also happens to treat the most severe cases. Without 
further analysis, definitive statements about relative efficiency could not be made. 
3.6.2 Efficiency and quality of care 
Just as differences in case mix can obscure comparisons between technical and 
allocative efficiency among providers, so too can differences in the technical quality of 
care provided. 
Figure 8: Technical quality of care and efficiency 
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Different levels of quality for example, often consume different levels of production 
inputs. Thus, failure to control for differences in quality may ascribe higher efficiency 
to lower-quality producers and vice versa. To illustrate this point, consider the two 
providers in Figure 8, C and D, each capable of producing the same volume of output 
(e.g. Q ambulatory visits) according to their respective isoquants. While both providers 
operate at the same output level, they provide different technical quality care: provider 
C is assumed to provide care of lower technical quality, HI, while provider D provides 
care of a higher technical quality, H2. 
Suppose that provider C performs at point I and provider D performs at point 2. If an 
analyst attempting to compare technical and allocative efficiency between the two 
providers did not take into account their differences in technical quality, slbe would 
reach the conclusion that provider C is technically and allocatively more efficient than 
D. This would arise from the fact that provider C uses fewer production inputs than D 
(Xal and Xbl versus Xa2 and Xb2, respectively) and, as a consequence, provider C 
produces the level of output Q at a lower total cost than D. This conclusion however, 
would be incorrect. An appropriate comparison of efficiency is one which, at any given 
level of output, relates technical quality to input use. The analyst should therefore 
establish a relationship between HI and (Xal, Xbl) for provider C and compare it with 
the equivalent relationship between H2 and (Xa2, Xb2) for the provider D. 
Contrary to what is suggested by isoquants C and D in Figure 8, higher technical quality 
does not necessarily imply greater use of inputs. Although it is assumed that technical 
quality is higher along the isoquant D than along C, and also that resource use is greater 
for D. This does not necessarily have to be the case for all situations, for example, 
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consider production of quantity Q according to F. Provider F's technical quality could 
be higher than C's, with F using smaller quantities of inputs when both providers 
operate at the far right of their isoquants (that is, production that is intensive in resource 
Xa). Alternatively, the technical quality of provider E could be greater than that of C at 
all points, yet with E consuming fewer inputs than C and thus being technically and 
allocatively more efficient. 
3.6.3 Allocative efficiency and input prices 
Depending on a variety of circumstances such as the incentives, constraints, and 
information available to health facility managers, some providers may operate in a 
technically efficient, yet allocatively inefficient manner. For example, in the case of 
production input prices, allocative inefficiency arises when production occurs at a point 
that is not cost minimising. This can happen because facility managers either do not 
know their input prices or in spite of knowing the prices they fail to minimise their costs 
for a number of other reasons. 
To distinguish between those two cases, consider the example of two providers 
operating at points 1 and 2 in Figure 9, each producing output level Q according to the 
same isoquant. Assume also that the two providers pay the same prices for their 
production inputs, Xa and Xb. Under those circumstances, provider 1 would be the most 
allocatively efficient of the two because the production cost would be BI, lower than B2. 
If an analyst wanting to study the allocative efficiency for these providers knew that 
both face the same input prices, s/he would not need to measure those prices at all to 
rightly conclude that 1 is more economically efficient than 2. 
Figure 9: Allocative efficiency and input prices 
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Suppose, instead, that providers 1 and 2 face different input prices. Unless the analyst 
knew exactly what those sets of prices were, s/he would be unable to make any 
statements about the providers' relative allocative efficiency. For example, although 
both providers could be cost minimisers, given the different prices that they face, they 
could also operate at different points along the production frontier. Alternatively, both 
could operate at points that are not cost minimizing. Thus, in order to ascertain relative 
allocative efficiency, both knowledge and the use of price information would be 
essential. 
3.7 Summary 
• In 1957 Farrell defined a measure of firm efficiency which could account for 
multiple inputs. He suggested the use of either a non-parametric piece-wise linear 
convex isoquant constructed such that no observed point lies to the left or below it, 
or a parametric function fitted to the data, to estimate the efficient isoquants from 
sample data; 
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• Chames et al. (1978) were the first to pursue the piece-wise-linear convex hull 
approach to frontier estimation proposed by Farrell (1957), resulting in the 
development of DEA; 
• Aigner et al. (1977) pursued the use of a parametric function proposed by Farrell 
(1957), resulting in the development of SF A; 
• Thus, there are two main alternative empirical approaches for estimating the 
production frontier that are distinguished by whether they are parametric (SF A) or 
not (DEA), and whether they are deterministic (DEA) or stochastic (SFA). 
Parametric methods assume a specific functional form for the frontier, whereas non-
parametric methods do not; and deterministic methods assume that the distance of a 
unit from its frontier is a result of inefficiency whereas stochastic methods assume 
that this is also partially due to random error; 
• Given the limitations of frontier techniques at present it may be that they are best 
employed in tandem, when possible, and if different methods suggest similar 
directions for results then the validity of such findings is enhanced. 
The next chapter reviews the use of these two parametric and non-parametric frontier 
efficiency measurement techniques to obtain data on the efficiency of health care 
services / systems. 
Chapter 4 
A REVIEW OF FRONTIER EFFICIENCY MEASUREMENT 
TECHNIQUES IN HEALTH CARE SERVICES IN LOW- AND 
MIDDLE-INCOME COUNTRIES 
In this Chapter, the evidence-base on the efficiency of health care services in low- and 
middle-income countries is reviewed. The review focuses exclusively on the use of 
parametric and non-parametric frontier efficiency measurement techniques in health 
care services / systems. 
4.1 Introduction 
Health care costs in most developed economies have grown dramatically over the last 
few decades, and it is widely believed that the inefficiency of health care institutions, 
has, at least in part, contributed to this phenomenon (e.g. Worthington 2004). In 
response, there has emerged, in recent years, a growing body of literature on the 
efficiency of health care services in industrialised countries, particularly in the US 
(Hollingsworth 2003). 
Unfortunately, there has not been a similar focus on efficiency in the production of 
health care services in less-developed economies. This is particularly disappointing 
given the developing world's greater scarcity of financial resources such that the 
inefficient use of scarce resources exacting a much higher penalty in terms of foregone 
health benefits. Productivity and efficiency improvements are thus critical, given 
resource constraints faced by the health sector in many developing countries. 
Improving the efficiency of health services in developed and developing countries 
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should be a major goal of public, private and non-profit providers alike. Knowledge of 
the levels and determinants of health services' efficiency can help policy-makers and 
health care managers take measures aimed at curtailing costs while maintaining 
acceptable levels of quality and access. However, there are methodological problems 
that make the measurement of both health services' productivity and efficiency 
challenging. 
Methods for measuring the efficiency of providing health services were described in 
Chapter 3. Briefly, therefore, frontier methods entail the estimation of an efficiency 
frontier or envelopment surface from observed sample data, based upon best 
performance within the sample. Measurement of the deviation of individual production 
units from this frontier allows the calculation of relative efficiency scores, and the 
computation of potential efficiency gains if units could achieve best performance levels. 
There are two major features that distinguish alternative empirical approaches for 
forming the frontier and measuring efficiency and productivity: whether they are 
parametric or not, and whether they are deterministic or stochastic. Parametric methods 
assume a specific functional form for the frontier, whereas non-parametric methods do 
not. Deterministic methods assume that the distance of a unit from its frontier is a result 
of inefficiency whereas stochastic methods assume that some of this is due to random 
error. DBA is a non-parametric, deterministic method, while SF A is a parametric, 
stochastic method. 
In order to assess whether, and the extent to which, productivity and / or efficiency has 
varied over time, the Malmquist index can be used. The Malmquist index is the mean 
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of two indices, measuring the change in efficiency from one time period to the next, 
allowing a breakdown of efficiency changes over time29. 
4.2 Aim and objectives 
The overall aim of this chapter is to identify applications of parametric and non-
parametric measurement techniques of health service efficiency to low- and middle-
income countries or regions. Studies were appraised with a view to determining: the 
methods and data used; models specified; and sensitivity analysis employed in order to 
better inform the subsequent parametric and non-parametric analyses in Chapters 7 and 
9. The studies' results and policy implications are summarised in order to place the 
findings from Chapter 7 and 9 in a broader context. 
4.3 Methods 
4.3.1 Definition of low- and middle-income countries 
This review has used the World Bank's classification of economies, which uses gross 
national income (GNI) per capita as its main criterion. Based on its GNI per capita, 
every economy is classified as low-income, middle-income (subdivided into lower-
middle and upper-middle), or high-income. Low- and middle-income economies are 
sometimes referred to as developing economies (World Bank 2005a). Economies are 
divided according to 2004 GNI per capita, calculated using the World Bank Atlas 
method. The groups are: low-income, $825 or lessJO; lower-middle-income, $826-
3,255; upper-middle-income, $3,256-10,065; and high-income, $lO,066 or more. 
29 See Hollingsworth et al. (1999) for further details. 
30 Bangladesh, with a ONI per capita of $430 in 2004 is a low-income country. 
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4.3.2 Search strategy 
Studies were sought for the period 1983 (the year noted by Hollingsworth (2003) in 
which the first application of a frontier efficiency measurement technique was 
published) up to and including September 2005. The following databases were 
searched: EconLit, Medline and Web of Science (Science Citation Index and Social 
Science Index). Keywords and MeSH terms included were: "efficien*", "producti*", 
"health care", "data envelopment analysis", "DEA", "stochastic frontier analysis", 
"SF A" and "Malmquist". A free text search in Google using the same keywords and 
"similar pages" was also performed. The references of key studies were examined. 
Key journals were hand-searched (e.g. the Journal of Medical Systems and the 
International Journal of Operations and Production). A message was posted on the 
DEA and Health Economic list-servers requesting additional studies. Finally, 
researchers known to be active in this area were contacted (e.g. Emrouznejad, 
Hollingsworth, Kirigia, Ozcan and Sambo). Editorials and letters were excluded and 
the search was limited to English-language research covering developing countries and 
regions. Thus two Spanish-language studies were excluded (Penaloze Ramos 2003; 
Pinzon Martinez 2003). 
4.4 Results 
4.4.1 General characteristics 
While Hollingsworth (2003) notes that the earliest application of a parametric or non-
parametric frontier efficiency measurement technique was published in 1983 
(Nunamaker 1983), a study from a low- and middle-income setting was not published 
until 1997 (Ersoy et al. 1997). However, since then, 23 additional studies have been 
published (Table 1). Of these 24 studies, 21 are intra-country analyses, of which 16 
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have used DEA, four SFA and one has compared both techniques. The study by AI-
Sharnrnari (1999) was re-visited by Sarkis and TaBuri (2002). Evans et al. (2001) used 
econometric methods to analyse the efficiency of national health systems. These results 
were re-visited by Gravelle et al. (2003) and Hollingsworth and Wildman (2003) using 
parametric and non-parametric techniques. Thus, three studies compared inter-country 
variation in efficiency. 
Five out of six World Bank regions were represented among the 21 intra-country 
studies, although only ten countries were represented (Table 1 )31. Twenty of the studies 
were published in peer-reviewed journals, of which four were published in the Journal 
of Medical Systems and two in the International Journal of Operations and Production. 
Of the remaining studies, two were book chapters, one was a paper from the African 
Econometric Society's 10th Annual Conference of Econometric Modelling in Africa and 
one was a working paper. Six authors had co-authored two or more of the papers: 
Kirigia=4; Sambo=3; Valdmanis=3; Ernrouznejad=2; Ozcan=2; and Walker=2. 
31 Including the Spanish language reports by Pinzon Martinez (2003) and Penaloza Ramos (2003), both of 
which were based in Colombia, would have ensured all six World Bank regions were represented. 
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Table 1: Summary of frontier measurement studies 
Reference Country I Topic Number of Method(s) Software used Time period Mean efficiency scores 
region units 
Al-Shammari Jordan Public hospitals 15 DEA LINDO 1991-93 91: 0.867 
(1999) 92: 0.937 
93: 0.977 
Bhatetal. India Public & grant-in~ 20 and 21 DEA NS 2000 Public: 0.85 
(2001) aid hospitals Grant-in-aid: 0.89 
Chakrabati & Rao India States 14 SFA Frontier 4.1 1986-95 Mean: 0.692 
(in press) 
Dervaux et al. Bangladesh Public and NGO 117 DEA NS 1999 46 (40%) vaccination delivery 
(2003) vaccination units operated with non-optimal 
delivery units scheduling of sessions 
Ersoyetal. Turkey Acute general 573 DEA Integrated DEA 1994 519 (91%) hospitals were 
(1997) hospitals System Version 5.1 inefficient 
Evans etal. Global National health 191 SFA NS 1993-97 Range: 0.08 - 0.992 
(2001) systems 
Gravelle et al. Global National health 191 SFA NS 1993-97 Country rankings and efficiency 
(2003) systems scores are sensitive to the 
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definition of efficiency and choice 
of model specification 
Hollingsworth & Global National health 191 Malmquist, NS 1993-97 DEA: 0.89 (0.49 - 1.00) 
Wildman (2003) systems DEA&SFA SF A: 0.84 (min = 0.52) 
Jacques & Koch South Africa Public hospitals 15 DEA Frontier Analysis 1999-04 NS 
(2005) 
Kathuria & Sankar India States 16 SFA NS 1986-97 Fixed effects models: 0.69-1.00 
(2005) Random effects model: 0.73-1.00 
ML effects model: 0.72-1.00 
Kirigia et al. South Africa Provincial 55 DEA DEAP 2.1 1995-96 Mean TE: 0.906 
(2000) hospitals Mean SE: 0.953 
Kirigia et al. South Africa Public primary 155 DEA EMS Data 1995-96 108 (70%) health centres were 
(2001) health care clinics Envelopment Software inefficient 
Kirigia et al. Kenya Public hospitals 54 DEA DEAP 2.1 NS Mean TE: 0.84 
(2002) Mean SE: 0.9 
Kirigia et al. Kenya Public primary 32 DEA DEAP 2.1 NS 18 and 13 health centres were 
(2004) health care clinics technically scale inefficient 
respectively 
Masiye et al. Zambia Public hospitals 20 DEA OnFront 1997 Mean: 0.64 
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(2002) 
Oseietal. Ghana Public district 17 and 17 DEA DEAP 2.1 2000 8 (47%) hospitals were technically 
(2005) hospitals & health inefficient with a mean TE score of 
centres 0.61. 10 (59%) hospitals were 
scale inefficient with a mean SE 
score of 0.81. 3 (18%) health 
centres were technically inefficient 
with a mean TE score of 0.49. 8 
(47%) were scale inefficient with a 
mean SE score of 0.84. 
Owino & Korir Kenya Public provincial, 4,22 and 10 SFA Frontier 4.1 1994-96 Mean: 0.70 
(1997) district and sub-
district hospitals 
Pavananunt Thailand Public community 662 SFA SPSS 1996-00 Mean: 0.55 
(2004) hospitals 
Ramanathan et al. Botswana Health districts & 22 and 13 DEA /SFA DEAP 2.1 / Frontier 4.1 1997 3 (14%) districts and 1 (8%) 
(2003) district hospitals district hospital were inefficient 
Sabin & Ozcan Turkey Public hospitals 80 DEA IDEAS 1996 55% of the public hospitals were 
(2000) inefficient 
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Sarkis & Talluri Jordan Public hospitals 15 DEA NS 1991-93 1991 range: 0.34-1.00 
(2002) 1992 range: 0.42-1.00 
1993 range: 0.52-1.00 
Valdmanis et al. Bangladesh Vaccination 117 DEA DEAP 2.1 1999 TECRS: 0.33 
(2003) delivery units TE VRS: 0.50 
Scale: 0.64 
Valdmanis et at. Thailand Public general 68 DEA OnFront 1999 Possible increases in capacity 
(2004) hospitals utilisation amounted to 5% of 
capacity 
Zereetal. South Africa Non-specific 86 DEAl DEAP 2.1 1992-93 Mean: 0.74 
(2001) hospitals Malmquist 1992-97 
NS: not stated; DEA: data envelopment analysis; SE: scale efficiency; SF A: stochastic frontier analysis; TE: technical efficiency 
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4.4.1 Methodological characteristics 
Tables 2 and 3 summarise the methods used by the 17 DEA studies and 5 SF A 
applications respectively. 
4.4.1.1 Software used32 
For the 17 DEAs, the following software packages were used: DEAP 2.1 (n=7), 
OnFront (n=2), EMS Data Envelopment Software (n=I), Frontier Analysis (n=I), 
Integrated Data Envelopment Analysis System Version 5.1 (n=I), LINDO (n=I), 
IDEAS (n=I) and the package was not specified on five occasions. Frontier 4.1 (n=3) 
and SPSS (n=I) were used for the SFAs. One SFA failed to specify the software used. 
4.4.1.2 Number and type of units 
The unit of analysis ranged from vaccination delivery units to national health systems, 
encompassing every level of health care. More specifically, 14 applications are of 
hospitals, five of primary health care centres, of which two were of vaccination delivery 
units. In addition, two studies analysed administrative units, e.g. states and provinces. 
All the units of analysis were public, with the exception of one study which compared 
the efficiency of public and private-not-for-profit vaccination delivery units. Excluding 
the health system analyses, the mean number of health facility units examined in the 
papers reviewed was 94 with a range of 13-573. 
4.4.1.3 Number and type of inputs 
The typical inputs were: different types of personnel (e.g. doctors, nurses, other health 
staff and administrative staff), different types of capital items (e.g. size of the facility, 
32 See Appendix 4 for a review of the different parametric and non-parametric efficiency measurement 
software available. 
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beds, equipment and vehicles) and different types of recurrent items (e.g. drugs, 
vaccines and miscellaneous expenditure). The selection of the inputs was rarely 
justified. The mean number of inputs was six and ranged from 1-14. 
4.4.1.4 Number and type of outputs 
The typical outputs were admissions and OPD visits, which were broken down by type 
to varying degrees, e.g. general medical admissions, paediatric admissions, maternity 
admissions, dental care visits, OPD visits for 'poor' patients and OPD visits for 'rich' 
patients. While most studies simply used a count of hospital admissions, one study 
adjusted inpatient cases with an average DRG weighting. As illustrated in Chapter 3, 
SF A is only well-developed for single-output technologies, unless it is considered 
acceptable to aggregate output into a single summary measure. Interestingly, one study 
aggregated output by using the unit costs of the outputs as the weights, while another 
study ran 15 SF As, i.e. an analysis for each of the outputs identified. With the 
exception of two of the SF As, which used infant mortality rates, none of the intra-
country studies used health outcomes as outputs. The selection of the outputs was 
rarely justified. The mean number of outputs was five and ranged from 1-14. 
It is not good practice to rely on a single technique or model specification to test 
robustness of results which may influence policy. To guard against incorrect inferences 
being drawn, it is essential that models are subject to extensive sensitivity analysis 
(Gravelle et al. 2003). Unfortunately, many of the studies reviewed failed to subject 
their data to sensitivity analysis. 
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Table 2: Methodological summary of the DEA studies 
Reference Model(s) Inputs Outputs 
Al-Sbammari 
(1999) 
1 input- and output-oriented VRS 
specification 
3: bed days, physicians, other health personnel 3: patient days, minor operations, major 
operations 
Dhat et al. (2001) 8 input- and output-oriented CRS 14: physical infrastructure index, equipment index, 
beds, expenditure on drugs, maintenance expenditure, 
specialized infrastructure, specialized equipment, OPO 
hours per week, laboratory hours per week, doctors, 
5: medico legal cases, laboratory cases, 
inpatients cases, OPO cases, maternal and child 
health cases 
Dervaux et a1. 
(2003) 
Ersoyetal. 
(1997) 
Jacques & Koch 
(2005) 
Kirigia et a1. 
(2000) 
specifications 
nurses, paramedical staff, administrative staff, non-
technical staff 
2 output-oriented VRS 5: vaccine wastage, full-time equivalent staff, size of the 5: OPT, lB, polio, measles and IT vaccines 
specifications facility, hours of operation and the number of sessions administered 
1 input-oriented CRS specification 3: beds, primary care physicians, specialists 3: inpatient discharges, outpatient visits and 
surgical operations 
NS 3: beds, nurses, doctors 3: inpatients days, surgeries, outpatient visits 
1 input-oriented VRS specification 9: doctors, nurses, paramedics, technicians, 
administrative staff, general staff, labour provisioning 
staff, other staff, beds 
NS 
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Kirigia et al. 
(2001) 
Kirigia et al. 
(2002) 
Kirigia et al. 
(2004) 
Masiye et al. 
(2002) 
Osei et al. (2005) 
I input- and output-oriented VRS 
specification 
I input- and output-oriented VRS 
specification 
1 input- and output-oriented VRS 
specification 
2: nursing staff, general staff 
12: medical officers / pharmacists I dentists, clinic 
officers, nurses, administrative staff, technicians I 
technologists, other staff, subordinate staff, 
pharmaceuticals, non-pharmaceutical supplies, 
maintenance of equipment, vehicles, and buildings, and 
food and rations 
6: clinical officers, other health staff, administrative 
staff, non-wage expenditure, beds 
2 input-oriented VRS specifications 6: total expenditure, non-labour expenditure, doctors, 
other personnel, wages of doctors, wages of other 
personnel 
I input-oriented and I output- 4 for the hospital analysis: medical officers, technical 
oriented, both under VRS, officers, support staff and beds 
specification used for hospitals and 2 for the health centre analysis: technical staff, support 
8: antenatal visits, births, child health, dental 
care visits, family planning visits, psychiatry 
visits, STI visits, TB visits 
7: OPD casualty visits, special clinic visits, 
MCHlFP visits, dental care visits, general 
medical admissions, paediatric admissions, 
maternity admissions and amenity ward 
admissions 
4: diarrhoea + malaria + STI + urinary tract 
infections + intestinal worms + respiratory 
disease visits, ANC + FP visits, immunisations, 
other general OPD visits 
7: child OPD visits, adult OPD visits, all OPD 
visits, child bed-days, adult bed-days, all bed-
days, deliveries 
3 for the hospital analysis: MCH care, 
deliveries, patients discharged 
4 for the health centre: deliveries, FVCs, other 
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health centres respectively staff MCH, OPD curative visits 
Ramanathan et al. 1 input- and output-oriented CRS 7: hospitals in the district, clinics in the district, health 14: 11 disease groups, new births discharged 
(2003) specification posts in the hospital(s), beds, doctors, nurses, other alive, inpatients discharged alive, patient days 
health staff 
Sabin & Ozcan 1 input-oriented VRS specification 6: patient beds, four levels of health labour, expenditure 3: mortality rate as quality measure, inpatient 
(2000) discharges and outpatient visits 
Sarkis & TaUuri 1 input- and output-oriented VRS 3: bed days, physicians, other health personnel 3: patient days, minor operations, major 
(2002) specification operations 
Valdmanis et at. 1 input-oriented VRS specification 1: total costs 5: DPT, TB, polio, measles and IT vaccines 
(2003) administered 
vatdmanis et at. 1 output-oriented CRS 7: beds, doctors, nurses, other staff, and allowance 4: outpatient visits for poor patients, outpatient 
(2004) specification expenditure, drug expenditure and other operating visits for non-poor patients, inpatient cases 
expenditure adjusted with average DRG weighting for poor 
patients, inpatient cases adjusted with average 
DRG weighting for non-poor patients 
Zere et at. (200 I) 1 input-oriented VRS specification NS NS 
NS: not stated; ANC: antenatal care; CRS: constant returns to scale; DPT: diphtheria; DRG: diagnostic related group; FP: family planning; FVC: fully vaccinated 
.. 
child; MCH: maternal and child health; OPD: outpatient department; STI: sexually transmitted infection; TB: tuberculosis; IT: tetanus toxoid: VRS: variable returns to 
scale 
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Table 3: Methodological summary of the SF A studies 
Reference 
Chakrabarti & Rao 
(in press) 
Model 
Technical efficiency effects model 
with panel data 
Output(s) 
A 'performance indicator' based on the infant 
mortality rate 
Kathuria & Sankar A Cobb-Douglas production function Infant mortality rate 
(2005) using the fixed-effects and random 
effects approaches with panel data 
Inputs 
6: Per capita PHC centres, per capita hospitals, 
health expenditure, births in institution, births in 
home by trained practitioners and per capita net 
state domestic product 
5: Primary health centres, doctors, para-medical 
staff, hospital beds and % of institutional 
deliveries 
Pavananunt A Cobb-Douglas production function IPD days, OPD visits and accident and emergency 3: Labour, capital and supplies / material 
(2004) 
Owino & Korir 
(1997) 
Ramanathan et al. 
(2003) 
using the fixed-effects approach with cases were combined into one aggregated output by 
panel data using the unit costs of the outputs as the weights 
A Cobb-Douglas production function cost 5: wages, admissions, outpatients, operations, 
beds 
A half-normal distribution 15: II OPD disease groups, all outpatients, new 
births discharged alive, inpatients discharged alive 
and patient days 
7: Hospitals in the district, clinics in the district, 
health posts in the hospital(s), beds, doctors, 
nurses and health staff 
IPD: inpatient department; OPD: outpatient department; PHC: primary health care 
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4.4.2 Summary of findings and recommendations 
4.4.2.1 Main findings 
Given that findings can differ for a number of reasons including differences in case mix 
and levels of technical quality, together with model specification issues, estimation 
techniques and data availability and quality (Hollingsworth 2003), results from different 
studies are not strictly comparable. Results are therefore strictly only valid for the units 
under investigation, and hence are not necessarily generalisable. For these reasons, no 
attempt was made to meta-analyse the findings by different types of units. A brief 
summary of each paper is provided below. 
4.4.2.2 Analysis of explanatory variables 
Institutional factors at the discretion of management as well as environmental factors 
beyond its control can affect the efficiency of a facility. Ten of the intra-country 
analyses failed to perform an analysis to explain variation in efficiency. However, of 
the remaining studies, Table 4 illustrates the range of variables tested, whether or not 
they were found to be significant predictors of efficiency and in which direction, and 
finally the methods used. It can be seen that 10 of the studies failed to perform an 
analysis of explanatory variables. Of those that did, location and type of ownership 
were the most commonly used variables. Two-stage regression was the method most 
often used to analyse the impact of environmental variables. 
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Table 4: Authors' analyses of explanatory variables 
Reference Explanatory analysis If yes, which variables considered? Which, if any, of these, were Which method(s) were 
performed? significant? used? 
Al-Shammari (1999) No 
Bhat et al. (200 1 ) Yes Type, location Grant-in-aid hospitals more efficient Mann Whitney 
than public hospitals 
Chakrabati & Rao Yes Literacy rate, proportion of rural population, All except the trend variable. Capital Single-stage analysis with 
(in press) revenue and capital expenditure on water expenditure on water supply and technical inefficiency 
supply and sanitation, year and trend sanitation and literacy have a negative effects specified in the 
impact, proportion of rural population model 
has a positive impact and revenue 
expenditure has a positive impact 
Dervaux et al. (2003) Yes Ownership and type Neither Kruskal-Wallis 
Ersoy et al. (1997) No 
Jacques & Koch (2005) Yes Average bed occupancy rate, size, bed Data availability has a positive impact Two-stage regression 
utilisation, data availability and response 
time 
Kathuria & Sankar Yes Rural literacy rates, health expenditure as a % of population having a lavatory has a Two-stage regression 
(2005) share of GDP, per capita income, positive impact 
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availability of water, % of population 
having a lavatory, % of mothers receiving 
after-birth care, % of children vaccinated 
Kirigia et aI. (2000) No 
Kirigia et al. (200 1) Yes Nursing staff, general staff, ANC visits, Nursing staff has a negative impact, Two-stage regression 
births, child health care visits, dental care births and dental care visits have a 
visits, FP visits, psychiatry visits, STI visits, positive impact 
1B visits 
Kirigia et aI. (2002) No 
Kirigia et al. (2004) No 
Masiye et al. (2002) No 
Osei et aI. (2005) No 
Owino & Korir (1997) Yes Shortage of staff, poor combination of all Survey 
inputs, irregular or non-functional theatres 
and laboratories, transport problems, lack 
of, or poor distribution of drugs and medical 
supplies, frequent breakdown or poor 
servicing of equipment 
Pavananunt(2004) Yes External factors: location, level of External factors: level of competition Multiple regression 
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Ramanathan et a1. No 
(2003) 
Sabin & Ozcan (2000) No 
Sarkis & Talluri (2002) No 
Valdmanis et al. (2003) Yes 
Valdmanis et al. (2004) Yes 
Zere et al. (2001) Yes 
competition. i.e. no. of hospitals / clinics 
nearby and community demographic. 
Internal factors: age of hospital, size, 
technology, managing service, managing 
human resources, managing financial 
resources 
Ownership, type, length of time a unit had 
been in operation 
Type and region 
Occupancy rate, average length of stay, 
outpatient visits 
and community demographic. Internal 
factors: age, size and managing 
financial resources 
Government units more efficient than 
NGO units, fixed units more efficient 
than outreach units, length of time a 
unit had been in operation positively 
correlated with efficiency 
Region 
Higher occupancy rates are associated 
with level of technical efficiency, an 
increase in the number of outpatient 
analysis 
F-test, Median test, 
Kruskal-Wallis, correlation 
Kruskal-Wallis 
Censored Tobit model 
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visits relative to inpatient days is likely 
to result in an increase in technical 
efficiency 
ANC: antenatal care; FP: family planning; GOP: gross domestic product; NGO: non-government organisation; STI: sexually transmitted infection; TB: tuberculosis 
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4.4.2.3 Policy recommendations 
Ten studies did not state any policy recommendations to improve efficiency in spite of 
finding high levels of inefficiency. Of the remaining studies, 15 strategies to improve 
efficiency were suggested. Most ofthese were supply-side strategies (see Table 5). 
Table 5: Authors' suggested strategies to improve efficiency 
Supply-driven Demand-driven Other 
- close beds 
- contract with private clinic 
practitioners to use excess beds at a 
price 
- identify characteristics of best 
performers and replicate in 
inefficient clinics 
- increase OPD activities 
- merge hospitals 
- reallocate surplus input to nearby 
or needy fmns 
- replace jobs-till-old-age-retirement 
with fixed shorter term renewable 
contracts 
- sell excess beds 
- send excess general staff on early 
retirement 
- transfer excess beds / staff to more 
efficient health facilities 
- boost demand for - use excess non-wage expenditure to 
services with uomet need improve the degree of responsiveness 
of dispensaries to patients' legitimate 
expectations 
- use excess non-wage expenditure to 
improve health centres' quality of 
services 
- use excess non-wage expenditure to 
support communities to start / sustain 
systematic risk and resource pooling 
and cost sharing mechanisms 
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4.5 Summaries of each study 
Summaries of all the efficiency studies are presented in the following section organised 
by type of analysis and geographical region. 
First though, Ramanathan et a1. (2003) attempted to construct and present relative 
efficiency indices for the services provided by 22 health districts and 13 hospitals in 
Botswana, using SFA and DEA. The analysis indicated that three districts had 
efficiency scores below the optimum level. Among the 13 hospitals considered, only 
one was found to have an efficiency score of less than one. The authors stressed that 
because health services involve a number of factors, their findings ought to serve as 
indicators for further scrutiny of those units (health districts and hospitals) that fell 
below the optimum efficiency level. 
4.5.1 DEA applications 
4.5.1.1 Studies from Europe and Central Asia 
Ersoy et al. (1997) used DEA to examine the technical efficiency of 573 Turkish acute 
general hospitals. Results illustrated that less than 10% of Turkish acute general 
hospitals operated efficiently compared to their counterparts. Inefficient, compared to 
efficient hospitals, on average utilised 32% more specialists, 47% more primary care 
physicians, and have 119% more staffed bed capacity. They also produced on average 
less output; specifically, 13% less outpatient visits, 16% inpatient episodes and 57% 
less surgical procedures. The authors note that hospital managers in Turkey generally 
have more control over inputs and therefore argue that they should devote more 
attention to the examination of inefficiencies generated by excessive input usage. 
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Again in Turkey, Sahin and Ozcan (2000) used DEA to examine public sector hospital 
efficiency in 80 provincial markets. Their results showed that 55% of the public 
hospitals operated inefficiently. An analysis of inefficient provinces suggested that the 
44 of these were over-bedded and employed excessive number of specialists and other 
health workers. They also spent approximately $70,000,000 from their revolving funds 
in excess compared to efficient provinces. 
4.5.1.2 Studies from sub-Saharan Africa 
Kirigia et al. (2000) employ DEA to identify and measure efficiency among 55 public 
hospitals in Kwazulu-Natal Province, South Africa. The authors found that the overall 
average level of technical efficiency among these hospitals in 1995-96 was 90.6%. 
Twenty-two (40%) of the hospitals had some level of technical inefficiency and 32 
(58%) were scale inefficient. In total, the authors estimated that the following inputs 
were not necessary in the production of hospital's stated output: 117 doctors, 2,709 
nurses, 61 paramedics, 58 technicians, 295 administrative staff, 835 general staff and 
1,752 beds. The authors provided a number of policy options that decision-makers 
might consider in order to realise these savings. 
Again in Kwazulu-Natal Province, Kirigia et al. (2001) investigated the technical 
efficiency of 155 primary health care centres. Forty seven (30%) were found to be 
technically efficient. Among the 108 (70%) technically inefficient facilities, 16% had 
an efficiency score of 50% or less. To achieve technical efficiency, the authors 
estimated that Kwazulu-Natal centres would, in total, have to decrease inputs by 417 
nurses and 457 general staff. Alternatively, outputs would have to be increased by 
115,534 antenatal visits, 1,010 deliveries, 179,075 child care visits, 5,702 dental visits, 
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121,658 family planning visits, 36,032 psychiatric visits, 56,068 sexually transmitted 
disease visits and 34,270 tuberculosis visits. 
Kirigia et al. (2002) examined the technical efficiency of 54 public hospitals in Kenya. 
Fourteen (26%) of them were found to be technically inefficient and 16 (30%) of the 
hospitals were scale inefficient. The authors provided the magnitudes of specific input 
reductions or output increases needed to attain efficiency. They also provided some 
suggestions for hospitals with excess inputs that policymakers might consider to 
improve efficiency, e.g. transferring excess staff to other health centres. With respect to 
increasing output, the authors suggested that the Ministry of Health could embark on a 
campaign to boost demand for under-utilised services. 
In 2004, once again in Kenya, Kirigia et al. (2004) measured the technical efficiency of 
32 public health centres. Their analysis suggested that 14 (44%) of these public health 
centres were technically inefficient. The inefficient health centres had an average 
technical efficiency score of 65%, which implied that on average, they could reduce 
their utilisation of inputs by about 35% without reducing output. In addition, 13 (41%) 
of the health centres were scale inefficient, and these centres had an average scale 
efficiency score of 70%. This implied that there was potential for increasing output by 
about 30% using the existing capacity / size. 
Zere et al. (2001) assessed the efficiency of 86 hospitals in South Africa. The results 
suggested that a significant number of the hospitals included in their analysis operated 
well below the efficient frontier; the mean efficiency was 0.74. The authors argue that, 
given the tight fiscal constraints and resulting stagnant real per capita health budgets in 
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South Africa, extending and improving the quality of primary health care services has to 
be funded through health service efficiency gains and / or increased health service 
revenue from non-tax sources. At the time the paper was written (2001), the main 
source of such revenue was that of user fees at public sector hospitals. In 1992-93, fee 
revenue was equivalent to approximately 9% of public sector hospitals' recurrent 
expenditure and fee revenue is noted to have declined dramatically since then. Thus the 
potential efficiency savings estimated in this study amount to more than three times that 
of the fee revenue collected, which means that very high levels of user fees would be 
required to generate revenues that could match the potential efficiency savings. The 
authors suggest the following options might be worth exploring to achieve the 
efficiency savings: bed closures, particularly in those hospitals that exhibit decreasing 
returns to scale; mergers of hospitals that exhibit increasing returns to scale, particularly 
those that are in close proximity to one another. 
4.5.1.3 Studies from Middle East and North Africa 
AI-Shammari (1999) evaluated the productive efficiency of 15 hospitals for a three-year 
period In Jordan. In 1991, eight (53%) of the sample of 15 hospitals were found to be 
operating inefficiently. In 1992 and 1993, the number of inefficient hospitals had fallen 
to six and four respectively. The author estimated both the potential reduction in the 
usage of inputs and the potential increase in the production of outputs for the hospitals 
identified as inefficient. AI-Shammari (1999) considered that the results could help 
policy-makers by providing new insights on the distribution of health resources to 
hospitals that will have the highest potential to utilise additional resources. 
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Sarkis and Talluri (2002) addressed certain issues that were not addressed by AI-
Shammari (1999). Specifically it considered: the simultaneous evaluation of all units 
across three years, ranking of efficient units and identification of 'global' benchmarks 
for improvement (the benchmarks are global because an inefficient unit in a particular 
year could have benchmark hospitals for the same as well as other years). The authors 
believe the identification of global benchmarks provide more complete information for 
the decision-maker about best practices necessary to improve the performance of the 
inefficient hospitals 
4.5.1.4 Studies from South Asia 
Bhat et al. (2001) used DEA to analyse efficiency of district and grant-in-aid hospitals 
in India. The findings suggest that the efficiency variations are more significant within 
district hospitals than within the grant-in-aid institutions. The overall efficiency levels 
of grant-in-aid institutions are higher than the district level hospitals. The grant-in-
institutions are relatively more efficient than the public hospitals. These differences are 
statistically significant. The study made an attempt to find whether location determines 
the efficiency levels of hospitals. For example, it may be argued that hospitals in 
remote areas, less dense or less urbanised areas would be relatively serving lesser 
population and therefore would be relatively less efficient. The mean difference of 
urban population and density of districts between less efficient hospitals and relatively 
efficient hospitals were not significantly different statistically. 
Valdmanis et al. (2003) examined whether and to what degree a sample of 118 
vaccination delivery units located in Dhaka City, Bangladesh, exhibited CRS, based on 
data collected in 1999. The authors found that the units were, on average, relatively 
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inefficient both in tenns of technical inefficiency as well as scale inefficiency. In order 
to become technically efficient, the units would have had to decrease their costs by an 
average of 50%, and if they had been operating at the right size, costs could have been 
reduced by a further 36%. The authors also considered some of the environmental 
factors that affected scale efficiencies, because these factors may have been beyond 
managerial control, yet affected units' positions vis-ii-vis the best practice frontier. 
Units that were relatively more inefficient, on average, were NGO outreach delivery 
units. Therefore, the government owned units, perhaps due to more centralised control, 
were better at long tenn planning. It was also found that units that had been practicing 
longer were relatively more scale efficient, which is perhaps attributable to a learning 
curve effect. 
Using the same data, Dervaux et al. (2003) modelled the optimal number of clinic hours 
and sessions needed in order to maximise outputs, i.e. vaccines administered. This 
analysis required two models: one DEA model with possible reallocations between the 
number of hours and the number of sessions but with the total amount of time fixed; and 
one model without this kind of reallocation in scheduling. Comparing these two scores 
identified the 'gain' that would be possible were the scheduling of hours and sessions 
modified while controlling for all other types of inefficiency. The authors found that 
optimality of scheduling was, on average, around seven sessions, with each session 
lasting four hours, per month. If optimality had been met, gains (i.e. the increase in 
vaccines administered) of between 10-20% could have been achieved. 
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4.5.1.5 Studies from East Asia and the Pacific 
Valdmanis et al. (2004) used DEA to assess the capacity of 68 Thai public hospitals to 
proportionately expand services to both the poor and the non-poor. The authors found 
that increases in the amount of services provided to poor patients did not reduce the 
amount of services to non-poor patients. Overall, hospitals appeared to be producing 
services relatively close to their capacity given fixed inputs. Possible increases in 
capacity utilisation amounted to 5% of capacity. 
4.5.2 SF A applications 
4.5.2.1 Studies from sub-Saharan Africa 
Owino and Korir (1997) set out to investigate and determine levels, causes, and effects 
of inefficiency in the public health system in Kenya. This study revealed an average 
inefficiency level of 30%. The inefficiency is a primary attribute of shortages of 
professional staff; poor combinations of inputs; irregular or non-functioning operating 
theatres and laboratories; transport problems; poor distribution or lack of drugs and 
medical supplies; and frequent breakdowns and poor servicing of machines and 
equipment. 
4.5.2.2 Studies from South Asia 
Chakrabarti and Rao (in press) estimated a stochastic production frontier with 
inefficiency effects based on data drawn from the fourteen major states of India over the 
period 1986 to 1995. The output of the production frontier was generated on the basis 
of infant mortality rates of the respective states. Elasticity estimates of the inputs 
incorporated in the production frontier, computed on the basis of the obtained maximum 
likelihood estimates of the parameters, contradicted the general notion that expenditure 
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on curative services does not generate a substantial impact on health. In fact, health 
expenditure as a percentage of net state domestic product and births in an institution, 
with relatively higher elasticity values were found to play a dominant role. 
Surprisingly, per capita real net state domestic product, which is a measure of an 
individual's command over privately supplied medical service, was found to have a 
relatively lower impact on output. 
Kathuria and Sankar (2005) analysed the performance of rural public health systems of 
16 major states in India using SF A and panel data for the period 1986-97. The results 
illustrated that the states differed not only in capacity-building in terms of health 
infrastructure created, but also in efficiency in using those inputs. It was found that not 
all states with better health indicators have efficient health systems. The authors 
concluded by noting that states should not only increase their investment in the health 
sector, but should also manage it more efficiently in order to achieve better health 
outcomes. 
4.5.2.3 Studies from East Asia and the Pacific 
Pavananunt (2004) analysed the technical efficiency of 662 public community hospitals 
in Thailand by using the fixed-effect production function model approach. The 
principal variables used for the analysis were service output indicators and inputs used 
for the provision of the services. The results indicate that larger size hospitals tend to be 
more efficient than the small size hospitals. The distribution of efficiency scores among 
the sampled hospitals clustered around 0.05-0.63 with a mean value of 0.55. Using the 
efficiency scores, hospitals were categorized into four groups. Among the sampled 
community hospitals, 11 % were ranked in the most efficient group, 42% in moderate 
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efficiency category, 38% in low efficiency and 9% in the least efficient group. The 
determinants of efficiency were also investigated by using a multiple regression model. 
The results indicate that internal factors, such as, age and size of community hospitals 
and aspects related to the management of human resources, were significantly 
associated with technical efficiency scores. 
4.5.3 Malmquist productivity applications 
The study by Zere et al. (2001) from South Africa described above also documented a 
decline in productivity by 12% among 86 hospitals over the period 1992 to 1993 due to 
a lack of technological advance. 
4.5.4 Studies of health systems 
It is important to note that the data presented above from the available DEA, SFA and 
Malmquist productivity applications were not collected for the purpose of cross-country 
comparisons, but rather, the studies were performed in isolation. Therefore, the current 
state of knowledge about cross-country differences in health service productivity and 
efficiency is limited. However, the keenly debated ranking of national health systems 
performed by the World Health Organization (2000) represents a useful starting point. 
The World Health Report 2000 (2000) focused on the performance of health care 
systems around the globe. It sought to improve the evidence-base for health policy by 
devising a method to measure and monitor the performance of health systems. More 
specifically, the report describes the relationship between population levels of health 
and the inputs used to produce health in 191 countries. The report used efficiency 
measurement techniques to create a league table of health-care systems, highlighting 
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'good' and 'bad' performers. Evans et al. (2001) described the methods used in the 
report. Using econometric methods, the estimated efficiency varied from nearly fully 
efficient (in relative tenns) to nearly fully inefficient. Countries with a history of civil 
conflict or high prevalence of HIV / AIDS were less efficient. Performance increased 
with health expenditure per capita. They concluded that increasing the resources for 
health systems is critical to improving health in poor countries, but important gains can 
be made in most countries by using existing resources more efficiently. 
Hollingsworth and Wildman (2003) argued that WHO's estimation procedure was too 
narrow and that contextual infonnation was hidden by the use of one method. They 
used and validated a range of parametric and non-parametric empirical methods to 
measure efficiency using the WHO data. The rankings obtained were compared to the 
WHO league table and demonstrated that there were trends and movements of interest 
within the league tables. The authors recommended that the WHO broaden its range of 
techniques in order to reveal this hidden information. 
Gravelle et al. (2003) assessed the robustness of the WHO results to definitions of 
efficiency and statistical procedures. The paper used the data originally analysed by the 
WHO. The results show that the country rankings and efficiency scores are sensitive to 
the definition of efficiency and choice of model specification. The authors concluded 
that econometric methods can yield insights into complex socio-economic phenomena. 
However, the lack of robustness of results to reasonable alternative specifications 
suggests that it is premature to use the methods adopted by the WHO to construct 
league tables of health systems. 
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4.6 Summary 
• There is a dearth of parametric and non-parametric efficiency measurement studies 
of health care in low- and middle-income settings. However, what there is suggests 
that resources are used inefficiently in the delivery of health care; 
• There is an emphasis, albeit weak, on hospital efficiency research in developing 
countries, which coincides with that in the developed world (Hollingsworth 2003). 
This can partly be explained by the fact that: hospitals account for the largest share 
of health care costs; governments tend to keep information on utilisation and costs, 
however inaccurate, in a uniform way, whereas private providers generally do not; 
the search for health care financing and delivery reform has focused on gauging and 
improving the performance of the public sector; 
• Given that findings can differ for a number of reasons including differences in case 
mix and levels of technical quality, together with model specification issues, 
estimation techniques and data availability and quality, results from different studies 
may not be strictly comparable. Results may therefore only be valid for the units 
under investigation, and hence are not necessarily generalisable; 
• Very few studies have subjected their data to sensitivity analysis, nor compared and 
contrasted the application of DE A and SFA to the same data sets; 
• A number of policy recommendation were touted by authors of the studies to 
improve efficiency; 
• Therefore, analysis of the efficiency of primary health care in Bangladesh clearly 
fills many gaps in the literature 
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The next Chapter provides a brief overview of the Bangladeshi health system in 
advance of Chapters 6-9, which present cost and efficiency analyses of aspects of 
Bangladeshi primary health care services in urban and rural areas. 
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ChapterS 
BACKGROUND AND CONTEXT - BANGLADESH 
In this Chapter, a description of the Bangladeshi health system is provided. The main 
aim of this chapter is to help place in context the case studies of vaccination services in 
Dhaka, and the delivery of primary health care in rural areas, which will be examined in 
Chapters 6-9. 
5.1 Introduction 
Bangladesh is a South East Asian republic bordering India, Myanmar and the Bay of 
Bengal (see Figure 10 below). Initially a part of Pakistan, known as East Pakistan, 
following partition from India in 1947, Bangladesh achieved full independence in 1971. 
In 1991 a parliamentary democracy replaced the military regime. It has nearly 600km 
of coast and is low-lying with many rivers, forming a fertile delta which experiences 
frequent and severe flooding. A tropical monsoon climate generates frequent 
cyclones33 • Rivers and flooding inhibit the development of road and rail transport; 
waterways are therefore significant. 
The estimated 2004 population of Bangladesh is 140.5 million (World Bank 2005b), 
living within an area of 147,520 sq. Ian making it one of the most densely populated 
countries in the world with 952 people per sq. Ian. The population is projected to 
double to around 250 million by the year 2035 before demographic growth stabilises 
(Vaughan et al. 2000). According to the 2001 population census, the urban population 
in Bangladesh is 29 million, and has increased by 38% during the last ten years, which 
33 In 1970500,000 people were killed in one of worst ever recorded natural disasters. 
107 
is about four times the rural rate. The population is largely Bengali and there are small 
numbers of ethnic minorities. The majority (85%) are Sunni Muslim, others are mostly 
Hindu. Life expectancy is 62 years and the population is young, with few aged over 65 
year (only 3% of the population)34. Illiteracy is widespread35, gender inequality is 
pervasive at all levels and many children work and therefore receive little education. 
For example, studies have reported discrimination against female children in the 
provision of food (Chen et al. 1981) and in health care seeking behaviours (Hossain and 
Glass 1988). There is a strong preference for sons in both early and later stages of 
family formation in Bangladesh (Rahman and DaVanzo 1993). Bangladesh has few 
natural resources; its manufacturing base is small although it is now beginning to 
exploit natural gas. In 2004, GNI per capita was around $US440 (World Bank 2005b) 
of which 40% is generated by agriculture; fishing, tea, and jute are important products. 
5.2 Health status indicators 
Bangladesh has made considerable progress over the past two decades in improving the 
health status of the nation. For example, the infant mortality rate has declined from 129 
to 46 deaths per 1,000 live births (BBS 1997; BBS 2003). The national coverage rate of 
immunisations increased from less than 2% in the 1980s to 69% in terms of children 
aged between 12-23 months completing recommended vaccines (Perry 1999). In 
addition, each of the twice-yearly National Immunisation Days (NIDs) for oral polio 
vaccination now reach more than 90% of the 25 million children under five years of age 
in Bangladesh (EPI 2001). 
34 Bangladesh is one of the few countries in the world (along with India and Pakistan) where the life 
expectancy at birth is lower for females than for males (BBS 2003). 
35 59% of the population aged 15 years or older (BBS 2003). 
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Figure 10: Map of Bangladesh 
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More than 80% of children one to five years of age receive vitamin A supplementation 
every six months; once during one of the two NIDs and once during National Vitamin A 
week. As a result, it is estimated that the number of children developing nutritional 
blindness each year has fallen from 30,000 to 6,000 (Perry 1999). 
Nevertheless, although as a result of large-scale government programmes there have 
been notable improvements in some health indicators, health status remains poor. For 
instance, in the 2001 national Health and Demographic Survey (Mitra et al. 2001), the 
incidence of low birth-weight babies (2,500g or less) was almost 50% and maternal 
mortality was estimated to be about 500 per 100,000 live births, one of the highest rates 
in Asia. Most (85%) deliveries still take place at home, and almost a third of 
Bangladeshi women report chronic or residual morbidities associated with childbirth. In 
addition, average nutritional calorie intake was estimated to be 88% of requirements and 
only 34% of the population had access to adequate sanitation. On the basis of a number 
of criteria, including a daily calorific intake of only 1,600 per person, it is estimated that 
approximately half of the rural population lived in absolute poverty in 1998, 44% of 
whom fell into the category of the very poor. 
A high proportion of child deaths are caused by poverty-related infectious diseases and 
malnutrition, most of which are readily preventable or treatable. The main causes of 
death, particularly in children, remain diarrhoeal diseases, acute respiratory infections, 
malnutrition, neonatal conditions, and accidents and injuries. 
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5.3 Ministry of Health and Family Welfare 
The Ministry of Health and Family Welfare (MOHFW) has overall responsibility for 
health sector policy and planning, and until recently there have been two separate 
directorates, also called the 'two wings', for health services and family planning (FP). 
This division of responsibilities between the two directorates was originally established 
in the early 1970s, since when there has been considerable independence and 
competition between them (Vaughan et al. 2000). 
They are both largely organised into vertical programmes and each has developed 
separate services, partiCUlarly for primary health care at the district (zila), sub-district 
(upazila36), union and village levels. This separation of services has also led to the 
development of specialised cadres of health personnel and training institutions, together 
with separate health facilities, supporting services and information systems (Vaughan et 
al. 2000). However, in recent years considerable efforts have been made to achieve 
greater integration by organising more joint services at the upazila level and below. 
SA Health services 
Health care provision in Bangladesh is highly pluralistic with a plethora of treatment 
options exist. Non-government service provision predominates, which includes both 
for-profit and non-profit organisations, and traditional and non-formal practitioners. 
The site of first access for most services, other than maternal and child health (MCH) 
and FP, is non-governmental, with a wide choice of providers depending on the 
symptoms, gender, socio-economic standing and geographic location (urban or rural) of 
the individual. Although allopathic practitioners are consulted in about 80% of cases 
36 Also known at thana. 
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when treatment is sought (Vaughan et al. 2000), the existence, length and quality of 
their training is as variable as the treatments they provide. 
By contrast, the organisation of Government of Bangladesh (GoB) health services 
remains highly centralised in the MOHFW and the two directorates in Dhaka. The 
public health system is structured as a hierarchical pyramid with five layers (Figure 11): 
one at the tertiary level, one at the secondary level and three at primary level. 
Bangladesh consists of six Divisions, and tertiary care is provided at this level. Each of 
the Divisions has Divisional Director's offices of Health and of Family Planning, which 
manage health services at this level. There are 64 Districts in Bangladesh, each of 
which has a Civil Surgeon responsible for managing health services at the secondary 
level. And finally, there are 460 upazilas in Bangladesh each with an Upazila Health 
Officer and an Upazila Family Planning Officer in charge of respectively preventive and 
clinical health services, and FP and reproductive health services. These officers manage 
the delivery of health care at the primary level. 
Bangladesh is served by medical colleges, each with around 650 beds, at the tertiary 
level, and district hospitals (50-200 beds) at the secondary level. The hospital system is 
over-used at both these levels, with high rates of self-referral, by-passing the sub-district 
hospitals, known as Upazila Health Complexes (UHCs). There is a high ratio of doctors 
to nurses in hospitals and potential to improve skill mix, but there is a notable lack of 
suitable nurses at all levels (Hossain and Begum 1998). 
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Figure 11: Organisation of health services 
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There has been a large GoB investment in the rural primary health care infrastructure, 
with the construction of more than 400 UHCs since the 1970s. The UHCs were 
established as the cornerstones of primary care. They were created to a standard design, 
including theatres, X-ray, pharmacy, basic laboratories, dental suites and delivery suites 
and each has a 31-50 bed ward. Physical facilities have deteriorated in most UHCs and 
poor staff practices exist in many (e.g. high levels of absenteeism (Chaudhury and 
Hammer 2004) and informal user-charging37). Skilled doctors are unwilling to work 
there, regarding postings as 'punishment' (Vaughan et al. 2000). As a result UHCs no 
longer enjoy public confidence and are under-used. The low state salaries earned by 
doctors have led to growth in private practice. Doctors are thereby diverted from their 
UHC duties and a vicious circle has evolved whereby their vested interests may wish to 
keep public sector service quality relatively low. 
37 A study undertaken by the MOHFW found that informal fees are common at all levels of the health 
system and they can amount to more than ten times the official charges (Killingsworth et a1. 1999), 
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Below the upazila level, there is a network of about 4,300 union health and family 
welfare centres. Therefore, although geographical access is reasonable for health 
facilities, they are characteristically under-utilised, particularly at the union-level. 
Services delivered at this level are commonly perceived to be of poor quality, suffer 
from shortages of drug supplies and are inefficiently managed (Vaughan et al. 2000). 
Below the union level, the system depends heavily on community workers who provide 
FP supplies and provide health advice. Controversially, this door-step approach was to 
be phased out in favour of services delivered through newly built community clinics 
serving a population of around 6,000 people (Ensor et al. 2002). 
The concept of an essential package of services (ESP) to be delivered in UHCs is well 
established, although delivery is patchy. The ESP consists broadly of (Ensor et al. 
2002): 
• reproductive health care, including safe motherhood (essential obstetric care, 
antenatal and post-natal care), FP, other reproductive services including sexually 
transmitted disease; 
• child health care, including acute respiratory infections, diarrhoeal diseases, vaccine 
preventable disease and adolescent care implemented through an integrated 
management of sick child approach; 
• communicable disease control, including TB, leprosy, malaria, filarial, kala-azar and 
emerging diseases; 
• limited curative care, concentrating on first aid for trauma, medical and surgical 
emergencies, asthma, skin diseases, eye, dental and infectious ear disease; 
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• behaviour change communication is being implemented as a way of influencing 
health behaviours and health-care-seeking practices across all of the ESP 
components. 
There are also a large number of NGOs that operate separately from the MOHFW 
(Abbassi 1999). However, there is an increasing tendency for the GoB to contract these 
NOOs to work in specific under-served areas and / or to carry out service programmes, 
particularly those for MCH-FP and disease control programmes (Loevinsohn and 
Harding 2005). Many of the NGOs working in FP have been directly supported by 
funds from bilateral donor agencies, particularly the United States Agency for 
International Development (USAID). A number of these NGOs also receive donor 
funding for primary health care and disease control programmes (Vaughan et al. 2000). 
Private practitioners of all kinds, including many medical graduates, are numerous in 
both urban and rural areas. Drugs are widely available through the large number of 
private pharmacies and shop outlets. The number of private medical practices and 
hospitals in urban areas, together with numerous unqualified practitioners, is growing 
rapidly. These practitioners are poorly regulated and there is no adequate system for 
registering or licensing them by the GoB. Moreover, financial incentives often militate 
against medical practice as professional supervision and regulation is weak (Abbassi 
1999). 
5.5 The National Immunisation Programme 
Following the eradication of smallpox, Bangladesh's Expanded Programme on 
Immunisation (EPI) was started in 1979 but little progress was made until the mid-
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1980s when the coverage rate of children fully immunised went from 2% to 62% during 
the period 1985 to 1990, with higher rates in some divisions and 80% in one area by 
1991. This accomplishment was considered so spectacular that it was hailed as the 
'Near Miracle' (Huq 1991). Such an achievement was not easy and was brought about 
by high political commitment, national and international pressure, mobilisation of 
various stakeholders including civil society and NGOs, and strong donor support. 
Shortly after the declaration of this spectacular success in 1991, concerns emerged 
regarding the sustain ability of the national immunisation programme (Walker et aI. 
2000). In fact, in May 1999, immunisation rates were reported to have dropped to 59-
62%. 
The national immunisation programme in Bangladesh aims to reduce morbidity and 
mortality from six vaccine-preventable diseases: diphtheria, measles, pertussis, 
poliomyelitis, tetanus and tuberculosis (TB)38. A fully vaccinated child receives six 
standard EPI antigens through eight vaccinations requiring, in theory, five contacts with 
health staff: three shots of DPT (which protects against diphtheria, pertussis and 
tetanus), three doses of OPV39 (which protects against poliomyelitis), one shot of BCG 
(Bacillus Calmette-Guenn, which provides protection against TB) and one shot of the 
measles vaccine. The recommended schedule in Bangladesh is: one dose of BCG at 
birth40, three doses ofOPV together with three doses ofDPT at ages 6, 10 and 14 weeks 
of age, and one dose of measles at age nine months of age. Pregnant women and those 
of childbearing age are given two shots ofTT (tetanus toxoid) to prevent maternal and 
neonatal tetanus. 
38 In 2004, hepatitis b vaccination was introduced, which requires three doses be given alongside the DPT 
schedule. 
39 A neonatal dose, OPVO, is also recommended but rarely administered because most births do not take 
Elace in a health facility. 
o In reality, BeG is given at six weeks of age alongside OPVI and DPTl. 
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The programme is run under two different systems; one for the rural and one for the 
urban areas. In the rural areas, the EPI is the responsibility of the MOHFW. Services 
are provided at district hospitals, UHCs, union-level clinics (although only when they 
act as an outreach site) and NGO clinics. In addition to these fixed sites, the 
programme, unlike in many countries, relies heavily on outreach activities provided by 
two types of government-paid fieldworkers: health assistants, who provide a range of 
basic health services through house-to-house visits and vaccination through outreach 
sessions, and family welfare assistants who mainly deliver family planning services, but 
also assist in providing EPI. The current EPI strategy is based on a model of conducting 
monthly outreach sessions through eight outreach sites per ward (which has a total 
population of approximately 8,000 people). Porters deliver vaccines from the UHCs to 
distribution points where the field workers collect the vaccines in vaccine carriers, and 
sterilised needles and syringes in pre-sterilised drums41 , and take them to the designated 
outreach sites. Almost all people live within 15-20 minutes walking distance of an EPI 
site. Government EPI outreach sites delivered vaccines to around 80% of all vaccinated 
children in rural areas, according to the year 2000 National EPI Coverage Evaluation 
Survey (EPI 2000). 
As noted above, a spectacular increase in national coverage was achieved in the 1980s 
and 1990s. However, because EPI was not a priority of municipal governments in the 
1980s, vaccination coverage in the urban areas was found to lag considerably behind 
that of the rural areas. As a result, a number of donors, mainly USAID and the Asian 
Development Bank stepped in to fill the gap, developing EPI and child health projects 
in urban areas starting from around 1988. 
41 Auto-disable syringes have been introduced in a phased fashion alongside the introduction of hepatitis 
b vaccine. 
117 
The EPI programme in the urban areas, which consists of six city corporations and over 
200 municipalities accounting for approximately 23% of the total population of 
Bangladesh, is a complex collaborative effort between municipal authorities, the 
MOHFW, the Ministry of Local Government, Rural Development and Co-operatives, 
NGOs and key donors (e.g. the World Bank, Swedish International Development 
Agency, United Nations Children's Fund and Japanese International Co-operation 
Agency). EPI services are provided at government clinics and outreach sites by a cadre 
of vaccinators, as well as by HAs and Vaccination Supervisors. Vaccines for the NGOs 
are provided by the MOHFW free of charge, through the local municipal authorities. 
Urban immunisation services are therefore provided by a complex combination of 
government, NGO, and private providers with little coordination between the various 
providers. 
It is interesting to note that despite the widespread use of private health practitioners, in 
Bangladesh only a fraction of the population receives immunisations from private-for-
profit providers (Levin et a1. 1999). Unlike in many countries, even middle-class 
children receive their EPI immunisations in the public sector, because of the 
programme's good reputation and the fact that the vaccines are free of charge. 
Despite the extensive infrastructure of EPI, especially in the rural areas, and the heavy 
use of outreach activities as the mainstay of the system, in 2000 only an estimated 53% 
of children were fully vaccinated by age one (Table 6). However, as illustrated by the 
high BCG rate (95%), access to the EPI programme is quite good. Unfortunately 
however, many children do not complete their series of vaccinations - drop-out rates 
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have been rising since 1995 and in 2000 were estimated at 27% from BeG to DPT3 and 
33% from BeG to measles (EPI 2001). 
Table 6: Results of 2000 national vaccination coverage evaluation survey 
Vaccine Rural Urban National 
BCG 95% 95% 95% 
DPT3 66% 74% 68% 
OPV3 66% 74% 68% 
Measles 61% 64% 62% 
Fully vaccinated child 52% 56% 53% 
Source: 2000 National Coverage Evaluation Survey (EPI 200 I) 
5.6 Health care expenditure 
While, total health expenditure in 2002 was US$1.54 billion, equivalent to 3.1 % of 
GOP, total public expenditure on health was US$417 million, which equates to 0.88% 
of GOP. On a per capita basis, these amounts equate to total expenditure per capita on 
health of US$11 of which US$3 is public expenditure. 
Table 7: Selected indicators of expenditure on health for the year 2002 
Indicator 
Total expenditure on health as % of gross domestic product 3.1% 
General government expenditure on health as % of total expenditure on health 25.2% 
Private sector expenditure on health as % of total expenditure on health 74.8% 
General government expenditure on health as % of general government expenditure 4.4% 
Private households' out-of-pocket payment as % of private sector expenditure on health 85.9% 
External resources on health* as % of total expenditure on health 13.5% 
Total expenditure on health per capita $11 
General government expenditure on health per capita $3 
• External resources enter the system as a financing source, i.e. all external resources whether passing 
through governments or private entities are included under the public or private health expenditures. 
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The main bilateral donors to the health and population sector in Bangladesh are the 
governments of Australia, Belgium, Canada, Germany, Japan, Netherlands, Norway, 
Sweden, the United Kingdom and the United States (Vaughan et al. 2000). The World 
Bank, European Union, United Nations Children's Fund (UNICEF) and Asian 
Development Bank are also major donors (Buse and Gwin 1998). Approximately one-
third of donor funding was channelled through the Fourth Family Planning and Health 
Project (FPHP4), which was supported by a consortium of the World Bank and nine 
bilateral donors, which the Bank had the responsibility for co-ordinating, and operated 
from 1993-98 (Buse and Gwin 1998). With donor support, SWAps, or sector-wide 
approaches (Cassells and Janovsky 1998), were adopted for the subsequent Fifth Health 
and Population Sector programme (HPSP), which ran for 1998-2003, and was thus in 
operation during the time data for this thesis were collected. 
5.7 Recent and current health sector reform programmes 
Although donors had periodically encouraged the GoB to adopt a national health policy, 
it was only in the 1990s that this became a condition of their support. 
5.7.1 Health and Population Sector Programme 1998-2003 
The HPSP was a five year sector-wide programme of the Ministry of Health and Family 
Welfare which ran from 1998 to 2003. The HPSP was supported by a consortium of 
donors, including the World Bank, which led the programme, the Swedish International 
Development Agency, the Netherlands, the UK Department for International 
Development, and the European Union. The aims of the strategy were to provide a 
sustainable universal package of essential services of health care for the people of 
Bangladesh, and to slow population growth, with an emphasis on client-centred, 
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accessible services, particularly for children, women and the poor. The ESP grew out of 
recognition that it is not possible to provide all of the services needed by all segments of 
the population. It included a prioritised list of interventions to be delivered at upaziJa 
level and below, with referrals to secondary and tertiary levels also identified (see 
above). Unfortunately the GoB faces significant resource constraints in funding the 
ESP (Rannan-Eliya and Somanathan 2003), even though as much as two-thirds ofHPSP 
financing was channelled into the ESP (Ensor et al. 2003b). It has been argued that the 
potential for additional resource mobilisation is limited and that improvements in the 
efficiency of health care services must be a critical component of efforts to provide the 
ESP to the whole population (Rannan-Eliya and Somanathan 2003). 
The HPSP also emphasised the integration of the health and FP wings of MOH&FW 
and the decentralisation of management and financial responsibilities to the district and 
upazila (sub-district) level. At the central level, the Directorate General of Health 
Services was re-organised. Beginning in July 1999, EPI was changed from a vertical 
programme with its own director to one of several programmes in the ESP that is 
administered by the Director, Primary Health Care and Line Director, ESP. The 
Programme Manager, Child Health & Limited Curative Care, manages EPI, ARI (acute 
respiratory infections), CDD (control of diarrhoeal disease), School Health, and Limited 
Curative Care. A Deputy Programme Manager (EPI) assists the Programme Manager in 
managing EPI activities. Under HPSP, cold chain, logistics, training, surveillance, and 
communications are under the authority of various line directors responsible for each of 
the respective sector areas (e.g., Logistics, Training, Unified Management Information 
System, and Behavioural Change & Communication). 
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5.7.2 Health Nutrition and Population Sector Programme 2003-2006 
Following on from the HPSP, the Health, Nutrition and Population Sector Programme 
(HNPSP) was initiated in 2004, including nutrition as a sub-sector. Also focusing on the 
vulnerable, including the elderly, the HNPSP emphasizes reducing malnutrition, 
mortality, and fertility, promoting healthy life styles, and reducing risk factors to human 
health from environmental, economic and social and behavioural causes. 
5.8 Summary 
• Bangladesh is one of the most densely populated and poorest countries in the 
developing world. Although there have been notable improvements in some health 
indicators since independence was achieved in 1971, health status remains poor, 
thus making health and population among the most important development issues; 
• The Ministry of Health and Family Welfare has overall responsibility for health 
sector policy and planning; 
• Health care provision is highly pluralistic and a plethora of treatment options exist 
with non-government service provision predominating; 
• On a per capita basis, total health expenditure in the year 2002 was US$1 of which 
US$3 was public expenditure; 
• At the time data collection took place for this thesis (1999-2003), the GoB was 
undertaking the HPSP, which focuses on the provision and utilisation of an essential 
package of services consisting of reproductive health care; communicable disease 
control; limited curative care; and child health care, under which the national 
immunisation programme falls; 
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• The EPI in Bangladesh was established in 1979 and became fully operational in 
1985. Increase in coverage was achieved first in rural areas. USAID implemented a 
programme to strengthen vaccination services in urban areas of Bangladesh in 1988; 
• The GoB faces significant resource constraints in funding the ESP. It has argued 
that the potential for additional resource mobilisation is limited, and that 
improvements in the efficiency of health care services must be a critical component 
of efforts to provide the ESP to the whole population. 
The next chapter presents the costs of delivering routine vaccination services in Dhaka 
City. 
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CHAPTER 6 
VARIATION IN THE COSTS OF DELIVERING ROUTINE 
VACCINATION SERVICES IN DHAKA, BANGLADESH 
This chapter presents the costs of delivering routine vaccination services in Dhaka City. 
After a brief introduction, there are three parts to this chapter. The first focuses on 
describing the methods used, in particular, the study design, sampling, data collection 
and analysis. The second part describes the data and results, focussing on: the total and 
mean cost per delivery unit by type and ownership; number and type of doses 
administered and wasted by type and ownership of delivery unit; and finally the 
weighted mean cost per dose by type and ownership of delivery unit. The chapter 
concludes with a summary of the chapter. 
6.1 Introduction 
A comprehensive review of the Bangladeshi national immunisation programme in 1998 
recommended the need for collecting cost information from urban areas (EPI 1998). 
While Khan and Yoder (1998) and Levin et al. (1999) both estimated the cost of the 
national immunization programme, neither reported the costs of the urban component of 
the programme, choosing rather to use a range of assumptions to extrapolate the costs of 
the rural component to urban areas.42 
42 Lacking data from urban settings, Khan and Yoder (1998) uused the costs of rural personnel as a proxy 
for those located in urban areas. They used a range of 14% to 25% of the cost of rural personnel as a 
proxy for the cost of urban personnel, which resulted in a range of$I1.58 to $11.96 per FVC (the cost per 
dose varied from $0.69-$0.71); in total, EPI activities cost about $18 million in 1997-98 prices. A year 
later, Levin et a1. (1999) estimated total cost of the routine national immunisation programme to be $28.9 
million resulting in $0.84 per dose and $18.06 per FVC. 
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While there has been some reports of the cost of providing vaccination services (e.g. 
Brenzel and Claquin 1994), few studies to date have detailed intra-country variation of 
these costs (Walker et al. 2004)43. Indeed, in the application of CEA of health services, 
it is rare to see detailed cost analyses across units. Cost data can provide valuable 
information for national decision-makers and development partners. It can help EPI 
programme managers to: strengthen national budgeting and planning; identify 
inefficiencies (e.g. high wastage rates, 'high' cost providers which might indicate 
inefficiency); and, identify priorities as an input to CEAs. However, the 
representativeness of reported costs is frequently questionable as they are often based on 
national estimates of total expenditure or estimates from a few facilities. Hence 
variation in the expected costs (and benefits) at sub-national levels is often not 
addressed. Therefore, as noted by the Immunization Financing Database team, "Further 
work is needed to better understand the sources of variation we find in the cost of 
immunization programs. Understanding this variability will be extremely useful for 
future analyses ... " (WHO 2005). Systematic and significant variation in unit costs 
between production units, can present a powerful basis for benchmarking and for 
identifying relatively inefficient units. 
In particular, the potential bias and inefficiencies involved in transferring data without 
resolving our understanding of variation could introduce inefficient interventions or halt 
the provision of efficient interventions. Alternatively variation within and between 
settings may not exist or may not significantly affect conclusions. It is therefore vital 
that research continues to assess how serious a problem this is and whether it leads to 
any systematic misallocation of resources. Different levels of efficiency in programme 
43 Both Khan and Yoder (1998) and Levin et al. (1999) used a top-down approach to costing. 
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operation within a particular setting would affect the unit costs of providing vaccines, 
which is the focus of the next chapter. 
6.2 Aim and objectives 
The overall aim of this chapter is to report and describe variation in the costs, from the 
perspective of providers, of delivering routine EPI in DCC, Bangladesh. The specific 
objectives are to: 
• estimate the total cost of providing vaccination services and unit cost per antigen 
administered in DCC using standard costing methods; 
• describe variation in these costs across providers; 
• rank delivery units from the highest to lowest unit cost per dose administered. 
6.3 Methods 
6.3.1 Dhaka City Corporation 
Dhaka City Corporation is the largest of four city corporations in Bangladesh with an 
estimated population of 5,622,298 in the year 200044• Rapid population growth rate of 
6% has resulted in high population density peaking at 300-600 people per acre in the 
'slum' areas of Dhaka. DCC area is divided into 10 administrative zones and 90 wards. 
Average population in each zone is about 562,229, with the largest population in zone 4 
(843,489) and the smallest in zone 10 (325,189). See Figure 12 for a map of Dhaka 
City. 
44 The estimate ofDCC area population for 2000 was calculated using the 1991 Census of Bangladesh. 
An annual growth rate of 6% was assumed. 
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Figure 12: Map of Dbaka City Corporation 
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Source: http://www.dhakacity.orglhtmVabout_dcc.html 
Table 8 presents the results from the 1999 national coverage survey for DCC. These 
figures illustrate that access to vaccination services per se is not a problem as evidenced 
by a coverage rate of 93% for BCG. There is a problem though of ensuring that 
mothers return with their children to complete the schedule at the appropriate time, as 
evidenced by the high drop-out rate between DPTI and DPT3. 
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Table 8: Results of 1999 national vaccination coverage evaluation survey for Dhaka City 
Corporation 
Antigen Valid coverage Crude coverage ~3 
BCG 93.3 93.3 
OPVl 89.9 93.8 
OPV2 78.1 90.4 
OPV3 73.7 87.5 
OPTl 88.4 92.3 
OPT2 79.0 89.9 
OPT3 74.6 87.0 
Measles 70.0 75.5 
Fully vaccinated46 60.8 75.5 
Source: 1999 National Coverage Evaluation Survey (EPI 2000) 
6.3.2 Selection of sample 
A comprehensive list of all facilities involved in the delivery of EPI services in DCC 
was used as the sampling frame to select a random sample of facilities. This list was 
prepared by the ICDDR,B to better understand the supply environment of primary 
health care services in Dhaka City (Mazurnder et al. 1997). In 1998 there were 511 
vaccination delivery units in DCC. The information contained in the list was used to 
stratify the EPI delivery sites by type (fixed or outreach) and location (zone). For the 
classification of the EPI sites by type, delivery units operating one day or less per week 
were defined as outreach sites while all others were categorised as fixed sites. From 
each of the defined stratum, 25% of facilities were chosen at random. This sampling 
procedure generated a sample of 132 EPI delivery sites.47 The classification of health 
4S Percentage of children vaccinated irrespective of the validity of the vaccination or age at 
administration. 
46 Percentage of children receiving all eight doses. 
47 It should be noted that no power calculation was undertaken to guide this sample size. 132 vaccination 
delivery units, representing approximately 25% of all units operating at the time in Ohaka City, were 
selected simply because time and money allowed the project team to do so. 
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facilities by ownership (government or NGD) could not be carried out prior to sampling 
as the listing of facilities did not contain this information. However, since the study 
selected a large proportion of all EPI sites at random (25%), the results of the survey 
should provide a reasonable indication of the relative importance of GoB and NGD 
providers of EPI services in urban Dhaka. 
Out of the 132 sites surveyed by the study, less than a quarter was GoB-run facilities. 
About 60% of all sites were NGD-run outreach centres. About 77% of the EPI delivery 
sites in Dhaka City were under NGD management and these sites organized 60% of all 
EPI sessions. The predominance ofNGOs in the delivery ofEPI in urban Bangladesh is 
in sharp contrast to the delivery structure in rural areas, where it is almost exclusively a 
publicly-run programme. 
6.3.3 Cost analysis 
Vaccination services have been costed by the 'ingredients' approach, in which the total 
quantities of goods and services actually employed in delivering the activities were 
estimated, and multiplied by their respective unit prices (Creese and Parker 1993). A 
structured questionnaire was used to collect information on resource use, including 
expenditure data, and the number of vaccinations administered for the calendar year 
1999 (see Appendix 5). This was pre-tested at non-sampled EPI delivery sites. 
Relevant information was obtained from various sources, including administrative 
records, interviews and direct observation. 
The first part of the instrument collected data on all capital and recurrent resources used 
in the process of delivering EPI services including donated items such as volunteer time 
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and space provided by communities. More specifically, the resources reviewed 
included: 
• capital items (resources typically with a unit cost greater than US$100 and / or a 
working life of greater than one year): equipment (e.g. refrigerator and cold boxes), 
furniture (e.g. tables and chairs) and vehicles; 
• recurrent items: staff (e.g. salaries and benefits of staff providing and / or supporting 
EPI services), rent (including utilities, operating and maintenance), vaccines, 
supplies (e.g. syringes and ice-packs) and short-term training. 
In lieu of obtaining the annualised value of land and buildings, the study collected 
information on the rent for facilities. If the facility was owned by the provider rather 
than rented (e.g. GoB facilities), the rental value for the facility was imputed on the 
basis of the average rent for similar sites in the same location. 
Capital costs were annualised using a 3% discount rate and the working life of all EPI-
related capital items was assumed to be five years. Joint (or shared) costs were 
apportioned to EPI on the basis of the proportion of time / space used for EPI activities. 
All figures are presented in 1999 US dollars using the average official exchange rate 
between January 1999 - December 199948 • 
The second part of the questionnaire collected information on other variables related to 
EPI services such as the number of sessions per month and year, the duration of these 
sessions and number of vaccines administered and wasted per session, month and year. 
48 1 USS = 49.50 Bangladeshi Taka 
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The unit cost of providing each vaccine was calculated in the following way: 
• the cost of the vaccine and the syringe (except for OPV which is administered 
orally) was assigned directly to each vaccine; 
• personnel, remaining recurrent items and all capital items with the exception of the 
cold-chain were distributed on the basis of the number of visits; 
• the costs of the cold-chain were distributed according to the vaccine doses 
administered. 
The calculation of number of visits took the following into account: 
• OPV and DPT vaccine doses were assumed to be administered at the same visits; 
• other vaccines, i.e. BCG, measles and IT are administered at separate visits. 
The weighted mean unit vaccine costs have been calculated using the number of 
vaccines administered as the weights. Also estimated and reported is the wastage rate, 
where the vaccine wastage is the proportion of vaccine supplied, but not administered to 
children, usually stated as a rate and calculated as: 
vaccine wastage rate = ([doses supplied - doses administered] I doses supplied) x 100. 
The cost per fully vaccinated child (FVC), as defined by the schedule, was also 
estimated, e.g. a child that received one dose of BCG, three doses of OPV, three doses 
of DPT and one dose of measles vaccine by their first birthday. 
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6.3.4 Missing data 
Delivery units with missing or 'incorrect' values were excluded from the analysis. The 
final data set consisted of 110 out of a possible 132 delivery units. Hence, 83.3% of all 
delivery units in the sample were included. Table 9 presents the total number of 
delivery units included in the final sample, split by location (zone), ownership (GoB or 
NGO) and type of delivery unit (fixed or outreach). 
Table 9: Final sample of vaccination delivery units 
Zone GoB NGO Total 
Fixed Outreach Fixed Outreach 
3 0 2 6 11 
2 5 0 0 6 
3 2 0 0 2 4 
4 0 4 11 16 
5 4 0 2 4 10 
6 0 2 6 9 
7 0 0 2 14 16 
8 2 11 15 
9 0 2 16 19 
10 0 0 3 4 
Total 17 5 15 73 110 
The type of data missing included: ownership form; duration of operation; and some of 
the inputs and outputs. 'Incorrect' values were identified after eye-balling the data. For 
example, where data indicated that a delivery unit had administered only one dose of 
each antigen it was excluded from the final sample on the grounds that this did not seem 
realistic, or plausible, given that the data were collected for the year 1999. This would 
suggest either that the data were entered incorrectly or that the delivery unit had only 
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operated for a very brief period of time during 1999. On some occasions outreach 
delivery units recorded administering a single dose of BCG and / or measles (n=13). 
While these data are suspicious, they are not entirely implausible given that both 
vaccines require a single dose to give protection against their respective diseases. 
Furthermore, a significant drop-out rate between DPT3 (given at 14 weeks of age) and 
measles (given at nine months of age) has been documented in coverage surveys in 
Dhaka and Bangladesh more generally. One delivery unit was excluded because a value 
of one was recorded for OPV when the other vaccines had values of 840, 360, 360 and 
360 for BCG, DPT, measles and IT respectively. As it was not possible to identify the 
cause of these 'incorrect' values, a decision to exclude them was taken. There were no 
systematic instances of missing data, i.e. missing data were evenly distributed across the 
zones and types of providers. 
6.4 Results 
6.4.1 Total and mean cost per delivery unit, by type and ownership 
The total and mean cost per delivery unit by type and ownership is shown in Table 10. 
Total annual cost of routine EPI services in the surveyed EPI delivery sites was found to 
be $197,583. The mean cost of running a vaccination delivery unit was $1,796 per year. 
However, mean costs vary by ownership type, most markedly among outreach units 
where the annual mean cost for GoB outreach sites was $2,867 compared to $1,070 for 
NGO outreach sites. The annual mean cost of fixed sites was $3,328 and $3,228 for 
GoB and NGO sites respectively. 
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Table 10: Total and mean cost per vaccination delivery unit, by type and ownenbip, in 1999 USS 
Type of facility 
GoB fixed (0= 17) GoB outreach (0=5) NGO fixed (0=15) NGO outreach (0=73) Total (0=110) 
Item Total cost Mean cost Total cost Mean cost Total cost Mean cost Total cost Mean cost Total cost Mean cost 
per facility per facility per facility per facility per facility 
Capital items 
Vehicles 0 0 0 0 0 0 300 4 300 3 
Equipment 1,187 70 124 25 2,102 140 2,485 34 5,897 54 
Furniture 631 37 102 20 1,221 81 881 12 2,836 26 
Subtotal 1,817 107 222 44 3,323 222 3,366 46 8,728 79 
Recurrent items 
Personnel 38,554 2,268 11,122 2,224 31,187 2,079 54,239 743 135,103 1,228 
Rent 4,588 270 481 96 6,288 419 3,420 47 14,777 134 
Vaccines 10,797 635 2,237 447 6,468 431 13,512 185 33,013 300 
Supplies 629 37 88 18 543 36 1,496 20 2,756 25 
Training 191 11 187 37 763 51 1,765 24 2,906 26 
Subtotal 54,759 3,221 14,115 2,823 45,249 3,017 74,432 1,020 188,554 1,714 
Total 56,576 3,328 14,337 2,867 48,572 3,238 78,098 1,070 197,583 1,796 
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6.4.2 Output of the delivery units 
Table 11 reports a range of output measures. The surveyed delivery sites provided an 
average of 2,232 vaccinations during 76 sessions per year or 34 vaccinations per 
session. Each session lasted for an average 4.2 hours, thus providing an average of nine 
vaccinations per hour. OPV doses are the most common type of vaccine provided by all 
delivery units, followed by DPT, whereas doses of BeG and measles are the least 
regularly provided. The NGO and GoB outreach sites administer the least number of 
vaccinations, whilst the GoB fixed sites provide the most number of doses per annum. 
Table 11: Mean number of vaccine doses administered by type and ownership 
Type offacility 
GoB fixed GoB outreach NGO fixed NGO outreach Total 
(n=17) (n=5) (n=15) (n=73) (n=110) 
Vaccines 4,462 3,437 3,493 1,370 2,232 
BCG 534 300 347 186 267 
DPT 1,232 1,085 1,008 350 609 
OPV 1,552 1,248 1,080 461 750 
Measles 491 334 210 118 198 
IT 654 470 847 256 408 
Number of sessions 172 48 138 43 76 
Vaccinations per session 29 72 30 33 34 
Duration of session (hours) 4 3 6 4 4 
Vaccinations per hour 8 21 7 9 9 
Table 11 illustrates that mix of vaccines provided varied systematically across delivery 
units. There could be several reasons for this. First, there has been a worldwide mass 
campaign to eradicate polio for many years and therefore more people could be aware 
of the benefits of the polio vaccine and consequently demand is higher for this vaccine 
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vis-a-vis the other vaccines available. In addition, the schedule requires three doses so it 
is perhaps not surprising that this is the most common vaccine administered. Similarly, 
it is not surprising to note that the BeG and measles vaccines are the least provided 
when they only require one dose each. However, it is interesting to note that OPT and 
OPV doses are supposed to be delivered together but the number of OPT doses 
delivered was about 19% lower than for OPV (Table 12). 
Table 12: Drop-out rates between BeG and measles, and DPT3 and measles 
GoB GoB NGO NGO Total 
fixed outreach fixed utreach 
BCG 534 300 347 186 267 
DPT3 411 362 336 117 203 
Measles 491 334 210 118 198 
MeaslesIBCG 92% 111% 61% 63% 74% 
MeaslesIDPT3 119% 92% 63% 101% 97% 
6.4.3 Unit costs 
Table 13 presents the mean number of vaccine doses administered, wastage, weighted 
cost per antigen and the cost per Fve by type and ownership of delivery unit. Vaccine 
wastage rates are highly variable across delivery units. For example, the BeG wastage 
rate among NGO outreach sites was 43% compared to 67% among GoB outreach sites. 
Wastage rates are highest for BeG (43 - 67%) and lowest for DPT (12 - 30%). The 
weighted mean cost per dose administered across type and ownership varied most for 
measles ($1.23 - $2.55) and least for OPT ($0.47 - $0.58). The cost per Fve ranged 
from $5.20 - $7.56. 
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Table 13: Mean number of doses administered, wastage and weighted mean cost per dose and fuDy vaccinated child, by type and ownenhip, in 1999 USS 
Type of facility 
GoB fixed (n= 17) GoB outreach (n=5) NGO fixed (n=15) NGO outreach (n=73) 
Vaccine No. of doses Wastage Cost per No. of doses Wastage Cost per No. of doses Wastage Cost per No. of doses Wastage Cost per 
administered (%) dose administered (%) dose administered (%) dose administered (%) dose 
BeG 534 55 1.08 300 66 1.54 347 60 1.52 186 43 0.96 
OPT 1,232 27 0.51 1,085 12 0.47 1,008 20 0.58 350 30 0.57 
OPV 1,552 33 0.46 1,248 43 0.49 1,080 34 0.59 461 33 0.49 
Measles 491 46 1.23 334 43 1.47 210 63 2.55 118 48 1.58 
FVC 5.20 5.87 7.56 5.72 
IT 654 47 0.79 470 42 0.92 847 27 0.59 256 38 0.66 
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A second method was used for calculating the cost per FVC. Based on a crude birth 
rate of 20.4 per 1,000 population there were estimated to be 114,695 births in the year 
2000.49 The infant mortality rate of 51 per 1,000 live births was assumed, and most of 
these deaths occur early in the first year. 50 Thus, about 95% of live births (108,845) 
were assumed to survive to the recommended age of vaccination (9-12 months). The 
cost per fully vaccinated child was determined by dividing 60.8% (see Table 8) of the 
number of children under the age of one year (66,178) by the cost of the programme 
(4.65 51 x $197,583 = $917,862). This yielded a cost of $13.87 per fully vaccinated 
child. 
Table 14 provides a breakdown of the weighted mean cost per dose administered by 
type and ownership of delivery unit. The mean fixed cost per dose (comprising capital 
items and salaries, which are fixed in the short-term) accounted for between 71 - 79% 
of the total mean cost per dose administered. The introduction of newer, more 
expensive vaccines such as those against hepatitis B, Haemophilus injluenze type b and 
rotavirus would reduce the proportion of fixed costs. 
49 The estimate of the crude birth rate for 2000 was calculated using the Bangladesh Bureau of Statistics 
estimate for 1996 (BBS 1997). It was assumed that trends observed from 1993-97 continued. 
50 The estimate of the infant mortality rate for 2000 was calculated using the Bangladesh Bureau of 
Statistics estimate for 1996 (BBS 1997). It was assumed that trends observed from 1993-97 continued. 
51 The total number of vaccination delivery units in Dee (n=511) divided by the total number of 
vaccination delivery units in the sample (n= 110). 
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Table 14: Weighted mean cost per vaccine delivery per dose, by type and ownership, in 1999 US$ 
Type of facility 
GoB fixed (n=17) GoB outreach (n=5) NGO fixed (n=15) NGO outreach (n=73) Total (0=110) 
Item Cost %of Cost %of Cost %of Cost %of Cost %of 
per dose total cost per dose total cost per dose total cost per dose total cost per dose total cost 
Capital items 
Vehicles 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.38 0.00 0.15 
Equipment 0.02 2.10 0.01 0.87 0.04 4.30 0.02 3.18 0.02 2.98 
Furniture O.oI 1.12 0.01 0.71 0.02 2.15 0.01 1.13 0.01 1.44 
Subtotal 0.03 3.21 0.01 1.58 0.06 6.45 0.04 4.69 0.04 4.42 
Recurrent items 
Personnel 0.51 68.15 0.65 77.58 0.60 64.52 0.54 69.45 0.55 68.38 
Rent 0.06 8.11 0.03 3.36 0.12 12.90 0.03 4.38 0.06 7.48 
Vaccines 0.14 19.08 0.13 15.60 0.12 12.90 0.14 17.30 0.13 16.71 
Supplies 0.01 1.11 0.01 0.61 0.01 1.07 O.oI 1.92 O.oI 1.39 
Training 0.00 0.34 0.01 1.30 O.oI 1.07 0.02 2.26 0.01 1.47 
Subtotal 0.72 96.79 0.82 98.45 0.86 93.55 0.74 95.31 0.77 95.43 
Total 0.75 100.00 0.83 100.00 0.94 0.03 0.78 100.00 0.80 100.00 
Due to rounding some items may appear to account for zero cost 
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Table 15 presents the unit cost per dose for all 110 vaccination delivery units. The 
weighted mean cost per dose administered was $0.80. The unit cost per dose ranged 
from $0.20 - $ 7.99; a 40-fold difference. 
Table IS: Cost per dose of individual vaccination deUvery units, in 1999 USS 
ID# Cost per dose ID# Cost per dose ID# Cost per dose ID# Cost per dose 
0.48 29 0.60 57 7.99 85 1.77 
2 2.23 30 0.41 58 1.82 86 0.54 
3 0.77 31 0.27 59 1.16 87 1.65 
4 0.80 32 1.53 60 2.29 88 1.03 
5 0.24 33 1.51 61 3.38 89 1.43 
6 0.23 34 0.97 62 1.03 90 1.76 
7 0.76 35 0.45 63 1.30 91 0.37 
8 1.01 36 0.48 64 0.44 92 0.64 
9 0.22 37 4.05 65 0.60 93 0.86 
10 0.42 38 2.21 66 0.87 94 1.46 
11 3.33 39 4.51 67 0.77 95 0.30 
12 0.66 40 1.03 68 1.59 96 0.82 
13 1.06 41 0.34 69 0.79 97 2.03 
14 1.04 42 1.00 70 0.27 98 0.77 
15 0.52 43 0.60 71 0.69 99 2.l0 
16 0.45 44 1.26 72 1.98 100 0.40 
17 0.81 45 0.92 73 0.48 101 0.67 
18 0.20 46 0.65 74 1.94 102 1.77 
19 0.48 47 3.27 75 1.37 103 1.35 
20 1.74 48 4.37 76 5.45 104 3.67 
21 0.39 49 2.12 77 2.76 105 0.37 
22 2.43 50 4.66 78 1.74 106 1.48 
23 1.04 51 3.11 79 1.32 107 0.76 
24 0.47 52 1.57 80 1.88 108 6.02 
25 0.49 53 2.20 81 0.69 109 3.99 
26 0.43 54 1.80 82 1.38 110 0.71 
27 2.04 55 0.65 83 0.72 
28 1.08 56 1.46 84 0.79 
Variation in the unit costs can be explained, in part, by the volume of output at each 
delivery unit and the wastage rates (Figures 13 and 14). The relationships suggest that 
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as the number of vaccines administered increases the unit cost decreases, and that the 
unit costs are lower when wastage rates are low. In general there is a positive 
correlation between the cost per vaccine dose and wastage (0.49), and this relationship 
is significant at the 0.01 level. Conversely there is a negative correlation between the 
unit cost and output (-0.39), which is also significant at the 0.01 level. 
Figure 13: Relationship between wastage and cost per dose in the vaccination delivery units 
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Figure 14: Relationship between service volume and cost per dose in the vaccination delivery units 
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6.5 Summary 
• DeC is the largest of six city corporations in Bangladesh. Rapid population growth 
rate of 6% has resulted in high population density peaking at 300-600 people per acre 
in the 'slum' areas of Dhaka; 
• This is the first study to report the costs of delivering vaccines in urban Bangladesh. 
The overall aim of this chapter was to report and describe variation in the costs, 
from the perspective of providers, of delivering routine EPI in DeC, Bangladesh; 
• The final data set consisted of 110 out of a possible 132 delivery units. Hence, 
83.3% of all delivery units in the sample were included; 
• The weighted mean cost per dose was $0.80. The unit cost per dose ranged from 
$0.20 - $7.99; a 40-fold difference; 
• This chapter estimated the cost per FVe to be between $5.20 - $13.87; 
• These data suggest that there are economies of scale attributed to vaccination 
clinics. The main reason for this relationship is the large fixed cost component per 
facility; 
• Systematic and significant variation in unit costs between production units can 
present a powerful basis for benchmarking and for identifying relatively inefficient 
units. 
The next chapter examines the same data by applying parametric and non-parametric 
efficiency measurement techniques. 
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Chapter 7 
DATA ENVELOPMENT AND STOCHASTIC FRONTIER 
ANALYSIS OF VACCINATION SITES IN DHAKA CITY 
CORPORATION 
This chapter examines the efficiency of the same vaccination delivery units presented in 
Chapter 6, derived by DEA and SFA. After a brief introduction, there are six parts to 
this chapter. The first describes the specific aim and objectives of this chapter. The 
second provides a description of the data used in the subsequent analyses. The third 
focuses on selecting the model specifications, in particular the inputs and outputs for the 
analyses. In total, nine specifications were included in this analysis; three for the DEAs 
and six for the SF As. The fourth part provides an overview of the performance of 
vaccination delivery units based on the nine specifications, focussing on a summary of 
the efficiency scores, and for the DEA specifications, the number of efficient delivery 
units and number of times these efficient units act as peers for inefficient units. This 
fourth section of the chapter also includes a discussion of two issues: changing the 
number of inputs and outputs; and the stability of efficiency scores and rankings across 
specifications. The fifth section presents some policy implications of the results, in 
particular the level of potential savings and targets for improved performance. The 
chapter concludes with a summary. 
7.1 Introduction 
The idea of an 'efficient' health facility is derived from the neoclassical production 
model in which health care providers choose the mix of inputs that minimise cost with a 
given demand. Under certain circumstances this is a reasonable characterisation of the 
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behaviour of some privately owned finns. However, cost-minimisation is only one 
among many possible objectives of the public sector. The existence of mUltiple goals 
may lead to compromises between, for example, improving access and minimising 
costS2• This may produce outcomes that are observationally equivalent to, but 
nonetheless different from, 'inefficient'. Furthennore, the specific incentives and 
constraints facing the public sector may lead to managerial behaviour that is actually 
inconsistent with cost-minimisation, for example, satisfactions3 • Thus, in the context of 
the particular institutions within which public providers operate, 'efficient' production 
may not be a realistic policy goal. Rather the objective should be to improve efficiency. 
One way to do this is to identify those facilities that are perfonning relatively better than 
others. The factors that are associated with these perfonnance differentials can then be 
identified, and interventions developed which can help bring the perfonnance of the 
'worst' facilities closer to that of the 'best' ones (Somanathan et aI. 2000). 
The previous chapter illustrated that the unit cost per dose delivered in a sample of 110 
vaccination delivery units in Dhaka City ranged from $0.20 - $7.99; a 40-fold 
difference. Systematic and significant variation in unit costs between production units 
can present a powerful basis for benchmarking and identifying relatively inefficient 
units. It is useful to know the level of congruence between unit cost data and efficiency 
scores obtained through the use of parametric and non-parametric efficiency 
measurement techniques. 
52 Due to the randomness of demand, on any given day the administrator of a health facility cannot predict 
with perfect certainty the number of individuals who will demand services. Without an active 
appointment schedule process, there is no way for staff to control the stochastic demand of potential 
patients (Dervaux et al. 2003). Hence, in order to vaccinate a certain number of children, some amount of 
excess capacity is required. 
S3 In 1966 Harvey Leibenstein published his seminal paper on X-efficiency, which allowed for non-
maximising behaviour (Leibenstein 1966). 
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Asking whether vaccination services are technically and scale efficient is important for 
a number of reasons. First, identifying sources of inefficiency in a programme may 
yield helpful insights to potential cost reductions. For example, some programmes may 
utilise too many inputs to produce outputs. By identifying this technical inefficiency, 
the programme could reduce input levels while maintaining output production at a lower 
cost. This would by definition make the programme more cost-effective. Second, it 
offers the chance to question the scale efficiency of existing services, with a view to 
recommending the appropriate size of delivery units. 
7.2 Aim and objectives 
The overall aim of this chapter is to assess the efficiency of routine vaccination services 
in DCC. The specific objectives are to: 
• estimate the efficiency of a sample of vaccination delivery units using DEA and 
SFA; 
• compare and contrast the results of the DEAs, SF As and unit costs obtained in the 
preceding chapter; 
• explore the effects of different specifications, e.g. changing the number of inputs / 
outputs, on efficiency scores and ranks; 
• for the DEA models, decompose technical efficiency into 'pure' technical and scale 
efficiency; 
• for the SF A models, compare the impact of applying different weights to outputs 
when aggregating output into a single measure; 
• investigate possible causes for differences in the efficiency scores among the sample 
of vaccination delivery units using a selection of environmental variables; 
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• consider the policy implications of the results, in particular the potential savings and 
related corollary, targets for improvement. 
7.3 Data 
Chapter 6 presented the results of a cost analysis of vaccination services in DCC. These 
data also provide the opportunity to assess the efficiency of EPI provision. As stated 
previously, the final data set consisted of 110 out of a possible 132 delivery units. 
Hence, 83.3% of all delivery units in the sample were included. 
For each delivery unit, inputs are defined as the number of full time equivalent (FTE) 
medical staff, size of the facility dedicated to the delivery of vaccines services (in 
square feet), the annual total number of hours of operation and the total annual cost. Six 
outputs were defined for each delivery unit: the number of doses of BCG, DPT, OPV, 
measles and IT vaccines administered in 1999, and the total number of all types of 
vaccines administered during the same period, to children less than five years of age and 
pregnant women. 
Table 16 contains the descriptive statistics of inputs and outputs. OPV vaccine was the 
most common type of vaccine provided, whereas the measles vaccine was the least 
regularly provided. The inputs and outputs are highly skewed. See Appendix 6 for 
information on the location, type of ownership and type of vaccination delivery unit for 
each of the 110 vaccination delivery units. 
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Table 16: Descriptive statistics of inputs and outputs for 110 vaccination delivery units 
Variable Mean Std. Dev. Min Max 
Inputs 
labour 2.98 3.14 20 
size of facility dedicated to 1,805 2,745 35 13,068 
delivery of EPI services 
total hours54 362 410 30 2,700 
total cost 2,075 2,379 238 15,077 
Outputs 
BCG 267 305 1,680 
DPT 609 699 24 3,264 
OPV 750 856 48 3,756 
Measles 198 214 960 
TT 408 452 12 2,208 
total number of vaccinesss 2,232 2,275 98 9,696 
7.4 Methods 
7.4.1 DEA models 
Given the Government's stated objective to mobilise additional resources vIa 
improvements in the efficiency of health facilities (see Chapter 5), input-orientated 
specifications under VRS have been adopted for each model, which considers what 
reduction in inputs is possible given existing levels of outputs. However, it should be 
noted that this specification runs contrary to the Government's stated objective of 
increasing routine DPT3 vaccination coverage by 12 months of age to 90% in each 
district by 2005. 
54 Annual number of sessions x hours per session. 
ss BCG, OPV, OPT, measles and TT. 
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For each model, the technology was initially constructed under CRS and strong 
disposability of inputs, TEcRS (as inputs increase, outputs must increase, ceteris 
paribus). Allowances were made in the constraints to allow for VRS technical 
efficiency (TEvRS). Further, the type of scale inefficiencies was determined by 
employing a third model, TENIRS. In all these cases the definitions given by Hire et al. 
(1994) were followed, which were described in more detail in Chapter 3. The DEAP 
programme by Coelli (1996a) was used for the computations. 
The linear programming problems are presented belows6• 
Linear programming problem 1: CRS technology 
FQ(TEcRS) = min..t 
s.t. ui ~ zM 
).q ~ zQ 
Z E 9l i + 
where Q is total costs, u is the outputs of each vaccination delivery unit "j", M is the 
matrix of outputs, i.e. the vaccines, q is the input costs and z is the intensity variable 
applied to costs and the outputs. 
In order to allow for VRS, a second linear programming problem is solved. 
S6 The linear programming problems presented here are where total cost is the sole input. See Chapter 3 
for the general specifications. 
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Linear programming problem 2: VRS technology 
Aq~zQ 
Z E~j 
+ 
The constraint on the z vector in the second linear programming problem allows the 
data to be enveloped more closely which in tum permits VRS to be exhibited. If the 
solutions to the two linear programming problems are equivalent then the technology is 
said to be operating at a cost, as well as a scale, efficient level. However, if they are not 
equal, to what extent inefficiency is caused due to operating at the wrong scale can be 
determined. Determining the type of scale inefficiency (either increasing returns to 
scale or decreasing returns to scale) requires the solution of a third linear programming 
problem, referred to as non-increasing returns to scale technology (NIRS). 
Linear programming problem 3 
FQ (TENlRS) = min A 
Aq~zQ 
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In order to define the type of scale inefficiency that is operating here, the solutions of 
TEcRS 
the three linear programming problems are compared. If --< 1 and TEcRS = TENIRS TEvRS 
TEcRS 
then increasing returns to scale exist. If--< 1 but, TENIRS > TEcRS, then decreasing TEvRS 
returns to scale exist. If TEcRS = TEvRS then by definition the vaccination delivery unit 
is operating under CRS. Using these models, the impact of scale effects on the delivery 
units can also be examined. 
Three DEA specifications were chosen, with outputs ranging from one to five and 
inputs ranging from one to three (see Table 17). As stated previously, a rule of thumb 
commonly used with DEA suggests that the number of observations in the data set 
should be at least three times the sum of the number of input and output variables 
(Cooper et al. 2003), i.e. for model DEA2 which has the most inputs (n=3) and outputs 
(n=5), the data set should contain at least 24 observations (3 x [3 + 5] = 24). An 
alternative rule of thumb suggested by Dyson et al. (2001) states that the number of 
observations should be at least twice the product of the number of inputs and outputs, 
i.e. model DEA2 should be run with a data set containing at least 30 observations (2 x 3 
x 5 = 30). According to either of these rules of thumb and the specifications chosen, the 
final sample size of 110 vaccination delivery units is acceptable. 
Appendices 7-9 present the data sets used for models DEAl, DEA2 and DEA3. 
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Table 17: DEA specifications 
Specification DEAl DEA2 DEA3 
Inputs 
labour ./ ./ 
facility size dedicated to EPI ./ ./ 
total hours ./ ./ 
total cost ./ 
Outputs 
BCG ./ ./ 
DPT ./ ./ 
OPV ./ ./ 
Measles ./ ./ 
IT ./ ./ 
total number of vaccines 
7.4.2 SFA models 
Frontier Version 4.1 (Coelli 1996b) was used to estimate a Cobb-DouglasS7 production 
frontier assuming a half-normal distribution: 
In(YI) = XI{l + VI - Ui , i = 1, ... , n 
where: 
In(yj) = logarithm of the production of the i th firm 
Xj = a vector of the logarithm of the input quantities of the i th firm 
P = a vector of unknown variables 
Vi = assumed to be independent and identically distributed normal random (stochastic) 
variables with mean zero and constant variance, av2 (N[O, a/]), and independent of the 
Uj 
57 The frontier programme estimates models which are linear in parameters. Hence to estimate a Cobb-
Douglas production frontier, the logarithms of the sample data were estimated. 
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Uj = non-negative random variables which are assumed to account for technical 
inefficiency in production and often assumed to be independent and identically 
distributed IN(O, <Jv 2)1 
Frontier Version 4.1 (Coelli I 996b ) was also used to estimate a translog58 production 
frontier assuming a truncated normal distribution: 
In(YI) = XiP + VI - Ui , i = I, ... , n 
where: 
In(yj), Xi, P and Vj are as defined above, and Uj has truncated normal distribution. The 
truncated normal distribution is a generalisation of the half-normal distribution. It is 
obtained by the truncation at zero of the normal distribution with mean, J..l, and variance, 
~. If J..l is pre-assigned to be zero, then the distribution is the half-normal. 
A general SF A specification was adopted in which the total number of vaccines was the 
output and three inputs (labour, size of the facility dedicated to the delivery of 
vaccination services and total hours) were considered. A limitation of SFA is that it's 
only well-developed for single-output technologies, or where it is acceptable to 
aggregate output into a single measure. Therefore, another objective of this chapter was 
to compare the impact of applying different weights to outputs when aggregating output 
into a single measure. Three different approaches for weighting outputs are compared: 
a unit weight applied to all outputs; weights inferred by the price of the vaccines; and 
weights inferred by the public health importance of the vaccine-preventable diseases in 
question (using DALYs as the indicator of importance). 
S8 The transcendental logarithmic function allows a wide range of non-linear models to be expressed in 
linear fOnD. It includes the logarithm of every explanatory variable, as well as their products and cross-
products. 
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Therefore, as both a Cobb-Douglas production frontier assuming a half-nonnal 
distribution and a translog production frontier assuming a truncated nonnal distribution 
were estimated, a total of six different models were run. Appendix 10 presents the data 
sets used for models SF AI-SF A6. 
Table 18: SFA specifications 
Method of aggregating outputs Cobb-Douglas Translog 
production frontier production frontier 
Unit weights SFAI SFA2 
Weights defined by price SFA3 SFA4 
Weights defined by DALYs SFA5 SFA6 
7.4.3 Analysis of environmental variables 
The ANOVA59 test was conducted in order to test the null hypotheses that the mean 
technical, 'pure' technical and scale efficiencies of the delivery units are the same 
across the: 
10 locations (zones 1 - 10); 
two types of ownership of the delivery units (GoB or NGO); 
two types of delivery unit (fixed or outreach); and 
type of ownership and delivery unit (fixed GoB, fixed NGO, outreach GoB, 
outreach NGO) 
against the alternative hypotheses that they differ from one another. As the ANOVA 
test requires the population variances to be equal, the results derived from this test alone 
may not be valid. Therefore, the Kruskal-Wallis test, the non-parametric version of the 
59 The One-Way ANOV A procedure produces a one-way analysis of variance for a quantitative 
dependent variable by a single factor (independent) variable. Analysis of variance is used to test the 
hypothesis that several means are equal (Altman 1991). 
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ANOVA test (Altman 1991), was also perfonned, which does not require any 
assumptions regarding the nonnality or variances of the populations. 
A correlation coefficient is an index that quantifies the linear relationship between a pair 
of variables (Altman 1991). The coefficient takes values between -1 and +1, with the 
sign indicating the direction of the relationship and the numerical magnitude of its 
strength. Values of -1 and + 1 indicate that the sample values fall on a straight line. A 
value of zero indicates the lack of any linear relationship between the two variables. 
The Pearson correlation coefficient, and two non-parametric correlation coefficients 
were estimated: Spearman's rho, which is a rank correlation coefficient, and Kendall's 
tau statistic, which likewise measures the correlation between two sets of rankings. 
Correlation coefficients were estimated between the efficiency scores and the number of 
years the delivery unit had been open, population density, male / female ratio and 
literacy. Table 19 presents the descriptive statistics of these variables. In can be seen 
that the vaccination delivery units had been open for slightly more than five years on 
average. The mean population density was 51,572 people per square lan, mean male-to-
female ratio was 1.34 and the mean literacy rate was 62%. 
Table 19: Descriptive statistics of the environmental variables60 
Environmental variable Mean Std. Dev. Min Max 
Years delivery site has 5.20 4.55 22 
been open since 2000 
Population density 51,572 42,180 4,555 168,181 
Male / female ratio 1.34 0.25 1.08 2.54 
Literacy 62.0 9.3 39.2 74.5 
60 Statistics for population density, male / female ratio and literacy are based on the ward statistics where 
the sites are located. 
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7.5 Results 
7.5.1 DEA models61 
Table 20 presents the efficiency results and shows that mean technical efficiency of the 
vaccination delivery units was 0.35, 0.41 and 0.32 in specifications DEAl, DEA2 and 
DEA3 respectively. In other words, under DEAl, if the vaccination delivery units were 
technically efficient and operated at the correct scale, costs could be reduced by 65% 
without sacrificing the current level of outputs produced. By decomposing this 
technical measure into 'pure' technical efficiency (TE VRS) and scale efficiency, it can 
be shown that slightly more of the technical inefficiency is due to units incurring too 
much cost in providing vaccines rather than operating at the wrong size. However, both 
sources of this technical inefficiency would have to be addressed for these units to 
become less wasteful of scarce resources. 
Table 20: Descriptive statisdcs of the DEA results (models DEAl-3) 
Measure Mean Std. deviation Min Max 
Technical efficiency 
DEAl 0.35 0.26 0.04 1.00 
DEA2 0.41 0.34 0.02 1.00 
DEA3 0.32 0.30 0.01 1.00 
'Pure' Technical efficiency 
DEAl 0.52 0.28 0.05 1.00 
DEA2 0.73 0.30 0.10 1.00 
DEA3 0.69 0.31 0.10 1.00 
Scale efficiency 
DEAl 0.66 0.25 0.11 1.00 
DEA2 0.57 0.35 0.02 1.00 
DEA3 0.49 0.35 0.01 1.00 
61 Appendices 11-13 show the unit-specific results. 
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A comparison between model DEA2, which has five outputs, and model DEA3, in 
which all the outputs are summed together (both models have the same three inputs), 
sheds light on the impact of aggregating outputs. It was found that the technical 
efficiency score drops from 0.41 to 0.32. A comparison between models DEAl and 
DEA2, which have one and three inputs respectively, but the same number of outputs 
(n=5), sheds light on the impact of aggregating inputs. It was found that the technical 
efficiency score increased from 0.35 to 0.41. These findings are consistent with the 
dimensionality issue raised in Chapter 3, whereby increasing the number of dimensions 
used in the characterisation of production reduces the discriminatory power of the 
analysis, i.e. it increases measured efficiency and the number of units identified as fully 
efficient (see below). 
Models DEAl - DEA3 suggest that the majority of units in this sample exhibited VRS. 
Table 21 shows that 87, 80 and 94 vaccination delivery units under specifications 
DEAl, DEA2 and DEA3 respectively, exhibited increasing returns to scale (IRS) 
(implying that they are too small). 17, 9 and 7 of the units under specifications DEAl, 
DEA2 and DEA3 respectively exhibited decreasing returns to scale (DRS) (implying 
that they are too large). And only 6, 21 and 9 of the units under specifications DEAl, 
DEA2 and DEA3 respectively were the 'right' size, i.e. they were operating at CRS. 
Table 21: Returns to scale in tbe vaccination delivery units (models DEAl-3) 
Types of returns to scale Number of delivery units 
DEAl DEA2 DEA3 
Increasing returns to scale 87 (79%) 80 (73%) 94 (85%) 
Constant returns to scale 6 (5%) 21 (19%) 9 (8%) 
Decreasing returns to scale 17 (16%) 9 (8%) 7 (6%) 
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7.5.1.1 'Efficient' units 
Table 22 presents the efficient vaccination delivery units by specification and the 
number of times that each of these vaccination delivery units act as peers. 
Table 22: Efficient vaccination delivery units and the number of times they are a peer 
Specification 
Efficient delivery unit DEAl DEA2 DEA3 Summation 
0 2 0 2 
4 0 4 6 10 
6 30 5 0 35 
9 75 22 22 119 
15 0 2 0 2 
16 0 9 0 9 
17 0 0 
18 63 18 17 98 
19 0 8 11 19 
21 0 5 6 11 
24 0 3 0 3 
29 0 4 0 4 
35 19 0 0 19 
40 0 0 
42 0 3 0 3 
70 36 0 0 36 
88 0 77 0 77 
91 0 26 14 40 
95 0 33 21 54 
96 0 3 0 3 
105 0 062 0 0 
Number of efficient delivery units 5 19 7 
62 Delivery unit 105 is efficient but does not act as a peer for any other delivery units. 
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Among the 110 vaccination delivery units, 21 of them were efficient (although one of 
these, delivery unit 105 did not act as a peer for any other delivery units) and acted as 
peers between 1 and 119 times across all three specifications. Only delivery units 9 and 
18 were efficient across all three models. Accordingly, these two units acted as peers 
the greatest number of times; 119 and 98 times each respectively. Delivery unit 9 is a 
fixed-NGO delivery unit, whereas delivery unit is a fixed-GoB unit. The former is 
located in zone 1, while the latter is located in zone 3. Therefore, these peers did not 
have similar characteristics (see Table 23). However, an additional six delivery units 
were efficient across two models; one of these is a fixed-GoB unit (4), while the 
remaining five are all outreach-NGO units (6, 19,21,91 and 95). Specification DEA2 
had the highest number of efficient delivery units (n=19), which is consistent with the 
dimensionality issue raised above and earlier in Chapter 3. 
A look at the other end of the efficiency scores shows that unit 108 is ranked third most 
inefficient and most inefficient in models DEAl (0.045), DEA2 (0.021) and DEA3 
(0.013) respectively (efficiency scores in brackets). Similarly, unit 57 is ranked the 
most inefficient, seventh most inefficient and fourth most inefficient in model DEAl 
(0.036), DEA2 (0.054) and DEA (0.035) respectively. It is also interesting to note that 
unit 96 was ranked second most inefficient under model DEAl (0.036), however it was 
deemed efficient under model DEA2 and had a rank of 13th most efficient (0.864) under 
model DEA3. 
Units 18,9,96, 108 and 57 have a cost per dose of $0.20, $0.22, $0.82, $6.02 and $7.88 
respectively, which ranks them as, from lowest to highest cost, 1 st, 2nd, 48th, 109th and 
158 
11Oth• Therefore, there appears to be a high level of congruence between the unit costs 
and the DEA efficiency results. 
Examination of the outputs for these five delivery units illustrates that the efficient units 
delivered far greater numbers of vaccines (Table 23). And it is also apparent that the 
inefficient units use much larger areas for providing vaccination services. 
Table 23: A comparison of the inputs and outputs for delivery units 9,18,57,96 and 108 
Variable 9 18 96 108 57 
Ownership NGO GoB NGO NGO NGO 
Type Fixed Fixed Outreach Outreach Fixed 
Location Zone 1 Zone 3 Zone 9 Zone 9 Zone 7 
Inputs 
labour 6 10 
facility size dedicated to EPI 270 600 150 1,600 1,000 
total hours 270 200 30 337 405 
total cost 970 1,561 9,785 582 4,347 
Outputs 
BeG 240 1,680 156 36 
OPT 1,164 1,800 420 24 180 
OPV 1,164 2,400 420 48 240 
Measles 300 960 36 24 
TT 1,548 960 180 24 72 
total number of vaccines 4,416 7,800 1,212 98 552 
7.5.2 SFA models63 
The use of unit weights meant that vaccines were given the following order of 
importance (from most to least): OPV, DPT, TT, BeG and measles. The use ofDAL Ys 
63 Appendix 14 shows the unit-specific results. 
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as weights meant that vaccines were given the following order of importance: DPT, 
measles, TT, BCG and OPV. And finally, the use of vaccine prices as weights infers 
the following order of importance: measles, OPV, DPT, BCG and IT. 
Table 24 presents the descriptive statistics of the SF A models. The mean efficiency of 
models SFAl, SFA3 and SFA5 was 0.487,0.524 and 0.476 respectively, for the Cobb-
Douglas production frontier assuming a half-normal distribution. For the translog 
production frontier assuming a truncated normal distribution, the mean efficiency of 
models SFA2, SFA4 and SFA6 was 0.275,0.247 and 0.289 respectively. 
Table 24: Descriptive statistics of the SFA results (models SFAl-6) 
Mean Std. Deviation Min Max 
SFAI 0.487 0.168 0.12 0.77 
SFA2 0.275 0.246 om 0.99 
SFA3 0.524 0.141 0.18 0.76 
SFA4 0.247 0.233 om 1.00 
SFA5 0.476 0.174 0.09 0.77 
SFA6 0.289 0.258 0.01 1.00 
It is interesting to note that the mean efficiency scores of the Cobb-Douglas production 
frontier models are higher than those observed for the translog models, although the 
maximum efficiency observed never reaches one. Across the six models, unit 108 was 
consistently the least efficient and unit 18 the most efficient. Therefore, there is a high 
level of congruence between the unit costs, DEA efficiency results and the SFA 
efficiency findings. 
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Table 25 shows the estimated coefficients of the stochastic Cobb-Douglas production 
frontier assuming a half-normal distribution (model SF AI) and the statistics for noise 
('Y) and the inefficiency component (LR test of the one-side error). A value of'Y of zero 
indicates that the deviations from the frontier are due entirely to noise, i.e. the model is 
equivalent to the traditional average response function, without the technical 
inefficiency effect Uj. On the other hand, a value of one indicates that all deviations are 
due to technical inefficiency. The null hypothesis that there are no technical 
inefficiency effects in the model can be conducted by testing the null and alternative 
hypotheses, Ho: 'Y = 0 versus HI: 'Y> O. 
Table 25: Estimated results of the stochastic Cobb-Douglas production frontier model (SFAl) 
Parameters p Standard error t-ratio 
Intercept (fJo) 5.716 0.833 6.860 
1n (labour) (fJ1> 0.390 0.138 2.826 
1n (size of EPI) (fJ2) 0.150 0.082 1.834 
1n (total hours) (fJ) 0.193 0.128 1.509 
0,2 1.844 0.897 2.054 
Y 0.693 0.372 1.861 
Log likelihood -156.929 
LR test of the one-sided error 0.608 
The results suggest that the null hypothesis can be rejected, that is the 'Y-estimate is 
greater than zero, which therefore implies that there are technical efficiency effects in 
the model and that the model is not equivalent to the traditional average response 
function. 
Table 26 shows the estimated coefficients of the stochastic translog production frontier 
assuming a truncated normal distribution (model SF A2). In this model, the 'Y-estimate is 
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equal to one, indicating that all deviations from the frontier are due entirely to technical 
inefficiency. 
Table 26: Estimated results of the stochastic translog production frontier (SFA2) 
Parameters p Standard error t-ratio 
Intercept <Po) 6.037 3.479 1.735 
In (labour) <PI) -1.793 1.461 -1.227 
In (size of EPI) <P2) -0.320 1.696 -0.188 
10 (total hours) <P3) 1.364 1.088 1.253 
(In labouri <P.) 0.130 0.154 0.848 
(10 size of EPI)2 <Ps) -0.107 0.099 -1.075 
(In total hours)2 <P6) -0.360 0.160 -2.245 
In (labour) • In (size of EPI) <P7) 0.076 0.101 0.750 
In (labour) • In (total hours) <Pa) 0.237 0.255 0.928 
In (size of EPI) • In (total hours) <P9) 0.361 0.129 0.279 
a/ 1.427 0.679 2.102 
Y 0.999 0.000 160,797.360 
J.I 1.722 0.458 3.757 
Log likelihood -148.708 
LR test of the one-sided error 4.547 
7.5.3 Comparison of the DEA and SFA efficiency scores and ranks 
Table 27 shows high correlation between the efficiency scores and ranks from the three 
DEA and six SF A specifications64• Correlation between the scores and ranks of three 
DBA specifications is upwards of 0.569 and 0.604 respectively. 
64 All correlations are significant at the 0.01 level (2-tailed) 
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Table 27: Correlations of unit cost, DEA and SFA results 
Unit DEAl DEA2 DEA3 SFAI SFA2 SFA3 SFA4 SFA5 SFA6 
costs 
Scores 
Unit costs 1.000 
DEAl -0.655 1.000 
DEA2 -0.517 0.636 1.000 
DEA3 -0.473 0.569 0.952 1.000 
SFAI -0.585 0.616 0.830 0.802 1.000 
SFA2 -0.475 0.614 0.834 0.855 0.810 1.000 
SFA3 -0.572 0.587 0.802 0.787 0.992 0.803 1.000 
SFA4 -0.461 0.627 0.798 0.825 0.790 0.975 0.786 1.000 
SFA5 -0.567 0.575 0.808 0.796 0.990 0.798 0.992 0.778 1.000 
SFA6 -0.456 0.578 0.784 0.827 0.804 0.943 0.799 0.951 0.814 1.000 
Ranks 
Unit costs 1.000 
DEAl -0.951 1.000 
DEA2 -0.705 0.650 1.000 
DEA3 -0.680 0.604 0.964 1.000 
SFAI -0.721 0.658 0.905 0.923 1.000 
SFA2 -0.688 0.622 0.873 0.907 0.919 1.000 
SFA3 -0.708 0.643 0.889 0.921 0.993 0.921 1.000 
SFA4 -0.685 0.630 0.853 0.898 0.921 0.986 0.931 1.000 
SFAS -0.690 0.626 0.883 0.913 0.988 0.908 0.992 0.917 1.000 
SFA6 -0.666 0.625 0.853 0.899 0.924 0.972 0.932 0.984 0.931 1.000 
There is a high degree of correlation between the efficiency scores of the six SF As, 
although a clear distinction between the Cobb-Douglas production frontier (models SFA 
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1, 3 and 5 have a correlation of upwards of 0.990) and the translog production frontier 
(models SFA 2, 4 and 6 have a correlation of upwards 0.943) specifications can be seen. 
Taken together, the scores of SFA models 1-6 have a correlation of upwards 0.778. 
Similarly, there is a high degree of correlation between the ranks of the six SF A of 
upwards of 0.908. Correlation between unit costs and DEA scores (upwards of -0.473), 
DEA ranks (upwards of -0.680), SF A scores (upwards of -0.456) and SF A ranks 
(upwards of -0.666) illustrates that unit costs increase as efficiency decreases. 
It is interesting to note that the correlation between DEAl and the other two DEA 
models (upwards of 0.569) and the six SFA models (upwards of 0.575) is lower than 
between models DEA2 and DEA3 (0.952), and between models DEA2 and DEA3 and 
the six SFA models (upwards of 0.784). This suggests that the manner in which the EPI 
services has been costed merits closer examination and / or the appropriateness of 
labour, facility size and total hours as proxies for total cost. 
7.5.4 Stability of efficiency assessment between the specifications 
While correlations describe overall relationships, they are not a satisfactory way to 
examine the changes in efficiency scores across different methods and specifications, as 
they do not show what happens to individual vaccination sites' scores (Jacobs 2001). 
Therefore, it is worth considering the effect of alternative specifications on the 
efficiency estimates for individual delivery units (Street 2003). 
It was found that of 110 vaccination delivery units, there were two whose efficiency did 
not vary between DEAl, DEA2 and DEA3 (they were efficient under all three 
specifications). Among the remaining 108 vaccination delivery units, the difference 
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between the maximum and the minimum score which a vaccination delivery unit 
obtained ranged from 0.036 to 1.000 (a difference in rank of 107 places). The 
difference between the maximum and minimum scores and ranks across the Cobb-
Douglas production models (SFA 1, 3 and 5) was 0.103 (0.322 vs. 0.425) and 15 places 
respectively. The difference between the maximum and minimum score and rank 
across the translog production function models (SF A 2, 4 and 6) was 0.334 (0.395 vs. 
0.730) and 22 places respectively. 
7.5.5 Analysis of environmental variables 
7.5.4.1 DEA models 
Tables 28 and 29 show the mean technical, 'pure' technical and scale efficiency scores 
of the vaccination delivery units by location, type and ownership by specification. 
Table 28: Technical, 'pure' technical and scale emciency of vaccination delivery units by location 
(models DEAl-3) 
Zone Technical efficiency 'Pure' technical efficiency Scale efficiency 
DEAl DEA2 DEA3 DEAl DEA2 DEA3 DEAl DEA2 DEA3 
0.50 0.70 0.53 0.58 0.81 0.70 0.81 0.84 0.75 
2 0.38 0.58 0.44 0.47 0.76 0.74 0.83 0.72 0.57 
3 0.63 1.00 0.95 0.79 1.00 0.97 0.80 1.00 0.97 
4 0.46 0.50 0.33 0.67 0.64 0.55 0.69 0.72 0.54 
5 0.30 0.45 0.36 0.40 0.75 0.66 0.79 0.67 0.62 
6 0.11 0.18 0.14 0.25 0.91 0.91 0.46 0.24 0.21 
7 0.30 0.20 0.15 0.54 0.53 0.52 0.57 0.42 0.34 
8 0.24 0.22 0.15 0.44 0.66 0.61 0.58 0.45 0.43 
9 0.34 0.45 0.36 0.53 0.92 0.92 0.62 0.50 0.40 
10 0.31 0.34 0.28 0.50 0.48 0.45 0.58 0.57 0.45 
Total 0.35 0.42 0.32 0.52 0.73 0.69 0.66 0.58 0.49 
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Table 29: Efficiency of the DEA models by type and ownership of the vaccination delivery units 
Type of unit Technical efficiency 'Pure' technical efficiency Scale efficiency 
DEAl DEA2 DEA3 DEAl DEA2 DEA3 DEAl DEA2 DEA3 
GoB (fixed) 0.35 0.64 0.54 0.39 0.71 0.68 0.89 0.87 0.77 
GoB (outreach) 0.35 0.39 0.27 0.47 0.58 0.57 0.70 0.62 0.44 
GoB 0.35 0.58 0.48 0.41 0.68 0.65 0.84 0.81 0.70 
NGO (fixed) 0.36 0.55 0.42 0.46 0.70 0.57 0.77 0.78 0.76 
NGO (outreach) 0.34 0.34 0.25 0.56 0.76 0.73 0.57 0.46 0.37 
NGO 0.35 0.37 0.28 0.55 0.75 0.70 0.61 0.52 0.44 
Fixed 0.35 0.60 0.49 0.42 0.71 0.62 0.83 0.83 0.77 
Outreach 0.34 0.34 0.25 0.56 0.75 0.72 0.58 0.47 0.37 
All 0.36 0.43 0.32 0.52 0.73 0.69 0.66 0.58 0.49 
The ANOVA and Kruskal-Wallis test, illustrate that the technical, 'pure' technical and 
scale efficiencies of the delivery units varied systematically by location (Table 30). 
With respect to scale efficiency the tests illustrated that GoB vaccination delivery units 
were, on average, relatively more efficient than NGO units, and that fixed vaccination 
delivery units were, on average, relatively more efficient than outreach units. Taken in 
combination, the results indicate that GoB fixed vaccination delivery units were, on 
average, relatively the most scale efficient type, whilst, NGO outreach units were the 
least efficient type. With respect to technical efficiency the tests indicate that NGO 
vaccination delivery units were, on average, relatively more efficient than GoB units, 
and that outreach vaccination delivery units were, on average, relatively more efficient 
than fixed units. Taken together, the results indicate that NGO outreach vaccination 
delivery units were, on average, relatively the most technically efficient type, whilst, 
GoB fixed units were the least efficient type. Finally, with respect to technical 
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efficiency, differences in ownership and type of vaccination delivery units made no 
difference. 
Table 30: Significance of selected environmental variables and technical, 'pure' technical and scale 
efficiency scores from model DEAl 
Technical efficiency 'Pure' technical Scale efficiency 
efficiency 
Environmental variable F-test Kruskal- F-test Kruskal- F-test Kruskal-
Wallis Wallis Wallis 
Zone (1- 10) 2.827 25.182 2.597 20.759 2.570 21.286 
(0.005) (0.003) (0.010) (0.014) (0.011) (0.011) 
Ownership 0.001 0.099 4.433 5.500 17.627 14.813 
(GoB orNGO) (0.974) (0.754) (0.038) (0.019) (0.000) (0.000) 
Type 0.032 0.063 5.644 7.914 27.816 21.654 
(fixed or outreach) (0.858) (0.803) (0.019) (0.005) (0.000) (0.000) 
Type and ownership 0.015 0.135 2.215 9.098 10.554 24.308 
(0.998) (0.987) (0.091) (0.028) (0.000) (0.000) 
Using specification DEAl, Table 31 shows that the length of time a programme site has 
been in operation is positively correlated with scale efficiency (significant at the 0.01 
level). 
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Table 31: Correlation coeftidents for selected environmental variables md teclmical, 'pure' techDicalmd scale effidency for spedfication DEAl 
Technical efficiency 'Pw"e' technical efficiency Scale efficiency 
Environmental Pearson Kendall's Spearman's Pearson Kendall's Spearman's Pearson Kendall's Spearman's 
variable tau rho tau rho tau rho 
Years delivery site 0.051 0.128 0.190 -0.090 0.059 0.072 0.348 0.168 0.253 
has been open (0.599) (0.047) (0.048) (0.351) (0.397) (0.456) (0.000) (0.016) (0.008) 
Population density 0.139 -0.032 -0.044 0.045 -0.030 -0.045 0.034 0.002 0.006 
(0.146) (0.629) (0.647) (0.642) (0.645) (0.638) (0.727) (0.973) (0.947) 
Male / female ratio 0.222 0.155 0.223 0.117 0.057 0.091 0.220 0.161 0.238 
(0.020) (0.18) (0.019) (0.222) (0.384) (0.347) (0.021) (0.014) (0.012) 
Literacy -0.039 0.019 0.030 -0.027 0.001 0.004 0.044 0.005 0.009 
(0.685) (0.772) (0.759) (0.777) (0.994) (0.966) (0.647) (0.934) (0.923) 
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7.5.4.2 SFA models 
Table 32 shows the mean efficiency scores of the vaccination delivery units by location, 
type and ownership using models SFAI - SFA6. 
Table 31: Efficiency of the SF A models by location, ownership and type 
Variable SFAI SFA2 SFAJ SFA4 SFA5 SFA6 
Zone I 0.61 0.50 0.62 0.48 0.59 0.47 
Zone 2 0.61 0.42 0.63 0.33 0.61 0.46 
Zone 3 0.72 0.76 0.72 0.75 0.72 0.80 
Zone 4 0.46 0.27 0.49 0.24 0.44 0.31 
Zone 5 0.60 0.34 0.61 0.28 0.59 0.37 
Zone 6 0.40 0.10 0.46 0.10 0.39 0.12 
Zone 7 0.41 0.17 0.47 0.16 0.39 0.18 
Zone 8 0.42 0.15 0.47 0.13 0.41 0.17 
Zone 9 0.47 0.24 0.50 0.20 0.45 0.23 
Zone 10 0.43 0.26 0.50 0.25 0.42 0.25 
GoB (fixed) 0.64 0.54 0.65 0.49 0.64 0.59 
GoB (outreach) 0.52 0.35 0.56 0.28 0.53 0.36 
GoB (all) 0.61 0.49 0.63 0.44 0.62 0.54 
NGO (fixed) 0.55 0.33 0.57 0.30 0.54 0.37 
NGO (outreach) 0.44 0.20 0.48 0.18 0.42 0.20 
NGO (all) 0.46 0.22 0.50 0.20 0.44 0.23 
Fixed (all) 0.60 0.44 0.62 0.40 0.59 0.48 
Outreach (all) 0.44 0.21 0.49 0.18 0.43 0.21 
All 0.49 0.27 0.52 0.25 0.48 0.29 
The ANOVA and Kruskal-Wallis tests illustrate that the efficiency varied systematically 
by location, ownership and type (Table 33). Table 34 illustrates that efficiency is 
positively related to the number of years the unit has been open for (significant at the 
0.01 level). 
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Table 33: Significance ofselected environmental variables and efficiency scores from models SFAI 
andSFA2 
SFAI SFA2 
Environmental F-test Kruskal- F-test Kruskal-
variable Wallis Wallis 
Zone (I - 10) 4.293 33.734 6.306 30.580 
(0.000) (0.000) (0.000) (0.000) 
Ownership 18.148 17.482 25.097 16.557 
(OoB or NOO) (0.000) (0.000) (0.000) (0.000) 
Type 23.743 20.832 23.177 19.677 
(fIXed or outreach) (0.000) (0.000) (0.000) (0.000) 
Type and ownership 9.579 25.144 11.149 23.779 
(0.000) (0.000) (0.000) (0.000) 
Table 34: Correlation coefficients for selected environmental variables and models SFAI and SFAl 
SFAI SFA2 
Environmental Pearson Kendall's Spearman's Pearson Kendall's Spearman's 
variable tau rho tau Rho 
Years delivery site 0.308 0.132 0.193 0.361 0.176 0.259 
has been open (0.01) (0.058) (0.044) (0.000) (0.011) (0.007) 
Population density -0.028 -0.018 -0.018 -0.073 -0.051 -0.071 
(0.771) (0.780) (0.854) (0.450) (0.435) (0.463) 
Male / female ratio 0.287 0.211 0.322 0.221 0.206 0.309 
(0.000) (0.001) (0.001) (0.020) (0.002) (0.001) 
Literacy 0.038 -0.003 0.000 0.027 0.018 0.027 
(0.693) (0.961) (0.996) (0.782) (0.782) (0.776) 
Although there is no diagnostic tool with which to choose the best model specification, 
some general rules of thumb can be applied (Jacobs 2001). The most important 
criterion for selecting one specification over another is whether the model is consistent 
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with theory and in some way theoretically justifiable. Another useful criterion is the 
number of efficient units. Ceteris paribus, the fewer the better, although there should 
be enough peers available to make useful comparisons. The distribution of efficiency 
scores makes another useful criterion. The wider the better, ceteris paribus. 
Figure 15 shows the frequency distribution of efficiency scores for the three DEA 
specifications and highlights that specification DEA2 produces the higher efficiency 
scores, while specification DEAl produces a spread of efficiency scores that are more 
average. 
Figure 15: Distribution of efficiency scores for the three DEA specifications 
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Figure 16 shows the frequency distribution of efficiency scores for the six SF A 
specificati ns and highlights that specification SF A6 produces the higher efficiency 
scores, while specification SFA3 produces a spread of efficiency scores that are more 
average. 
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Figure 16: Di tribution of efficiency scores for the six SFA specifications 
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7.6 Policy implications 
A potential strength of DEA is its diagnostic capability; DEA provides clues on how 
each inefficient health centre can improve efficiency in line with their peers. However, 
the choice of specification will determine the level of inefficiency, and hence savings, at 
an individual as well as an 'industry' level. Accordingly, this section focuses on linking 
the results of DEA with two related policy implications: the level of potential savings 
and targets for performance. 
7.6.1 Potential savings 
Model DEAl , and models DEA2 and DEA3, should be examined in tum, because the 
former uses total costs as the sole input, while specifications DEA2 and DEA3 use the 
amount of labour, amount of space used and total hours as inputs; the interpretation of 
the data is thus quite different. Average efficiency scores ranged from 35% for 
specification DEAl , to 32 - 42% for specifications DEA3 and DEA2 respectively. In 
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other words, if delivery units were technically efficient and operated at the correct scale, 
total costs could have been reduced by 65%, and the use of labour, space dedicated to 
EPI and the number of hours, on average, could have been reduced by 58 - 68% without 
sacrificing the current level of outputs produced. 
Given that the average total cost of operating the 110 delivery units was $2,075, this 
equates to an average saving per delivery unit of $1,359. Similarly, given that the 
average use of labour, facility size and hours was 2.98 FTE, 1,805 ft2 and 362 hours 
across the 110 delivery units, the results from models DEA2 and DEA3 suggest 
reductions in these inputs of between 1.74 - 2.03 FTE, 1,056 - 1,229 ft2 and 212 - 247 
hours respectively. 
7.6.2 Targets for efficiency improvement 
DEA results can also be used as a managerial tool to improve efficiency of delivery 
units as it provides targets to achieve efficiency for each delivery unit. In light of the 
inevitable transaction costs of implementing efficiency improvement programmes, it is 
reasonable to target improvement to those delivery units which have most to gain, i.e. 
currently the least efficient. Table 35 provides an example of identifying target delivery 
units for possible improvement using specifications DEAl and DEA2. In these 
specifications, there were respectively 105 and 91 inefficient delivery units of which 32 
and 28 accounted for almost 40% of the technical inefficiency of the whole sample. 
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Table 35: Thirty-two and 18 most inemcient delivery units using specifications DEAl and DEAl 
DEAl DEA2 
Delivery Share of Cumulative Delivery Share of Cumulative 
unit inefficiency % inefficiency % unit inefficiency % inefficiency % 
57 1.34% 1.34% 108 1.52% 1.52% 
96 1.34% 2.68% 33 1.52% 3.04% 
108 1.33% 4.01% 90 1.49% 4.53% 
39 1.31% 5.32% 99 1.48% 6.01% 
50 1.31% 6.63% 78 1.47% 7.48% 
104 1.30% 7.93% 58 1.47% 8.95% 
109 1.30% 9.23% 57 1.47% 10.42% 
76 1.30% 10.53% 104 1.45% 11.87% 
61 1.30% 11.83% 85 1.45% 13.32% 
38 1.28% 13.11% 66 1.43% 14.75% 
47 1.26% 14.37% 74 1.43% 16.18% 
51 1.26% 15.63% 76 1.42% 17.60% 
22 1.25% 16.88% 32 1.41% 19.01% 
77 1.25% 18.13% 62 1.40% 20.41% 
53 1.24% 19.37% 61 1.40% 21.81% 
37 1.23% 20.60% 77 1.39% 23.20% 
48 1.23% 21.83% 80 1.39% 24.59% 
97 1.22% 23.05% 48 1.39% 25.98% 
49 1.22% 24.27% 47 1.38% 27.36% 
74 1.22% 25.49% 72 1.38% 28.74% 
99 1.21% 26.70% 59 1.38% 30.12% 
72 1.21% 27.91% 51 1.37% 31.49% 
11 1.21% 29.12% 11 1.36% 32.85% 
60 1.21% 30.33% 109 1.36% 34.21% 
2 1.21% 31.54% 28 1.36% 35.57% 
54 1.20% 32.74% 63 1.35% 36.92% 
85 1.19% 33.93% 79 1.34% 38.26% 
58 1.19% 35.12% 89 1.34% 39.60% 
102 1.17% 36.29% 
52 1.17% 37.46% 
46 1.17% 38.63% 
33 1.16% 39.79% 
After identifying these target delivery units, infonnation from the DEA results can be 
used to set unique target levels for each type of input that inefficient delivery units need 
to meet in order to become more efficient. Table 36 presents actual and target resource 
use for these delivery units. For example, it cost delivery unit 108 $582 to administer 
one dose ofBCG dose, 24 doses of DPT, 48 doses ofOPV, one dose of measles and 24 
doses ofTT (a total of98 vaccinations). To become an efficient delivery unit, it should 
cost $242. Alternatively, to produce that level of output, the unit used one member of 
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staff, 1,600 square feet of space and 337 of hours. In order to become an efficient 
delivery unit it would not need to reduce use of staff, however it would need to use 166 
square feet and 35 hours. 
Table 36: Actual and target resource use for the 32 and 28 most inefficient delivery units, using 
specifications DEAl and DEA2 
DEAl DEA2 
Actual Target Actual Target 
Delivery Total cost Total costs Delivery Staff Size Hours Staff Size Hours 
unit unit 
57 4,347 338 108 1 1,600 337 1 166 35 
96 9,785 497 33 5 900 900 1 37 35 
108 582 242 90 1 2,700 506 1 186 35 
39 6,313 493 99 1 9,801 100 1 3,279 33 
50 1,651 284 78 2 450 200 1 79 35 
104 911 260 58 2 324 324 1 35 35 
109 2,532 341 57 10 1,000 405 1 45 37 
76 3,599 403 104 3 200 200 1 35 35 
61 2,135 324 85 1 300 300 1 35 35 
38 15,077 1,255 66 2 843 506 1 66 41 
47 1,204 301 74 3 160 160 35 35 
51 1,030 286 76 2 490 270 1 63 35 
22 2,588 423 32 3 2,613 70 1 1,022 34 
77 1,177 311 62 8 2,700 2,700 1 240 240 
53 1,094 300 61 2 980 504 1 80 44 
37 12,022 1,383 77 375 375 I 35 35 
48 833 270 80 288 288 39 36 
97 1,010 302 48 320 320 1 37 35 
49 1,026 316 47 1 300 300 1 35 35 
74 483 257 72 1 3,267 2,400 1 52 38 
99 1,382 354 59 2 252 252 1 35 35 
72 325 255 51 1 225 225 1 35 35 
11 1,668 399 11 2 13,068 225 1 61 41 
60 2,217 450 109 2 1125 337 1 37 37 
2 1,085 330 28 6 864 216 1 53 37 
54 540 277 63 1 535 248 38 36 
85 485 275 79 9 3,600 1,800 527 224 
58 434 272 89 
102 2,008 460 
52 2,793 585 
46 2,793 585 
33 448 277 
175 
7.7 Summary 
• In this chapter, the efficiency of vaccination delivery units in Dhaka City, 
Bangladesh was examined. This was achieved through the use of DEA and SF A, in 
which best practice frontiers from 110 units were constructed; 
• Given the Government's stated objective to mobilise additional resources via 
improvements in the efficiency of health facilities, input-orientated specifications 
under VRS were adopted; 
• The mean technical efficiency of the vaccination delivery units was 0.35, 0.41 and 
0.32 in specifications DEAl, DEA2 and DEA3 respectively. These findings are 
consistent with the dimensionality issue. The DEA specifications indicate that the 
majority of units in this sample exhibited IRS; 
• The mean efficiency of the Cobb-Douglas production frontier models SFA1, SFA3 
and SF A5 was respectively 0.49, 0.52 and 0.48. For the translog production 
frontier, the mean efficiency of models SFA2, SFA4 and SFA6 was respectively 
0.28, 0.25 and 0.29; 
• There appears to be a high level of congruence between the unit costs, the DEA and 
SFA efficiency scores. However, the maximum difference in score and rank 
between the DEA and SF A models was large, particularly for the DEA models; 
• Efficiency varied systematically by location, type and ownership. Length of time a 
unit had been in operation was positively correlated with scale efficiency; 
• After identifying inefficient delivery units, unique target levels for each type of 
input can be identified. 
The next Chapter presents the costs of providing health care among a sample of health 
centres in rural Bangladesh. 
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Chapter 8 
VARIATION IN THE COST OF DELIVERING PRIMARY 
HEAL TH CARE IN RURAL BANGLADESH 
This chapter presents the costs of providing health care among a sample of health 
centres in rural Bangladesh. After a brief introduction, there are three sections to this 
chapter. The first focuses on describing the methods used, in particular, the sampling 
and data collection. The second part describes the results, focussing on the mean cost 
per health centre by district, and the weighted mean cost per visit. The chapter 
concludes with a summary of the chapter. 
8.1 Introduction 
Chapters 6 and 7 presented data on the cost and efficiency of vaccination services in 
urban Bangladesh. Chapters 8 and 9 focus on rural Bangladesh. Ideally the same 
services would have been analysed, but as stated in Chapter 5, vaccines are not routinely 
provided at union-level health centres (although they regularly act as an outreach site 
once per month). While the DFID-funded study from which the health centre data come 
from (see Chapter 1), did collect data from nine UHCs, which co-ordinate EPI activities 
in rural areas, this sample was clearly too small to conduct the subsequent parametric 
and non-parametric in the following chapter. Therefore, the data collected from 36 
health centres are used. 
As previously noted in Chapter 5, in 1998 Bangladesh began a sector-wide approach to 
extend health care to vulnerable populations, especially through a package of essential 
services emphasising maternal care, certain communicable diseases and child health. 
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The package was designed to improve population health status through a targeting 
approach which singled out facilities used more by the poor, effective services for 
diseases borne proportionately more by the poor, and rural areas where population 
health is the lowest. As such, the assumption was that improvements in health status 
could be supply-led (Ensor et al. 2002). 
First-level government health centres in rural Bangladesh are usually staffed by a 
paramedic (medical assistant or sub-assistant community medical officer), who is 
usually male with at least four years of clinical training. In addition, there is a female 
reproductive health worker (family welfare visitor) who has had 18 months training in 
the MCH and FP services. In some facilities, there is a position for a doctor, but in most 
cases these positions remain vacant (Arifeen et al. 2005). 
On average, the government funds one health centre for every three unions, at a cost of 
around $4,000 per health centre, which is mostly for the salaries of the health and 
support staff (Ensor et al. 2003a). In addition, each health centre receives a medical and 
surgical requisite allocation of around $1,250, most of which is for drugs. As Ensor et 
al. (2003a) note, " ... the current allocation process ... bears[s] little relation to either the 
size of the population or the number of patients treated". Therefore, the overall aim of 
this chapter is to estimate the cost, from the provider perspective, of delivering the ESP, 
excluding reproductive health services65, at union-level health centres. The specific 
objectives are to: 
• estimate the total and unit costs of delivering health care services; 
• describe the variation in these costs. 
6S FP services were excluded for the purpose of the DFID-funded project, which required the cost per visit 
for general health services. 
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8.2 Methods 
8.2.1 Selection of sample 
Data were collected from 36 health centres from three districts in Bangladesh 
(Brahrnanbaria, Chandpur and Moulvi Bazar). These districts were selected to represent 
high, medium and low performing districts using a variety of indicators of disease, 
vaccination coverage, health service provision and access to health services (BBS 1997; 
UNICEF 1999). The following variables were included for each of the 64 districts in 
the country: 
• To reflect major childhood diseases: 
- number of episodes of diarrhoea per 1,000 popUlation; 
- number of deaths from diarrhoea per 1,000 popUlation; 
- number of episodes of pneumonia per 1,000 population; 
- number of deaths from pneumonia per 1000 population; 
- number of cases of measles per 1,000 population; 
- number of deaths from measles per 1,000 population. 
• To reflect access to health care: 
- number of health centres; 
- number of beds per 1,000 population; 
- percentage of women delivering with an untrained midwife; 
- percentage of children never vaccinated with DPT vaccine; 
- percentage of children vaccinated with two or more doses of DPT vaccine; 
- percentage of children never vaccinated with OPV vaccine; 
- percentage of children vaccinated with two or more doses of OPV vaccine; 
- percentage of children vaccinated with measles vaccine. 
• To reflect socio-economic variables: 
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• percentage of boys aged 6-10 years old in primary school; 
• percentage of girls aged 6-10 years old in primary school; 
Each district was ranked from best to worst for each of the above variables. These 
rankings for all the indicators were summed together for each district, and a rank 
established. These figures were compared with the ranked position of each district 
using two other approaches; the poverty index and the Human Development Index 
(Khatun 2001). Because the development of such indices is often controversial, only 
those districts that were consistently placed using all three approaches were included. 
For example, for a district to be chosen as a top third district it had to be in the top third 
of the Human Development and poverty indices and it also had to appear the greatest 
number of times in the top third of the index specifically constructed. This happened 
for the districts shown in Table 37. 
Table 37: Ranking of districts using tbree different indices 
Top third for all indices Mid third for all indices Bottom third for all indices 
Chandpur Dinajpur Brahmanbaria 
Chittagong Gazipur Kurigram 
Dhaka Kishoreganj Netrakona 
Jhalakati Madaripur Nilpharmari 
Khulna Manikganj Rangpur 
Narayanganj Masura Sherpur 
Comilla Moulvi Bazaar 
Feni 
As any of these districts could have been selected using this process, availability of data 
was considered, particularly whether the local-level planning system had been 
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introduced66, and whether the vaccine against hepatitis B was planned for introduction 
(which at the time included: Faripur, Feni, Jessore, Joypurhat, Moulvi Bazar and 
Pirojpur districts)67. It was also considered whether ICDDR,B was known and working 
within the area to be a potential benefit and a reason for selection. Therefore the final 
selection was: Chandpur, Moulvi Bazar and Brahmanbaria (Figure 17). 
Within each district, two or three Upazilas were selected at random, from which three to 
eight health centres were selected at random, such that 12 health centres from each 
district were selected. This process meant that the sample selected in Chandpur, 
Brahmanbaria and Moulvi Bazar districts represented 13.5% (12 / 89), 12.4% (12 / 97) 
and 17.9% (12 / 67) of all health centres. Therefore, across the three districts 14.2% of 
all health centres were selected (36 / 253) (see Table 38). However, two health centres 
were excluded for missing output data. Therefore the final sample was 34 health 
centres. Table 40 provides some background details on each of the chosen upazilas. 
Table 38: Sample of health centres 
District Upazilas Number of sites Final sample 
Brahmanbaria Akhaura 4 4 
Kasba 4 4 
Sarail 4 3 
Chandpur Haziganj 4 3 
Shahrasti 8 8 
Moulvi Bazar Borolekha 5 5 
Kulaura 4 4 
Srimongal 3 3 
Total 36 34 
66 The local-level planning system was being introduced in five districts at the time of data collection 
~Dhaka, Mymensingh, Radshahai, Chandpur and Gopelganj). 
7 Again, this was motivated by the DFID-funded project. 
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Figure 17: Map of Bangladesh with Brahmanbaria, Chandpur and Mouli Bazar Districts indicated 
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Table 39: Background statistics of the selected Upazilas 
Indicator Brahmanbaria Chandpur Moulvi Bazar 
Kasba Akhaura Sarail Hajigonj Shaharasti Borolekha Srimongal Kulaura 
Area (sq. km) 207.76 72 239.52 190 168 458 4.15 678 
Number of Unions 10 5 10 11 9 12 10 17 
Number of Wards 30 15 30 36 27 36 30 51 
Number ofViUages 258 125 146 157 169 325 204 575 
Number of households 55,295 23,616 49,785 51,855 37,958 33,006 52,275 66,771 
Total population 319,309 144,510 327,533 331,511 242,092 253,435 268,358 417,683 
Number of 0-11 months old 11,222 4,448 10,490 10,742 6,152 8,123 8,322 11,825 
Number of under 5 years old 66,092 23,797 54,330 41,902 38,733 44,447 46,644 68,460 
Number of adolescents (10-19 years) 73,441 33,235 75,332 76,248 55,681 58,291 61,640 96,067 
Number of 15-49 years old women 48,355 29,039 70,280 74,988 53,494 42,466 53,600 93,822 
Number of births registered (July 00 - June 01) 11,249 5,277 5,556 8,161 6,152 2,301 500 87 
Number of deaths registered (July 00 - June 01) 315 1,445 1,650 724 602 546 20 7 
Number of GoB health centres 5 4 9 11 11 7 8 13 
Number ofNGOs (H&FP) 2 0 2 NS NS 3 3 4 
NS: not stated 
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8.2.2 Cost analysis 
The cost analysis was perfonned using standard costing guidelines, and adopted a 
provider perspective (Creese and Parker 1993). The health centres were costed by the 
'ingredients' approach, in which the total quantities of goods and services actually 
employed in delivering the activities were estimated, and multiplied by their respective 
unit prices68• Cost infonnation was obtained from various sources, including 
administrative records, interviews and direct observation. Price data were collected 
from surveys undertaken in the upazila sadars69• The prices of drugs were obtained 
from the Bangladesh National Fonnulary (MOHFW 2003). Cost and output indicators 
were collected for the financial year July 2001 - June 2002. All figures are presented in 
2002 US dollars using the average official exchange rate between July 2001 - June 
20027°. 
Resources, and hence costs, have been categorised according to whether they are capital 
(land, buildings, transport, equipment and furniture) or recurrent (drugs, supplies, 
personnel, logistics and miscellaneous) items. To estimate the cost of buildings used to 
deliver general health services, the space used for reproductive health services was 
excluded. Area in square feet has been costed on the basis of the construction cost 
stated in the Public Works Department in 2003. A notional 25 year working life for 
buildings was used. Furniture and equipment for reproductive health services were 
excluded. Estimates of the working life of different pieces of furniture and equipment 
were obtained from the study by Barkat et al. (1999). Finally, a 3% discount rate was 
used in conjunction with the resource-specific working life estimates in order to obtain 
estimates of the annual economic equivalent costs of capital. 
68 See Appendix 16 for a copy of the health centre facility survey form used to collect the data. 
69 The sadar is the district capital. 
70 IUS$ = 59.63 Bangladeshi Taka. 
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In order to allocate the time and thus cost of staff for general health services, excluding 
reproductive health services, the estimate from the work by Barkat et al (1999) was 
used, in which 76.30% of staff time was devoted to general health services.71 
The disease profiles routinely compiled by the health centres from July 2001 to June 
2002 were used. This enabled four measures of output to be used: visits of patients 
aged under one year, visits of patients aged from one to four years, visits of patients 
aged greater than four years and visits for all age groups. Unfortunately, these data 
were not available broken down by ESP line items, e.g. child health care, communicable 
disease control and limited curative care. 
8.3 Results 
8.3.1 Total cost, output and unit cost per health centre 
Table 40 presents the total costs, unit costs and cost profile of the health centres. The 
average annual cost per health centre was $8,873 and the annual number of visits was 
11,582, resulting in a cost per visit of$0.77. 
The cost per visit ranges from $0.31 to $1.77 per visit (a 5.5-fold difference), among the 
sample of 34 health centres (Table 41). The number of visits at the health centres 
largely determines the unit cost of delivering care. The unit cost of treating patients 
declines as the number of visits increases (Figure 18). A negative correlation was found 
between the cost per visit and the number of visits, and this relationship was significant 
at the 1 % level. This implies that marginal cost is lower than average cost. 
71 It should be noted that the Barkat et al. (1999) study is now rather dated and used a relatively small 
sample. With more resources, alternative approaches to allocate staff time would have been explored 
such as time-and-motion methods. Given the importance of staff costs, it is important to bear in mind the 
potential sensitivity of results presented here and in the proceeding chapter to this assumption. 
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Table 40: Total cost, output and unit cost per visit, by District, in 2002 US$ 
Cost category Brahmanbaria Chandpur Moulvi Bazar Total 
Cost %of Cost %of Cost %of Cost %of 
total cost total cost total cost total cost 
Capital 
furniture 3,445 2.94 3,422 3.40 4,215 4.54 11,082 3.57 
equipment 4,795 4.09 4,333 4.31 3,820 4.12 12,949 4.17 
transport 0.00 0.00 189 0.20 189 0.06 
land & 5,284 4.51 3,008 2.99 4,082 4.40 12,374 3.98 
building 
Sub-total 13,523 11.55 10,763 10.70 12,306 13.26 36,593 11.78 
Recurrent 
salary 54,978 46.94 41,855 41.59 46,491 50.10 143,325 46.15 
drugs 47,901 40.90 46,790 46.50 32,583 35.11 127,274 40.98 
supply 57 0.05 195 0.19 355 0.38 606.58 0.20 
miscellaneous 657 0.56 1,030 1.02 1,070 1.15 2,757 0.89 
logistics 0.00 0.00 0.00 0.00 
Sub-total 103,594 88.45 89,870 89.30 80,499 86.74 273,963 88.22 
Total 117,117 100.00 100,633 100.00 92,806 100.00 310,556 100.00 
Total number 169,025 78,682 157,668 405,375 
of visits 
Cost per visit 0.69 1.28 0.59 0.77 
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Table 41: Total cost, output and unit cost per visit, by health centre, in 2002 US$ 
total cost Number of unit cost 
patients 
FWCl 7,651 7,172 1.07 
2 FWC2 8,136 4,807 1.69 
3 FWC3 6,317 6,274 1.01 
4 FWC4 9,032 5,106 1.77 
5 FWC5 5,983 3,478 1.72 
6 FWC7 12,959 9,261 lAO 
7 FWC8 12,048 13,913 0.87 
8 FWC9 8,758 6,446 1.36 
9 FWC 10 14,642 11,705 1.25 
10 FWC 11 6,877 3,892 1.77 
11 FWC 12 8,230 6,628 1.24 
12 FWC 17 4,707 8,723 0.54 
13 FWC 18 9,023 14,058 0.64 
14 FWC 19 11,192 8,920 1.25 
15 FWC20 10,381 16,696 0.62 
16 FWC21 13,438 16,560 0.81 
17 FWC22 4,686 7,783 0.60 
18 FWC23 7,322 11,950 0.61 
19 FWC24 12,347 24,106 0.51 
20 FWC25 12,030 14,504 0.83 
21 FWC27 11,017 9,087 1.21 
22 FWC28 10,021 15,816 0.63 
23 FWC33 11,464 37,062 0.31 
24 FWC34 6,357 14,929 0.43 
25 FWC35 7,075 6,775 1.04 
26 FWC36 8,050 8,916 0.90 
27 FWC37 5,941 6,434 0.92 
28 FWC38 6,049 9,304 0.65 
29 FWC39 11,961 7,085 1.69 
30 FWC40 7,702 15,070 0.51 
31 FWC41 6,867 11,815 0.58 
32 FWC42 7,067 6,268 1.13 
33 FWC43 7,157 22,490 0.32 
34 FWC44 7,117 11,520 0.62 
Total 310,556 405,375 0.77 
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Figure 18: Relationship between service volume and unit cost in the health centres 
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These results show a clear inverse relationship between the cost per visit and service 
volume among the 34 health centres. It seems that the optimum service volume, 
corresponding to the lowest average cost, has not yet been reached in the sample of 
centres. A significant factor appears to be the existence of substantial fixed costs 
associated with the delivery of general health services at these health centres. Although 
Table 41 above classifies staff as a recurrent item, in line with standard costing 
guideline , in reality personnel costs are fixed in nature, at least in the short-term. Thus 
between 52% and 63% of the resources used to produce these services were fixed, 
which means that these resources change little, if at all, as the volume increases or 
decreases. Under these conditions, the results, as expected, show that up to a certain 
volume of service, a larger number of visits tends to reduce the average cost. 
These results provide estimates on the supply-side cost of the ESP. Given that much of 
the variation in unit costs can be attributed to variation in the number of visits, these 
findings also suggest that differences in the factors affecting demand, such as distance 
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living from the centre, infonnation on services and perceived quality, are also at play, 
rather than differences in resource availability per se. Nevertheless, this analysis of the 
cost of union-level health centres suggests that further efficiency gains may be possible 
if the best perfonning centres are taken as the standard at different levels of outputs. 
Other centres could then be helped to achieve similar levels of productivity. 
8.4 Summary 
• Bangladesh began a sector-wide approach to extend health care to vulnerable 
populations in 1998, especially through an ESP emphasising maternal care, services 
for certain communicable diseases and child health; 
• The current allocation of resources to union-level health centres bears little relation 
to either the size of the population or the number of patients treated. Therefore, the 
overall aim of this chapter is estimate the cost, from the provider perspective, of 
delivering the ESP and to describe variation in these costs; 
• Data were collected from 36 health centres from three districts in Bangladesh 
(Brahmanbaria, Chandpur and Moulvi Bazar), although two health centres were 
excluded because of missing data. The aim in selecting the districts was to represent 
high, medium and low perfonning districts using a variety of indicators of disease, 
vaccination coverage, health service provision and access to health services; 
• The health centres were costed by the 'ingredients' approach. Cost and output 
indicators were collected for the financial year July 2001 - June 2002; 
• The average annual cost per health centre was $8,873 and the average annual 
number of visits was 11,582, resulting in a mean cost per visit of $0.77; 
• The cost per visit ranged from $0.31 to $1.77 per visit (a 5.5-fold difference), among 
the sample of 34 health centres. The number of visits at the health centres largely 
189 
detennines the unit cost of delivering care. A significant factor appears to be the 
existence of substantial fixed costs associated with the delivery of general health 
services at these health centres. 
Ensor et al. (2003a) stated that the efficiency with which services in Bangladesh are 
delivered at the local level is " ... an important subject for future investigation". The 
next chapter analyses these data using parametric and non-parametric efficiency 
measurement techniques in order to identify whether further efficiency gains might be 
possible. 
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Chapter 9 
DATA ENVELOPMENT ANALYSIS AND STOCHASTIC 
FRONTIER ANALYSIS OF PRIMARY HEALTH CARE CENTRES 
IN RURAL BANGLADESH 
This chapter presents the efficiency of health centres derived by SF A and DEA, using 
the data presented in Chapter 8. Following a brief introduction, there are five parts to 
this chapter. The first presents the data. The second describes the models used. In 
total, five models are included in this chapter; three for the DEAs and two for the SF As. 
The third part provides an overview of the performance of health centres using 2001-02 
data based on the five models, focussing on a summary of the efficiency scores, the 
number of efficient health centres and the number of times health centres are a peer. 
This section also includes a correlation analysis of the scores and ranks between the 
different specifications. The fourth section illustrates how DEA can be used to identify 
unit-specific and industry-level potential savings, and associated targets. The chapter 
concludes with a summary. 
9.1 Introduction 
As previously stated, the ESP consists of reproductive health care; child heath care; 
communicable disease control; and limited curative care. Unfortunately, the GoB faces 
significant resource constraints in funding the ESP. Previous reports have found that 
the potential for additional resource mobilisation is limited, and suggested that 
improvements in the internal efficiency of health care services must be a critical 
component of efforts to provide the ESP to the whole population (Rannan-Eliya and 
Somanathan 2003). The preceding chapter estimated a 55-fold difference in the cost 
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per visit across a sample of health centres, which suggests there is scope to improve 
efficiency. Furthermore, because government-funded health facilities in Bangladesh are 
not profit-seeking entities, coupled with the fact that their input mix is largely 
determined by external rules and budgetary allocations, they cannot be assumed to 
operating efficiently. 
Therefore, the overall aim of this chapter is to assess the efficiency of a sample of health 
centres in rural Bangladesh, in order to identify the scope to mobilise additional 
resources via improvements in their operating efficiency. The specific objectives are to: 
• use DEA and SF A techniques to identify the level of technical and scale efficiency 
in the sample of health centres; 
• compare and contrast these findings with those from the preceding chapter on the 
unit costs of the sample of health centres; 
• investigate possible causes for differences in the efficiency scores; 
• identify the potential savings and related targets for the sample of health centres. 
9.2 Data 
As stated previously in Chapter 8, the final data set consisted of 34 out of a possible 36 
health centres in three Districts in Bangladesh (Brahmanbaria, Chandpur and Moulvi 
Bazar. Hence, 94.4% of all health centres in the sample were included. All data are for 
the period July 2001 - June 2002. 
Data from Chapter 8 illustrated that on average 88.4% (range: 77.6 - 97.2%) of the total 
annual operating cost of the sample of health centres is accounted for by expenditure on 
staff and drugs. Therefore, on the input side, in addition to total cost, expenditure on 
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staff and drugs were also included as model inputs. The number of patients treated aged 
below one year, between one and four years of age, and greater than four years of age 
were included as model outputs. In addition, the outputs were summed together to 
produce the total number of patient visits for all age groups. The descriptive statistics 
are given in Table 42. 
Table 42: Descriptive statistics of inputs and inputs 
Variable Mean Std. deviation Min Max 
Inputs 
total cost ($) 8,812 2,656 4,686 14,642 
staff expenditure ($) 4,138 1,340 1,376 6,441 
drugs expenditure ($) 2,889 1547 269 7,775 
Outputs 
total number of patients 11,310 6,737 3,478 37,062 
total number of patients aged < I year 692 676 83 3,121 
total number of patients aged 1-4 years 1,699 982 580 4,464 
total number of patients aged 4+ years 8,920 5,738 2,742 32,010 
A summary of the specifications, described in more detail below, is included in Table 
43. The total number of input and output variables ranged from three to five. A 
common rule of thumb used with DEA suggests that the number of observations in the 
data set should be at least three times the sum of the number of input and output 
variables, i.e. 3 x (2 + 3) = 15 (Cooper et al. 2003). An alternative rule of thumb 
suggested by Dyson et al. (2001) states that the number of observations should be at 
least twice the product of the number of inputs and outputs, i.e. 2 x 2 x 3 = 12. 
Therefore, according to either of these rules of thumb, and the specifications chosen, the 
final sample size of 34 is acceptable for the proposed DEAs. However, the sample 
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appears to be at the limit of acceptability for SF A, which will be explored in more detail 
in the results section. 
Table 43: DEA and SFA specifications 
Specification DEAl DEA2 DEA3 SFAl'~ 
Inputs 
total cost ($) .t' .t' .t' .t' 
staff expenditure ($) ./ .t' .t' 
drugs expenditure ($) ./ .t' .t' 
Outputs 
total number of patients 
total number of patients aged < 1 year .t' 
total number of patients aged 1-4 years .t' 
total number of patients aged 4+ years .t' .t' 
Number of variables 4 3 5 3 
9.3 Methods 
9.3.1 DEA models73 
Given the Government's stated objective to mobilise additional resources via 
improvements in the operating efficiency of health facilities, an input-orientated 
specification has been adopted for each model. This considers what reduction in inputs 
is possible given existing levels of outputs. This specification is also consistent with the 
fact that treating fewer patients is clearly better, in the sense that it may reflect 
successful health promotion and prevention programmes. However, this needs to be 
balanced against the fact that utilisation rates of government health facilities are low, 
suggesting that there could be considerable unmet need. The assumption of CRS is only 
appropriate when all health centres are operating at an optimal scale. Yet, in reality 
72 Two models were run using the same inputs and outputs. 
73 The data used for models DEAl-3 are presented in Appendices 16-18. 
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there are reasons to suspect that health centres may not be operating at optimal scale, 
therefore a VRS specification is additionally adopted. 
For the DEA models, the technology was initially constructed under CRS and strong 
disposability of costs (as costs increase, outputs must increase, ceteris paribus) TEcRS. 
Allowances can be made in the restraints to allow for VRS TEvRs. Further, the type of 
scale inefficiencies were determined by employing a third model TENIRS. In all these 
cases the definitions given by Hire et al. (1994) were followed. The DEAP programme 
by Coelli (1996a) has been used for the computations. The linear programming 
problems presented in Chapter 7 apply here too. 
9.3.2 SFA models 
Frontier Version 4.1 (Coelli 1996b) was used to estimate a Cobb-Douglas production 
frontier assuming a half-normal distribution (SF AI) and a translog production frontier 
assuming a truncated normal distribution (SFA2). 
9.3.3 Analysis of environmental variables 
The ANOVA and Kruskal-Wallis tests were conducted in order to test the null 
hypotheses that the mean technical, 'pure' technical and scale efficiencies of the 
delivery units are the same across the three districts against the alternative hypotheses 
that they differ from one another. 
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9.4 Results 
9.4.1 DEA models74 
Table 44 presents the efficiency results and shows that technical efficiency (TE CRS) 
was 0.53 in specification DEAl, 0.48 in specification DEA2 and 0.58 in specification 
DEA3. In other words, if health centres were technically efficient and operated at the 
correct scale, expenditure on staff and drugs could be reduced by 47%, 52% and 42% 
respectively without sacrificing the current level of outputs produced. 
Table 44: Descriptive statistics of the DEA results (models DEAl-3) 
Specification Measure Mean SD Min Max 
DEAl Teclmical efficiency 0.53 0.25 0.18 1.00 
'Pure' technical efficiency 0.69 0.21 0.34 1.00 
Scale efficiency 0.75 0.20 0.32 1.00 
DEA2 Technical efficiency 0.48 0.26 0.18 1.00 
'Pure' technical efficiency 0.68 0.12 0.31 1.00 
Scale efficiency 0.69 0.24 0.27 1.00 
DEA3 Technical efficiency 0.58 0.28 0.21 1.00 
'Pure' technical efficiency 0.73 0.20 0.32 1.00 
Scale efficiency 0.77 0.22 0.30 1.00 
By decomposing this CRS technical efficiency measure into 'pure' technical efficiency 
(TE VRS) and scale efficiency, it can be shown that slightly more of the technical 
inefficiency is due to health centres using too many inputs in treating the different age 
groups of patients rather than operating at the wrong size. However, both sources of 
this technical inefficiency must be addressed for these facilities to become less wasteful 
of scarce resources. 
74 The centre-specific results for models DEAI-3 are presented in Appendices 19-21. 
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Figure 19 illustrates the frequency distribution of efficiency scores of the three DEA 
specifications. It highlights that specification DEA3 produces slightly higher efficiency 
scores, while specifications DEAl and DEA2 produce a spread of efficiency scores that 
are more average. 
Figure 19: Di tribution of efficiency scores for the three DEA specifications 
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Efficiency scores 
Table 45 shows that the majority of health centres, 30, 30 and 27 for specifications 
DEA 1 and DEA2, and DEA3 respectively, exhibited IRS (implying that they are too 
small), four, four and six of the centres under specifications DEAl , DEA2 and DEA3 
respectively exhibited DRS (implying that they are too large) and only one centre under 
specification DEA3 was the 'right' size. 
Table 45: Returns to cale in the health centres (models DEAl-3) 
Types of returns to scale Number of health centres 
DEAl DEA2 DEA3 
Inerea ing returns to scale 30 (88.2%) 30 (88 .2%) 27 (79.4%) 
Constant returns to cale 4 (11.8%) 4 (11.8%) 6 (17.6%) 
Decreasing returns to cale 0(0%) 0(0%) I (3.0%) 
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Table 46 presents the efficient health centres by specification and number of times that 
each of these efficient health centres act as peers. 
Table 46: Emcient health centres and the number of times they are a peer 
Efficient health centre Specification Summation 
DEAl DEA2 DEA3 
12 29 29 27 85 
14 0 26 25 51 
19 0 0" 
20 3 0 10 13 
22 11 0 0 11 
23 9 13 10 32 
33 10 3 9 22 
Number of efficient health centres 5 5 6 
It can be seen that number of efficient health centres varied according to the three 
specifications. There were five efficient health centres in specifications DEAl and 
DEA2 while there were six efficient centres in specification DEA3. The greater the 
number of input and output variables in a specification, the greater the number of 
efficient health centres. This finding is consistent with the dimensionality issue; 
increasing the number of dimensions used in the characterisation of production reduces 
the discriminatory power of the analysis, increasing measured efficiency and the 
number of health centres identified as fully efficient. 
Among the health centres, seven of them were efficient and acted as peers between I 
and 85 times across all three specifications. However, only health centres 12, 23 and 33 
were efficient across all three models; unit 12 is located in Moulvi Bazar whereas units 
75 Delivery unit #19 is efficient but does not act as a peer for any other delivery unit(s). 
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23 and 33 are located in Brahmanbaria. It is interesting to note that health centre 20, 
which was efficient in specification DEA2 and DEA3 but not DEAl, had a score of 
0.425 in specification DEAL Health centre 12 acted a peer the greatest number of 
times: 29, 29 and 25 for specifications DEAl, DEA2 and DEA3 respectively - a total of 
85 times. 
9.4.2 SFA models 
The mean efficiency under models SFAI and SFA2 was 0.998 and 0.929 respectively. 
The output file produced by Frontier 4.1 (Coelli I 996b ) reported that "The likelihood 
value is less than that obtained using OLS! - try again using different starting values". 
As stated in Chapter 3, it is possible to specify the starting values in the instruction file 
of Frontier Version 4.1. Therefore, the candidate specified the starting values manually, 
but the output file reported the same message. The candidate contacted Tim Coelli, the 
author of Frontier via email for advice, who in response commented on the problems of 
small samples, and the fact that noise can be a particular problem in developing country 
data sets (Tim Coelli, personal communication 2005). He advised running an OLS 
regression, saving and plotting the residuals in order to identify any outliers76• 
Using SPSS, one case where the prediction was three standard deviations or more from 
the mean value of the dependent was identified (health centre number 23). This case 
was dropped from the analysis and the SF A models re-run. This made no difference to 
the findings, suggesting that the small sample size is the over-riding problem. It was 
76 The presence of outliers (that is, the presence of large residual variation) in the sample can cause 
stochastic frontier models to perceive that there is too much noise in the data and therefore may find little 
or no inefficiency in the sample, even in cases where there is some. As a result, all units may appear to be 
almost 100% efficient. In this way, the main potential advantage of SF A of decomposing the residual 
into noise and inefficiency has turned to be a great disadvantage as it fails to differentiate between units' 
efficiency. 
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reported in Chapter 3 that in empirical applications samples of size under 30 are usually 
considered to be small. It appears that in this instance the sample size of 34 health 
centres is too small. It is worth recalling that this sample was selected on the basis of 
available resources in light of the range of other costing activities taking place as part of 
the larger project described in Chapter 177. 
9.4.3 Stability of efficiency assessment between the three DEA specifications 
This section focuses on the stability of efficiency scores across the specifications. This 
will be explored in two ways: efficiency scores and efficiency ranking (Table 47). 
Because the efficiency scores are not normally distributed, it is important to consider the 
ranking of the scores as well. Moreover, ranking, unlike the score, does not depend on 
the number of variables included in the specifications. 
There is a high degree of correlation between the scores and ranks of the three 
specifications (upwards of r = 0.609 and r = 0.742 respectively). Equally, there is a 
high degree of correlation between the unit costs presented in the preceding chapter and 
the scores and ranks of the three DEA specifications (upwards of r = -0.688 and r = -
0.792 respectively). The relationship is negative illustrating that as efficiency increases, 
unit costs fall. 
77 Cost data were also collected from nine sub-district hospitals and three district hospitals. Furthermore, 
approximately 600 patient records were abstracted, 800 exit interviews were administered to caregivers 
taking children to receive vaccination services, 600 interviews were administered to caregivers of 
children with a vaccine-preventable disease treated on an out-patient basis and 75 interviews were 
administered to caregivers of children with vaccine-preventable diseases treated on an in-patient basis. 
Finally, approximately 30 interviews were conducted with physicians to ascertain how they usually treat 
children with vaccine-preventable diseases. However, it is also worth noting that a sample of 34 health 
centres is generous in comparison to most cost and cost-effectiveness analyses. 
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Table 47: Correlations of unit cost and DEA results78 
Unit costs DEAl DEA2 DEA3 
Scores 
Unit costs 1.000 
DEAl -0.841 1.000 
DEA2 -0.688 0.609 1.000 
DEA3 -0.750 0.810 0.884 1.000 
Ranks 
Unit costs 1.000 
DEAl -0.900 1.000 
DEA2 -0.811 0.742 1.000 
DEA3 -0.792 0.866 0.915 1.000 
While correlations describe overall relationships, they are not a satisfactory way to 
examine the changes in efficiency scores across different methods and specifications, as 
they do not show what happens to individual vaccination sites' scores (Jacobs 2001). 
Therefore, it is worth considering the effect of alternative specifications on the 
efficiency estimates for individual delivery units (Street 2003). 
Table 48 presents details of the maximum change in the efficiency score and rank across 
specifications. It was found that of 34 health centres, there were three whose efficiency 
did not vary between DEAl and DEA2 (they were efficient under all three 
specifications). Among the remaining 31 health centres, the maximum difference in the 
efficiency score which an individual health centre obtained was 0.626, which equated to 
a change in rank of 20 places. However, there was an even greater change in ranking 
when comparing the results of the unit costs and specifications DEA2 and DEA3; health 
78 All correlations arc significant at the 0.0 I level (2-tailed). 
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centre 14 had a unit cost of $1.25 per visit which ranked it 26th, while it was found to be 
fully efficient in specifications DEA2 and DEA3. 
Table 48: Maximum cbanges in individual estimates of efficiency 
Unit costs DEAl DEA2 DEA3 
Scores 
DEAl NA 0 
DEA2 NA 0.626 0 
DEA3 NA 0.626 0.575 0 
Ranks 
Unit costs 0 
DEAl 15 0 
DEA2 25 20 0 
DEA3 25 20 17 0 
9.4.4 Analysis of environmental variables 
Table 49 gives the technical, 'pure' technical and scale efficiency of the health centres 
by district. 
Table 49: Technical, 'pure' technical and scale efficiency of health centres by location (models 
DEAl-3) 
Location Technical efficiency 'Pure' technical efficiency Scale efficiency 
DEAl DEA2 DEA3 DEAl DEA2 DEA3 DEAl DEA2 DEA3 
Brahmanbaria 0.65 0.65 0.81 0.74 0.79 0.88 0.87 0.81 0.91 
Cbandpur 0.30 0.28 0.34 0.55 0.54 0.57 0.55 0.59 0.63 
Moulvi Bazar 0.63 0.50 0.60 0.77 0.72 0.75 0.80 0.67 0.78 
Total 0.53 0.48 0.59 0.69 0.68 0.73 0.75 0.69 0.78 
Table 50 shows that technical, 'pure' technical and scale efficiency varied 
systematically according to the location of the health centres. The districts were 
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selected to reflect high (e.g. Chandpur), medium (e.g. Moulvi Bazar) and low 
(Brahmanbaria) perfonning districts using a variety of indicators of disease, vaccination 
coverage, health service provision and access to health services. The efficiency data 
presented in this thesis are not consistent with this classification. The results presented 
in Table 50 are for specification DEAl. However, the findings were also significant for 
specifications DEA2 and DEA3. 
Table SO: Significance of selected environmental variables and technical, 'pure' technical and scale 
efficiency (models DEAI-3) 
Technical efficiency 'Pure' technical efficiency Scale efficiency 
Environmental variable F-test Kruskal- F-test Kruskal- F-test Kruskal-
Wallis Wallis Wallis 
Location, i.e. districts 7.817 13.465 6.513 9.353 2.732 4.883 
(Brahmanbaria, Chandpur, (0.002) (0.001) (0.004) (0.009) (0.081) (0.087) 
MoulviBazar) 
9.5 Policy implications 
A potential strength of DEA is its diagnostic capability; DEA provides clues on how 
each inefficient health centre can improve efficiency in line with their peers. 
Accordingly, this section focuses on linking the results of DEA with two related policy 
implications: the level of potential savings and targets for performance. 
9.5.1 Potential savings 
The mean efficiency scores were 0.53, 0.48 and 0.59 respectively for specifications 
DEAl, DEA2 and DEA3. In other words, if health centres were technically efficient 
and operated at the correct scale, total costs, on average, could have been reduced by 
47%, and specifically, expenditure on staff and drugs could have been reduced by 
between 41 % - 52%, without sacrificing the current level of outputs produced. Given 
203 
that the mean total cost of the 34 health centres was $8,812, this equates to an average 
saving per health centre of $4, 142. 
To achieve efficiency of all centres, the inputs, expenditure on staff and drugs, have to 
be reduced by a different percentage. In specifications DEA2 and DEA3, drug 
expenditure requires a greater percentage reduction than expenditure on staff. Therefore 
managing drug expenditure plays the most important role in efficiency improvement.79 
9.5.2 Targets for efficiency improvement 
DEA results can be used as a managerial tool to improve efficiency of health centres as 
it provides targets to achieve efficiency for each health centre. In light of the inevitable 
transaction costs of implementing efficiency improvement programmes, it is reasonable 
to target improvement to those centres which have most to gain, i.e. currently the least 
efficient. 
Table 51 provides an example of identifying target health centres using specification 
DEA2. In this specification, there were 30 inefficient health centres of which nine 
(30%) accounted for almost 40% of the technical inefficiency of the whole sample. 
After identifying these target health centres, information from the DEA results can be 
used to set unique target levels for each type of input which inefficient health centres 
need to meet in order to become efficient. 
19 Staff should perhaps be excluded from this analysis given that wages are generally beyond the control 
of the health centres. This is an issue that will be explored in more detail in the next chapter. 
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Table 51: Nine most inefficient health centres using specification DEA2 
Health centre Share of inefficiency % Cumulative inefficiency % 
10 4.67% 4.67% 
29 4.67% 9.34% 
4 4.52% 13.86% 
5 4.49% 18.35% 
6 4.30% 22.65% 
32 4.15% 26.80% 
2 4.13% 30.93% 
25 4.12% 35.05% 
8 4.11% 39.16% 
Table 52 presents actual and target resource use for these nine health centres. For 
example health centre 10 which spent $3,389 on staff and $3,311 on drugs was 
inefficient. In order to become an efficient health centre it needs to reduce consumption 
to $1,864 on staff and $1,821 on drugs. 
Table 52: Actual and target resource use for the nine most inefficient health centres, using 
specification DEAl 
Actual resource use Target resource use 
Health centre Staff Drugs Staff Drugs 
10 3,389 3,311 1,864 1,821 
29 6,441 2,780 2,969 1,281 
4 3,854 3,900 1,821 1,843 
5 2,558 2,314 1,961 1,774 
6 5,871 6,058 1,824 1,882 
32 3,701 1,755 2,837 1,345 
2 2,711 3,660 1,486 2,006 
25 3,869 2,191 2,590 1,467 
8 3,588 4,010 1,701 1,901 
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9.6 Summary 
• Unfortunately the GoB faces significant resource constraints in funding the ESP; 
• Previous reports have found that the potential for additional resource mobilisation is 
limited and have suggested that improvements in the efficiency of health care 
services must be a critical component of efforts to provide the ESP to the whole 
population; 
• Given the Government's stated objective to mobilise additional resources VIa 
improvements in the efficiency of health facilities, an input-orientated specification 
under VRS was adopted to assess the technical efficiency of a sample of 34 
representative health centres; 
• Technical efficiency was 0.53 in specification DEAl, 0.48 in specification DEA2 
and 0.58 in specification DEA3. By decomposing this technical measure into 'pure' 
technical and scale efficiency, it was shown that slightly more of the inefficiency is 
due to health centres using too many inputs in treating the number of patients seen 
rather than operating at the wrong size; 
• The majority of health centres exhibited increasing returns to scale; 
• There is a high degree of correlation between the scores and ranks of the three 
specifications and the unit costs presented in the preceding chapter. However, 
among the inefficient health centres, the maximum difference in the efficiency score 
which an individual health centre obtained was 0.626, which equated to a change in 
rank of 20 places; 
• Technical, 'pure' technical and scale efficiency varied systematically according to 
the location of the health centres. 
The next chapter the results presented in Chapters 6 - 9 are discussed. 
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Chapter 10 
DISCUSSION OF FINDINGS 
This thesis set out to explore whether, and the extent to which, interventions to provide 
health care in Bangladesh are delivered efficiently. Previous chapters have presented 
data on the cost and efficiency of the provision of primary health care in urban and rural 
Bangladesh. In this chapter, the study results are discussed. It is divided into two 
sections. The first discusses methodological issues, in particular the limitations of the 
data, analysis and interpretation. The second section discusses the main findings of the 
thesis. In particular, it focuses on the: variation in unit cost data; variation in efficiency 
estimates; implications of inefficiency on CEA; constraints to efficiency improvement 
(particularly in relation to human resources); and cost-effectiveness of efficiency 
improvement programmes. 
10.1 Methodological matters 
Theoretically, in order to measure the technical and allocative efficiency of a firm, it is 
necessary to know the underlying production and cost functions for that firm. This 
requirement poses significant problems for 'real-world' applications in health care. 
First, the extreme heterogeneity and complexity of health care interventions effectively 
rules out the development of engineering-type production functions for all but the 
simplest interventions. If bottom-up engineering functions cannot be described, then 
some form of statistically derived estimation from observed data becomes necessary. 
In spite of this, it can only be assumed that a statistically estimated production or cost 
function reflects the underlying, 'true' function if it is assumed that firms are always 
technically and allocatively efficient in their operation. This thesis has shown that there 
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are good reasons to conclude that health care facilities are unlikely to meet these 
conditions in reality. Consequently it is not possible to observe the isoquant or 
production possibilities frontier of an efficient facility, and any estimated production or 
cost function cannot be assumed to fully represent the production frontier or the 
underlying cost function. 
Frontier estimation methods involve the estimation of an efficiency frontier (or 
envelopment surface) from an observed sample of data, based upon best performance 
within the sample. The efficiency of other facilities in the sample is defined relative to 
these best performers. Specifically, measurement of the deviation of individual firms 
from this frontier enables the calculation of relative efficiency scores and the 
computation of potential efficiency gains if all units could achieve best performance 
levels. 
There are two major features that distinguish alternative empirical approaches for 
estimating the production frontier: whether they are parametric or not; and whether they 
are deterministic or stochastic. Parametric methods assume a specific functional form 
for the frontier, whereas non-parametric methods do not; and deterministic methods 
assume that the distance of a unit from its frontier is a result of inefficiency whereas 
stochastic methods assume that this is also partially due to random error. This thesis 
used parametric and non-parametric techniques to measure the efficiency of primary 
health care in Bangladesh. In doing so, it challenged the assumption of technical 
efficiency implicit in CEA. 
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The remainder of this section focuses on the issue of measurement error. In particular it 
considers the potential for measurement error in the data sets used in this thesis, 
discusses the potential implications of measurement error on DEA and SFA and reflects 
on a number of solutions that have been proposed in the literature to mitigate the 
potential effects of measurement error. In addition, it considers some of the issues when 
interpreting efficiency estimates and possible extensions to the models presented in 
chapters 7 and 9. Finally, it discusses a number of constraints related to conducting this 
research within the larger WHO- and DFID-funded projects. 
10.1.1 Measurement error and other 'noise' 
Measurement errors are errors in reading, calculating or recording a numerical value 
(Everitt 1995). It is the difference between observed values of a variable recorded 
under similar conditions and some fixed true value. Clearly errors in the original data 
cannot usually be rectified, but errors introduced at a later stage can be minimised if 
certain steps are taken in the process starting from the collection of the data to its 
analysis. 
Appendices 5 and 15 present the data collection tools used at the vaccination delivery 
units and the health centres respectively. A coding sheet for data was prepared for both. 
Data were entered into Excel and SPSS. Errors in recorded data are common. For 
example, the recorded values may be wrong because of confusion over the correct units 
of measurement, digits may be transposed when data are transcribed, or data may be 
mistyped when being entered onto a computer. Data checking aims to identify and, if 
possible, rectify such errors in the data. To minimise these types of errors, the data 
were entered twice by two different people. Differences between the two files were 
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checked and the 'correct' values obtained by consulting the original questionnaires. As 
noted in Chapters 6 and 8, before beginning the main cost and efficiency analyses, the 
data were screened, which involved producing histograms of variables, and pairs of 
variables were inspected by scatter diagrams. These plots gave a first idea of the 
average value, the variability, the shape of the distribution, and whether there were any 
outlying or missing values. Finally, analyses were conducted on Excel, SPSS, DEAP 
and FRONTIER. 
As stated above, errors in the original data cannot usually be rectified. A report by 
Uddin et al. (2002) provides an indication of the quality of the data collected and 
analysed. As part of health sector reforms in Bangladesh (see Chapter 5), the Unified 
Management Information System Unit of the Directorate General of Health Services of 
the MOHFW introduced a new record-keeping and reporting system. The objective of 
the new system was to record and report on the ESP offered at the upazila level and 
below. From February 2000, service providers at the union level began to use the new 
record-keeping and reporting tools. Uddin et al. (2002) assessed the extent to which the 
new system was functioning at the union level. 
Monitoring was conducted in 36 randomly selected health centres of Chittagong district 
and 15 randomly selected health centres of Jessore district during February 2000-March 
2001. It was observed that the new record-keeping and reporting tools were being used, 
and fulfilled the record-keeping and reporting requirements at the union level of both 
the districts. The service providers committed less than 10% of errors, such as omitting 
data and entering incorrect data, when they were observed during service delivery, and 
the rate of errors increased to as much as 34% when they were not. The workload 
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during peak hours, inadequate training and inadequate supervision contributed to such 
errors. Unclear instructions from the national level to discontinue the use of some 
record-keeping and reporting tools of the previous system also contributed to errors. 
With systematic monitoring and supervisory support, the authors believed that the 
extent of errors could be reduced gradually. 
It is therefore apparent that the potential for measurement errors existed. This potential 
has been exacerbated among the health centres included in this thesis by the small 
sample size. For these reasons, it is pertinent to investigate the possible influence of 
measurement error and other 'noise' on the study findings. 
10.1.2 Influence of measurement error and other 'noise' 
One of the primary criticisms of deterministic frontier models, such as DEA, is that no 
account is taken of the possible influence of measurement errors and other 'noise' upon 
the frontier (Coelli et aI. 1998). All deviations from the frontier are assumed to be the 
result of technical inefficiency. Yet, as with regression analysis, deviations from the 
frontier may be due to a number of factors other than inefficiency such as omitted 
variables and measurement errors. 
These factors are not testable. As a result, interpreting DEA scores as measures of 
efficiency requires a high degree of 'blind' faith in the model. This is because, when 
there are outliers the method envelops the outermost observations without asking 
whether these observations are genuine or the result of an error. Even a single outlier 
can result in finding huge inefficiencies for most comparators without this being 
necessarily true. This is particularly the case where an observation contains inputs 
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which are significantly smaller, or outputs which are significantly larger, than other 
observations employing a similar input mix or producing a similar output level (Coelli 
et al. 1998; Cooper et al. 2003). 
SF A recognises the presence of errors and aims, in principle, to separate these error 
components from the measures of inefficiency. In practice, this effort is not always 
successful as, often the estimated inefficiency component represents a small fraction of 
the overall residual variation (Kumbhakar and Lovell 2000). This practical nuance may 
cause many problems in the analysis. For example, it can make SF A vulnerable to 
outliers. 
The presence of outliers in the sample can cause the stochastic frontier model to indicate 
that there is too much noise in the data and therefore may find little or no inefficiency in 
the sample, even in cases where there is some. As a result, all units may appear to be 
almost 100% efficient, which at first sight appeared to be the problem faced by the 
stochastic frontier models used in this thesis in Chapter 9 (although this appears to be 
due primarily to the small sample size). In this way, the main potential advantage of 
SF A of decomposing the residual into noise and inefficiency becomes a disadvantage as 
it fails to differentiate between units' efficiency. There are other instances in which the 
stochastic frontier model ceases to have the role it is intended to have. Sometimes, SF A 
can suggest that the noise residual has been drawn from a distribution with a very small 
variance. Consequently, deviations from the frontier are almost entirely due to the 
residual supposed to measure inefficiency. In these cases SF A collapses to a 
deterministic form, with the result that the frontier 'envelopes' the observations from 
below, resulting in at least one unit estimated to be 100% efficient. 
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Therefore, outliers can cause problems in both SFA and DEA but for completely 
different reasons: while SF A can fail to find any inefficiency at all, DEA is likely to 
find too much inefficiency in the sample. 
10.1.3 Approaches to mitigate the potential effects of measurement error 
Outliers could be removed from the analysis to remedy this problem and find 'sensible' 
scores of inefficiency, although any such choice would be inherently arbitrary and 
difficult to be make. Timmer (1971) adopted the suggestion of Aigner and Chu (1968) 
of deleting a percentage of the sample firms closest to the estimated frontier, and re-
estimated the frontier using the reduced sample. However, the arbitrary nature of the 
selection of a percentage of observations to delete has meant that this so-called 
'probabilistic' frontier approach has not been widely followed (Coelli, Rao and Battese 
1998). 
An analysis of the data sets for outliers, which identifies observations with inputs or 
outputs lying more than three standard deviations on either side of the sample mean, 
indicated that the vaccination delivery units and health centres used inputs and produce 
outputs commensurate with size. Therefore, no significant outliers were discovered. 
However, future research could include the application of more sophisticated methods 
to identify influential outliers in DEA using modifications suggested by Wilson (1995) 
and Lovell et al. (1993). 
This thesis also sought to account for the deviations from the identified frontiers by 
performing a two-stage approach whereby the resulting efficiency scores were analysed 
against an array of independent factors that may affect efficiency but are out of the 
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managers' or policy-makers' direct control. While the two-stage approach 
recommended by Coelli, Rao and Battese (1998) was used in this thesis, alternative 
techniques exist, which were reviewed in Chapter 3. 
Valdmanis (1992) (based on Nunamaker 1985) suggests, as a possible answer to these 
problems, that researchers run a number of different models for each data set and 
evaluate the sensitivity of the results to changes in model specification. These changes 
may take the form of alternative input and output definitions. While this approach does 
not address the issue of measurement error per se, if different methods suggest similar 
directions for results then the validity of such findings is enhanced. The purpose of the 
sensitivity analysis would be to assess whether the ranking and efficiency of an 
individual firm is variable-specific (or model-specific) or whether the results are robust 
to changes in data set specification. Valdmanis (1992) cautions that ' ... for a model to 
be considered robust, it must be shown that minor changes in the list of variables cannot 
alter fundamentally the conclusions of the DEA model'. 
Another method of evaluation is to compare the results of DEA and SF A applied to the 
same data sets. As Hollingsworth (2003) notes that " ... given the limitations of frontier 
techniques at present it may be that they are best employed in tandem". As a result, the 
best approach is the use of different techniques in tandem. Thus both methods serve as 
signalling devices (Jacobs 2001). To the extent that there is no a priori reason to prefer 
one methodology over another, it seems prudent to analyse efficiency using a broad 
variety of methods to 'cross-check' . 
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This thesis has examined the consistency and robustness of efficiency scores across 
DEA and SFA techniques when applied to the same data sets. Sensitivity analysis was 
carried out within the DEA and SF A models by changing the model specifications 
(omitting and including different variables) and testing for the robustness of the results 
(Jacobs 2001; Valdmanis 1992; Nunamaker 1985). While models proved to be 
relatively robust in this respect, there was some inconsistency across the different 
methodologies. Caution is therefore warranted against literal interpretations of units' 
efficiency scores and rankings. Reasonable correlations suggested convergent validity. 
However, while on average, scores and rankings were fairly stable across specifications, 
some units experienced dramatic movement in where they were ranked. This implies 
that it would be inadvisable to rely on a single specification if the objective was to set 
unit specific efficiency targets, such as those presented in Chapter 7 and 9. 
The different efficiency scores should not therefore be interpreted as accurate point 
estimates of efficiency, but might more usefully be interpreted as indicating general 
trends in inefficiency for certain units (Jacobs 2001). The point estimates of 
inefficiency in either method are indeed sensitive to specification, measurement and 
data errors. However, when several specifications were used, general trends could be 
discerned as to which units usually came out as being more efficient and which ones 
generally emerged as inefficient. It is therefore imperative that several specifications be 
employed to gauge an overall picture of efficiency. It might also be useful to explore a 
number of DEA re-sampling techniques (including jack-knifing and bootstrapping) 
which have been developed to obtain more statistically robust measures of estimated 
frontiers (e.g. Ferrier and Hirschberg 1997; Atkinson and Wilson 1995). 
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Ultimately, data accuracy is paramount to parametric and non-parametric analyses as 
inaccurate data in, for instance the DEA methodology, will affect not only that unit's 
efficiency rating but also potentially the efficiency ratings of other units as well. The 
level of random 'noise' is a reflection of the quality of the data and will affect the ability 
to measure efficiency. Nevertheless, in spite of these problems, it should be recognised 
that the approaches used in this thesis are only relative and that further efficiency gains 
could still be possible beyond the identified frontiers. 
From the GoB's point of view, improving on data deficiencies would probably 
contribute more to better efficiency estimates than further experimentation with 
alternate specifications and estimation techniques. In particular, data on outputs and 
quality of care and outcome indicators would be important. There may not be a strong 
self-interest in the accurate reporting of data and as such incentives might be needed to 
ensure this. 
10.1.4 Interpreting efficiency scores 
As noted in Chapters 7 and 9, a potential strength of DE A is that it can identify potential 
efficiency gains and the targets that need to be met in order to realise such gains. 
However, while these methods prove useful diagnostic tools it would be inappropriate 
to base funding and resource decisions or indeed efficiency targets entirely on the 
efficiency estimates arrived at (Skinner 1994; Newhouse 1994; Hadley and Zuckerman 
1994). Relative efficiency assessment and target setting based on only one method may 
provide inappropriate incentives to managers. Therefore, given the limitations of 
frontier techniques at present it may be that they are best employed in tandem when 
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possible; if different methods suggest similar directions for results then the validity of 
such findings is enhanced. 
Particularly under DEA, the Pareto efficiency criterion has the advantage of regarding 
each separate input and output as being equal in value thus allowing units to be rated 
along their best dimensions. However, this same advantage could also create the 
perverse incentive for managers to act in a dysfunctional manner trying to improve their 
efficiency rating by engaging in creative accounting, and alteration of the input / output 
mix (Nunamaker 1985) if DEA performance measures were incorporated into an 
incentive scheme. 80 
Poorly constructed output measures in any method could also lead to units devoting 
more resources to achieving low priority outputs simply to improve their perceived 
efficiency. For example, the different weighting schemes used in Chapter 7 illustrate 
that the methods used to aggregate different outputs into a single measure of output, 
which is required for stochastic frontier methods, can influence findings. Similarly, 
failing to list ESP-specific outputs, rather than the number of age-specific visits, 
weakens the ability of the techniques to set targets to improve the efficiency of the ESP. 
Equally, the examination of vaccination services in isolation is also of concern, when 
many of the sites provided a range of other health services. It is plausible that, allowing 
a certain level of inefficiency in vaccination services may allow sufficient flexibility for 
a health centre deliver to other services more efficiently. 
80 An incentive scheme has been introduced by the Global Alliance for Vaccines and Immunization as a 
means to increase vaccination coverage rates. The scheme is supported by a data quality audit exercise, 
which is used to verify reported performance (GA VI 2005). 
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Consideration needs to be given to whether units should be allowed some time to adjust 
their activities in such a way that they are more directed at agreed priority outputs 
before their relative efficiency is assessed. However, this should not detract from the 
usefulness of a baseline assessment of efficiency which can help inform the process. If 
these or similar results were to form the basis of a performance target-setting regime, 
careful consideration would have to be given to the potential incentives provided by the 
implicit weights provided by the model selections. 
A note of caution with regards interpreting targets based on efficient 'peers'. Efficient 
peers give a measure of efficiency that is empirically obtainable in a given scenario (e.g. 
given available resources and institutional set-up), as firms are directly compared against 
a peer or combination of peers. Hence one can compare the efficiency of individual 
facilities or administrative areas against realistic benchmarks. For example, unions, 
upazilas or zones which are classified as efficient health service delivery units, or 
'peers', could become 'model' areas where new policies and procedures for improving 
efficiency, quality, promoting community involvement, and fostering sustainability are 
implemented and closely monitored. Such administrative areas would have the 
potential for becoming training sites where field staff could be trained by persons 
working with programmes currently engaged in the effective provision of the ESP. 
These same programme sites could offer strong potential for carrying out local 
operations research activities to strengthen the efficiency of service delivery. However, 
in some instances, the hypothetical target unit on the frontier will consist of a 
combination of the largest and smallest efficient 'peer' units. Thus, there is a 
pedagogical problem because the manager of the in-between-sized unit may not find it 
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interesting to compare himself neither to the largest units, nor to the smallest units. The 
results may therefore, in some instances, give little help to practical policy questions. 
10.1.5 Extensions to the models presented 
The models considered in this thesis are cross-sectional in the sense that each 
vaccination delivery unit and health centre was observed at a single point in time. In a 
panel data set, each unit is observed not only once but over a period of time and thereby 
the ability to make statistical inferences increases. Panel data models tend to be less 
susceptible to multicollinearity and degrees of freedom problems (Coelli et al. 1998; 
Cooper 2003). Furthermore, if assumptions about the functional form of the 
distribution of the inefficiency effects are difficult to justify, and the functional form of 
the relationship between cost and outputs requires a lot of data for the estimation to 
proceed, it is desirable to use panel data analysis. In particular, panel data analysis 
avoids making strong distributional assumptions about the inefficiency effects. By 
contrast, these effects are usually assumed to be either fixed or random - a number of 
these types of studies were reviewed in Chapter 4. This means that in the fixed effects 
models the firm-specific inefficiency effects are treated as fixed (Skinner 1994), while 
in random effects models the firm-specific inefficiency effects are treated as realisations 
of some random process (common for all facilities). The standard error of each effect 
can then be used to make assessments of how far each unit differs from the 'best 
practice' units. 
A specific issue that arises in panel data is that of modelling the time aspect of 
inefficiency. In traditional panel data models efficiency is assumed to remain 
unchanged over time. This assumption may be difficult to justify particularly when 
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observing the same units over a long period of time. For example, it is natural to think 
that efficiency will improve over time as new working practices are developed, and 
differences in efficiency may narrow if units can learn from 'doing' and / or each 
other's practices. Chapter 7 suggested that the efficiency of the vaccination delivery 
units was related to such learning effects. With panel data analysis it is possible to not 
only the check whether a unit's efficiency is improving over time relative to the frontier, 
but also whether the frontier itself is shifting. DEA Malmquist indices can also be used 
to examine productivity change over time (Hollingsworth, Dawson and Maniadakis 
1999). 
Scope exists to develop a panel data set of vaccination services, as data could be 
collected alongside routine national coverage evaluation surveys. Not only would this 
enable extension to the analyses presented in this thesis, but it would likely improve 
knowledge about variation for different scales of production and settings. These data 
would inform whether and how costs vary with the level of production of vaccination 
services, which would guide decisions about whether and how much to expand existing 
vaccination programmes. It should also allow a better-defined relationship between 
costs and effects of provision of existing services and new services to be questioned. 
10.1.6 Input- versus output-orientated models 
Given the GoB's stated objective to mobilise additional resources via improvements in 
the efficiency of health facilities, input-orientated DEA specifications were adopted in 
Chapters 7 and 9. However, as stated in Chapter 7, an input-orientation runs contrary to 
the Government's stated objective of full vaccination coverage. And while an input-
orientation is consistent with the fact that treating fewer is clearly better, in the sense 
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that it may reflect successful health promotion and prevention programmes, it needs to 
be balanced against the fact that utilisation rates of government health facilities are low, 
suggesting there could be considerable unmet need (see Chapter 5). 
Input-orientated measures help identify by how much input quantities can be 
proportionally reduced without changing the output quantities produced. In essence this 
reveals the quantity of variable resources that could be reduced, as fixed resources 
cannot be reduced in the short-term. The alternative output-orientated specification 
would reveal by how much output quantities can be proportionally expanded without 
altering the input quantities used. This is perhaps more palatable from a policy-makers 
perspective. However, as noted in Chapter 5, under-utilisation of union-level facilities 
is well documented, so the recommendations would have to be demand-led, although 
they would need to ensure that supply-side considerations have been met. 
The indivisibility of inputs may explain why reduction or substitution predicted by the 
models would not take place in practice. The context of the health care setting 
concerned, in particular the way in which the supply and demand for factor inputs is 
regulated, may also have important implications for the divisibility of inputs. For 
example, although it might improve technical efficiency for staff to be made redundant, 
contracts and trade unions obviously ensure that this cannot be enacted in the short-
term. If an output-orientation were adopted, it would hold constant all inputs, which 
would 'solve' this particular problem. But equally there are challenges in interpreting 
output-based models, particularly within the health sector as demand is stochastic. 
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10.1.7 Constraints of conducting this research within a larger project 
As stated in Chapter 1, these data were not collected for the purpose of parametric and 
non-parametric efficiency measurement analyses. Rather, they were collected for the 
purpose of CEAs. As illustrated in Chapter 2, such studies do not examine the relative 
efficiency of production units as one of their objectives because efficiency is already 
assumed. The focus of CEAs tends to be on providing a point estimate of the cost of a 
given service or intervention, where wider consideration of efficiency requires 
comparison of a sample of several production units. Therefore, it is important to ask 
what the immediate implications were for this thesis. 
The main implication is perhaps the sample size of each case study. The case studies 
examined data from 110 vaccination delivery sites and 34 health centres providing basic 
primary care. Given that the sample sizes for both case studies were not selected for the 
purposes of efficiency analyses it was thus fortunate that the sample of 110 vaccination 
delivery units was adequate for both parametric and non-parametric analyses. The same 
fortune did not extend to the 34 health centres; while this thesis has illustrated that DEA 
can be implemented on a relatively small data set, Chapter 9 highlighted the problems 
of conducting parametric analyses on a small sample. 
Although the power to differentiate firms diminishes as the sample size falls, DEA still 
gave meaningful results with the limited sample. However, it should be noted that in 
DEA, the efficiency scores tend to be sensitive to the choice of input and output 
variables and, in some circumstances, relatively small samples may lead to relatively 
inefficient firms defining the frontier. This is because there is likely to be at least one 
factor (use of input or production of an output) for which a firm is distinct. Even if this 
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is not in fact an important variable, its use in a DEA could put that firm on the frontier. 
On the other hand, SF A requires a larger minimum sample size in order to stand up to 
statistical testing. Indeed, Chapter 9 illustrated that the sample of 34 health centres was 
too small. Were this research undertaken again, a larger sample of health centres should 
besought. 
A brief note regarding missing values is also merited at this point. In general terms, 
there are three possible approaches for analysing datasets with incomplete or missing 
observations. The simplest solution is to ignore the problem and work only with the 
subset of observations with complete data. Alternatively, the analyst can use a range of 
alternative statistical techniques and perform a single imputation for each missing value, 
whereby the incomplete observations are replaced with a single imputed value. The 
final approach is to use methods such as multiple imputation using Markov chain Monte 
Carlo techniques (Briggs et al. 2003; Manca and Palmer 2005). 
In both case studies, a complete case analysis approach was adopted in which all cases 
with missing data were excluded from the analysis. Given that the incomplete 
observations in both case studies were missing completely at random, there is no reason 
to believe the results are biased in any way. As evidenced by the analyses presented in 
Chapter 7, the exclusion of 22 vaccination delivery sites because of missing 
observations did not affect the ability to perform parametric and non-parametric 
efficiency measurement analyses. Chapter 9 highlighted that a sample size of 34 health 
centres was too small to perform parametric analyses. The use of methods to impute 
values for missing observations in provide a full sample of 36 health centres with which 
to work with would not have resolved this problem; a sample of 36 health centres is 
equally as small, and restricts analysis to the degree. 
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The second implication relates to the selection of the inputs and outputs, which were 
therefore essentially post hoc. As noted above, improvements in the output data should 
be seen as a priority of future similar studies, but which have efficiency measurement as 
their main focus (or at least an objective). Similarly, the choice of environmental 
variables was also essentially post hoc. It would have been interesting to complement 
the quantitative analyses presented here with qualitative research undertaken to better 
understand the unit-level managerial characteristics of good practice. Unfortunately this 
was not possible given the requirements of the larger project. 
Related to the sample size issue, it might have been preferable to have collected data 
from urban and rural settings in Bangladesh on the same service. However, in 
retrospect, the fact that two different services have been investigated and both found to 
exhibit large degrees of inefficiency strengthens the study. Both of the services are 
delivered at the primary level. Future research of efficiency using methods similar to 
those followed in this thesis might be extended to also include secondary and tertiary 
health care facilities to give a more comprehensive indication of the efficiency of health 
services in Bangladesh. Although the 'Bangladesh health facility efficiency survey' 
conducted by Rannan-Eliya and Somanathan (2003) collected data from these higher 
levels of care, they presented simple ratio measures as their indicators of efficiency. 
10.2 Discussion of findings 
The discussion of findings covers the following aspects: variation in unit costs; 
variation in technical and scale efficiency; the implications of inefficiency on CEA; the 
constraints to improving efficiency (particularly in relation to human resources); and the 
cost-effectiveness of efficiency improvement programmes. 
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A relatively large body of literature exists presenting cost studies for different levels and 
types of health care provider in many developing countries (e.g. Barnum and Kutzin 
1993; Adam et al. 2003). The most commonly used technique for measuring costs of 
public health interventions in developing countries is the accounting approach, which 
was used in Chapters 6 and 8. 
10.2.1 Variation in unit costs 
Chapters 6 and 8 focussed on the 'cost' in cost-effectiveness and in particular the need 
to describe variation in the cost of providing health care services. Chapter 6 reported a 
40-fold difference in the cost per dose administered among the 110 vaccination delivery 
units. Chapter 8 reported a 5.5-fold difference in the cost per visit among the 34 health 
centres. Importantly, the same methodology was used to cost each of the vaccination 
delivery units and health centres, which means that methodological inconsistencies can 
be excluded as a potential source of the variation in the unit costs observed. 
These results illustrate that service volume at the vaccination delivery units and health 
centres appears to be one of the most important factors influencing the unit costs. The 
findings presented in Chapter 6 and 8 show a clear inverse relationship between the unit 
costs and service volume. Good managers of health facilities try to choose 
combinations of personnel (of various types), supplies and other inputs that will 
minimise the costs for a given volume, at the prevailing rates of pay and prices. When 
the total costs (of the cheapest combination) are divided by the service volume, an 
average cost function is derived. When presented in a graph, the curve shows that the 
average cost first falls and then rises as the service volume increases (Figure 20). It 
seems that the optimum service volume, corresponding to the lowest average cost, has 
225 
not yet been reached in either of the samples because neither of the average cost curves 
showed a trough throughout the range of service volumes studied. Both case studies 
therefore, suggest that increasing the volume of service (doses or visits), in those units 
that saw relatively few visits, or administered relatively few doses, would lower the 
average cost. 
Figure 10: Typical curve showing relationship between service volume and average cost 
volume 
A significant factor contributing to this relationship appears to be the existence of 
substantial fixed costs associated with the delivery of both services. Although both cost 
analyses classified staff as a recurrent item, in line with standard costing guidelines, in 
reality personnel costs are fixed in nature, at least in the short-term, which means that a 
significant portion of the resources required for the delivery of both services change 
little, if at all, as the volume increases or decreases. Under these conditions, therefore, 
the results, as expected, show that up to a certain level of utilisation of resources, a 
larger volume of services tends to reduce the unit cost. However, there must be some 
point beyond which a higher volume of service is accompanied by inefficient utilisation 
of resources, which raises the average cost. This point does not appear to have been 
reached in any of the units analysed in Chapters 6 and 8. 
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With respect to Chapter 6, vaccine wastage was noted as another cause of variation in 
the unit costs. Vaccine wastage is important as it can indicate programme errors. For 
example, it can highlight that too many drops of OPV or the wrong dosage for other 
vaccines is used; cold-chain failures or poor logistics; and false reporting of more 
vaccinations administered than vaccine received. There are also economic implications 
associated with wastage. If wastage can be reduced without affecting coverage, it can 
result in significant resource savings for programmes. This is especially true for very 
poor countries, such as Bangladesh, which do not typically have budgetary flexibility to 
expand programme financing (Dervaux et al. 2003). 
The literature appears to suggest that distance could be important in determining 
vaccine wastage rates. Unfortunately, no data were available on the distance of the 
fixed delivery units from the outreach sites with which to test this theory. Nor were 
data available regarding the distribution of households around these delivery units. 
However, the outreach sites clearly experienced higher rates of wastage, suggesting that 
a relationship exists between distance and wastage rates which is worth exploring 
further. 
A study from Benin and Guinea suggests that these problems, if identified, can be 
addressed for little extra cost, and can result in a rapid increase in vaccination coverage, 
as well as the more efficient use of other primary health care facilities (Soucat et al. 
1997). To investigate differences in the cost of delivering vaccines between centres the 
authors measured various parameters associated with access to, and availability of, 
services. In Benin outreach activities increased accessibility (from 77% to 95%) in the 
worst group, but utilisation remained low when compared to the best group, 
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demonstrating that improved accessibility does not necessarily increase utilisation. 
Those centres performing best in terms of coverage had effective social mobilisation 
and channelling strategies, and those performing worst had a severe problem with drop-
out rates. In Guinea, the worst performing centres were those for which access was 
difficult - where the service is available, but not readily accessible. The better 
accessibility in Guinea was explained by improved outreach activities in the best-
performing group. Further studies of this type are required to help inform decision-
making regarding the optimal use of additional resources for vaccination services. 
The results discussed here provide estimates on the supply-side cost of the ESP. The 
results are based on the average level of efficiency in the sample zones and unions. 
Systematic and significant variation in unit costs between production units, can present 
a powerful basis for benchmarking and for identifying high cost and thus relatively 
inefficient units. Thus, further efficiency gains might be achieved if, instead, the best 
performing facilities were taken as the standard at different levels of output. Other 
facilities would then be helped to achieve similar levels of productivity. Chapter 7 and 
9 analysed these data in order to discern whether and to what degree the health facilities 
were being operated efficiently. 
10.2.2 Variation in efficiency 
While there has been a recent expansion in the number of efficiency evaluations 
(Hollingsworth 2003), there remains a dearth of literature on the measurement of 
efficiency from low- and middle-income countries (see Chapter 4). This is 
disappointing given the developing world's greater scarcity of resources, which results 
228 
in the inefficient use of resource exacting a much greater penalty in tenns of foregone 
benefits. 
Chapters 7 and 9 presented the efficiency of providing vaccination services in Dhaka 
and the efficiency of providing primary health care at union-level health centres in rural 
Bangladesh. The findings illustrated that these services were being provided 
inefficiently. Not only was there a large degree of technical inefficiency present, but the 
majority of the units were operating at IRS, which questions the applicability of cost-
effectiveness analyses that assume CRS. 
With respect to technical efficiency, Chapter 7 illustrated that differences in ownership 
and type of vaccination delivery units made no difference. However this was not true 
for technical and scale efficiency, where it was found that NGO-outreach delivery units 
were the most technically efficient and GoB-fixed delivery units were the most scale 
efficient. The technical, 'pure' technical and scale efficiency of the delivery units 
varied systematically by location. 
It is difficult to interpret these findings. It appears that delivery units trade-off scale and 
technical efficiencies. The findings suggest that government-owned units, perhaps due 
to more centralised control, were better at long-tenn planning. It was also found that 
units that had been practicing longer were relatively more scale efficient, which is 
perhaps attributable to learning effects. This suggests that merging the smaller sites 
would reduce excessive costs attributed to scale diseconomies. However, mergers 
should not be pursued too hastily, especially if access to vaccination services would be 
compromised. 
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Chapter 9 explored whether location affected the efficiency of health centres. 
Technical, 'pure' technical and scale efficiency varied systematically according to the 
location of the health centres. The districts were selected to reflect high (Chandpur), 
medium (Moulvi Bazar) and low (Brahmanbaria) performing districts using a variety of 
indicators of disease, vaccination coverage, health service provision and access to health 
services. The efficiency data presented in this thesis are not consistent with this 
classification. 
It would be interesting to better-understand why location influences efficiency. It may 
boil down to the management skills of the zonal programme managers. Future analyses 
should include a qualitative component that attempts to tease out the characteristics of 
good practice. 
10.2.3 Technical efficiency and cost-effectiveness analysis 
Chapters 7 and 9 both illustrated that the case studies were delivered at less than full 
technical efficiency. Failing to account for differing levels of technical, and therefore by 
definition allocative, efficiency among providers could have significant implications for the 
validity of the results of economic evaluations. If technical inefficiencies exist it means 
that a cost-effectiveness ratio does not reflect the minimum efficient point of production 
at a given level. Not knowing whether, or the degree to which, a cost-effectiveness ratio 
incorporates technical inefficiency could have a significant impact on decisions. 
Consider, for example, a facility operating inefficiently - excess costs are incurred 
given the outputs produced. If these excess costs could be reallocated elsewhere, then 
there exists the possibility of potential Pareto efficiency gains. 
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This thesis has illustrated that inefficiencies occur in the provision of preventive and 
basic curative servicesSl • In the case of successful preventive programmes, the need for 
the associated curative services will be averted. A question which therefore needs to be 
addressed is whether accounting for inefficiencies in both of these elements of the 'cost' 
of the cost-effectiveness ratio would cancel each other out. The extent to which this 
might happen is related to health care seeking behaviour. 
10.2.4 Scale efficiency and cost-effectiveness analysis 
Using DEA, Chapters 7 and 9 illustrated that the case studies exhibited VRS, thus 
violating the frequently stated assumption of CRS in the provision of health services 
(Elbasha and Messonnier 2003; Jacobs and Baladi 1996). Whether economies of scale 
are likely to be exhibited to the same degree in other health services or other health 
settings is an empirical question. However, assuming eRS when costs and cost-
effectiveness ratios in reality change with production, will produce biased estimates of 
any change in production and the bigger the expected change the larger the bias is likely 
to be. Not investigating or accounting for these economic forces could produce biased 
results that might mislead policy. 
The presence of VRS has other implications. First it means that interventions cannot be 
treated as divisible for a population and retain the same average level of cost-
effectiveness. In such a case, Johanesson (1996) suggests that the decision-maker's 
willingness to pay approach for choosing the allocation of health interventions would be 
more appropriate than maximising outcomes subject to a fixed budget. This is simply 
81 It is likely that an examination of the efficiency of diagnostic services would highlight inefficiencies 
also. No empirical studies of these services were identified in Chapter 4. 
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because the latter either provides a programme or not, and therefore there is no division 
of programmes. 
Johanesson (1996) also suggests that interventions with IRS are presented as 'mutually 
exclusive' options for each level of production within a league table. However, in the 
event that IRS exist over all levels of production, the greatest level of production will 
demonstrate extended dominance over all other options, and therefore all production 
prior to the minimum efficient point would be excluded. Thus interventions with IRS 
are less likely to be provided, but conversely, assuming CRS when IRS exist means that 
interventions are likely to be over provided. 
The recent review on learning effects with health technology (Ramsey et a1. 2000) and 
its potential application to understanding economies of scale and CEA is also of interest. 
However, researching this issue will require larger sample sizes for the resources and 
costs of providing services than usually underpin CEAs in practice. Therefore it is 
important that randomised clinical trials provide costs from each trial centre (e.g. Coyle 
and Drummond 2001; Raikou et a1. 2000; Wilke et al. 1998) and that the analysis of 
variation include analyses of technical and scale efficiency. 
10.2.5 Efficiency and the generalisability of cost-effectiveness data 
Ignoring the possible existence of technical inefficiencies and VRS would make 
generalisability of cost-effectiveness ratios suspect and could lead to a misallocation of 
resources. Consider, for example, a more efficient health system incorporating cost-
effectiveness ratios of health interventions from a less efficient health system. The cost-
effectiveness ratios will be higher than could be expected if the services were provided 
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within their own system. If the transported ratio is used, the intervention would be less 
likely to be adopted and hence inefficiencies in one system are imported into another. 
Failure to adequately incorporate some assessment of the relative efficiency of 
providers may therefore also bias the outcomes of CEA within health systems. For 
example, consider a new intervention provided by a highly motivated and efficient 
provider compared to standard care at a low-efficiency provider. As a minimum, 
therefore, good practice in economic evaluation should seek to compare interventions 
between providers with similar levels of technical efficiency, while sensitivity analysis 
should attempt to consider the impact of different levels of technical efficiency on 
results. 
10.2.6 Constraints to efficiency improvement 
Human resources policy has the potential to be an important support to, or major brake 
upon, efforts to improve efficiency, therefore the potential importance of attitudes to job 
losses cannot be over-stated. Where major inefficiencies have been identified, it is 
highly unlikely that equivalent savings can be realised without job losses. Chapters 6 
and 8 illustrated that staff accounted for a considerable proportion of the costs of 
providing services in the case studies. Chapters 7 and 9 identified scope for substantial 
reductions in total costs, and by implication staff costs. However, as WHO (2000) 
notes, 'tensions' may arise between managers and politicians when the right to shed 
workers is withheld due to political pressure. It is particularly important that politicians 
understand that they will not be able to have both savings and no job losses, and that 
squeezing non-personnel funds is likely simply to exacerbate existing inefficiencies. 
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Therefore, employment contracts should make some provision for reassignment of 
duties or redeployment (functionally or geographically), even if fixed-term contracts are 
not felt to be feasible (the latter clearly offer the opportunity of non-renewal, greatly 
facilitating skill substitution). Careful assessment of skill requirements and skill-mix 
should be undertaken regularly, so that opportunities presented by routine departures of 
staff (promotion, job moves, retirement etc.) can be exploited to allow skill substitution. 
Institutional and professional inflexibilities can easily jeopardise attempts at skill 
substi tution. 
Remuneration policies and practices also seem likely to have a significant impact on the 
efficiency of service delivery in developing countries (Hensher 2001). Ensuring that the 
remuneration of skilled health workers is adequate seems frequently to be overlooked in 
the attempt to control costs and expenditure. However, there are several persuasive 
arguments as to why inadequate remuneration of skilled health workers will undermine 
efficiency. For example, the generic theory of efficiency wages (e.g. Stiglitz, 1987; 
Yellen, 1984), argues that productivity is directly affected by wage levels through 
attracting and retaining higher quality workers, and through motivating higher levels of 
effort and morale. However, this argument may not hold when, in effect, the 
government sets the market-clearing rate for health workers in Bangladesh. 
Failure to attract and retain adequate quantities and quality of staff will lead to technical 
inefficiency because of skill shortages. For example, unfilled vacancies in key posts 
mean critical activities do not take place, and efficient operation becomes significantly 
degraded. Finally, persistently low pay almost always opens the door to unofficial 
'private practice' using public facilities and time, if not to full-blown theft and 
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corruption. The wastage of resources and low productivity that result may well 
outweigh the 'saving' in salaries achieved by a low wage policy. 
The case studies in this thesis identified significant operating inefficiencies in the 
delivery of vaccination services and primary healthcare. In both instances, low 
utilisation and high fixed staffing costs appear to be contributing significantly to the 
levels of inefficiency. As a result, the question is whether policy-makers want to 
maintain current output, and thus release inputs for other uses, or whether they want to 
increase outputs until current inputs are efficiently employed. In other words, do they 
want a higher utilisation of primary care in the community served by the health centres, 
or would it be more cost-effective to take the efficiency savings and invest them into 
another programme, or another community? This thesis has not sought to answer these 
questions. However, if, after careful consideration, policy-makers in Bangladesh 
decided that it was indeed cost-effective and desirable to increase output of the existing 
providers and their services, then they would essentially be faced with a series of tasks 
related to improving the productivity of the current units. If, however, they required 
only current output levels, and what they really wanted were the efficiency savings, then 
they face two sets of tasks: how to improve productivity (of those who are going to keep 
their jobs) and how to identify the surplus inputs and extract them / convert them into 
savings. 
If it is assumed that policy-makers have decided to put efficiency savings to some 
alternative use, they must then consider how far and how rapidly the current inputs can 
be converted to a new application, either physically (if they are suitable for 
redeployment), or via realisation into cash savings. This is clearly very much a problem 
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of short-run versus long-run, and will largely depend on the extent to which institutional 
factors constrain the adjustment process. Returning to the case studies in this thesis, 
assume it has been identified that the highest priority use for the efficiency savings is to 
establish additional health centres in currently under-served regions. Therefore, at the 
health centres identified as inefficient, the policy-makers might have good reason to 
believe that some or all of the resources released by efficiency improvements could be 
directly transferred. For example, the staff probably already have the appropriate 
training and spare equipment could be moved. However, even in this relatively 
straightforward case, constraints may still be faced, e.g. will the redeployed staff be 
willing to work for a new employer (perhaps moving from the local government to the 
MOHFW), and how will their contracts be transferred? Do their employment contracts 
allow policy-makers to transfer staff involuntarily? What period of consultation with 
trade unions may be required before definite decisions could be taken? Do procedures 
exist to allow policy-makers to initiate a process of redundancies? Do they have an 
effective human resources policy to allow them to select those who will stay and those 
who will go? If not, can they plausibly retrain the staff - if not to go to the highest 
priority programme, then at least to do something deemed more valuable than their 
current role? This option reduces the scale of the efficiency saving that would 
ultimately be realised, but at least provides a solution that is less allocatively inefficient 
than the present situation. How long will all these processes take to work through? 
10.2.7 The cost-effectiveness of efficiency improvement programmes 
In light of the above discussion, when is it cost-effective to introduce an efficiency 
improvement programme? Efficiency improvement and implementation methods seek 
to change the behaviour of individuals or organisations in response to inefficiencies. 
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Behavioural change comes at a certain cost and achieves a certain level of change; it is 
never costless. The economics of efficiency improvement could provide a way of 
thinking about inefficiency and identify, for policy-makers and practitioners, the best 
use of scarce resources to achieve efficiency improvement goals. A model for working 
through the economic issues of efficiency would combine the costs and effects of 
corrected inefficiency with the costs and degree of behavioural, institutional or system 
change achieved by an efficiency improvement method in the policy maker's locality. 
Because it is hardly ever possible to have one empirical study that gathers all the data 
needed to study the cost-effectiveness of an efficiency improvement strategy (and this 
thesis unfortunately has failed to do so), the models by Mason et al. (2001), Lobo et al. 
(2003), Severens (2003) and Verstappen et al. (2004) developed to examine when it is 
cost-effective to introduce a quality improvement programme are discussed below as 
they can provide guidance on the likely design of such a model. 
In the economic evaluation of quality improvement interventions, costs have been 
subdivided into different phases of the quality improvement process (Verstappen et al. 
2004). First, there are costs related to the task of collecting evidence to identify best 
practices, and conversely, poor or inefficient practice. Therefore, the costs of the 
research presented in Chapters 6 and 8 reflect these costs, which can be classified as 
developmental costs (fixed costs). Second, there are costs associated with organising an 
efficiency improvement programme, e.g. replace jobs-till-old-age-retirement with 
shorter term renewable contracts. Such costs are basically one-time costs and can 
therefore be considered fixed costs, unless the intervention used after the experience 
that is gained is subject to change. In that case, the efforts associated with a revision of 
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the strategy must be considered execution costs. If the efficiency programme targets 
behaviour rather than legislation, the magnitude of behavioural change is unlikely to 
remain constant over time (Durieux et al. 2000), and a decision would need to be taken 
as to whether efficiency improvement is a 'one off or whether periodic 
reimplementation should be costed. On the other hand, the costs of the actual execution 
of the efficiency improvement strategy are not relevant until the moment the strategy is 
executed (Lobo et aI. 2003). Such costs can be considered fixed or variable, depending 
on the amount of detail included in the cost study. 
Costs might sometimes be associated with a change in health care provision as a result 
of the application of an efficiency improvement strategy. Of course, this would depend 
on whether the analysis was measuring output-orientated efficiency, which addresses 
the question, "By how much can output quantities be expanded without changing the 
input quantities used?". The analyses presented in this thesis have measured input-
orientated technical efficiency, which would result in a supply-side recommendation 
such as replacing jobs-till-old-age-retirement with fixed shorter term renewable 
contracts; no change in health care provision would be examined in this situation. 
However, an output-orientated analysis would need to develop a demand-side 
intervention, which is more challenging (Ensor and Cooper 2004). And in this 
situation, as a result of the application of a social mobilisation intervention, for instance, 
vaccinators may see more children. Non-medical costs, such as parents' cost for time 
and travel, and possibly costs resulting from absence from work, can also be analysed 
on this level. These changes in health care provision costs are always considered 
variable costs. 
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Mason et al. (2001) distinguish between treatment cost-effectiveness (the incremental 
costs and benefits of a treatment) and policy cost-effectiveness (combining treatment 
cost-effectiveness with the cost and magnitude of change achieved by an improvement 
programme). Policy cost-effectiveness is most likely to remain attractive in those 
treatments that are highly cost-effective, e.g. vaccination services and primary health 
care more generally (World Bank 1993; Doherty and Govender 2004), and most likely 
to become unattractive when the cost-effectiveness of treatment is borderline. 
As a general rule, the larger the efficiency deficit, the lower the marginal 
implementation cost of an efficiency programme. Therefore, an efficiency deficit must 
reach a minimum threshold before an efficiency improvement programme becomes 
economically attractive, that is, saves costs or shows an acceptable marginal cost-
effectiveness ratio. Similarly, it may not be economically attractive to further improve 
the efficiency of care once an efficiency deficit is reduced to a certain size. 
This chapter has discussed the findings of this thesis. The next, and final chapter, 
concludes the thesis. It considers the generalis ability of the findings, and provides some 
policy recommendations for programme managers and decision-makers. It will also 
consider some research priorities for the future. 
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Chapter 11 
CONCLUSIONS 
This chapter is divided into five sections. The first section summarises the objectives, 
methods and findings of the thesis. The second section presents the thesis' conclusions. 
The third section considers the generalisability of the findings. The fourth section 
provides some policy recommendations for programme managers and decision-makers. 
And finally, the fifth section considers some future research priorities. 
11.1 Summary of thesis 
This thesis has contributed to the methodological development and application of cost, 
and more broadly cost-effectiveness, analysis of health care programmes by exploring 
whether, and to what degree, health care is delivered efficiently in one developing 
country, Bangladesh. It compared and contrasted two different efficiency measurement 
techniques, and applied them to the delivery of primary health care in urban and rural 
Bangladesh. 
The specific objectives of the thesis were to: 
1. Describe the empirical evidence on the efficiency of health care programmes in low-
and middle-income countries and regions; 
2. Estimate the cost of delivering vaccination services among a sample of vaccination 
delivery units in Dhaka City; 
3. Estimate the cost of delivering primary health care among a sample of health centres 
in rural Bangladesh; 
4. Estimate the efficiency of delivering these services using DEA and SFA; 
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5. Describe the variation in efficiency among the units and explore some of the causes 
of this variation; 
6. On the basis of these findings, describe the potential implications of inefficiency in 
the delivery of health care programmes; 
7. On the basis of these findings, make recommendations on how policy-makers in 
Bangladesh and elsewhere could improve efficiency, and make recommendations on 
further research relevant to health care efficiency issues. 
This thesis has addressed the study objectives in the following ways. While there has 
been a recent expansion in the number of efficiency evaluations (Hollingsworth 2003), 
and despite a large and growing body of literature on the measurement of health facility 
costs in developing countries (Barnum and Kutzin 1993; Adam et al. 2003), a review of 
the literature revealed that there is a paucity of data on the efficiency of health care in 
the developing world (objective 1). 
Standard costing methods were employed to estimate the cost of delivering vaccination 
services and primary health care in urban and rural Bangladesh respectively (objectives 
2 and 3). In essence, standard costing methods assume full technical efficiency, but as 
cost data are generally summarised into a single estimate, they reflect the average level 
of efficiency exhibited among the sample of facilities costed. These analyses identified 
a large degree of variation in unit costs which could be indicative of varying degrees of 
technical efficiency. Therefore, parametric and non-parametric efficiency measurement 
techniques were applied to the same data (objectives 4 and 5). Using DEA and SFA a 
large degree of inefficiency among both the vaccination delivery units and primary 
health care centres was identified. 
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Objective 6 was addressed in the preceding chapter, and objective 7 is addressed in the 
rest of this concluding chapter. More specifically, the remainder of this chapter reflects 
on what has been presented in the preceding ten chapters and draws lessons from the 
theoretical and empirical infonnation. It discusses the generalisability of the findings 
within and beyond Bangladesh. It makes recommendations on how policy-makers in 
Bangladesh and elsewhere could best approach the issue of inefficiency within the 
health sector. Areas for future research are then outlined. 
11.2 Thesis conclusions 
From this research the following can be concluded: 
1. Based admittedly on limited evidence, health care systems in both developing and 
developed countries, display significant intra-system variations in technical efficiency. 
2. There is scope for significant savings from reductions in relative inefficiency 
achieved by pulling poor perfonners up to benchmark perfonnance levels 
(notwithstanding any scope to further improve the efficiency of 'frontier' production 
units). 
3. Technical and scale inefficiency is present, to a large degree, in the delivery of health 
care in both urban and rural Bangladesh. 
4. When technical inefficiency exists, as illustrated in the case studies, it means that a 
cost-effectiveness ratio does not reflect the minimum efficient point of production at a 
given level. A facility operating inefficiently incurs excess costs given the outputs 
produced. If these excess costs could be reallocated elsewhere, than there exists the 
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possibility of potential Pareto efficiency gams, which would by definition make 
programmes more cost-effective. 
5. Health programmes are administered in settings that often violate the frequently 
stated assumption of constant returns to scale. Assuming constant returns to scale when 
average costs and cost-effectiveness ratios in reality change with production, will 
produce biased estimates of any change in production and the bigger the expected 
change the larger the bias. 
6. Ignoring the possible existence of technical inefficiencies and variable returns to 
scale will make the generalisability of cost-effectiveness ratios suspect and could lead to 
a misallocation of resources. 
11.3 Generalisability of findings 
The importance of the findings depends on the extent to which they can be generalised. 
1. The results of parametric and non-parametric efficiency measurement studies are 
sample specific82• The scores only reflect the dispersion of efficiencies within each 
sample and they say little about the efficiency of one sample relative to another. When 
efficiency scores for two different samples of health facilities are compared, as each 
sample is compared it is not possible to make conclusions on their relative efficiency as 
each sample is compared to the most efficient production unit in its own sample. A 
meaningful comparison would require samples to be combined, which may not be 
82 CEA results are equally site-specific although much current research is seeking ways in which to 
increase the generalisability or transferability of findings from one setting to another (e.g. Sculpher et a1. 
2004). Nevertheless, it is commonly implicitly and sometimes explicitly assumed (incorrectly) that 
results can be readily generalised among different settings. 
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possible among (or even within) countries where outputs and inputs are defined 
differently and costs would have to be converted to a common currency which again 
reduces comparability. As a minimum, therefore, good practice in economic evaluation 
should seek to compare interventions between providers with similar operational 
efficiency levels, while sensitivity analysis should attempt to consider the impact of 
different levels of technical and economic efficiency on results. 
2. The relative nature of measuring efficiency requires that each country develop a 
strategy of its own and that, in turn, its own efficiency improvement programme. There 
is scope for sharing of experience and expertise, both in measurement and in 
implementing efficiency improvement measures, but it is essential to identify specific 
problems related to inefficiency from the top to the very lowest level of the system, and 
to develop solutions which will fit local realities and overcome particular local obstacles 
and constraints. Hensher (2001) proposed that a successful national-level approach to 
developing an efficiency improvement programme would contain the following 
components (which are not all sequential steps): 
• identification and quantification of major areas of technical inefficiency and 
potential gains from efficiency improvement; 
• assessment of priority employment of funds / resources released through efficiency 
improvements; 
• identification of key causes of identified inefficiencies; 
• assessment of possible interventions to improve efficiency; 
• assessment of likely COnstraints acting upon efficiency improvement options, and 
estimation of likely scale of savings realisable; 
• implement structural changes required to facilitate major or one-off improvements; 
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• implement organisational and cultural shifts to continuous productivity 
improvement, including appropriate performance management and incentive 
systems. 
Each of these steps are briefly discussed in tum. 
Identifying and quantifying major inefficiencies 
The review of methods (Chapter 3) and studies (Chapter 4), in addition to the 
applications presented in this thesis (Chapters 6 - 9) provide a clear sense of the range 
of techniques available for deployment in the search for inefficiencies in health systems. 
Most critical, however, is the development, full implementation and subsequent 
maintenance of a basic data reporting system, which provides useful, meaningful 
information on activity, expenditure, productivity and efficiency. A basic level of 
confidence in their quality and comparability is required before they can be used to 
inform efficiency improvements programmes. As noted in Chapter 10, as part of health 
sector reforms in Bangladesh, the Unified Management Information System Unit of the 
Directorate General of Health Services of the MOHFW introduced a new record-
keeping and reporting system. This system should provide the necessary data to apply 
the techniques for efficiency measurement presented in Chapter 3 (although facility-
specific expenditure data may be lacking, and as discussed in Chapter 10, additional 
data on case-mix and the quality of care would be desirable). As Uddin et al. (2002) 
illustrated, there is scope to improve the quality of these routinely reported data. 
Nevertheless, without regularly available routine data, policy-makers are forced to rely 
on one-off sample data and special studies, such as those described in this thesis. These 
stop-gap approaches to data militate strongly against measurement of progress and 
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improvement over time, and generally fail to cover all providers, which are both serious 
impediments to the process of efficiency improvement. It is probably preferable, as is 
the case now in Bangladesh, to obtain maximum coverage of even a very crude data 
system than it is to focus on obtaining more sophisticated data at pilot sites - because 
without the former, no analysis will be possible at any sites other than these pilots. 
However the parametric and non-parametric approaches used in this thesis are likely to 
require specialised technical and academic expertise in order to employ them, which 
may be lacking in many low- and middle-income countries. 
Assessment of priorities for additional resources 
Where sophisticated sectoral resource allocation processes are being developed (e.g. 
application of sectoral cost-effectiveness analysis) the assessment of priorities for 
additional resources is likely to be relatively straightforward, in the sense that analyses 
already undertaken can be used directly. In the absence of such work, some discussion 
will need to take place regarding the stated health priorities of the country, and their 
likely fit with the level and mix of resources which are likely to become available given 
the nature of the inefficiencies that have been identified. The core question here is to 
ask whether more of the same is desired (i.e. increased output for current inputs), or 
whether the desire is to release resources for other uses (current output for reduced 
inputs), in order to plan efficiency improvement measures accordingly. 
Identification of causes of major inefficiencies 
It is essential to understand why particular inefficiencies are arising if there is to be any 
realistic chance of reducing them. While an analysis of environmental variables can 
help shed light on the causes, it is likely that this will be a qualitative exercise. The 
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people responsible for the inefficient services are likely to be the best source of insight 
into causes of inefficiency. Whether more formal qualitative research methods are used 
to elicit their views, or whether managers simply spend time to ask questions and listen 
to opinions, those who are caught up in the heart of inefficient practices must be 
questioned in detail about why things happen as they do and, critically, how things 
might be improved. A significant portion of technical inefficiency probably relates to 
extremely micro-level custom and practice, which general managers or researchers may 
not necessarily be able to identify as inefficient. Overdyk et al. (1998) provide a 
fascinating discussion of the extremely micro-level changes in scheduling, organisation 
and day-to-day operation which they undertook to achieve significant improvements in 
the efficiency of their operating rooms, involving a level of intervention that no 
centralised policy could effectively capture. 
Assessment of possible interventions and likely savings 
Identifying potential remedies to inefficiencies requires a two-track process. At one 
level is the grass-roots approach of involving workers and stimulating process 
improvements and initiatives by all those involved in the process of health care delivery. 
However, there is, of course, an extensive stock of experience and knowledge already 
available internationally, which can be drawn upon to provide rather more fundamental 
changes and innovations. The Effective Practice and Organisation of Care topic group 
in the Cochrane Collaboration undertakes systematic reviews of interventions to 
improve health professional practice and the organisation of health services. However 
the great majority of reviews are based largely on studies in high-income countries and 
there are few intervention studies in low- and middle-income countries of strategies to 
improve the coverage of effective interventions (Haines et al 2004). 
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It will also be important to appreciate that many savings will take a considerable time to 
realise, and may well require up-front investment, i.e. there needs to be an acceptance 
that significant savings are unlikely to be realised without some up-front investment 
('spend to save'). Thus, for example, the shedding of excess staff will require funding 
for redundancy packages, retraining measures, etc. 
Structural change and 'Big Push' efficiency improvements 
Eliminating very pronounced inefficiencies may well require concerted, deliberately 
planned structural change. Substantial analytical and planning effort will be required, 
while significant additional funding will be required for implementation. Key areas 
requiring funding include redundancy payments for excess staff; capital costs of site 
closure and disposal (which can be significant); increased expenditure on professional 
management; improvement works to upgrade facilities which are remaining open; and, 
quite possibly, new infrastructure. The provision of such capital transformation funding 
would seem to be an ideal use of donor funding; a discrete, non-recurrent programme 
whose explicit aim is to unlock efficiency savings. 
Shifting to continuous efficiency improvement 
In general terms, developed countries have consistently improved productivity in health 
care over a long time span (Hensher et al. 1999). Yet on the basis of Zere et al. (2001) 
(reviewed in Chapter 4), it seems likely that many developing countries have faced 
either static or negative productivity and efficiency change over recent years. A number 
of factors have probably contributed to this lack of demonstrated efficiency gain. 
Foremost has been a general insufficiency of funds, leading to bottlenecks and 
inefficient input mixes. But Hensher (2001) argues that another key contributor has 
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been the continuing failure to develop a strong cadre of non-medical, professional 
health service managers in most developing countries. He argues that: 
"The continued dominance of medically qualified administrators, often with 
very little or no management training, loath to take on their colleagues, and often 
still practicing clinical medicine for much of their working day, represents a lost 
opportunity to spark (or, if necessary, to bludgeon) change" (Hensher 2001). 
Professional managers, armed with data with which to benchmark and compare 
performance, given basic authority to adjust resource use and production processes, 
themselves judged significantly upon their ability to improve efficiency, are required. 
This would represent a fundamental change in the commitment of health systems in 
developing countries to improving both technical and allocative efficiency (Hensher 
2001). 
3. A model to examine when it IS cost-effective to introduce an efficiency 
improvement programme should be developed which would be generalisable in 
structure. In principle, such a model would enable policy-makers to work through the 
steps listed above. 
11.4 Policy recommendations 
This section addresses the penultimate objective of the study by making 
recommendations on how policy-makers in Bangladesh and elsewhere could improve 
efficiency. 
There is widespread agreement that MOHFW service providers and upazil a-I evel 
management staff have learned how to serve the 'system' better than they have learned 
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how to serve their clients. In preparation for the Government's Health and Population 
Sector Program, 1998-2003, the Government's Task Force on Community and 
Stakeholder Participation carried out an assessment of the local perception about 
Government health and FP services in five villages in different regions of Bangladesh 
using a participatory rural appraisal methodology (Task Force 8, 1997a, b and c). The 
assessment showed that, according to the villagers, even though Government health 
services are officially free, poor people are commonly charged fees by the staff. Village 
practitioners, in contrast, charge fees which are transparent, well-known in the 
community, and affordable. Furthermore, the villagers who participated in these 
discussions with the Task Force maintained that Government service providers treat 
them with disrespect, and the providers give priority to the better-off clients. The 
villagers stated that the Government health care facilities are dirty and lack waiting 
rooms, toilet facilities and privacy. Finally, they complained that the providers (and 
particularly the doctors) were rarely there, the facilities were often closed, and that the 
facilities, more often than not, lacked drugs. The facilities were also frequently 
inconveniently located, often at some distance from the markets where they are 
accustomed to consulting private local practitioners (Task Force 8, 1997a, b and c). Not 
surprisingly, villagers often view Government health services only as a provider of last 
resort, when local village practitioners have failed in their attempt to resolve the 
problem and the family is becoming desperate. 
Thorough, systemic changes will be required in the MDHFW which promote 
accountability to the community, improve productivity and performance of health staff, 
encourage decentralisation, improve quality of care, increase the responsiveness of the 
providers to the needs of clients, promote community and NGD involvement, and 
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provide local monitoring based on accurate information. Although the need for these 
changes is recognised, the capacity of the Government system to reform itself is a major 
issue (Perry 1999). 
Below are a series of comments on how health care needs to be improved in the future 
years, if resources are going to be used more efficiently. 
1. Systemic changes in the MOHFW should be seen as equal in importance to 
technical and financial support for improving service delivery at the local level. High-
level political support along with strong managerial and technical support will be 
needed to carry out these proposed changes. Fostering competition between the 
Government health service system and the private sector might promote change within 
the Government system, as might the increasing practice of 'contracting out' basic 
Government services to private organisations, including NGOs. Such an approach is 
currently being implemented in the metropolitan areas of Bangladesh by the Ministry of 
Local Government, Rural Development and Cooperatives through a project for urban 
primary health care funded by the Asian Development Bank (Loevinsohn and Harding 
2005). The extent to which this increases health service efficiency needs to be 
evaluated before such schemes are widely replicated. 
2. Strengthening independent monitoring of health status and utilisation of services at 
the upazila level would make it possible for the MOHFW to more rationally direct its 
limited resources to those areas with the greatest need (Ensor et al. 2003a). Funds could 
be directed to those upazilas and urban zone with, for instance, the highest rates of 
morbidity and mortality. 
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3. Unions and upazilas should be identified which have efficient (and high-quality) 
Government health service delivery units which can become 'model' upazilas where 
new policies and procedures for improving efficiency, quality, promoting community 
involvement, and fostering sustainability can be implemented and closely monitored. 
Such upazilas would have the potential for becoming training sites where field staff 
could be trained by persons working with programmes currently engaged in the 
effective provision of the ESP. These same programme sites could offer strong 
potential for carrying out local operations research activities to strengthen the efficiency 
of service delivery. 
4. The need for documentation and evaluation of local service delivery activities will 
continue, and future progress in reaching the Millennium Developed Goals by 2015 will 
depend in part on scaling-up activities that have been proven to be successful on a 
smaller scale and which are carefully monitored and adjusted during the scaling-up 
process. Thus, there will need to be strong financial support for these operations 
research activities. 
5. Compared to many developing countries, Bangladesh has a dynamic and innovative 
health sector, and the country's experience with operations research concerning health 
services is one of the most extensive in the world (Perry 1999). There has been little 
effort so far, however, to review and synthesise the lessons learned from these 
experiences or to assess their implications for the further development of primary health 
care services at the local level. Of particular concern in a country like Bangladesh is 
ensuring that efficient quality primary health care services reach those most in need. 
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There is a need for operations research which is population-based and focussed on 
health and demographic outcomes as well as on the process of service delivery. 
11.5 Agenda for future research 
In addition to the operations research suggested above, the following are topics for 
future research. 
1. Future research should consider ways to improve the models presented in this thesis 
through the possible inclusion of some alternative variables, such as data on other 
services provided by the vaccination delivery units or ESP-specific outputs, rather than 
the age-specific number of visits. 
2. Improved and more comprehensive quality measures would be extremely useful as 
staff may very well argue that they are less efficient because they are providing better 
quality patient care. Quality variables relating to patient outcomes would be very useful 
to include in such analyses. Vaccination services may be a 'special case', given that 
quality does not vary much, so there is little in the way of trade-off between cost and 
qUality. Unlike the provision of a service such as vaccination, which can be quite easily 
defined, and its production relatively well-planned and managed, treatment of patients 
as a product, for example, is more challenging. However, the cost implications of 
meeting minimum quality standards are unknown since the link between quality and 
outcomes is unclear. Therefore, efficiency data should be linked to the data on the 
management of patients, which in turn should be linked to available guidelines, such as 
those developed for the Integrated Management of Childhood Illness. This will help 
'tease out' whether inefficiency is due to using too many resources to manage patients 
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with particular conditions, or whether facilities / providers identified as being among the 
best perfonners are in fact inappropriately treating patients. 
3. Longitudinal data would be useful to highlight changes in efficiency and the 
productivity of units relative to peers and relative to their own perfonnance and may 
help produce more robust efficiency estimates. It may be the case that over time, a 
health facility's activity rises, and hence its capacity utilisation and measured efficiency 
changes. A longer tenn examination of changes in capacity utilisation and efficiency 
could assess how progress is being made towards achieving potential efficiency 
improvement targets. Longitudinal data would help clear up several questions such as 
whether some outliers are merely one-off data anomalies, whether inefficient units are 
truly that, or have made improvements on prior perfonnance, and more importantly 
whether efficiency scores change from year to year and display inconsistency. 
4. More research is necessary in order to better understand the detenninants of 
efficiency. Although advances have been made in productivity analysis in recent years, 
the effective use of productivity measures is dependent on the consideration of a host of 
factors that may influence organisational perfonnance. There is a need to determine the 
relative impact of different strategies and policies on productivity and efficiency. In 
particular, the role of institution~ and culture, as well as financial and organisational 
factors, in the incentive structure governing manager and provider behaviour, needs to 
be better understood if inter-country comparisons are to be interpreted correctly and if 
best practice is to be applied successfully across countries. Detailed investigative 
studies in a sample of relatively efficient health facilities to document key attributes of 
best practice should be perfonned. 
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5. A related question is when is it cost-effective to implement an efficiency 
improvement programme? As a starting point, an evidence-base on the costs and effects 
of strategies to improve efficiency needs to be collated. It will be important to 
recognise the context-specific nature of many strategies, but consideration should be 
given to whether and how a matrix can be developed to summarise certain scenarios. 
In conclusion, if something is deemed worth doing then it should be carried out in a way 
which ensures the optimum use of scarce resources. An exclusive focus on switching 
resources from less cost-effective to more cost-effective activities will not realise the 
full benefits in terms of improved allocative efficiency if providers on the ground are 
not producing services at lowest cost. Furthermore, while more money is certainly 
needed to tackle poor countries' health problems such as Bangladesh, how it is spent is 
more important than how much is spent. 
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ABSTRACT 
This fucility·bused study estimated the costs of providing child immunization scrvices in Dhakn. 
Bangladesh. t'n>m the perspective of health care providers. About a quancr of all immunil.ation (EPI) 
delivery sites in Dhaka city were surveyed during 1999. The EI)I services in urban Dhaka are deli· 
vered through a pannership of the Government of Bangladesh (GoB) and n,)Il'governmental organiza· 
tions (:-.IOOs). About 77% of the EP! delivery sites ill Dhaka were under the management Ilf NGOs. 
nnd 62% of all vaccinations were provided through these sites. TIle uutrelleh facilities (both G(lB and 
NGO) provided immunization services at a much lower cost than the pemlwlent static facilities. 111e 
a.erage cost per Il1clIsles· .... accinated ehild (M V{'). an indireet measure of numbt'r of children fully 
immunized (FIC the number of children immuniz.cd b)' first year of life), was LS$ 11.61. If all the 
immunillltion dlls("'S delivered by the facilities were administered to children who were supposed to be 
immuni7.cd (l'VC), the cost per child would have been US$ 6.91. The wide gllp between the cost per 
MVC und Ihe Cllst per I've implies Ihllt the C(lst (If immunizing children clIn be r~oUuccd significanlly 
thl\lugh better targt'ting 1)1' children. The incrcmental ellS! of adding new services (lr interventions with 
current E1'1 wa.~ quite l(lw, not signitlcantly higher than the actual eostllf new vaccin~:s (lr drugs til be 
added. MIOs in Dhaka lIl(lbilized nbllul lJSS I S.OOO from the l(lcal community to support the immu· 
nizatilln activities. Involving Illeal community with EI'I activities not only will improve the sustain· 
ability oCthe programme but will also increase the immuni7.ation coverage. 
I(~. worm: Immunization: Co~ts and cost analy~is: Heald, facilities: ]'.;on-govcmmental organil.ations; 
• Communi!)' participation: Bangladesh 
INTRODlICfI()N 
The Expanded [>rogramme on Immunization (EPI) 
aims tll reduce morbidity and mortality from six vaccine-
l·(lrn:'pnll ..... ncc IIlld reprint re4u~'Sb should N dddrcsscd tll: 
I>r. M. Mllhmud Khllo 
Tulu"c t :ni\ ~n;it\ Sclk",I., .. I'\lhlie II~ulth and 
I'rupicnl Mcdi~inc 
I ~~o ('anal S\I'l:cl. II I 'lOll 
J>;C\\ Orlc:all'. 1.,\ 70 Ill. , :S:\ 
Lmail: khana:lulanc . .:~u 
preventable diseases: tuberculosis. diphtheria, pertus· 
sis. tetanus. measles, and poliomyelitis. A fully·immu· 
nized child (f'lC) receives six standard EPI antigens 
through eight vaccinations given in the first year of 
life. The rec(lrnmendl.oU !iChedulc is: one !>hllt ,lfllacille 
Cnlmctte Guerin (HCG) lit birth. three dtlses of oral 
polio vaccine (O[>V) together with three shots of diph· 
thcria·)l(.'I1ussis·tctanus (D[>l) lit age 6. J O. und J 4 wt.'eks. 
and one soot of measles vaccine at age I) months. Along 
with these six antigens. the routine EPI also included 
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two dose~ of tetanus tox(lid (IT) fill' preg.nant women 
and one dose of vitamin A for children III the time of 
thc stud)'. Thc main EPI programme (the routine EPI) 
is supplemcnted by othcr intcrventions. such as National 
Immunization Day (NID). mop-up ancl' MD. acute flac-
.:id raralysis (AFPI surveillance. and matenlill and nt'(l-
natal tetanus (:V1Vn surveillance. 
LPI has reduced morbidity and mortalit, from vlle-
.:inc-prevcntnblc diseases in Bangladcsh. bllt little is 
knllwn ahout C\ISlS and elTc.:tiveness of urban El'l. A 
comprehensive review in I WI! and two studies on the 
cost-etl'cctivcncss of the Bangladesh LI'I have pointed 
0111 the need for collecting cost inltmnation from urban 
areas 11-4). Unlike rural Bangladesh. urban EPI is 
delivered throulf,h a partnership between the public 
sector and the private sector. In fue!, the private ser-
vice pnwiders. especially NUOs. play such an impor-
tant role in urban LI'I that estimates hased on national-
level expenditure or cost data will be II signiticant under-
estimate of total ~"(lsts if the C(lntribution of NODs is 
not included. Ilowever. the exact level of involvement 
ofMiOs in EPI delivery was not known at the time of 
the study. The national-level data do not include all the 
costs in.:urn.'<l hy !'J(iOs and. thereltlre. an attempt to 
~'Stilllate the c,lsls \If urban El'l will be eXlrenll:ly usc-
ful for culcuillting the actual C()st of immunizalion in 
Banglade'h. 
MATERIAI.S AND Mt:THOOS 
Study desilln and samllllnil 
This facility-ba.~ed study estimated the costs of provid-
ing routine El'l services fWIll the perspective of El'l 
service pnwidcrs. A c\llllprehensivc list of all the faci-
lities inwlvcd in the ddivery of 1.:1'1 services in Dhaka 
city wa.~ used as the sampling n'lIllle to select a random 
..ample of faciliti~. l'he then l'man I h:alth I'nl g.ranlmc 
of I(,DDR.B prepared the list to better understand the 
supply environment of primary healthcun: services in 
Dha"a cit), (51. Infonnation contained in the list was 
u~'<l for stratifying the El'l delivery sit~ by I)'pc (stat-
ic and outreach! and location (zone within Dhaka city). 
For the c1assificlltion of the El'l sites by lype. health 
ccnt~'S op':rating one day or less per week were defin~'<l 
as outreach sites. while 1111 othel's were categorized as 
static sites. From each of the stml" delined. 25% of tile 
Iildlities. choscn at random. generated a SIImple of 132 
EPI delivery sites. The: classification of health facilities 
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by ownership IglwemmentlNGO) could not be carried 
out prior to drawing of the sample duct\! lack of infor-
mation. Since the sludy selecled II large pnlp"rtion 
(25%) of ull EPI sites. the results of the survey should 
indicate the relative imponancc (If the Government of 
Bangladesh (GoB) and )\00 ~ervicc pl\l\'iders in urban 
Dhuka. 
Datil eoll«tion 
Facility-based data were collected from the [PI deli-
very sites for 1 m. Two approaches were f()lIow~'d for 
collecting data on the usc of resources. costs. and num-
ber of imlllunizations delivered. -nlC: first approach 
obtained in fonnation on Ihe usc of resources and the 
number of vllccinations administered from the record-
keeping and IIcc(lunting books of the facility. The sec-
ond approach interviewed tacilit)' stalT to obtain rele-
vant addilinnal infom18tion. In most cases. the manag-
er or the vaccinator of the facility was interviewed. To 
ensure that the enumerators coll~'Ct all the relevant data 
from the health facilities. II Siructured questionnaire 
was designed. The cost pan of thc instrument collect-
ed data on all the resources used in the process of 
delivering EPI services. including donaled items. vol-
unteer time. resources provided through other health 
activities. and space provided by the communities. The 
resources reviewed included a comprehensive list of 
capital and recurrent items. The capital items of EPI 
included vehicle. equipment. c.g. refrigerator. cold 
hoxes. etc., furniture. e.g. tables. chairs, etc .• and train· 
ing of facility statf 1\1 increase human capital endow-
ment (long-ternl training leading to a diploma or II 
degree). 'I'he recurrent items nf El'l included salary 
(salaries and benefit.~ of manager. vaccinator. physi-
cian. ctc.). rent (rent. utilities. operation. and mainte-
nance). vaccines. supplies. c.g. syringe. icc-pack. etc .. 
transport. and rc.:urrent training I short-term training 
for maintaining skills and knowledge of the service 
providers). For obtaining the anllualized value \If land 
lind buildings. the stud)' collected information on the 
current rent for all facilities. If the facility was owned 
by the service provider rather being rented fnJlllothers. 
c.g. GoB facilities. the rent value for Ille facility was 
imputed at the live rage rent for sites of the same type 
(static/outreach) and locution (zone). 
CapiUII cos!., were annualized using a discount rate 
of 5%. and the economic life llf 1111 EPI-relevant capi-
tal items was assumed to be five years. For health-sec-
tor cust-effectiveness analysis. most researchers prefer 
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usin/!. 1\ low dis\:,'unt rate of 3-5%. Since II number of 
EPI co,ting studies used a 5% discount rate. using the 
same rale will allow an easy comparison of results of 
the study with rrior studies. For non-exclusive reS4.lurees. 
such as resources used in delivery of other primary 
heulthcare services us well, ~'osts were aplX'ttioned 10 
EPI bused on the proportion of time spenl by the service 
providers ('II EPI activities. ('ost data obtained were 
thr 19')9. All the local clln'cllc)' values were convertcd 
into US dollars using the 1999 exchange rate of USS 
I.ll0=Tk -19.50 (fl). F()r costing the vaccines. the 1997 
l"lICEF prices were inllllted hy II taetor of ~.5% per 
)·car. Thc SUI'\'C) collected infonnation on other vuri-
abies relating 10 L.PI service-delivery. such as days of 
OIX'f'.lIion of the fucililY per year. hours of operation 
per du),. and number of vaccines delivered per year. 
This study did nOl collect any infonnation un house-
h"ld-Ievcl costs. such as travel costs of the mother and 
child 10 the EPI delivery facililY. 
Rt:SlJLTS 
[PI d~II\1el')' lIltes lind [PI sessions 
The 1:1'1 dclivcry sites were usually located in nr ncar 
residential arca~ of urban Dhaka. A typical static facility 
was located in a large building with multiple rooms 
pnl\' iding h~ulth and non-health sCI'\'iccs to thc popu-
lation in the area. lbc types of services delivered 
include: m;\lernal und child health services. cUI" .. tive 
care. family plunning. microcredit activities. literacy 
sessions. etc. A typical outreach facility was locat~-d in 
a much smaller building in a residential area not well-
connected 10 nthcr parts of the city by main roads. 
Outreach sites do not huvc resident LOPI staff. and 
teams travel there frolll other static sites. 
Of the 112 sites surveyed by the sludy. less than a 
quarter were (joB-run facilitil.,);. and about 60% of ull 
the sites were N<lO-nm "utreach centres, In 19')9. 
38°." of 11.028 EI'I sessions in the surveyed sites were 
organil.cd b)' the government static sites •. '% by the 
govcrnmenl outreach sites. 29% by the NGO slatic 
sitcs. and .11 ";', b)' the NOD outreach sites. On average. 
th~ Ei'l delivery sites organil.cd 84 (range 12-288) El'l 
sessions per site per year. NGOs played a very impor-
tant role in tbe delivery of EI'I services in urhun 
Dhaka, About 770,'0 of the EPI delivery sites in Dhaka 
city were under the management lIfNGOs. and these sites 
organin.'d 60",. of the El'l sessions. The predominWlI.'C of 
MlOs in the delivery of El'l in urhan Bungladesh is in 
sharp contrast 10 the delivery structure in rural areas. 
where it is almost exelusively a publicly-run progl" .. mme. 
Cost of [PI sen'i~s 
The cost of EPI service-del ivery by vllrious cost items 
is shown in Table I. The total annual cost of rouline 
EPI services in the surveyed EPI delivery sites was 
USS 4fl 7 .171. The capital cost constituted 24°/0 of the 
total cost. Since [PI is n labour-intensive programme. 
personnel cost constituted 51 % of thc totnl cost. Table 
I shows that about 5.~% of the total [PI cost in urban 
Dhaka WIIS due to Ihe IIctivities t,f NGOs. If we consi-
der cost allocation within the (Joll and NGO struc-
tures. about half of all [PI costs in th.: NGO sector was 
due to serviet .... delivcry through the outn:ach sites. while 
it was only 8°'. for the government sector outreach 
sites. This indicates the ~'I11pha.~is 1':(lOs a.~sign on deli-
vering EPI services from outreach sites rather thlln 
from static sites, 
Tllble 2 reports thc average cost per fllcility byown-
ership-type and facility-type categories, The average 
cost of running M EI'I facility was t!S$ :UOO pcr year 
in Dhaka city in 1999. However. the costs varied sig-
nificantly by ownership t)-pc. i.e. whether Ihe facilities 
were run by NGOs or GoB. In general. the static sit<-':; 
were more expensive to organize than the outreach 
sit<-'S fnr both Ihe GoB and NGO sectors. The average 
cost uf running II statk and an outreach delivery site 
was about LJS$ 7.500 and !ISS 2.100 respective I)'. The 
cost of running II GoB stlllic site was US$ 8.300 cum-
pal\.-d tolJSS fl,500 for NGOs. NOOs nel..'dt.'tIless money 
In run the outreach sites ...... US$ 1.300 per site pt:r year 
Clll1lllared to l'SS 2.900 for the gllvemmcnl sites. The 
NGO outreach Sill'S had a milch lower slIlary cost. as 
they usually had only vaccinators to provide services. 
A~ expected. the pcnnancnt static sites uscd ell(litnl 
itcms much more intensively than the outreach sites. 
On average. the ell(lital ~ost of the static sil~'S was about 
30% of the total EPI cost and on I}' about 5% tor (lut-
reach sites. 
t:lTettiveness of delivery structure 
Table 3 presents a number of etl't,"''tivcness or (lutput 
measures of urban EPI. The surveyed [PI delivery 
sites provided 508.188 vllccinations through 11.028 
El'l iI\.'Ssions in 1999. The distribution of the number of 
vaccinations administered was a.~ follows: BeG 10%. 
OPT 24%. OI'V 30%. measles 7%, vitamin A 13%. and 
,,. 15%. 'flle highest number of vaccinations was due 
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l.ble I. Total annual cost (US$) ofimmunization in surveyed sites in 1999 
GoB static GoB outreach NGO slUtic NGO outreach Total cost "10 of 
Cost (n=24) (n=6) (n=22) (n=80) (n~ 132) tnlal cost 
Capilal cosl 
Vehicle 0 0 212 .100 512 (J.II 
[quipmcl1l 1,913 127 ".341 2.687 9.067 1.94 
Furniture 46.392 106 2.584 1.071 50,154 10.74 
Training (non·recurrent) 26.397 0 21.998 4.400 52.794 11.30 
Subtotal 74.702 233 29.134 8.457 112.526 24.20 
Rc<:um.'I1t cost 
SIIIIII)' 90,740 13,480 73,622 59,308 2J7.14') 51 
Rent 7.585 507 9,14.1 :1.624 20.860 4.47 
Vaccine 24.904 2.(,(,9 29,895 29.568 87.036 18.63 
Supplies 944 148 1.129 1.560 U81 0.81 
Training (recurrent) 380 202 970 1.846 3.398 0.73 
Transport 1.078 144 631 568 2,421 0.52 
Sub·total 125.631 17.150 115.390 96.474 354.645 75.80 
Iiltal cost 200,3.U 17,383 144524 104,Q31 467.171 
{j"n 'llllk: liowrnmelll·run Slali, sit~'S: (jon ulIIrcach: (io\"Cmmcnl·nm l>lllrcach siles: N{iO stalic: NUD·run ~1alic sit"s: 
'{iO ,I\lIrcach: :\{iO·run oU1I'Cllch site, 
til the deliver\' of OI'V. nnd the lowest was for measles. 
OPT and Ol;\, dos~'S were supposed to be del ivered 
to!lelher. hul the number of OPT d()scs dclivered was 
ab;lut 19'''' lo\\er than thai ofOpV. This probably indio 
womcn compart:d 10 the llUtrcach sil~'S for all six wltigcns 
in the rouline El'l. On average. 46 vaccinations were pro-
vid~'Il per El'l session organized or about 12 vaccina· 
tions per hour of session. i\ number of delivery sites 
Tahir 2. Averagc enst (lJSS) per facility by Iype and ownership Ilff:ldlity in 199') 
('Ilst GoB static GoB outreach I'GO static ~GO outreach Average cost/site 
\-Iean capital cost 
Vehicle 0 0 
Equipment 80 21 
Furniture 1.9.1.1 18 
Training (non·recurrent) 1.100 0 
Sub·tolal 3.113 39 
Runge 12-44.548 11-59 
~1ean re.:urrent el'st 
Salary .l.781 2.247 
Rent 31(, 85 
Vllccine 1,038 445 
Supplies :19 25 
Training (recurrent) 16 34 
Tmnsport 45 24 
Sub·total 5.235 2.858 
Rangc 1,49)-47,958 808-4.141 
'I('tal (mean) 8.347 2.897 
Runge 1.60 1-49,507 838-4.187 
catcs Ihe relatiw difficulty of delivering injectables 
cllmpared 10 an oral vaccine. 'lable 3 indicates thai .14°,. 
of all vaccinations was carried oul by the government 
stalic sit~'S. 4% by the governmcnt outn:ach sitcs. 3~;. 
b) th~ l\(J0 Slatic Sit~5. and 24% b)' the NGO (}ulreach 
sites. The static sites immunized m(lre children and 
10 4 4 
197 .~4 69 
117 13 380 
1.000 55 400 
1.324 106 852 
26-13549 6-4435 6-44~48 
.1':;46 741 1.797 
416 45 158 
1 • .'\59 370 659 
51 20 29 
44 23 26 
29 7 18 
5.245 1,20() 2.687 
556-13.829 278-6.427 278-47,958 
6,569 1.J12 3,5:19 
592-23.235 312-6.670 .~ 12-49.507 
reported zero vaccinuti()ns during their El'l sessions. 
An EI'I session pruviding no vacdnatklll at all indicates 
the presence ()f slack time of EIlI delivery SlUff due to 
lack of demand. All the EPI delivery sites alS\lt'Cpolt~-d a 
signitil:ant wastage of \'t«;.:ines. and the wasilige rates 
were used for ~'Stimalillg the Illtal Ctlst of immunization. 
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Tablf J. Total annual numher of vaccinations delivered by type and ownership of facility in 1999 
0013 0013 NGO NGO Vaccination! Vaccinatil)ni Vaccinationl 
VIII;cinc static outreach static outn:ach Total facilitv session hour of sessi()n 
\n=2~) (n=()) (n=22) (n=80) :\ 13=:\/1.,2 C'"tVll,028 1~~(,/4' 
BCG 18.27(, 1.500 17.S80 14.25(, 51.612 ~91 4.68 1.17 
DI'T 47.J52 5.424 45.780 25.884 124.440 943 11.28 2.82 
OJ'V 59.892 6.240 5.1.760 ~3.'l12 15.1,804 1.165 n.95 3.49 
l\'leasles 15.228 1.668 11.424 8.988 :"308 283 3.38 0,85 
Vitamin A 12.672 2.712 JI,092 19J68 65.8~4 499 5.97 1.49 
n 21.876 2.364 31.284 19.656 75.180 570 6.82 I. 71 
rotal 175.296 19.908 190.92(J 122.064 508.18S 3.850 46.08 11.52 
• n", nnlllNr Ill' facilities survc)cd \\lIS 132. and lh~"", theiliti"s ory.unized II.02K s.:ssions durin~ 1')<)9, Since the avcr.g" 
dunui"n or II sc~.i(ln \\lI~ 4,0 hour!!. IOIllI hour~ or s.:~sions ,'an I'C calculaled b)' mullil'l),in!! Ihe number of s.:ssiolls b) 4 
IlC(,=lladllc C"lmcue Guerin: DI'T=l>irhlheria·p.:nllssis,,,,wllI.s: (lI'V=Orull'0lio ,:tcdnc: TI'=Tctanlis tuxllid 
Averagt' rost of dt'livering [PI 
L: sing Ihe numbers reported in Tables I and 3. we coo 
calculate the averclge cost per unit of ()utput produced 
b) the EPI delivery sites. Table 4 reports the average 
costs per unit of various ()utcome mcasures. The aver-
age cost pcr 1::1'1 session in 1999 was about lJSS 4.2. 
"'hile the avC'rage cost per dose IIdmini!nered. exclud-
ing vitumin A and tetanus toxoid. wus USS 1.18. Since 
measlc~ is the last vllccine a child should get in the [PI 
schedule. the number of children immunized agllinst 
measle, cun be u'ed as lin indirect measure of fully-
immuniled children. The average cost per measles-
\'accinated child (MV(,) was USS 11.61. and the awr-
age cost Wtl.~ lower for the :-IOU facilities cum pared to 
that for the 1I0vemment facililies. We do not have lilly 
Tllble ... Average cost (\:S$) per unit ofoulI'ut in 1999 
Cnst OoB 
static 
('ost )lI:r session 48 
('ost per hour of session 11.56 
('ost per dose: (without IT and vitamin A) 1.40 
('list per d,'se (with TT ood vitamin A) 1.14 
('ost per I've 8.07 
('ost)ll:r MVC (without Tf and vitamin A) 12.93 
('()st per MV(' (with TT) 1.1.05 
('ost per MVC (with vitamin A) D.03 
Cost per MVC (with TT and vitamin A) 13.16 
infonnation I,n the number of children fully immu-
nized by 12 m(lnths Ilf life (FIC). In (lur sample. the 
estimated number of children immunized agllins! IKG. 
DPT. OPV. and measles wus 51.612. 4 1,480. ~ 1.268. 
and 37.308 respectively. Since the number (If children 
immunized against measles was lower compared to 
other vaccinations. we can usc :\-\VC as a rough guide of 
FIe. Th(Tt'filre. l;S$ 11.6 J may be considered an approxi-
mation of per FIC cost in urblln Dhaka. 
Table 4 ulso reports P hypothetical number. cost per 
I've. Rnd cost of providing Rllthe EI'I "uccinalions to 
all infants without incomplele vllccinations (some chil-
dren receiving only few vaccines) or double-d()sing, 
This hypotheticlil C()st per rvc is simply the total cost 
of providing three doses of DPT. three doses of OPV. 
GoB NGO NGO Average 
outreach static outreach C()st 
(,0 46 31 42 
17.25 7,92 8.00 10.06 
1.13 1.02 1.06 1.18 
(J.S7 0.76 0.86 0.92 
6.81 6.19 6.16 6.91 
10.07 11.50 9.80 11.61 
10.17 11.65 9.97 J 1.75 
10.32 12.51 11.51 12.38 
10,42 12.65 11.67 12.52 
('ost p.:r session nnd ~'(lstl'Cr hour nf scs..ion include rl' nnd villlmin A 
Inl> ... .,. "ith Illllllhl:""uf EI'I sessions Rnd "ours .. fEl'l sc .. ion not sh",,,,, 
COSI p.:r dose (\\'ithoul IT and \'iwlllin A)=lltlllil ~lIst--"T vaccine: cost-vilamin A vaccine ~'()st-transron cl1st'2Jll--supply 
~ost'3illll / Ilnlnl doSI.~rl dnSl.~\ilamin t\ do~1 
('osl ""r :l.IVC (\\'itholll TI' lind \ itumin r\ )'-'II"lal .'o.;I-'I"r vucchl<' cnst",vitnmin A \ Kcl'inc cosl-, tnlnsl'ml c'I>I'21('--'"I'ply 
cow.V 1 01 i 11l1~aslcs dose I 
l osl p.:r :>VIV(' (\\ ith rO-lllllul eel,!--\, itamin t\ \'ucdnc cost-tmnsport cost'l!b-~"pply cClst'l!lOl/lmclIslcs dose I 
('nsl ""r MVl' (with "humin A)'''III'I,,1 cu'" -Tl \ucdnc c .. sl"lnlllSf'<,n l>'S\'li(,--'"rpl> c"sl·2!1()Jiln~.slc' Josel 
I'V( '=I'ull) \,uccinul.-d child: MV(,=Mcasks-\uccinull!d child 
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one dose of Ben and one dose of measles vaccines to 
II child, I've was computed in two steps: tirst. cost per 
sJX'Citic antigen was calculated. and then FVe was 
cllmput~-d (Tables 5 and 6 in Appendix). The averag.e 
estimaled cost per FVC is unly abuutlJSS 6.91. imply-
ing. Ihat llIany children received partial imlllunizations 
(k,wcr completion rail' due to drop-olrtsl. and some might 
have receivcd thc same vaccines more frequently than 
th~ [PI schedule suggests. The cost per MVC (USS 
11.61 I. in general. should be close to the hypothetical 
cost per rve (tS$ 6.91) in the absence of significant 
pllrtial vaccinations ()r double-dosing. The high cost of 
MVC compared to the hypothetical minimum cost indi-
cates Ihat Ihc svstem (tor both GoB and NGOsI can be 
made much n;ure effective if children are identified 
and vaccinated in a timely manner without significant 
mistargeting or double-dosing, For Ihe purpose of esti-
mating thc ~'osts withuut mistargeting or double-dllsing. 
il is IlIII ncc,"-ssary to identify the mistargeted cases. If 
the number of children receiving measles vaccination 
were fully immunil.ed. we can calculate the tOlal vac-
cination cost for the cohort. The rutio ol'this hy'pothc-
tical cost and actual cost may be used o.~ a mClIsure of 
degree: llf mistargeling by ~lth GoB IUld NGDs. 
Cnst per VAccinated child, either the cost per MVC 
or Ihe hYPI,theticul cost per I've. cnn bc used as a 
mca.~ure of etliciency of the EF'I delivery system. Table 
4 indicmes Ihtlilhe cost per MVC was the highest (liSS 
11.9)) for the government static sites and was the low-
~'SI (LSS ().SO) tilr the NOO outreach sites. BelWCl:n 
the governnu:nt and the NGO delivery stru(.1ures, the 
MiO static facililies were m(lre cost-effective (llSS 
11501 than the govemmcnt static Incilitics (l.IS$ 11.93). 
The '<GO oUlreach sites were also more Ctlst-effcctive 
thlUl the gOl/ernment outreach sites (US$ 9.80 and US$ 
10.07 per \1V(, respectively). If the cost of delivering 
TT vaccines is included with other vaccines. the aver-
age cost per \1V(' increases by about 14 cents. If the 
cost of distributing vitamin A is added. the overage 
cost per \1VC increases by 77 cents. Therefhre. addin!! 
these olhcr services with the traditional vaccine docs 
not increasc the cost per child significantly. The incre-
mcntal C(lst of adding a new vaccine will bc slightly' 
higher than the C()st (If the vllccine itself. The addition-
al c()SI of udministering the vaccine or distribution of 
~'itamins appears relatively low. 
FIDllncing of [PI 
The EPI a(.1ivities of the Ministry oft-Ieahh and Family 
Welf.,re (MoHFW), GoB. tire supported by a donor Ctlll-
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sortiulll comprising GoB. World Bank, lJnit(.'Ill'-:!IIions 
Children's Fund. World Health Orgnnillllion. U.S. Agency 
/(lr International IJcvelopmcnt, Japanese Intemational 
Cooperatilln Agency. and l>epartmel1l for International 
Developmcnt-UK. Additional donor involvement was 
found in the surveyed EI'I deliver" sites of Dhal..a Citv 
Corporation ([)('(:). such as f\o~eigian Aid. Swedisil 
International Development Agency. Ford Foundation. 
Action Aid. etc. '111cse additional sources nf support can 
he clltegori7..cd into three groups: (a) agencies provid-
ing both monetary and logistical (vaccines. supplies. 
tT'.tining) support. (b) agencies providing only monetary 
SUpJXlrt. and (C) agencies providing only logistical sup-
JXlrt. The resources received by all EPI service imple-
menters ITom the EPI lIeadquarters were vaccines. 
supplies. [PI-rclah:d truining, and sOllle capital equip-
ment.lfwe exclude Ihese common resources. the addi-
tional resources that NGOs mobilized filr EPI were 
about USS 177.460 for the surv\:)'cd facililies. If we 
project thi~ C(lst for uroan Bangladcsh. the additional 
rcsources mobilized hy ~GOs t()r El'l scrvices become 
USS 1.4 million. Since these n:soun:cs do 110t show up 
in the macru-Ievcl cost accounting of EI'I. the cost of 
delivering EPI is usually underestimated, Furthermore. 
NOOs in Dhaka were able to ycncrulc about lJSS 15.000 
(orliSS 177.460) from local community resources. This 
was C'stimated from the resources used by Ihc ;\100 
outreach sites where lIIost space (rent) and funliture 
were provided by Ihe local community. such as a room 
in private households. schools. pharmacy. cultural 
clubs. etc. Thus. even the PllOr communilies of the cilY 
can potentially support some EI'I activities. 
D1SCIJSSI()~ 
[PI is ()ne of the most cost-effective health interven-
tions with high p()tential benefits and low C(lsts n.4.7-
121. Most cost studies of EPI used national- or regional-
level s~'Condary data without supplementing informa-
tion by collecting faci Iity-Ievel data, This study esti-
mated the cost of delivering EPI in urban Bangladesh 
using facility-based surveys. The survey results indi-
cate that the secondary data sources would huve under-
estimaled the urban EPI C(l'1S by at least 40-50%. The 
'<GO outreach-delivery structure is highly dependent 
on community-level resources. and none of these are 
IICcounled for in the secondary data. Even the govern-
ment delivery system solicits additional resollrcc.~ fmm 
the communities around their outreach sites. Despite 
the underestimation of costs, EPI renluins II highly cost-
effective intervcntion, If we use cost per Mve as a 
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mcasure of cost per fully-immunized child. the cost 
r~'lllains kss than LS$ 15 per child. This cxcludes the 
sodctal costs of vac.:ination that wcre not assessed in 
this stud). 
.. \n important conclusion of this study is that it is 
tca.~iblc to genemtc a significant amount of 10c',11 resourees 
!\'r delivcring EPI scrvic~'S. All the ~GO outreach sites 
mobilized resour.:cs from the communities in which 
they \\00.. Therefore. it is rea.~ible to genenlte some 
Il'cal resoun:es even from p(lor regions tor conducting 
immuni7.ation services. Inwlving the local Ci)mmunity 
with EPI activities not only will improve the sustain-
ability of the programme bul will also help increa.~ 
rates of immunization coverage. Furthermore. in the 
absence uf community invl,lvement. GoB Ilnd NOOs 
\vl,uld have tn SUPI)ly these resources. ~'Specially if 
emphasis is put nn the delivery of El'l thn)ugh Matic 
sites. The additional resources generated by !'J{iOs in-
.:Iuded resources from local oomlllunitics and from 
additional donor Il!,!encics. Thc estimated additional 
resource genemted by N{j()s in urhan Bangladesh was 
ahout USS 1..1 million per ycar. If we add this cost with 
the estimat\,'S of L~'Vin 1:/ al. (4). lotal cost of [PI for 
Bllngladesh ~'C()mes about USS 31 million. about 6% 
higher than their estimate. Although it is not a vcry sig-
nificant increase in total cost. it is imponllnt to derivc 
the actuall'l'Source usc in the EPI pn)grammc ti)r plan-
ning and polk)' analysis. 
If the average costs of delivering different ly~'S of 
services are eonsidcl'l'd. it is clcar that the outreach 
facilities (both government and non-government) are 
more Cilst-e/lcctiw than the static fadlities. The ~GO­
\lutreach sites delivered [PI services at the lowest 
:IVeralle cost. probably due to the externality created by 
Cilmmunity participation. using capital items 1t,'Ss inten-
sively and having minimal stail' providing services. It 
is usually assumed thutthe public sector must organize 
and deliver preventive: services. especially in pt>l)r 
Ciluntries where the demand lor preventive services is 
expcct~-d to be low. The fact that NGOs delivered 62% 
of all immuniZlltions in urban Dhaka clearly demon-
strat~'S nu inherent disadvantlltle llfNGOs compared to 
the public sector in pnwiding immunization servic~'S. 
Funhernlllre. )l;GOs in Dhaka delivered EI'I services at 
a lower cost than the government sites. which suggests 
that :'I/(;Os can successfully organize and deliver pre-
ventive scrviL'Cs in a potlr cnmmunity and, in the case of 
urban Dhaka. they were more efficient than the GoB. 
Khan :\1\' ~t III. 
Anuther important finding of the study is tllllt the 
incremental cost of adding services should not be sig-
nificantly higher than the actual cost of new vaccincs 
or drugs to be added. The new vaccine will tlbviously 
incrcllse the cost of acquiring thc commodities and 
supplies. but the current delivery structure has cnough 
shll:k in the system to be able to ddiver the new vac-
cine without employing additiunal pt"r5onnel or other 
inpats. For example. the number of vuccine duses deli-
v(''red. including the distribution of vitamin A capsulcs. 
was less than 12 per hour of El'l scs.~i()n in urban Dhaka. 
This number can be increased hy ~O% without chang-
ing the size ofthe facilities or the number nf personnel 
involved with delivery. 
This study also indicates that thc current EPr deli-
very structure could be made more cmdent. Apart 
from the wastagc ofvlICcines and slack timc ofpcrson-
nel. better targeting of children alone should signiti-
cantly lower the avcr'dge cost ofEPI. If the ,,"olllpiction 
r'dtc of vaccination can be improved and double-dosing 
avoided. cost per MVC ShUllld decline 10 abuut USS 7. 
The t'Stimated cost per MVC was US$ 11.61. indicating 
thut pcrft.'Ct targeting can reduce the cost per Fye by 
about 60%. Ilowcyer. no system can be 100% ellicient 
in terms of targeting ()f completion rates. but it should 
be I>ossibic to reduce the cost per MV(' by at least l.:S$ 
2-3 by beth:r managing the delivery structure, training 
providers. lind mobilizing the community. Better usc of 
existing human resources and vaccines should reduce 
the cost per Fye even further ,~ithollt increasing the 
service-delivcry costs. 
One of the important aspects of the El'l delivery 
structure identified by the study is the complex nature 
of the system in urban Dhakll. The predominance of 
:-.IGOs in the delivery of EPI in urban Bangladesh is in 
sharp contrast to the EPI delivery structure in rural 
arcas. where it is almost exclusively a publicly-nlll 
programme. Despite thc high degree of involvcment of 
the private ~ector in urban Epl. the delivery structure 
has remllined relatively inefficient. ·J11ereforc. sU!x'on-
tmeting health activities to the I,rivate sector. by itself. 
may not impruve efficiency in the deliver)' ofEPI. It is 
imponant to identify the factors IItTccting the efficien-
cy of NGO lind government facilities. including the 
paynu,'I1t mechanisms adopted by the contracting arrange-
ment. 
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Appendh 
Table !I. J\vcragc cost (USS) reT specific antigen in 1999 
Vllccm\: GoB stlltic GoB outreach NGO StallC l'GO outreach Avcrage Cllst 
BeG 1.79 1.82 1.23 1.03 1.39 
OPT 0.73 0.S4 0.52 0.62 0.63 
ory 0.63 0.55 0.49 O.S:! 0.55 
\1caslcs 1.20 1.72 1.93 1.71 1.98 
Vitamin A 2.41 1.04 0.97 1.42 1.38 
rr 1041 1.09 0.65 0.70 0.90 
Cost rer .' .... cine Unligcn~-lcupltal costl6' .<alaryI61 renV6 'recurrent trainin~/6' transport ,"'SV()l supply 
tl"t·IIO·SllCdlk Ia.:cinc Cu>tJ1tkl. ,,!'srecilk 'uccin~ doscs udministcn .. d 
Suppl) cnst multiplied hy lilO iflUccine is injel'!uhle 
(,uB stalic: (jo'~rnmcnl·r\ln stalk sit~s; GliB ollln· .. ,·I1: (i"lernmcnl·run uutreach siles; '-100 shllic: NO()' 
nm stalic sites; 'lO() uutreach: N(iO'run out roach sites 
n( ·(i~lIu";lIc Cuhncttc (iuerin; IWT=()iphlhcria-rerlussis'lclunus; OI'V=Orall",liu laccinc; rr=T.:tnmls 
t,)\,oid 
Table 6. Costs (USS) of sp'-cific antigens' in 199'1 
Vacdnc GoB static GoB outreach NC;O static 1'\OOoutrell,h Total cost 
BeG 3.492.10 277.47 2.422.82 2,050.59 8,242.99 
DPT MOS.08 476.07 4.891.88 3.453.77 14.426.80 
()\>V 8,772.95 1.011.09 7.06738 5,093.21 21.944.64 
Measles 4.231.01 410.37 2,915.01 2.801.80 10.358.18 
Vitamin A I.J08.62 372.84 11.273.04 15,068.46 28.022.95 
H 1.-194.05 121.57 1,324.49 I. I OOS-I 4,()40.65 
Total 24.903.81 2.669.40 29.894.61 29568.38 87.036.21 
·Cnst. tin IIntiJ.1~ns incllKlcd doscs administered nnd doses wasted 
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Abstract 
ARE VACCINATION SITES IN BANGLADESH SCALE 
EFFICIENT? 
Vivian Valdmanls 
Damian Walker 
Julia Fox-Rushby 
London School Qf Hyglenll & TropIc'" Medicine 
ObjeCtives: The overall aim of this study is to discern whether and to what degree vaccination sites 
exhibit constant returns to scale. 
Methods: Data Envelopment Analysis is used to compare all the facilities in the sample in terms of 
input costs used to produce multiple outputs. The application considers the Expanded Program on 
Immunization (EPI), which operated in Dhaka City. Bangladesh, during 1999. 
Results: A preponderance of EPI sites were determined to be operating at increasing returns to scale. 
Conclusions: Our findings question the applicability of cost-effectiveness analyses that assume con· 
stant returns to scale. 
K8'fWOrds: Scale, Efficiency, Immunization, Data envelopment analysis, Bangladesh 
Cumpared with other health interventions, vaccinations are judged to he one of the most 
cost-cm:ctive ways of improving and maintaining child hcalth. cspecially in low-incomc 
l'ountries (16). This view has heen held for a considerahle time (e.g., 15) and may help 
til c)(plain the increase in glohal covcrage of thc Expanded Program or Immunization 
(EPt) from an lIVCl'llgc of 5 percent at ils inception ill 1974 10 thc cun'Cnt average of 
110 perl'cnl (4). Many cost and cost-eO'cctivencss analyses ofEPI ('ountry progmms in low-
income countries have heen evaluuted at a given level of production (c.g .. II l, usellonly 
a few prllviJers (e.g., 4), (lr aggl'\.'gah:d lind ave .... gell at II l'"untry level (c.g., 1;14). Even 
when studies estilllatcd the cnst:; of increasing cllvel'Uge rutes or predicted country-wide 
estimates of C(lSts from II small study, most have assumed u lineur functioll to "scale-up" 
progrums ( 10), For example, if the unil cost per fully vaccinaled child is $20, the increasc 
in expanding vaccination services jilr another lifLy children is assumed to he $1.O(x). 
That such l'(lnstant returns to scale exist is dlluhted. For example. England et al. (5) have 
hypothesized that many impediments exist to scaling lip measles control in West and Centrul 
Africa and suggested that consideruble investment would he needed in manngemenl tuld 
he'llth systems hefore expullsion. In reviewing the cost prnliles of immunizlltion prognuns 
from accounting-husl,,1 cosl studics, some investigators have found that the proportion of 
lixl.'ll c,'sts indk'atCN the likely existenl'e of cl'unnmiCN of scale (e.g .. R). 
If u\'cragc cnsts lind incremental c()st-etlcctiveness rutios did change with pnxJuctilln, 
then assuming constllnt return!> tu sl'ale would produce hiased estimates of tiny change 
in production, and the higger the exrx-'l.:tcd ~'hungc, the larger the bias, Even if size were 
accounted for. there is no notion of hest practice henchmllrking (2) or knowledge of how 
this Illight change hy selling. In this study. both of these issues are addressed hy II novel 
We acknowleclfe and \hank Dr. Suhaila Kahn at lCDDR.B for her organiZation of the data collection and 
\Jr, Mahmud Khan at Tulane University who was one of the principal investigators on the wile Mudy. Viviall 
Vuldmani~. Dllmian Walker. and Juliu Fu~-Ru"bb)' are members of the Hoollh Economics and Financitll! Program, 
which i. IlUpported by funds from the United Kingdom Det>arUnenl for International DevetopmeOl (DFlD). 
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application of data ellVclopmenl analysis. Thrce ohjectivcs are pursued: lirst. the cost of 
delivering wUline v""'dnation scrvices fwtn the perspective ofthc providcrs is detenuincd; 
sccnnd. the outputs of vaccination silCS for each provider in ternlS of thc numher of doses of 
cal'h type of vuccinc is assesscd: third. the scale cllicicncy of thc vaccination sites as well 
as factors that explain variation in ~ale erticicnL'Y are cv~.lualcd. 
THE BANGLADESH EPI 
The EPI in Bangladesh was estahlished in 1979 and hecamc fully operational ill 1985. 11 
aimed 10 reducc morhidity and mortality from six vaccine-prevenhthle discases. Therefore. 
it fully v:tccinaled child received six stalld:trd EPI antigens against diphtheria. pertussis. and 
tetanus <DIYn. tuherculosis (TB). polio. and mcasles through eight vaccinations. Prcgnant 
women werc ulso given vaccinations to prevent maternal and neonntal tetanus. Since 1985. 
vaccination covemge has incrcased from 2 perccnt for all antigens to II reported 92 percent 
for BCG and 62 percent for measles (16). However, immunization coverage rates were much 
lower in urhan compal\,'(.\ with rural arcas. Thcrcfore. in 1988. the Unitcd States Agency for 
International Devclopment implemcntcd n progrmn to strengthen vaccination servkes in 
urhan areas in conjunclion with the array of government .Ind Ilongovernment fundcl's and 
pro\' iders of service. 
METHODS 
Oat<l envelopment analysis (DEA) was used to allow comparison of all the clinics in the 
smllple in terms of input costs used in the production of multiple outputs. OEA is a nonpllra-
Illetrk. deterministk approa<"'h using lineal' programming techniques that defines It "best 
practicc" production frontier. Firms lying on the production frontier arc considered to be 
operuting llt the best pr.tctice or in other words. provide a benchmark a lu Birch and Gufni 
(2). However. it should be noted that the measure of etlicicncy is considered to he rela-
live rather than ahsolute. as no a priori information exists as to whut should he considered 
as ahsolute ellicien,,·y. The benchmark clinics. lhat is. those that ~\re technically and scale 
emdent. reflectthc best practice for the given sample of clinics. 
A henefit of this DEA approach is that. hy identifying hest pmctkchy a "hlC<lI" standard. 
it muy he assumed that given certain productive characteristics (as well ns environmental 
ones) hest prac:tice l'un he feasibly reproduced at the less-efficient clinics. Another henent 
of the DEA approach used here is thut the overall technical enkicncy (TECRS ) measure can 
he decomposed into pure technical elliciency (TEVRS) and scale eflkiency (SE). In othcr 
words. TECRS = TEVRS x SE. 
Whereas there have heen a plethora of other related studies applying DEA to the health 
care sector using quantities of inputs in their natural units to produce outputs (see 13 for 
a review). we spccilied the objective as minimizing input cost'> given OUlputs (6:7). As the 
objective of this study is to determine scale effects. the delinition of the cost minimi/.ing 
technology used here was applicable. 
The technology was initially conslmcled under constant rctUI1lS to sc,llc and slrong 
disposahility of costs (as costs increase. outputs must increase. ceteris p,lribus) TEcRS. 
Allnwalll;cs can he mude in the restraints to aJlow ror variahle returns tll scule TEvRs. 
Furthermore. we detcnnined the type of scale inefficiencies by using a third Illodel TENIRS. 
In all these cases. we followed the definitions given by Fare. Grosskopf. and Lovell (7) unl! 
solved similar linear programming prohlems. We used the OEAP program hy Coclli (3) for 
the computalions. 
The technology is said to be operating at a cost- as wen as scale-eflkient level if 
T~s = TEvRs. However. if they were not equal.thc extent til which inefficiency was caused 
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due to operating at the wrong scale was assessed. Determining the type of scale inefficiency 
(either increasing or del:reasing returns to scale) required the solution of a third linear 
programming problem. referred to as nonincreasing returns to scale technology (NIRS). 
To deline the type of scale inefllciency that is operating here. we compared Lhe solutions 
of the three lincar programming prohlcms. If ~ < I. TEeRs = TEN1RS thcn increasing 
returns to scale exist. If ~ < 1. hut. TENlRV> TECRs. then decreasing returns to scale 
TE 
exist. Such models allowed for the impact of scale effects on the EPI clinics to be evaluated. 
However. deviations from the best practice frontier may be due to independent factors 
that may hc out of the managers' or policy makers' direct control. Thercl<lrc. (he measures 
of ellh.:iency were analyzed by usin~ a variety of statisticaltcsts. in conjunction with olher 
environmental factors that may atrect scale efficiency. 
DATA AND RESULTS 
Our sample was ohtained hy mc,ms of a 1999 cost analysis of EPI services undertllken 
in a random smnple of 25 pereent of the facilities (132 of 511) providing EPI serviccs in 
Ohuka City Corponltinn. To be pursimonious. five outputs (the amount of doses given for 
OPT. TB. polio. measle. ... and IT in 1999) and one input (total program costs of the EPI 
hy site) were specified. Only progmm site. .. with full information were included. The limll 
d:'lla scI consisted of 117 of a possihle 132 total clinics. Hencc. R9.3 perccnt of all clinics 
sampled were included. The type of missing data thut resulted in sites being excluded from 
the sample included ownership forn1. type of vaccination site. duration of operation. as well 
as some of the outputs. The dcscriptive statistics arc given in Tahle I. 
Turning ncxt to our efficiency results given in Table 2. we found that overall efficiency 
(TE CRS) was only 0.33. In other words. if program sites were technkally emdent and 
opcmh.-d tit the \,·on·el·t ~·aJc.l·osts on Ilvcmge could htlve hcclIl'l-duccd hy 67 pcn.'ent without 
sllcrilicing the cun'ent level (If outputs produced. By decomposing this ovemlJ measure into 
pure tcchnical efficiency (TE VRS) and scale efficiency. we found that mol'c orthe ovemll 
inl'l'lkicncy was due tn sites incurring loo mUl'h cost in producing the "rray of v"cdn"tions 
mther Lhan opcrnting at the wrong size. However. both sOUJ\"es of this ovcmll inefficiency 
must be addressed for th<.'se sites to become less wasteful of scarce resources. 
Given the findings that the sites in this sample exhibited vdriahle retul11s to scale. the 
type." of diseconomies of scale were cxmnined next. Tllhle 3 shows that the mtyority of 
the program sites exhihited increasing returns to scalc (sugge. .. ting thtlt they arc too small). 
17 progmm sites exhibit decreasing returns to scale (suggesting that they are too large), and 
only six progmm sites were the "right" size. 
In Tables 4 and 5. we assessed whether diOcrcnces in effidem:y followed systematic 
patterns due to fucturs heyund manageritll control. Tallie 4 displays statistically signifkant 
dill'eren<.·cs helwccnlhe efficiency uftwo ownership I<wms. tlnd shows that s<'·.Ile efficiency 
is rel~Iti\'ely grcater in govel11ment-uwned program sites. As outreach sites were st.ttistka11y 
significllntly Icss scale efficient than fixcd sites. we infer that satellite sites nrc too smull 
given the best pmctice frontil'r. 
Although the EPI program has h<..'Cn in existence in Dhaka City Corpoftltion since 19R8. 
not 1111 sites begun providing EPI services at the snme time. Tahle 5 shows that thc length 
of time a program site has been in operation is positively correlated with s<.~ale efficiency. 
DISCUSSIONIPOLICY IMPLICATIONS 
The sites in oLlr sample were. on average. relatively inefficient both in terms of tcchnical 
inemciency as well as scule inefficiency. To become technicalIy emden!. progmlll sites 
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Table 1. Descriptive Statistics of Outputs and the Inputs 
Varia!>le Mean SD 
BeG 257.40 304.94 
DPT 578.57 685.54 
Plliio 707.42 842.91 
Ml:asks 190.28 210.83 
11 390.03 443.37 
TI'lllll:(lSls 2.600.31 4.972.79 
Table 2. Descriptive Statistics of Efficiency Measures 
Mea"ure Mean SD 
TEeRS O..t~ 0.26 
TE VRS 0.50 0.29 
Sl·at.: H.M 0.27 
Table 3. Returns to Scale in Vaccination Sites 
Typo:s of relurns to scale 
Inl:reasing 
C"nsl:tnt 
Dl·m.·lIsing 
Min Max 
I 1.6XO 
I 3.2M 
I 3.756 
] 960 
I 2.20& 
238 45.716 
Min Max 
0.001 1. on 
0.0]2 1.00 
0.007 1.00 
Numhl.'r of v(lcdnllliun sites 
95 
tt 
17 
Table 4. Selected Statistics between Ownership and Type of Clinics and Efficiency 
G!I\'Crnl1l~'nt (N = 25) 
NGO(N =92) 
Fixed(N=35) 
OUlreachlN=82) 
M\,:an Scale 
emcien,,), score 
0.77 
OliO 
0.79 
0.57 
NGO. not govemment owned. 
F-h:st 
(I' > F) 
8.82 (.003) 
19.73 (.0001, 
Median lest 
«(1 > Zl 
2.47 (.0] l 
3.81 (.0001) 
Kru!lknl-Wallis 
(I' > X2 ) 
9.77 (.fl02) 
17.80 (.000 I) 
Table 5. Correlation Coefficients for Time Since EPI Clinic Opened and Total Cost and Scale 
Vuria!>lcs 
limcb.clIlc 
Tntal costs/scale 
EPI. Expand«! Program on Immunimion. 
Correlation clIi.'llicicnl 
0.34 
0.16 
(.O()O I) 
(.08) 
INTL. J. OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 19:4.2003 695 
287 
Valdmanis at al. 
would have had to decrease their costs hy an average of 50 percent. and if they had heen 
operating at the right size. costs could h.wc heen reduced hy a further 36 percent. Sites 
thm were relatively more inenicicnt. nn average. were not government-owned satellites. 
Therefore. the govcrnmentally owncd sites. perhaps due to more centralized control. ap-
penrcd to he better at long-tenn planning. We also found that sites that hud hcen practicing 
longer were relatively more scale efficient. which is perhaps attrihutahle to "Ieaming curve 
elTel·!. 
The presence of pure tcchnic.\1 incfficicncies suggests that. if such cost data were used 
as the numc .... tor of II cost-clTcl1iveness ratio. a cost-effectiveness anlllysis would not rclled 
the minimum etlicient point of production at a given level. However, tn ascertllin whether 
this outcome is likely to he the case. researchers need to hegin using a larger sample size of 
provider units for costing, l~srccial1y if results arc intended for usc heyond the gcogmphical 
focus til' .111 evaluation. 
0ur cvidcnce provides cmpirical support to Jacohs and Baladi's (9) contcntion that 
assuming constant returns to scalc might not bc realistic. The prcscnce of increasing returns 
has two partkulllr implications. First. that this intcrvention cannol he treuted as perfectly 
divi~ihlc within U popululilln ,Uld retain the smne levcl of increment'11 cost-eITectiveness. 
Second. it suggests that. if constant rcturns to sClIle lIfC assullled when increusing relurns to 
scale exist. an intervenlion is likely to he overprovided in that form. Finally. the potentiul 
learning elTcd raises questions about how relevant it is to transfer cost-clTel'liveness mtios 
nver time (lr ncross countries as levels or tcchnology diller (12). Therefore, we l'onc1uue 
th<lt ignoring the possihle existence of technil'al inefficiencies and variahle returns 10 scale 
wlluld make the generali/.ability of cost-effectiveness ratios ~uspecI and could worsen mlhcr 
th"n improve the a\location of resources. 
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Parameters of Control when Facing Stochastic 
Demand: A DEA Approach Applied to Bangladeshi 
Vaccination Sites 
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V. VALDMANIS AND D. WALKER 
An .Im ofvaccinatloo pro8flll1l5 I. near.romplete coverage, One method'<v achieving this I. f<v health fllCliities 
provldlns lhelle serviclls 10 operale rrequentl~ and for many hours durlns each scSllon. However. If vaccine 
villi. are I\(~ (ully u",--d. tho> ",mainder t. oflen dl..,ardcd. considel\!d II> WASIC, Wlth"ul an a.1ive appointmenl 
.chedule process. there Is no way for facility stuff to control the .loch&~lc demand of potential patients. and 
henc:u reduco ......... And yet Nducin8 tIIII hours of opel'llllon Of number of se .. tons per week could hinder DC",," 
10 vlll:dnallllll oervil:es, In lieu of any formal 5yot.'1TI of conln,lIIn, demand. we propose 10 model the optimal 
RUmber of hours and !IeIlions In order to maximize outputs. t'he number and type of VIlIlCIne.< provided given 
Inputs. usilll Data IinwloplIIIJnt Analy"'~ eOliA). InputR IN ddined AI the amount of vaccine wast. and the 
number or run-ume equlvalenl staff, sIl.e of tile facility. number of hours or openulon and the number of 5eSilons, 
0u1J'U1s are defined III the number and type of vaccines aimed at children and pregnant women. This analysis 
NqIIIn.'S two lIlOdel~: one DEiA model wllh possIble R!allocaUons betwllWl the number of hours and the number 
of se ... lo". but with lhe total amounl 01' lime bed and one fl10del without this kind of reallocation in liChI.-dullny, 
Comparlns tIlese two 1I4'OfeS we can idenUfy the "gain" Ihat would be possible were the ""hedulln. of hours 
and """"'0lIl modIlled while controltog for aU other types of Inefflcielll:Y. By modeltng an output-bllliOd model. 
we nwntain lho obj""1ive of increa.'ilns ,overage while assistin, declsion·malw", determining oplimal 0l""adng 
pr""""*"'. 
",,.....,..,.: data envelopment analysiS. vacclnatlo" programs. Bansl""""" 
.JRI. elM.ilk.llon: D2. II 
I. Introduction 
ResuurCll constraints in making health CIlI\! allocations were highlighted nllhc recenl Earth 
Summit in Jllhunneshurg repurled hy Stulman el al. (2(102) whll asscrll.ld Ihal "mol\! work. is 
nw\.'SSnry In IISSC~' the ctncicncy of resource utili zalion in specific counlries", Th,'reforc, 
climinaling cuo'cnl ineflkiendes in health care programs may yield health Wid munelary 
gains. As rart (If this eflicicn.:y/cffcl'livencss role of ,crvices in health ClIfC. vaccinaliol1s 
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,,~ainsl pI'Cvenla\lle illnesses arc 1"I,.'porll.'tIlo he line lit' the mosl ~ust-cflcclive health CIlI'!: 
inlerwntions provided (World Developmenl Report, 199.\). 
"In I qln, the Wnrld Bank developed the concept that lIosencc nl' health wa~ 1I nmin 
ohsHlde to the cconmnic development of pnor countries :md indicated Ih:II vaccinalion 
wlluld he a lirst step 10 improved economics:' (Rappuoli. Miller and Falkow. 20()2). One 
aim or va.:cination programs llperating in low and middle-income countries is near-cnmplete 
cnvcrage, Specifically. the Commission on Macrocconomks lmd Health orthc Wnrld Heallh 
Organization (WH() eXJX'Cts" target of IWk covcrage (England l't <II .. 20()1). 
Bolll govcnllnentally run clinics and private rllr-prufit or non-prulit non-governmental 01'-
gani7.atiol1s (NGO~) also prtlvidc vaccinalions. However, very litHe has Ix-en reported il1100 
literature (either I\~fcn,.ed or "grlty") on the relative productivity or these sectors in providing 
vaccine nr prcvenllllive services, I Property righls. hnwever. may atrt'Cl orgllni7.ational goals 
Ihllt may lead to ineflicient usc lIf inpub, ineflicient scheduling. or bUlh. 
The Expanded Program on Immunization (EPI) in BM~ladesh WIIS cSlahlishcd in 1979 
mId oc'l.·,une fully llpt~rati(\nal in 19115, A fully vaccinatt'<l child reccive~ six standard EPI 
mlligcn~ against diphthcriu-pert\lssis-t~~llInus (OPT). {lOll polio va~cinc (OPV).lInd Ba~iIIus 
or C.IIlllelle lind Gu~rin (BCG) 10 ward nIT luhcrculosis (TB) and measles. In IIddililln. 
women Ill' ~hildhearin3 aile also r\,.,\:civc II cOlll'se of val'cinations "llainstlelal1l1s (m, Thc 
cllmplete v:K'cimllion ~ch(.'<lulc includes eight vOlccinatinns administered :tI Ilve conlllcls 
with hl'lIl1h care slall', 1llc progrmn has tx,·"'n very successful as evidenc~d hy nn incrcmil' 
in v"ccinlltion covcrage rut~s from 2et for all antigens III a reported 92(k for BCG and 62th 
for measles. Huwever, ITlOl'e 1\.'Ct.mlly. covcrage n'le~ apl)ear 10 have reached a phlleau. with 
onty ~9tH of childl\.'llllnder the lIge of I year nf IIge having reccivet.lll full coul'sl~ nf .... "ccincs. 
The Government of Bangladesh (GoBI's st:lIl~d objective is "to incl\~"se ~owmg:e wilh II 
full series lIf r\Juline vllccines gl'lldually to III lellsl 9()% in Illt distri~ls by 2()()S" (Walker 
el al.. 20(0). 
Along with the IIl1cmpt to incl\~ase vllccination mtes, there is the other C\lmmCnSUl'lltl~ 
ll~i\''Clivc of reducing VIIccine waste. Ovenllt wastage r.lIcs2 in devcloping countries have 
I'l\,~n I:stimatoo to he around SOIl· hy Ihl: Unitt.'tI Natiulls Children's Fund (UNICEF) and 
World Health Organization (WHO. 1999). Vaccine wIIl>\uge is important as it eml show 
prollnllll (\mlrs. For example. it can highlighl Ihllt too many drops of OPV Of thl' wrong 
dosllge fur other vaccines is used: cold-chain failures or poor logistics: and fnlse reporting (If 
more vuccinalions administered than vaccine receiVed, There arc "Iso economic implicalions 
llhSI~'illt\,'tI with wUstugl'. If wastage can be n..'tIuced without nl1l.'Cting covcmgc. il can result 
in signilkunt fund savings for prllgl'llms, This is especially Inle for very I'0or clluntries. 
which do not tylliclllly have hudgetllry Hexibility to cxpmld prograllliinancing. 
In Bangladesh, vaccine wastage rule is also high (estimated to he around 401;;. ror DPT 
during 199R-1999), Further. there is no set acceptable wastllge mte that can he upplioo 
universally, however nornllli rates nf wuslnge clln Ol~ expected (EPIIWHO. 1910) rrom 
hctwccn 2~tk tll 5()~ , 
In view of this problem with \J1Il'cine wa.~te. the Gowrnment of Bungladesh (GoB) ha.~ 
propo.lst.,\lthe following solutions: 
• The pnllllo\inn nl un open Villi po.)licyJ lor DTP. rf. and OPV: 
• A 1\.~lucli\lll in the nUIllIl\,!r lIf vacdnation sessiuns. 
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On the supply side. nne melhod ror al'hieving complele vaccinntion coverage is for hC:llth 
fucilitie!> providing th\.'SC services to opefllte h"IXluenlly und to stay 0Jll~n for longer hours 
durilltl each session. This pennit' individualilexibility in gelting children vaccilluted. How-
ever. scheduling uf appoilltmcnh i!> nol done. mIller patienls enler 011 a wulk-in basis fur 
their vacdnalions. Again. we stress thai onc problem with thi!> policy h that if vaccines 
are not fully us\.-d during II sessinn. lhey nre oHell discllrded :lOd l'onsidcl\xl w:\~le. Simply 
reducing tile hOUN of lliler-dlion (lr numllCr of scssions ller week to possihly rl.-duce wu~le 
c,)uld hinder lIceess 10 vaccinlliion services. Withcml an aClive apl'ointmcnt schedule pru-
cess however. there is no way for clinic slalr III cOlltrullhe stoch!lstic demand or potential 
putients. In lieu or any fonnal system of conlrolling arrivab for vaccinations via a schedul-
ing ~ystem. we I'ro(lose. inlhis I'llpcr. to model thl' o(ltimal num!x'r of hours und numlx'r of 
M'ssillns in urder to 11l8xil1lilC the vaccines delivered-using Datil Envelopmcnt Anlllysis 
IDEAl. 
In temls of an ocllnomic model. ineflkiency ClIO be viewed in two clJuiV'.Ilenl ways. First. 
we can mellsure inefficiency comparing the observed llutJllJt(s) to an npti mIl I setnf output(s) 
thutl"Csulls from :1 I1Illximil.inll output while maintaining inpul conSilIO\. s.:cond. we can 
comp.1I\lthe ubserved input with an optimal input basket that COIllCS from a minimi/Jltion of 
input for;\ constllnt oulput. Hcre we upl for the fonncr ;lIld hence our aim in this paper is 10 
iL\Ccrtuin how clinics IUld hellith centors c()uld maximile the numbers of delivered vaccines 
while muintaining wastage Md other inputs constMt. To ac~'omplish this. we l'mploy two 
modds.onc DEA model. which allows It)r the reallocation ootwecn Ihe numller of hours und 
Ihe numlx'r of scs~ions and one nltl<kl without Ihis SlIme reallocation. By taking the ratio of 
the two scores obtnincd via the DEA Illodels the "guin" thlll cun he made if the schl.oOuling 
of hours and sc~si(lns are modificd CM llC measured. In essence. we control for (lnlductivc 
lin)cmcic~,,'Y (the conversion (If inputs into outpUlS) and just focus on the time rclall'tl 
inputs. Further. by Ill(ldeling lin output-based mood. we mllint"in the olljcctive (If increasing 
coverallc while assistinll decision-makers determining uptimal operating processes. In the 
next sectiun uf the papur. we describe the model!> employ~oO here. A oescripliolluf the data 
Md the I\'sults IIIV pre~enl~-d in Scclion 3. Section 4 concludes the pllper with dilicussion 
:1110 policy implications. 
1. Methods 
To iIIustmle (lur melh(ldoloI;lY. we \ISC VlKrin~tion C~'llCrs o(ll'mting in Bangladcsh in 1m. 
S(I\.'Cilically. we employ I.lIltu cnvelopment analysis (DEA). as descrillCd ny Farrell (1957) 
!\Ild Fiire. GfIlsS~\II'f ano Lovell (1994). which is IlUI1icuiarly relc"!\Ilt fur this IInalysis 
oocause of its IIhility 10 employ multiple illJllHs und outputs and does not require un II priori 
spccilication of a cost or (lfIlli! function. This work. howtwer. oitTers from typkal DEA 
studies in that Wt~ do not formally address inefticient'y Jlt'I' .fl!. Thc reuson for this approach 
is IlCcause deviations from the fronticr mily IlC cauS\.-d Ily botl! manallcrilll errors (a Iypical 
reasoll for inclllcien\.'Y) and lhe stochaslic nature of demand. Since scheduling apJlointm.:nls 
is not fClIsihlc for Ihe population in our samph.:, becausc they do nOI. in !!eneral. own clocks 
or watches nor do tlley have reliailic sources of\mnsportati()n, we "~1I1 only IIddress the issue 
llfellldellcy sulljcct totime/llv~lilllbility c.onstmints whilt~ maintainill!! as much Ilexillility as 
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rxlS.~il'llc. Flu1her we demonstrate an alternative (I"plication of the DEA framework wh~re 
the ul'l.ieclivcs an: not strictly maxilllil.ing outputl> Of minimit.in!! inputs. 
By usinllthil> approach. we also IIddrcs~ the rxlli~'Y prorxlsul of /indin!! th\.· uptimal fre-
quency "f sessions and hours/session of immunil.ation clinics as suggested in the "Ex (landed 
Program on Immunization National Plan of Action 2001-200S". This prnrx)~al has hccn 
I,ut forward due to the potential high costs due to wastage. 
As stall.'<I abow. we an: more interested in npplying the DEA methodology in order 
10 asscs~ optimal scheduling ralher Ihan an cfliciency sludy of productive tl..'Chllologies. 
Therefore. mlher than using inplll costs tn ennstnlct an iso-cost line we use time in order tn 
imrx1se an "iso-time" c(mstminl. Belbre. however, specifying the relevant DEA models to 
11<: solved. we Ocscritle the microeconomic underpinnings to (lUI' apprnllch. 
In ligun: I. we illu~trule the impllct ufthe possible Irdde-ont1<:twccn Ihe number uf scssion 
,uld the lime PCI' SI..'Nloion on elliciency as evnlualed vhl DEA. As we opt for output ori .... '1l1ed 
nl!)(lels. we pfl..'Scnt th\.~ unalysis in the outplll space. Here we ~~onsidcr two outputs Y I and 
Y2 that deline. tor example. tW() types (If vaccines. We also cnnsi(kr three ohsmvlllions. 
a. band f. with different schedules of sessions defined toy the length per sessioll (L) and the 
Ilumtler of sessions IS) and dilTercnt levels or output but with equnl total hours of operation 
(ISO-lime = L *.n lind with l-'qual usc or other relcvwlI inputs (xo). In a tl'llditionnl una lysis 
without rellll(x11Ii(1Il11Il1ong inpuls (our tirst DEA mudel). each of the three ohscrvulions 
lil's in s~"ar.lIc output production sets (P(xD• L. .q) sinl~e they llilli.!r in the sch~,{!ulinll 
YI 
"'!lUll' J. In~luslon or Ibe trade otr between lhe number of sessions and lhe lime per ,""sslon In OIlA IIVllullioo. 
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of ~ssions. WI! consider h~~I'l' two technklilly t~mcicnt ohM'1'vutions «(/ and II) lying nn Ihe 
ht1und,1I)' uf their (lll\ptlt prouuctinn scls IInu one incfflcknt ohscrvlItion c lying in lhe intcrior 
"f ih outl'UI produ':lion \ct. Withoul any Imdl!-off !lctwl!cn thc Il!nglh and th,' num!lcr of 
~c,sion,. the technkal incllicicncy of Ilhservalilln (' is mea,ured liS usual as the Mio (If 
Ill\.' two distances (k'/O('. Conl>idcring now the tra(l\: off po~~ihility hetwccn thc length of 
,cssion and the numher of ,\!ssions (our second DEA model). production plans are Illluged 
agains1 a new output production SoCI ( P R(.\o. L. s»4 delincd hy thc iso-time input, which 
indicates all lilt, possible schcdule~ with a tnlal lime of 12 hours. The fronlk'f of Ihis Il\!W 
prtlllu(·tion sct is ,imply ~fincd as Iho outer envelnp or all iniliul production scts with thc 
samo Mill h(1urs of opor.llions. Clcnrl). ohscrvntions a and b nre still emcicnt ,inn~ they 
also lie on the frontier of th(' new prlldl1t~lion sct. Hent'C. thcy havc:1Il optim:1I scheduling 
"f thcir Sl!ssiuns and nn trade-orr hetwl.'Cn thc Icngth of session and the nUlllhcl' of ~ssions 
is nc\.'C~sary til mllintllin th~ir le~hnkal ~mciency. Thb trade-on' will he fUl1ually delinl'\.l 
in our nlll\lcIs by the A vllIiabh .. that indicatcs silllullllncnllsly the possihle irll'roasc in the 
"'ngth nl se~sion ml<l the pns~ihk~ decrea~ in the nllm!lcr of ,,"ssinns in order til 11I(lint:lin 
the tlltal hours nf opcnltions ~()nstant: (A. L) .«( Ili.) • .I') = i~Hime. Since nil rc;lIlo(:;uion 
is n\,.'Cdl'\.l for ohSl.'1vations (1 and b. we have the optimal)"~ = I and;"r, = I. Onlhc contrary. 
evcn il lIb\Crvatiol1 (' removcs its technical ineflkielll.·Y hy rea~hing thc initial ('mntier at 
1", it will slilinot be at optimul pmcti~c undcr fcasihlc realillcutillns bctwl.'Cn thc Icnllth Ill' 
session and the numhcr of sessions. Observation (," pr<llIuccs more of the two outputs while 
maintaining tht~ sum~~ total hours of operations and all ()tm~r inputs (·onstant. Hen~(~, the 
totaltt'Chnical incllicicncy under rcasillie reallOl.·alion is lU(''asured hy Ihe distance 1l(,";Oc. 
In order to a'lloess the net ell'ect oJ' the rellllocation. we define the gain as the ratio of lhe 
two technical ctliciency mca.·mros (01'· /Oc)/(Oe' IOc) = (Oc·/Oc'). It rcprescnL~ the net Bllin 
hy in~'fCasinll in Ihe Icngth oj' sessions (from 1.5 hours to 4 hours) and by dt'Creasing the 
number of sessions (from 8 to :\). For ob~~rvation c. we have thc optimlll AC· = 8/.l '> I. 
From this simple iIIustl"<ltion. several pmperties of our models can he highlightt'd. First. 
lhe two mlXlels nrc nested sinc\! the frunticr of thc output IIWductioll sct under li.!lIsiblc 
realillcatilln is the outer cnvelop of thc initial rrontiers. Thcrcli)rc. tcchnicnl incflicicncy 
measures arc Ilrdef\.'d under hoth nlodl!ls ,II1d thc net g;tin ffllm re;l\l!x'utiun is always positivc 
«(lc· Ilk') is always grenler tholl Ilr (,'qual to OIlC in an output DEA Irulllewllrk). Second. 
snm~' ohservations mlly he eflkiont under hoth models (,\S (/ and b ill our illu~h'l\tion) and 
they are sillulI(.'{lallangcncy points of (he frontiers under both nullleis. A simpl\! analogy is In 
thut of cllicient Ilh~rvations undcr hoth Cllnstant and vlIrillhle returns to sC(llc in traditional 
DEA m<xlcls. Third, although it is not the case in our iIIu.'Itmtion, the (lutCI' enVl'lop l'(1fl 
includc parts III the iniliall'rontiers but not ollly at one point. l11el'l!fnrc. thc optimal vullle 01 
the A vuriable nUlY llut he unique and a Il(lst-optimal analysis is rcquired 10 compute lowcl' 
,uld up~r hounds on the f~lIsihle tr.K1c-oll'.5 
Next we formally :r;~'CilY the two DEA 1l1llUCls. Th~~ first mod~~1 is given hy: 
Max "j' 
"J',:'j 
s.t. 
J L:j vllcdfle",j 2: "j' . "IIIOCilU'mj' VIII = I .... , M 
.;-\ 
(I) 
294 
J E ~J wu,~/(~",j ::: W'L~lemj' 'l/m = I .. , '. M 
I-I 
J E:i limej ::: lillie,. 
i-I 
J E:j se.t~;(1"'\·j ::: .~e.Hi()II.\· /' 
j-I 
J E:j oIlier illputS •. , ::: olliff iI/PllfSn}, '1/11 = I. .... N 
.i-I 
J E:j= I 
i-I 
DERVAUX Err AL. 
(2) 
(.1) 
(4) 
(51 
(6) 
When' J is the numller of ohscrvations in the sumple. M is the numhcr \'I)" Iype of vaccines 
prnvilk.xl and N b the nUIlINI' ur olhers rel",vlInl inpuls. The: 's arc Ihe inlensity vilrillhk~s thai 
~'unslrucllhc convcx pruduclion rronlier.lntuiliVl.'ly. for an (los,'nalion j'. Ihe llIodel se~~ks 
;1 rerL~1l1 oh~crvuliun. cnnstruc"~lI as ;1 cnnwx cnm\'linalion of 01" oh~~rwd ohscrvations 
via lhe :.'s vt'riuhle~. ensuring thllt this referem~ provides the ~allle Ill' more of .. ad1 or the M 
vllLocincs (conslraint I). TIli, must he accomplished while incurring the SllnlC or less wnstage 
1m Ihe M vaccines (constnlinl 2). using the same or less length of lime pcr session anti lilt.' 
sanlC or fewl.'1' numher of sessions (conslr:tinls 3 :md 4) while consuming the same (II' less 
Ill' all otOOT1\ inputs (conSlnlint 5). The refertmt ol'lSl.~rvati(}n is the !lne that sntisfies all these 
constraints and that maximizes the provision of all vaccines compared to the evaluated oll-
So.'rvation j'. The measure is given hy hi. which indicates thnl for the ohscrvation j' the max-
imal pcn;clltage ofadditillllul vaccines thaI could be mude while maintaining all the inputs 
constant. We note thllt in this model. lime lind sessions cmmot be substituted ror each other. 
In the Sl.'C(lOO mndel. we change the constraints on tht~se tWI} time inputs so that we must 
now solve: 
Malt h~. 
hj".:'J.l. 
S.1. 
J E:'1 vaccine"j 2: h) . . \'i/c'cine.,j' "1m = I ..... M 
.I-I 
J E:j walle.,) !S wC/S/e.,j' '\1m = I ..... M 
i-I 
J L:'j timej !S A' timl'j' 
i-I 
f- . I . £- <./ ,{e.U/on.~ j ::: r . se.m{)I/.~.i' 
i-1 
(2') 
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J E Z j lITller itlpUUni ::: olliff it/puts.j' V" = I ....• N 
j-I 
J 
EZl= I 
i-t 
(5') 
(6') 
TIle ").. .. variahle in !loth time lInd sessinns constraints ~' and 4'. forces the\,(.' two inputs 
III he direcl invcrses of ~'ach othcr. thercforc lotal lilTl~' is held tixed for each dink in our 
~amplc. This allows IL~ 10 conslruct the iso-tin~ curve and analyze each clinic's sch\.'liuling 
pr.lClice hoilling hoth IOHlllin~ and lechnology (iXL'<I. Note that the Iwo mndeb;u'C neslL'li 
since Ihe lirsl mo<k~1 is included in the second mood. wilh ).. forcL'li to I. Thus. il is possiblt~ 
III have eit~'1' /, j ::: hi· or the ratio II'j' /" j' ::: I. In bolh models. "j' or II'j' gives Ihe total 
ineflicicncy of the clinic evaluated. hence the "f'/" j' ratio provides the net gains that can he 
ochiewd if schcdulinll werc to be optimized whilc controlling for incfticicncy. This is the 
lllIIin stfL'Illlth of our modeling approach-while we cannot clearly interprel the productive 
indUdency mellsul\'<I (specillcnlly if it is due to mllnag(~rial non-performancc nr ~IOChllSli(' 
lIemand eth.'Cls). we cannot ignore it. Ralhcr. we evuluatc Ihe possihle et'liciem.'Y gains from 
0111 uptimal schedule of sessiuns conlnlllinll foJ' produ..:lion inulliciclll.:),. In uther WIlI\lS. the 
I,' 1/' roltio givlls the percentage of additional vaccine allowed hy an oplimal ~chlldulll of 
Ihe sessions even if lhe clinic i~ nnl fully Ililkicni. We siress Ihm this is a relative mC<ISlIre 
,imilllr In the u~ual relativily of JIlCasurcs given in DEA. The key 10 our lInuly'C~ Ihcrllfore 
i~ Ihe ratill (lflhe two scores ralhe,. than one mcasure or Ihe other. 
Th~' ). variahle cun he either grcaler Ihan. equal Iu Uf' Ics~ Ihan I. The inlefpret:lliun Ill' 
this vllrillhl~ is thai if i.. i~ Illss th,1Il one Ihere (trc too few scs"ions hUI 100 many hours per 
session. The conwrsc is true if)" is grcaler thrul one (\00 nlIIny sessions hul too few hours 
re" session). If A is ('qual 10 one. then Ihere is 1111 optim.t1 rcpllrtilioning of the numlx'r of 
~ession.~ and the hours per ~'Ssions (independently of whelherthll clinic is glohally em dent 
or ioofficient). Note that since).. is UnCofL'llrained (except a natural positivily constraint). il 
may Icud from a thllorclical poinl of view to any scheduling Ihut may he irrclilislic Of simply 
nol feasihle. Hencc.lilllC reslrictions Set~m 10 he required to ensure Ihillthe 1\..'I1gth of sessions 
I hill'S the number of sessions is helong to SOI11(~ hounds (e.g. dUf'lltion ·session < 16K houTS 
a WI..'C\(). Nevcrtheless, it is not IlIlCesslll'Y in our context since we opt for variahle rctums 
10 scale DEA models. Therefore. the constraint on activity variables Le. LJ~I:} = I 
(''1ISUI\~S Ihat the 'lI'til11al value~ for Ihe rcfl..'rence sct associated to thc time and ses.\jon 
CI'nstfllilllS life Iincnr comhinalions of ohserv(,'li values among th~ sample observations. So. 
we avoid possihle infinite extensions of ollservcd prodUction plans II' in constllnt relullls 
10 sCllle Illodels for eXlIlllplc. Thus. it is nol necesslU'Y 10 include IxIUIl\Js on the lullil lime 
~incc \lptimul values itrc conslrnincd 10 he !I)WI..'f (at mosl Cljual) to o!l.\Crved valucs in the 
slImplc. 
"'nally. W(~ stress tWI) tl~chniclil pOints th,lIl1re impol1l1nllo implemenllhcsc models. firsl. 
note thllt in the SCl:ond model with the A vllrillhle leads to II nonlinear prognull. Wherells 
~ullle ,'rublems for the ~'!itiml\tioll Illay uf'isc. thll nonlinearities IIlV flul excessive and ft.'wnl 
l'fOtlrammintl solwrs handle them ca~i1y. SI..'Cond. as staled alxlVe. multiple sollllillns for 
lhe ).. variable IllIIY urisc in program 2 leading to tbe same optimlll solution. A pllSl-nptimal 
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IUlalysis is l\,'quin .. 'lI 10 compute lower and upper Iimils on lhe }.. variab!\!. It simply involves 
IWll additional progmlUs with a new Objl.1Cliw function thai seeks to maximise and minimize 
i.. respectively nnd hy induding 1I new con~tmint forcing the h' variable to he equal to its 
optimal value h'·. In case of multiple solutions. we udnpt the 'philosophy' of the DEA 
appruOlch which alw!lYs evaluates an ohscrvution under its hest possihle light and we keep 
the nearest ~olution from the initial scheduling or evaluatell vaccine's sites . 
• 1. Datu and Result .. 
lI. cl1~t-cfrccti\'eness analysis (11' m~~aslc~ ~'(1\ltnll h(ts b~~l~n ulllk'rlaken in Dee (Wallier c\ (II .. 
20(10). This study was huscd on n ~tmtilicati()Jl of health centers by ;r.one and type of site 
(lix~'lI or siltellile (lllttreach». from which 132 sites were mndlllllly select~'lI n:prcsenling 
25'" or all Ihe EPI delivery sites. W,· further -;elected only clinics for nur linal samph.~ 
thllt did not hllve missing datu for inputs, outputs, or time related variabks. The I1nal 
s .. mple size we study here cOI\.~ists of 117 clinics. TIlese included 35 (3()(O Iixed and 
8:! 170'«) outreach delivery sit~s. or th~ lixt.'() si tl.!S , 19 (54.3~) Were ()1.lCml~'lI by Ihe 
ll(lvl!mment and It. (45.7(1'-) by Non-Govemml!ntal 0t'llanizalions t NGOs). or the salellite 
~itl.'S. It. ( 17 .4CJi ) were operatt.'lI by the government and 71'1 (82.1'1%) by NOOs. Bel~ause thb 
",.ltlier study alsu I:ollect .. >d dnta on the total costs of delivering EPI activities nnd site- lind 
IUlti~en-sp\.'Cilic wa.\tu.:1.! niles. il provided an 0l)purtullity to assess the rull.! of scht.'lIulinl,l 
(In th~' elliciency or EPI pnwisi(]n and therefore rorms the ba~is of the daHl analyzl~d in this 
parer. 
Inputs are delined as the numllCr of full time l.'quiv(llenl medical ~hlff. size of the facility 
(k'dicat,,'lIto thl.! EPI (ill ~lual\,'(ll11elel's),the IIl1mber of hours of operation, and the number 
of ses.,iuns, Th~~ level or waslnge lIy vaccine type is also gh·1.!11 ,1\ II cOllstmint. Olilputs are 
dclined as thl' nUllllwr and Iypt~ of live vaccines aiml'.d al child~'n less than 5 yeilrs of age 
IUl\! prot/nalll Wllmen. Tallie I \"'1II1lains the descriptiVl.' statistics of inpul~ IUld outp\lt~. 
We I1Cltttum to the results on the possihle clliciellcy gllins and the observed and optimal 
scheduling or clinic hours which are presented in Table 2, 
The result~ rresenled in Table 2 illustmte that61l'l of the clinics ollCfllte with an optimul 
scheduling of vaccination sessions, The rest of the clinics are t.'qunlly split between two 
gnlups resulting in 20% of Ihe lolal number or clinics. The post optimal unalysis reveals 
that It.~. of ollservalions have multiplc solutions for the A variahle. As stnted abovc. we 
kl.'\.'(l in this Ci\.\C, the closest vlllue compared to the initial s..:heduling of session\. The 
lirst ~'1'llIlP .haraclcri/.cd by A < I may be interpMt.'lI as clini.s with \00 long hut too few 
~essions per month. The second group with i.. '> I is chunlcleriZI.'lI hy clinics with too shorl 
hilt too mOllY S1.~s~ion.~ pcr month. Within these two groups. clinks nOI cmployin,l! optimal 
schedulin@ may increll'iC the tot .. 1 nllmbcr of vllccines by W'A for th(lse with A <: I and by 
11Y.f I'llI' dillies I\,'\.'\!iving SCllres of i. '> I. which is statistically signilicmllly different from 
clinics npcralinl,! wilh relatively optimal schedules (i.. = I), Here, we slress again that these 
IllJt~'I1lillll#l1ins arc solely due tn the scheduling of sessions onc\"~ we hllvc controlled for other 
~(1UI\'l'S of inefticicncies. The wftstllge of vaccines in..:urrcd hy the non-oplimi7.ing clinks is 
Ills ... sliltislically significilntly greater Ihan Ihe clinks ollCraling wilh optinml scheduling. 
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Ii."'" f. Des.:ripUvc staliSlics of inpuls and OU!pUIS. 
Variable Mean Sid. Dey. Minimum Maximum 
INPUTS 
Lalxll' 3.11 3.47 20 
Facility size dedkaled 10 F.PI 368_H 406.81 30 2.700 
BCOwute 126.12 142.()9 0.50 701.46 
DPT"'II5k! 147.75 141.42 0.50 746.66 
OPVwas\e :!IS.49 263.72 0.00 1795.50 
MeGilllllwUIe 90.22 100.89 0.50 46.~.91 
TTwasIe 140_~7 133.05 0.50 515.88 
Monthly "" ... Ions 6_10 5.33 24 
Hours/session 4.14 1.44 U g 
OUTPUTS 
Num/ler of DCO yacclnes 2!l9_~9 ~.31 i6S0 
Numher of OPT VIII't'lne.. 581.67 6117.67 3264 
Numher or OPV vaccines 710.70 84S.78 3756 
NUlIlher of """,,.Ie!;. vaccine 190.98 211.60 960 
Number of TT vaccines 389.87 445.27 2208 
1"",,, 1. Results by optimal schedulinB of 5e11Sions. 
A'-': I ),-1 >. > I K-W lests" 
Number of clinics 23 71 23 
'I 20'l> 60,*, 20'1 
limaency Bil lIS 1M. 0'1. 19% ... 
I'*' of 100ai Y1ICI.'ines) 
Wasles 49'J 2S% 44% ••• 
t'*' "flOlal_-.:lnllll) 
Numher of hounlllllSlion 
0bIerved 4.70 4.18 3.47 
UpIImal 4.05 4.18 4.19 lIS 
DI~ 0.65 0.00 -0.72 
Number of oeulonllllnonth 
<:XIIemd 3.83 6.70 7.52 .. 
Opdrnal 4.41 6.70 6.06 lIS 
Dlffilrence -O.SS 0.00 +1.46 ... 
"K-W stlnd for rile Kru.kaI-WaiU. slaU.rt"" to test If seyeral samples rome fromlhe same population . 
•• IIICI ... means slsnillcant tIIlhe 5')(, level and \he I'*' level te'f'CCllYely. 
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fi/il/rt'~. Etliclen~')' plns and optimalll'ade off ror lieoslons' IiCheduUnll, 
Nt'le hllwcvt'r Ihul ewn oplimal dinics incur waslagt'. hut their niles (Ire signiticllflIly 
luwer. 
Clinics clas.~ilied as having a >.. < I operate I Mf more hours per session but 13c,f, fewer 
sessions per nl(mth than the ()plimnl level. This relationship is just the converse for those 
clinks cntegori/t~d a,~ huving: a >.. :;. I: they have to inl'feasc the time of Sl..'Ssinn hy 17'« while 
\k.'Crca!iing the number of sessions by 24cl. Further the differunces tx'twt.>cn ohserved and 
"ptimllilime is stlltistkally signilicanlly diflcnmt amllng the clinics hased on scheduling. 
hut !here is nu stlllistically significllnt dill'erence for uptimal opcmtions vis-a-vis schcduliJ1!!, 
We also provide It I.lraphicul depiction or the relationship hctwoon i.. lind etlkienl'y gains in 
pert't'nt. This i!\ givtm in figure 2. We observe II positive relutionshil' hetwl~n Ihl' n(ltimal 
s.:heduling and the eflkien<.:y of clinics. The V-shape cnlTll.!s from thc ordering of the optimal 
>..: as the value of>" is Ic~s Ihan unity and dl.'Crcases, clinics Clln incrua.~ingly gain more wilh 
the same dynamic occurring for an incTClIsing A fur clinics with II j, >- I. However, we note 
thOlt eOiciclll.'y gains are not symetric in the two cases and !lOlins woukllx~ higher for clinics 
r(",\ludnll the numller of sessions Ii. > I). 
We ure ahll illtere~ted illlll'lIanilatiullul features such us rrivale nlln-gllvemmentaJ lIr-
gllnil.ations (NODs) which in !his slImple are non-proUt. Anolher organizational aspecl of 
lhese clink'S Ihut may lelld tn less Ihun optimal scheduling would he whether they weTC 
fixed or S;\Icllite clinkl\. In Table] we present the main chnracterislics (If dinirs :dong 
their nWOl.'I'Ship and their type. In Table 4 we present the mean results of reilltive gains. 
l>cheduling IliIrti(jonillll (A) lind dillcrenws ill scht..'\Iuling lhe lillie <lnd number or sessions 
by ol1lllnizlllional fbrm, 
From an orglUlizalional perspective we are also interested if information c.,n he gleaned 
hy assessing Whethcl' the comhinlltion of ownership and type (lfclinic (Ii xed versus satellite) 
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7 .. /Jlr.l. Acdvlty by ownership and Iype or clinics. 
Total Vaccines No. of No. of 
Ofpnizatlol\al Variable N cavenge) Hours Sessions 
NOOIIilWd 16 330' '.9 11.3 
Oovemn_tlftxed 19 1t077 3.9 IH 
NOOI~alelHte 76 1342 3.9 3.S 
0001lmnlcntlll8telllte 6 2867 3.' 4.0 
li,hI .. 4. Rc.uils by ownerlihlp and type of cURics. 
OrJanlzalklllal F.mclen~'Y Mean Dlr.ln 
Variable IV Oain5 ;,. Hours 
NOOIfixed 16 U~ 1.D4 -0.12 
Oovtmmentlftxed I~ 8.7% I.I~ -0.41 
NOOIsalelUte 76 3.8% 0.98 0.12 
Oovemmentlsaleliitg 6 2.4% 1.08 -0.2.1 
k-W test" ns ... 
-k-W lland for the Kruokal-Walli.Ila1i5tics to test I! SIlvera! .. mpl ... <'O",e from thi! 'am .. population. 
" and ... liliiii\1 stplftelllt lithe ,% level and the I ~ lewl re5pllCdwly. 
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Total 
Wastage 
32% 
36% 
33% 
3'% 
Dlf.in 
Sessions 
O.~I 
1.21 
-0.10 
0.2.1 
. ..
also perfnl'ln ditT~'fCntly in lerms of the scheduling of vaccinations. Frnm Tahle ~. we nnte 
Ihat lliohally lixcd clinics perform twice the number (If vaccinations of satellite ~·enters. 
While there is no signillcanl dilR'tCnce fly amount of total vaccines provided hy fixed clinics. 
non-lll1vcrnlOOnllll sulellile ccnlers pcrfornl half liS many vaccinutions thml governmental 
t.: .. 'I1b .. 'fS. Turning next tn the scheduling is~ue. we note nn significant ditTerem:es among 
s"tcllile~ centers cven though non-governmental fixed clinics have longer se~si(lns. In lerms 
of wlistallc_ there is no statistically significant dilTcrcoce IIIllC)nll all types of clinics. 
fnllll Tablc 4. we ohserve thaI on average all foul' ofglUlillllional forms could have 
ochiewd ¥Uins in efficiem:y from more optimal scheduling but there is no l!1ohal signif-
icant ditTerenccs among them. Government/llxed dinies currently nrc Ihe le:lst e!lieient 
(relatively) to the other three organizational forms Sincl~ they could gain Ihl' mosl ft'<lm 
nllwing frnm its ohserved position tn an optimal pnsition (N.7Q). ()hscrvl~d NGO clioil'S 
po.!rtill111 ",'Ialively beller than the other form in the sl·hl.'()lIling of their se~sions If. = 1.04 
and;' = 0.911 for tixed lind satl!lIile respt.'Ctively). Again. the most important improvement 
in sch<.'\luling is rclute~llo govenlml.'I1tall1xcd clinics. On averallc, they hllV\! to reduce the 
number of sessions by I .21 by month and 10 increase the lenglh of sessions. 
4. DlsruS8lon 
The pllrpll~ of this paper WIIS II) assess if the 117 vacl:inlltion clinics operating in Dhaka. 
B,lRglaUcsh mllCllhc ohjectives of maximi:t.ing vaccinc~ produc .. '\l. We accomplishl.'\lthis 
ohjective by emplnying DEA tet.:hniques to two separate mnd~ls-one withoul constraints 
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on the two time elemcnt~ (hours per ~ssion and number of sessions) and another wilh lime 
~'(ln\lraints. By lakinllthe ralio or lhe resulting sl:ores hy clinic, we lire Ilhle 10 delermilll~ 
whlltllllins could Ile ma~tc in tcnns of inl'J'Cnsing the number nf val:dnes (lr<lvided if dinies 
hll\l been o(ll'l'aling with lin optimal sl:hedule. We avoid milking IIny statements regarding 
finn inel1kiency, in u produl:live sense, since we hypothesize Ihill the dist.Ulee a .:link is 
fn'm lhe fflllllier Illll)' be due 10 the slol:hastic nalure of Ihe demand for thesc dink sen'kes 
IUld nut just managerial inetlicienQ'. 
The underlying reason fnr pursuing this line of inquiry is hecauhe thl! Governmenl or 
Banglad~~h has rel:olllJllenlled Ihat ooe way tll reduce wash: wou Id he 10 reduce MlIllC 
vl\cdnation sessions, In a similar vein 10 this stringent policy. we round Ihal oplimality 
could Ile allained if in some ea.<;cs, both number (If session~ llnd hours of opcl'lllion per 
~c~~ioll were alll~n.'d. 
To summ.1rize our results, we found thaI optimality of scheduling was, on avemge. lIf1lund 
hevcn scssiuns with eal:h session lasting four hllUfl> per Illonth. If optimalit)' hall to~'Cn llIeL 
1IlIin1> (i.e. amounl and tYJlI) of Vllccincs providcd) could have ix'Cn achieved rrom between 
I II III ~O'l. In other words. the clinics not operating wilh oplimul schedules could increaSl~ 
the numller "I' vaccint~s provided whill! rcdudng Ihe wasle inl:ull\~d. Howt~vl!r. Ihis h nollo 
'''Y thut ICI'II wu\lc h II possitoilil)' since sOllle wasle is incvilllhic. We rounlllhlli oplimally 
"~'l'ill~'\l dinics did inl:ur wasle (2W*) hUithis rate Wits signifkltnll)' lower thlUl clinic, Ihat 
did nul nJll)ratc optimal schedules. It wal> alsu demonstrated thallhc relalionship belwt'Cn j., 
;md cllkicncy gnins e:\hihited .1 type of sclile disecnnnmy with clinics thlll were n~~ncd for 
more session~ hUI for 'i.'wer hours per scs.~ion lIum WIIS optimal, in,'urred thl' highl.'r ~Iegnx' 
of inefikil'nl'Y. AnalY1-ing our results hy organilational 1'01'111 of the clinil:s. wc further 
found that gm'CmnlCnlllillt-u clinics lend(.'(\ to hllve too man), sessions. which muy he one 
reaM)n li)r the ,'t.lI:lIS the GoB policy. However, we did find that 11 xed sile clinics, especially 
Ihose lhal an: puhlicly owned provided mon: totlll vlIccines on nvcragc without statistically 
signiticunlly more wlls'age. This IIlIly also \1e due to Ille attenUation of property rights in 
g(lV~'111l~'fIlal dinies. whereas lhey may be less conccrned with efficiency of scheduling 
and mOl'll concenk.>d with overall access and provision of vaccines. This hypolhesis is borne 
oul further sinw govemmcnillixcd clinics provided more lolal vacl:ine~ than the other 
three organizlltionai types. In addition. NGO clinics wert.' more inclined to O!llYaiC ulmore 
oplimal sch\,'liuling than gowrnmcntlll clinics for hoth type of centers (lillcd (tIld !;lItellilc). 
()ne rellS{ln may toe that despite Ihe non-prolil slatus of the privulc I:linics in our sample and 
lhe sialed nhjel:tive of mallimiling vaccines provided. they may be mon: closely monitored 
bv lhe relative funding agencies . 
. Wherea!> Wt.' focuSl..-u on what could be lermed avoidable W<lstc, the WHO'~ reviSt.'(' Plllil')' 
~tatenwnt un "The use of' openl>d multi-doSt.! vials Ilf vaccine ill sutoscqllcnl immullir,alion 
~~'~sitln~" ~u~eslS thut the fCvis\,,'\I polic)' has the plltcnlialtll ft'\lucC vaccine waslage r.lt~s 
by up to 3l),">f. resulting in 1U1Ouai s(IYings \\'orldwil.le of $40 million (US) in vllccine costs 
I WHO, 20(0). Note howevcr thllt this figurc re(lre~ents current usc HI' vlIcl:incs which are 
nol as expensive as future Y3Cl'ines for the prevt.'fIlinll of" diseases such as Hepatitis II and 
Haf"WI)"ilu.~ IlIjlUt'IIlJ1t T.'11f B (HIB) in which Cl\!ies WIlsIe ortllCsc vacdnes would inl:ur 
higher costs. Further research combining Sl.'hcduling as well as an open viaillolicy is the 
IlClttllillural ~ll'P t(lWllrds addressing the GoB's concerns (If vacdne WlL\tC. 
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l. In a ..,.ro:ll using the Medllne search engIne and the Slsle ... arch cnlline fur "gray lit.,ratu"," "" only found 
ooe anlcle thai WIll appIll.'abk! 10 our /'IlIIClII'Ch question. 
2 ....... ""I~ wost. I. W proportion of v..,~;ne supplied. but not adminIstered to children. usually Slated as a rate 
and Is I.'8lculated till: VlWl.'lne wastage rate - ([doses supplied - dulleS admlnls!en,dVdoses supplied) _ lOll. 
3. Open vials Call be open and shut and therefore reusable for IonllCl' periods of time . 
... A. usual. I't~ I_Us fur a lrudlU0II81 output productlon sel while in our !.'OOtUKt RI'(x) stands for the output 
produellon SCI ,.1th feulble Rlallocallonl anlOnB parts of the Inputs. 
~. We thank IllllIIIOOymous refeNfl for pointing out this relevanl pulnl. 
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Appendix 4: A brief review of some of the stochastic and data envelopment analysis software 
SFA software 
Stochastic frontiers can be estimated using a different range of mUlti-purpose 
econometric software which can be adapted for the desired estimation. This software 
includes well-known statistical packages such as SPSS, Shazam, GAUSS and SAS. 
However, the two most commonly used packages for estimating stochastic production 
frontiers and inefficiency are FRONTIER 4.1 (Coelli 1996b) and LIMDEP (Greene 
1995). A more detailed review of both packages is provided by Sena (1999). 
FRONTIER 4.1 is a single purpose package specifically designed for the estimation of 
stochastic production frontiers (and nothing else), while LIMDEP is a more general 
package designed for a range of non-standard, i.e. non-OLS, econometric estimation. 
An advantage of the former package is that estimates of efficiency are produced as a 
direct output from the package. The user is able to specify the distributional 
assumptions for the estimation of the inefficiency term in a programme control file. In 
LIMDEP, the package estimates a one-sided distribution, but the separation of the 
inefficiency term from the random error component requires additional programming. 
FRONTIER is able to accommodate a wider range of assumptions about the error term 
than LIMDEP (see Table I), although it is unable to model exponential distributions. 
Neither package can include gamma distributions. Only FRONTIER is able to estimate 
an inefficiency model as a one-step process. An inefficiency model can be estimated in 
a two-way process using LIMDEP. However, this may create bias as the distribution of 
the inefficiency estimates is pre-determined through the distributional assumptions used 
in its generation. 
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Table 1: Distributional assumptions aUowed in the software 
Distribution FRONTIER LIMDEP 
Time invariant fann specific inefficiency 
Half-nonna) distribution ./ 
Truncated nonnal distribution ./ 
Exponential distribution JC 
Time variant fann specific distribution 
Half-nonnal distribution ./ 
Truncated nonnal distribution ./ 
One-step inefficiency model ./ 
DEA software 
Most of the general-purpose mathematical optimisation software can be adapted to 
solve DEA problems. Examples of programme code for DEA models have already 
been published and are readily adaptable, e.g. Olesen and Petersen (1995) present the 
GAMS code for a DEA model that can be adapted to suit most analyses. Emrouznejad 
(2000) developed a SAS programme for different DEA models, including options for 
input- and output-orientation orientated CRS and VRS models. The Emrouznejad 
(2000) programme can be downloaded from 
httt>:lldeazone.comlsoftwarelindex.htm#sasdea 
These general programmes offer the possibility of a wide range of applications using 
non-specialist DEA software. However, there are several DEA-specific programmes 
that provide a variety of interesting facilities. Seven of the most common ones are listed 
below: 
1. DEAP 2.1 (Coelli 1996a); 
2. DEA-Solver Professional 4.0; 
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3. EMS 1.3; 
4. Frontier Analyst 3.1.5; 
5. IDEAS 6.1; 
6. OnFront 2.02; 
7. Warwick DEA 1.0; 
The key features of the different software packages are summarised in Table 2. 
Table 1: Key features of tbe packages 
Package Malmquist Weight Input I output Multi-stage CRS/VRS NIRS 
index restrictions orientation DEA 
DEA Solver ./ ./ ./ 
DEAP ./ ./ ./ 
EMS ./ ./ ./ ./ 
Frontier Analyst ./ ./ ./ 
IDEAS ./ ./ 
OnFront ./ ./ ./ 
WarwickDEA '/. ./ ./ ./ 
• This can be carried out by doing some modifications to the programme 
Of the packages described above, EMS and DEAP are free. 
References 
Barr RS (2004) DEA Software Tools and Technology: A State-of-the-Art Survey. In 
Cooper WW, Seiford LM, Zhu J (Eds) Handbook on Data Envelopment Analysis 
Boston: Kluwer Academic Publishers. 
305 
Coelli TJ (1996a) A Guide to DEAP Version 2.1: A Data Envelopment Analysis Computer 
Program, CEPA Working Paper No. 8/96, Department of Econometrics, University of 
New England. 
Coelli TJ (l996b) A Guide to FRONTIER Version 4.1: A Computer Program for 
Stochastic Frontier Production and Cost Function Estimation. CEPA Working Paper No. 
7/96, Department of Econometrics, University of New England. 
Emrouznejad A (2000) An extension to SAS/OR for decision system support. 
Indianapolis: Proceedings of the SAS User Group International Conference. 
Greene W (1995) LIMDEP (Version 7): User's Manual and Reference Guide. New 
York: Econometric Software Inc. 
Hollingsworth B (1997) A review of data envelopment analysis software. The 
Economic Journal 107(443): 1268-1270. 
Olesen 0, Petersen N (1996) A Presentation of GAMS for DEA, Computers and 
Operations Research 23(4): 323-339. 
Sena V (1999) Stochastic frontier estimation: a review of the software options. Journal 
of Applied Econometrics 14(5): 579-586. 
306 
Appendix S: Facility survey form for vaccination deUvery units 
Date: 
Name of interviewer: 
Name of respondent, designation: 
Name of facility, address: 
I. Type of vaccination delivery unit: 
Key: more than one day per week = 1, one day per week = 2, other (specify) = 3 
2. How many days/sessions held per month? 
3. How many hours is one session? 
4. Address ofEPI site: 
a. Zone 
b. Ward 
5. From which year routine EPI services started in this delivery site: 
6. Activities, other than routine vaccination services, delivered at this unit: 
7. Which organization manages this EPI unit: 
8. Which organization or agency funds (monetary and . or logistical) this EPI unit: 
9. Building and construction: 
a. What kind of facilities are there for immunization services: 
Key: room = I, corridor = 2, veranda = 3, other (specify) = 4 
b. Type of construction material: 
Wall: 
Floor: 
Roof 
c. What is the size of this facility (square feet)? 
Length: 
Width: 
Total: 
d. What is the size of the area used just for routine EPI (square feet)? 
Length: 
Width: 
307 
10. Vehicles: 
Type Quantity Unit cost % of use for 
routine EPI 
Jeep 
Pickup 
Bic:ycle 
Motorcycle 
Other (specify) 
Other (specify) 
11. Travel: 
Activity Collection of EPI meetings Social Other 
vaccine stock mobilisation activities 
for EPI Jspecjfy) 
Number of trips per month 
Distance per trip (km) 
How? 
Key: bus= I, baby-taxi=2, 
unit's vehicle=3, on 
foot=4,bicycle=5, 
motorcycle=6, other 
(specify)=7 
Expenditure per round trip_ 
Duration per round trip 
12. Equipment: 
Type Quantity Unit cost % of use for 
routine BPI 
Refrigerator 
Cold box 
Steam steriliser 
Vaccine carrier 
Other (specify) 
Other (specify) 
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13. Supplies used for vaccination activities: 
Type Quantity Unit cost 
Brush 
Card (child) 
Card (mother) 
Carry bag 
Cotton (roll) 
Day carrier 
Dial thennometer 
Duster 
Icepack 0.4 litre 
Icepack 0.6 litre 
Indent fonn book 
Mixing syringe SmI 
Moni flag 
Monthly report book 
Needle 18 gauge {box of 121 
Needle 23 gauge (box of 12) 
Needle 26 gauge (box of 12) 
Pamphlet 
Plastic bowl 
Poster 
Register book (child) 
Register book (mother) 
Soap 
Soapbox 
Steriliser bag 
Syringe O.OSmI (box of 10) 
Syringe O.SmI {box of 101 
Syringe Iml (box of 10) 
Table cover 
Tally sheet 
Timer 
Others(specify) 
14. Furniture: 
Type Quantity Unit cost % of use for 
routine EPI 
Table 
Chair 
Bench 
Other (specify) 
Other (specify) 
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IS. Staff: 
a. Salaries 
Type Quantity Salary % of time for n 
(including all routine EPI 
benefits) 
Doctor 
Paramedic 
Health assistant 
Nurse 
Counsellor 
Vaccinator 
Health educator 
Health worker 
Driver 
Cleaner 
Guard 
Other (specify) 
Other (specify) 
b. Training 
Type Long-term Short-term 
Number of Number of Type of Number of Number of Type of 
type of staff sessions traini~ ~eofstaff sessions training 
Doctor 
Paramedic 
Health assistant 
Nurse 
Counsellor 
Vaccinator 
Health educator 
Health worker 
Other (specify) 
16. Expenditure for the following items: 
Item Amount 
Gas 
Electricity 
Water 
Telephone 
Postage 
Printing 
Repairs and maintenance 
Other (specify) 
Other (specify) 
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17. Vaccines: 
State the range of State the number of State the total State the number of State the number of vials State the number of 
vaccines provided doses in each vial number of doses vials of each of each vaccine supplied vials of each 
at this site (OPV, of the vaccines administered of vaccine in stock at with between July 1998 - vaccine at the end 
DPT,BCG, each vaccine at this the beginning of June 1999 of June 1999 
measles, other site the July 1998 
(specify) 
BCG 
DPT 
OPV 
Measles 
IT 
Other (specify) 
Other (specify) 
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Appendix 6: Location, type of ownership and type of vaccination delivery unit 
Serial # Location Type of ownership Type of vaccination delivery unit 
{zonel {GoB orNGO} {fIXed or outreach~ 
1 1 NGO fixed 
2 1 NGO outreach 
3 1 NGO outreach 
4 1 GoB fixed 
5 1 NGO outreach 
6 1 NGO outreach 
7 1 GoB fixed 
8 1 NGO outreach 
9 1 NGO fixed 
10 2 GoB outreach 
11 2 GoB fixed 
12 2 GoB fixed 
13 2 GoB fixed 
14 2 GoB fixed 
15 2 GoB fixed 
16 3 GoB fixed 
17 3 NGO outreach 
18 3 GoB fixed 
19 3 NGO outreach 
20 4 NGO outreach 
21 4 NGO outreach 
22 4 GoB fixed 
23 4 NGO fixed 
24 4 NGO outreach 
25 4 NGO outreach 
26 4 NGO fixed 
27 4 NGO fixed 
28 4 NGO outreach 
29 4 NGO fixed 
30 4 NGO outreach 
31 4 NGO outreach 
32 4 NGO outreach 
33 4 NGO outreach 
34 4 NGO outreach 
35 4 NGO outreach 
36 5 NGO outreach 
37 5 GoB fixed 
38 5 GoB fixed 
39 5 NGO fixed 
40 5 GoB fixed 
41 5 NGO fixed 
42 5 GoB fixed 
43 5 NGO outreach 
44 5 NGO outreach 
45 5 NGO outreach 
46 6 NGO outreach 
47 6 NGO outreach 
48 6 NGO outreach 
49 6 NGO fixed 
50 6 NGO outreach 
51 6 NGO outreach 
52 6 NGO fixed 
53 6 NGO outreach 
54 7 NGO outreach 
55 7 NGO outreach 
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56 7 NGO fixed 
57 7 NGO fixed 
58 7 NGO outreach 
59 7 NGO outreach 
60 7 NGO outreach 
61 7 GoB outreach 
62 7 NGO outreach 
63 7 NGO outreach 
64 7 NGO outreach 
65 7 NGO outreach 
66 7 NGO outreach 
67 7 NGO outreach 
68 7 NGO outreach 
69 7 NGO outreach 
70 7 NGO outreach 
71 8 NGO outreach 
72 8 NGO outreach 
73 8 NGO outreach 
74 8 NGO outreach 
75 8 NGO outreach 
76 8 NGO outreach 
77 8 NGO outreach 
78 8 NGO outreach 
79 8 GoB fixed 
80 8 NGO outreach 
81 8 NGO outreach 
82 8 NGO fixed 
83 8 NGO fixed 
84 8 GoB outreach 
85 8 NGO outreach 
86 9 NGO outreach 
87 9 NGO outreach 
88 9 NGO outreach 
89 9 NGO outreach 
90 9 NGO outreach 
91 9 NGO outreach 
92 9 NGO outreach 
93 9 NGO fixed 
94 9 NGO outreach 
95 9 NGO outreach 
96 9 NGO outreach 
97 9 NGO outreach 
98 9 NGO outreach 
99 9 NGO outreach 
100 9 NGO outreach 
101 9 GoB outreach 
102 10 NGO outreach 
103 10 NGO outreach 
104 10 NGO outreach 
105 10 GoB fIXed 
106 1 NGO outreach 
107 1 GoB fixed 
108 9 NGO outreach 
109 9 GoB outreach 
110 9 NGO outreach 
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Appendb 7: Data for model DEAl 
Serial # BeG DPT OPV Measles IT Total cost 
I 324 1104 1404 300 1884 2382 
2 72 168 192 24 36 1085 
3 216 612 708 120 372 1572 
4 900 984 1704 720 720 3981 
5 348 360 2400 300 600 954 
6 360 384 2400 324 648 918 
7 456 1380 1380 336 384 2965 
8 108 168 168 84 396 924 
9 240 1164 1164 300 1548 970 
10 972 3264 3420 792 1248 4063 
11 228 240 240 72 144 1668 
12 444 1644 1644 504 924 3389 
13 84 816 1296 480 552 3377 
14 48 804 696 132 384 2117 
15 432 1896 2460 696 876 3251 
16 480 1200 1500 480 600 1901 
17 804 3012 3444 432 432 6532 
18 1680 1800 2400 960 960 1561 
19 576 3036 3756 576 1308 4398 
20 24 48 60 12 132 474 
21 396 804 996 324 612 1207 
22 156 300 300 60 264 2588 
23 804 900 516 516 960 3796 
24 72 588 744 156 2208 1730 
25 132 468 540 96 216 702 
26 120 360 360 60 420 566 
27 252 888 924 36 156 4546 
28 I 216 252 36 192 747 
29 912 2616 2736 312 1308 2779 
30 192 252 312 144 396 531 
31 960 720 840 240 360 829 
32 I 36 72 36 12 238 
33 60 84 84 24 48 448 
34 132 360 360 108 324 1102 
35 36 36 84 48 972 519 
36 600 1800 2184 384 612 2659 
37 576 1608 1608 540 816 12022 
38 600 1404 1884 432 564 15077 
39 84 348 552 204 216 6313 
40 864 1788 2520 636 1164 7172 
41 720 1860 1860 360 1920 2271 
42 540 744 744 636 552 3166 
43 216 312 312 204 384 906 
44 72 156 156 1 192 716 
45 216 192 192 108 312 928 
46 180 516 684 168 252 2793 
47 36 84 84 1 168 1204 
48 1 60 60 60 12 833 
49 84 144 180 36 48 1026 
50 24 60 120 36 120 1651 
51 24 108 132 24 48 1030 
52 180 516 684 168 252 2793 
53 60 108 168 60 108 1094 
54 60 84 108 24 36 540 
55 84 324 420 96 84 648 
56 456 1176 1332 156 600 5357 
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57 36 180 240 24 72 4347 
58 48 48 60 12 72 434 
59 48 108 168 48 120 519 
60 192 336 336 84 36 2217 
61 108 264 360 96 240 3599 
62 336 984 1188 204 480 3086 
63 1 216 216 12 108 708 
64 144 420 588 168 240 677 
65 84 240 420 96 96 560 
66 84 180 312 48 48 577 
67 60 144 228 48 12 375 
68 36 84 84 1 24 359 
69 60 276 276 48 60 561 
70 900 432 420 360 420 672 
71 120 144 144 36 204 441 
72 60 204 264 60 120 1382 
73 324 660 756 300 600 1261 
74 24 60 96 36 36 483 
75 96 240 240 120 240 1260 
76 1 168 168 1 60 2135 
77 48 144 144 24 72 1177 
78 I 96 96 12 36 416 
79 492 1704 2100 396 768 7087 
80 60 132 132 1 12 626 
81 180 420 420 180 480 1144 
82 396 1476 1752 276 1596 7483 
83 300 1560 1560 300 1440 3662 
84 60 216 240 240 228 768 
85 12 84 84 1 96 485 
86 300 360 300 240 180 738 
87 72 96 96 12 168 724 
88 48 204 204 48 240 759 
89 24 132 132 24 216 745 
90 1 72 72 1 24 296 
91 864 900 840 240 240 1131 
92 480 240 240 240 240 912 
93 300 828 936 108 288 2100 
94 48 48 48 12 360 745 
95 840 540 360 360 240 686 
96 156 420 420 36 180 9785 
97 36 132 156 60 120 1010 
98 480 240 240 240 240 1090 
99 36 48 48 1 24 325 
100 720 300 300 180 300 707 
101 336 1512 2028 516 384 3165 
102 192 168 408 192 192 2008 
103 120 96 240 240 96 1053 
104 36 60 96 24 36 911 
105 864 1440 2400 960 1020 2422 
106 36 156 216 60 24 718 
107 228 1200 1500 300 420 2742 
108 1 24 48 1 24 582 
109 24 168 192 24 252 2532 
110 108 324 324 240 252 875 
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Appendix 8: Data for model DEAl 
Serial # BeG DPT OPV Measles IT Labour Faci1i~ Hours 
I 324 1104 1404 300 1884 20 600 154 
2 72 168 192 24 36 2 79 79 
3 216 612 708 120 372 1 1620 216 
4 900 984 1704 720 720 2 252 252 
5 348 360 2400 300 600 2 405 405 
6 360 384 2400 324 648 1 432 432 
7 456 1380 1380 336 384 2 600 450 
8 108 168 168 84 396 2 75 75 
9 240 1164 1164 300 1548 1 270 270 
10 972 3264 3420 792 1248 2 9000 1296 
11 228 240 240 72 144 2 13068 225 
12 444 1644 1644 504 924 2 3267 324 
13 84 816 1296 480 552 2 4500 720 
14 48 804 696 132 384 1 990 135 
15 432 1896 2460 696 876 2 4019 162 
16 480 1200 1500 480 600 1 300 300 
17 804 3012 3444 432 432 10 2500 144 
18 1680 1800 2400 960 960 1 600 200 
19 576 3036 3756 576 1308 10 2000 144 
20 24 48 60 12 132 6 113 113 
21 396 804 996 324 612 4 120 120 
22 156 300 300 60 264 3 6750 164 
23 804 900 516 516 960 6 816 144 
24 72 588 744 156 2208 5 959 338 
25 132 468 540 96 216 2 270 270 
26 120 360 360 60 420 1 108 108 
27 252 888 924 36 156 13 12500 100 
28 I 216 252 36 192 6 864 216 
29 912 2616 2736 312 1308 9 450 450 
30 192 252 312 144 396 1 216 216 
31 960 720 840 240 360 1 9000 135 
32 I 36 72 36 12 3 2613 70 
33 60 84 84 24 48 5 900 900 
34 132 360 360 108 324 3 1350 270 
35 36 36 84 48 972 5 7200 360 
36 600 1800 2184 384 612 7 7500 900 
37 576 1608 1608 540 816 2 3000 500 
38 600 1404 1884 432 564 2 4019 375 
39 84 348 552 204 216 4 1000 240 
40 864 1788 2520 636 1164 1 4019 525 
41 720 1860 1860 360 1920 3 4096 1500 
42 540 744 744 636 552 2 180 180 
43 216 312 312 204 384 1 750 375 
44 72 156 156 1 192 1 200 200 
45 216 192 192 108 312 1 240 240 
46 180 516 684 168 252 1 560 192 
47 36 84 84 1 168 1 300 300 
48 I 60 60 60 12 1 288 288 
49 84 144 180 36 48 1 144 144 
50 24 60 120 36 120 1 100 100 
51 24 108 132 24 48 1 225 225 
52 180 516 684 168 252 6 10800 180 
53 60 108 168 60 108 1 225 225 
54 60 84 108 24 36 2 94 94 
5S 84 324 420 96 84 1 180 180 
S6 4S6 1176 1332 156 600 8 600 600 
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57 36 180 240 24 72 10 1000 405 
58 48 48 60 12 72 2 324 324 
59 48 108 168 48 120 2 252 252 
60 192 336 336 84 36 3 405 405 
61 108 264 360 96 240 2 980 504 
62 336 984 1188 204 480 8 2700 2700 
63 1 216 216 12 108 1 535 248 
64 144 420 588 168 240 2 843 843 
65 84 240 420 96 96 2 300 300 
66 84 180 312 48 48 2 843 506 
67 60 144 228 48 12 2 162 81 
68 36 84 84 1 24 1 4247 33 
69 60 276 276 48 60 2 400 400 
70 900 432 420 360 420 2 320 320 
71 120 144 144 36 204 1 288 288 
72 60 204 264 60 120 1 3267 2400 
73 324 660 756 300 600 4 315 315 
74 24 60 96 36 36 3 160 160 
75 96 240 240 120 240 1 1100 270 
76 1 168 168 1 60 2 490 270 
77 48 144 144 24 72 1 375 375 
78 1 96 96 12 36 2 450 200 
79 492 1704 2100 396 768 9 3600 1800 
80 60 132 132 1 12 1 320 320 
81 180 420 420 180 480 4 225 225 
82 396 1476 1752 276 1596 7 3375 864 
83 300 1560 1560 300 1440 14 1633 270 
84 60 216 240 240 228 3 216 216 
85 12 84 84 1 96 1 300 300 
86 300 360 300 240 180 1 150 150 
87 72 96 96 12 168 1 270 270 
88 48 204 204 48 240 1 35 35 
89 24 132 132 24 216 1 1012 675 
90 1 72 72 1 24 1 2700 506 
91 864 900 840 240 240 1 216 72 
92 480 240 240 240 240 1 7840 225 
93 300 828 936 108 288 3 980 64 
94 48 48 48 12 360 1 653 326 
95 840 540 360 360 240 1 150 60 
96 156 420 420 36 180 6 150 30 
97 36 132 156 60 120 1 5227 60 
98 480 240 240 240 240 1 2613 272 
99 36 48 48 1 24 1 9801 100 
100 720 300 300 180 300 1 180 180 
101 336 1512 2028 516 384 2 1012 675 
102 192 168 408 192 192 3 750 225 
103 120 96 240 240 96 4 700 700 
104 36 60 96 24 36 3 200 200 
105 864 1440 2400 960 1020 2 1000 180 
106 36 156 216 60 24 2 252 252 
107 228 1200 1500 300 420 3 675 675 
108 1 24 48 1 24 1 1600 337 
109 24 168 192 24 252 2 1125 337 
110 108 324 324 240 252 2 2500 150 
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Appendix 9: Data for model DEAJ 
Serial # Total vaccines Labour Facili~ Hours 
I 5016 20 600 154 
2 492 2 79 79 
3 2028 1 1620 216 
4 5028 2 252 252 
5 4008 2 405 405 
6 4116 1 432 432 
7 3936 2 600 450 
8 924 2 75 75 
9 4416 1 270 270 
10 9696 2 9000 1296 
11 924 2 13068 225 
12 5160 2 3267 324 
13 3228 2 4500 720 
14 2064 1 990 135 
15 6360 2 4019 162 
16 4260 1 300 300 
17 8124 10 2500 144 
18 7800 1 600 200 
19 9252 10 2000 144 
20 276 6 113 113 
21 3132 4 120 120 
22 1080 3 6750 164 
23 3696 6 816 144 
24 3768 5 959 338 
25 1452 2 270 270 
26 1320 1 108 108 
27 2256 13 12500 100 
28 697 6 864 216 
29 7884 9 450 450 
30 1296 1 216 216 
31 3120 1 9000 135 
32 157 3 2613 70 
33 300 5 900 900 
34 1284 3 1350 270 
35 1176 5 7200 360 
36 5580 7 7500 900 
37 5148 2 3000 500 
38 4884 2 4019 375 
39 1404 4 1000 240 
40 6972 1 4019 525 
41 6720 3 4096 1500 
42 3216 2 180 180 
43 1428 1 750 375 
44 577 1 200 200 
45 1020 1 240 240 
46 1800 1 560 192 
47 373 1 300 300 
48 193 1 288 288 
49 492 1 144 144 
50 360 1 100 100 
51 336 1 225 225 
52 1800 6 10800 180 
53 504 1 225 225 
54 312 2 94 94 
55 1008 1 180 180 
56 3720 8 600 600 
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57 552 10 1000 405 
58 240 2 324 324 
59 492 2 252 252 
60 984 3 405 405 
61 1068 2 980 504 
62 3192 8 2700 2700 
63 553 1 535 248 
64 1560 2 843 843 
65 936 2 300 300 
66 672 2 843 506 
67 492 2 162 81 
68 229 1 4247 33 
69 720 2 400 400 
70 2532 2 320 320 
71 648 1 288 288 
72 708 1 3267 2400 
73 2640 4 315 315 
74 252 3 160 160 
75 936 1 1100 270 
76 398 2 490 270 
77 432 1 375 375 
78 241 2 450 200 
79 5460 9 3600 1800 
80 337 1 320 320 
81 1680 4 225 225 
82 5496 7 3375 864 
83 5160 14 1633 270 
84 984 3 216 216 
85 277 1 300 300 
86 1380 1 150 150 
87 444 1 270 270 
88 744 1 35 35 
89 528 1 1012 675 
90 170 1 2700 506 
91 3084 1 216 72 
92 1440 1 7840 225 
93 2460 3 980 64 
94 516 1 653 326 
95 2340 1 150 60 
96 1212 6 150 30 
97 504 1 5227 60 
98 1440 1 2613 272 
99 157 1 9801 100 
100 1800 1 180 180 
101 4776 2 1012 675 
102 1152 3 750 225 
103 792 4 700 700 
104 252 3 200 200 
105 6684 2 1000 180 
106 492 2 252 252 
107 3648 3 675 675 
108 98 1 1600 337 
109 660 2 1125 337 
110 1248 2 2500 150 
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Appendix 10: Data for model SFAI-6 
Serial Total Total vaccine Total vaccine Labour Size of Total 
# vaccine weighted by weighted by DALY EPI (sq ft) hours 
Erice ~OOO,OOOs~ 
1 5016 348 9938 20 600 154 
2 492 40 1115 2 79 79 
3 2028 158 4499 1 1620 216 
4 5028 422 10237 2 252 252 
5 4008 342 4351 2 405 405 
6 4116 349 4666 1 432 432 
7 3936 327 9949 2 600 450 
8 924 62 1850 2 75 75 
9 4416 313 9862 1 270 270 
10 9696 794 23889 2 9000 1296 
11 924 70 1921 2 13068 225 
12 5160 416 12909 2 3267 324 
13 3228 282 7687 2 4500 720 
14 2064 164 5603 1 990 135 
15 6360 539 15255 2 4019 162 
16 4260 355 9956 1 300 300 
17 8124 685 19644 10 2500 144 
18 7800 641 16456 1 600 200 
19 9252 756 21493 10 2000 144 
20 276 17 487 6 113 113 
21 3132 249 6941 4 120 120 
22 1080 79 2316 3 6750 164 
23 3696 275 8953 6 816 144 
24 3768 221 6644 5 959 338 
25 1452 117 3376 2 270 270 
26 1320 93 2821 1 108 108 
27 2256 182 5352 13 12500 100 
28 697 53 1609 6 864 216 
29 7884 607 17853 9 450 450 
30 1296 95 2646 1 216 216 
31 3120 239 5865 1 9000 135 
32 157 15 402 3 2613 70 
33 300 23 659 5 900 900 
34 1284 97 2962 3 1350 270 
35 1176 54 1581 5 7200 360 
36 5580 460 12829 7 7500 900 
37 5148 419 12800 2 3000 500 
38 4884 406 10825 2 4019 375 
39 1404 122 3262 4 1000 240 
40 6972 563 14770 1 4019 525 
41 6720 483 14569 3 4096 1500 
42 3216 273 8188 2 180 180 
43 1428 110 3282 1 750 375 
44 577 38 1108 1 200 200 
45 1020 73 2033 1 240 240 
46 1800 149 4070 1 560 192 
47 373 23 673 1 300 300 
48 193 20 659 1 288 288 
49 492 40 1060 1 144 144 
50 360 27 665 1 100 100 
51 336 28 785 1 225 225 
52 1800 149 4070 6 10800 180 
53 504 40 1050 1 225 225 
54 312 25 646 2 94 94 
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55 1008 87 2414 1 180 180 
56 3720 288 8132 8 600 600 
57 552 45 1216 10 1000 405 
58 240 16 422 2 324 324 
59 492 38 999 2 252 252 
60 984 83 2384 3 405 405 
61 1068 83 2266 2 980 504 
62 3192 255 7152 8 2700 2700 
63 553 43 1387 1 535 248 
64 1560 130 3515 2 843 843 
65 936 81 1962 2 300 300 
66 672 57 1324 2 843 506 
67 492 44 1077 2 162 81 
68 229 18 507 1 4247 33 
69 720 60 1864 2 400 400 
70 2532 194 4945 2 320 320 
71 648 44 1248 1 288 288 
72 708 57 1597 1 3267 2400 
73 2640 207 5987 4 315 315 
74 252 22 567 3 160 160 
75 936 73 2254 1 1100 270 
76 398 31 1008 2 490 270 
77 432 34 1018 1 375 375 
78 241 20 637 2 450 200 
79 5460 445 12516 9 3600 1800 
80 337 27 765 1 320 320 
81 1680 126 3860 4 225 225 
82 5496 400 11561 7 3375 864 
83 5160 381 11948 14 1633 270 
84 984 87 2723 3 216 216 
85 277 19 585 1 300 300 
86 1380 116 3517 1 150 150 
87 444 28 805 1 270 270 
88 744 53 1670 1 35 35 
89 528 35 1112 1 1012 675 
90 170 13 433 1 2700 506 
91 3084 243 6704 1 216 72 
92 1440 113 2959 1 7840 225 
93 2460 196 5556 3 980 64 
94 516 25 755 1 653 326 
95 2340 187 5322 1 150 60 
96 1212 93 2760 6 150 30 
97 504 40 1191 1 5227 60 
98 1440 113 2959 1 2613 272 
99 157 11 307 1 9801 100 
100 1800 131 3100 1 180 180 
101 4776 419 11598 2 1012 675 
102 1152 98 2196 3 750 225 
103 792 76 1918 4 700 700 
104 252 21 508 3 200 200 
105 6684 568 14358 2 1000 180 
106 492 44 1214 2 252 252 
107 3648 308 8760 3 675 675 
108 98 7 167 1 1600 337 
109 660 45 1354 2 1125 337 
110 1248 107 3360 2 2500 150 
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Appendix 11: Results of model DEAl 
Serial # Overall efficienc~ Technical efficienc~ Scale efficienc~ T~e of returns to scale 
I 0.502 0.75 0.669 drs 
2 0.131 0.304 0.432 irs 
3 0.331 0.402 0.822 irs 
4 0.294 0.304 0.966 irs 
5 0.962 0.962 1 
6 1 1 1 
7 0.391 0.395 0.989 drs 
8 0.29 0.435 0.667 irs 
9 1 1 1 
10 0.673 1 0.673 drs 
11 0.129 0.239 0.541 irs 
12 0.407 0.418 0.974 drs 
13 0.243 0.268 0.906 irs 
14 0.316 0.348 0.91 irs 
15 0.504 0.529 0.952 drs 
16 0.542 0.565 0.96 irs 
17 0.391 0.601 0.651 drs 
18 1 1 1 
19 0.592 1 0.592 drs 
20 0.174 0.592 0.293 irs 
21 0.571 0.65 0.879 irs 
22 0.098 0.163 0.601 irs 
23 0.266 0.272 0.978 irs 
24 0.726 1 0.726 drs 
25 0.566 0.756 0.749 irs 
26 0.534 0.806 0.662 irs 
27 0.164 0.176 0.929 irs 
28 0.246 0.477 0.516 irs 
29 0.791 1 0.791 drs 
30 0.624 0.863 0.723 irs 
31 0.961 1 0.961 irs 
32 0.246 1 0.246 irs 
33 0.161 0.619 0.26 irs 
34 0.275 0.414 0.663 irs 
35 1 1 1 
36 0.579 0.587 0.986 drs 
37 0.113 0.115 0.98 drs 
38 0.081 0.083 0.973 irs 
39 0.054 0.078 0.696 irs 
40 0.224 0.29 0.772 drs 
41 0.689 1 0.689 drs 
42 0.327 0.341 0.957 irs 
43 0.443 0.565 0.784 irs 
44 0.199 0.464 0.428 irs 
45 0.296 0.444 0.667 irs 
46 0.16 0.209 0.765 irs 
47 0.09 0.25 0.358 irs 
48 0.117 0.324 0.361 irs 
49 0.121 0.308 0.391 irs 
50 0.055 0.172 0.322 irs 
51 0.09 0.277 0.323 irs 
52 0.16 0.209 0.765 irs 
53 0.106 0.275 0.388 irs 
54 0.134 0.512 0.262 irs 
55 0.432 0.681 0.634 irs 
56 0.186 0.19 0.977 irs 
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57 0.036 0.078 0.462 irs 
58 0.146 0.626 0.233 irs 
59 0.212 0.579 0.367 irs 
60 0.129 0.203 0.635 irs 
61 0.066 0.112 0.594 irs 
62 0.272 0.292 0.932 irs 
63 0.254 0.501 0.507 irs 
64 0.552 0.772 0.715 irs 
65 0.427 0.724 0.59 irs 
66 0.309 0.616 0.502 irs 
67 0.363 0.855 0.424 irs 
68 0.197 0.759 0.26 irs 
69 0.41 0.704 0.583 irs 
70 1 1 1 
71 0.386 0.785 0.491 irs 
72 0.127 0.256 0.497 irs 
73 0.479 0.553 0.865 irs 
74 0.124 0.532 0.234 irs 
75 0.192 0.312 0.615 irs 
76 0.066 0.152 0.433 irs 
77 0.103 0.265 0.388 irs 
78 0.192 0.666 0.289 irs 
79 0.206 0.208 0.992 drs 
80 0.178 0.488 0.365 irs 
81 0.357 0.458 0.779 irs 
82 0.171 0.224 0.764 drs 
83 0.355 0.395 0.899 drs 
84 0.508 0.666 0.763 irs 
85 0.144 0.566 0.255 irs 
86 0.529 0.706 0.749 irs 
87 0.174 0.433 0.402 irs 
88 0.224 0.461 0.487 irs 
89 0.176 0.432 0.408 irs 
90 0.203 0.883 0.23 irs 
91 0.703 0.79 0.889 irs 
92 0.449 0.561 0.801 irs 
93 0.334 0.37 0.901 irs 
94 0.283 0.473 0.598 irs 
95 0.976 1 0.976 irs 
96 0.036 0.051 0.71 irs 
97 0.12 0.299 0.399 irs 
98 0.376 0.469 0.801 irs 
99 0.127 0.784 0.162 irs 
100 0.76 0.828 0.919 irs 
101 0.415 0.423 0.982 irs 
102 0.155 0.229 0.678 irs 
103 0.371 0.486 0.763 irs 
104 0.063 0.285 0.219 irs 
105 0.654 1 0.654 drs 
106 0.192 0.449 0.427 irs 
107 0.376 0.39 0.964 irs 
108 0.045 0.415 0.109 irs 
109 0.063 0.135 0.465 irs 
110 0.451 0.59 0.765 irs 
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Appendix 12: Results of model DEAl 
Serial # Overall efficienc:r Technical efficienc:r Scale efficienc:r T~e of returns to scale 
I I 1 1 
2 0.346 0.5 0.693 irs 
3 0.357 1 0.357 irs 
4 1 1 1 
5 0.969 1 0.969 drs 
6 I 1 1 
7 0.579 0.61 0.948 drs 
8 0.826 0.871 0.948 drs 
9 I 1 1 
10 0.907 1 0.907 drs 
11 0.126 0.5 0.252 irs 
12 0.568 0.572 0.994 irs 
13 0.272 0.5 0.544 irs 
14 0.601 1 0.601 irs 
15 1 1 1 
16 1 1 1 
17 1 1 1 
18 1 1 1 
19 1 1 1 
20 0.17 0.31 0.55 irs 
21 1 1 1 
22 0.258 0.333 0.775 irs 
23 0.935 0.937 0.998 irs 
24 1 1 1 
25 0.387 0.5 0.774 irs 
26 0.715 1 0.715 irs 
27 0.434 0.508 0.854 irs 
28 0.127 0.173 0.736 irs 
29 1 1 1 
30 0.417 1 0.417 irs 
31 0.744 1 0.744 irs 
32 0.093 0.487 0.191 irs 
33 0.022 0.2 0.109 irs 
34 0.201 0.333 0.603 irs 
35 0.417 0.423 0.986 irs 
36 0.198 0.203 0.98 drs 
37 0.447 0.5 0.893 irs 
38 0.414 0.5 0.827 irs 
39 0.175 0.25 0.701 irs 
40 1 1 1 
41 0.456 1 0.456 drs 
42 I I 1 
43 0.312 I 0.312 irs 
44 0.195 1 0.195 irs 
45 0.346 1 0.346 irs 
46 0.303 1 0.303 irs 
47 0.1l1 1 0.111 ITS 
48 0.106 I 0.106 irs 
49 0.234 1 0.234 irs 
50 0.225 1 0.225 irs 
51 0.1l6 1 0.116 irs 
52 0.206 0.307 0.67 irs 
53 0.146 I 0.146 irs 
54 0.169 0.5 0.337 irs 
55 0.434 I 0.434 irs 
56 0.388 0.389 0.997 irs 
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57 0.054 0.1 0.538 irs 
58 0.053 0.5 0.107 irs 
59 0.114 0.5 0.227 irs 
60 0.183 0.333 0.55 irs 
61 0.098 0.5 0.195 irs 
62 0.096 0.125 0.768 irs 
63 0.129 1 0.129 irs 
64 0.155 0.5 0.31 irs 
65 0.22 0.5 0.44 irs 
66 0.08 0.5 0.16 irs 
67 0.277 0.5 0.555 irs 
68 0.169 1 0.169 irs 
69 0.156 0.5 0.311 irs 
70 0.58 0.637 0.91 drs 
71 0.188 1 0.188 irs 
72 0.114 1 0.114 irs 
73 0.438 0.445 0.984 irs 
74 0.081 0.333 0.243 irs 
75 0.191 1 0.191 irs 
76 0.084 0.5 0.167 irs 
77 0.105 1 0.105 irs 
78 0.052 0.5 0.104 irs 
79 0.138 0.146 0.945 drs 
80 0.106 1 0.106 irs 
81 0.4 0.401 0.998 irs 
82 0.313 0.46 0.679 drs 
83 0.644 0.644 1 
84 0.322 0.412 0.783 irs 
85 0.069 1 0.069 irs 
86 0.626 1 0.626 irs 
87 0.142 1 0.142 irs 
88 1 1 1 
89 0.14 1 0.14 irs 
90 0.04 1 0.04 irs 
91 1 1 1 
92 0.286 1 0.286 irs 
93 0.735 0.94 0.782 irs 
94 0.233 1 0.233 irs 
95 1 1 1 
96 1 1 1 
97 0.32 1 0.32 irs 
98 0.286 1 0.286 irs 
99 0.047 1 0.047 irs 
100 0.849 1 0.849 irs 
101 0.476 0.5 0.952 irs 
102 0.169 0.333 0.508 irs 
103 0.141 0.25 0.565 irs 
104 0.067 0.333 0.2 irs 
105 1 1 1 
106 0.145 0.5 0.291 irs 
107 0.434 0.434 1 
108 0.021 1 0.021 irs 
109 0.127 0.5 0.255 irs 
110 0.299 0.5 0.598 irs 
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Appendix 13: Results of model DEA3 
Serial # Overall efficienc~ Technical efficienc~ Scale efficienc~ Tl)2e of returns to scale 
I 0.73 0.766 0.953 drs 
2 0.258 0.5 0.516 irs 
3 0.26 1 0.26 irs 
4 1 1 1 
5 0.569 0.58 0.981 irs 
6 0.677 1 0.677 irs 
7 0.425 0.5 0.85 irs 
8 0.503 0.569 0.884 irs 
9 1 1 1 
10 0.622 1 0.622 drs 
11 0.101 0.5 0.202 irs 
12 00403 0.5 0.806 irs 
13 0.207 0.5 00414 irs 
14 0.382 1 0.382 irs 
15 0.931 0.936 0.994 drs 
16 0.902 1 0.902 irs 
17 0.878 0.897 0.979 irs 
18 1 1 1 
19 1 1 1 
20 0.094 0.31 0.302 irs 
21 1 1 1 
22 0.148 0.333 00444 irs 
23 0.534 0.536 0.995 irs 
24 0.268 0.277 0.969 drs 
25 0.276 0.5 0.551 irs 
26 0.603 1 0.603 irs 
27 0.351 00461 0.762 irs 
28 0.072 0.167 00432 irs 
29 0.766 1 0.766 drs 
30 0.35 1 0.35 irs 
31 0.577 1 0.577 irs 
32 0.042 00485 0.086 irs 
33 0.019 0.2 0.093 irs 
34 0.114 0.333 0.343 irs 
35 0.076 0.2 0.381 irs 
36 0.154 0.154 0.999 
37 0.33 0.5 0.66 irs 
38 0.333 0.5 0.665 irs 
39 0.133 0.25 0.533 irs 
40 0.894 1 0.894 irs 
41 0.287 0.333 0.862 irs 
42 0.862 0.876 0.985 irs 
43 0.183 1 0.183 irs 
44 0.165 1 0.165 irs 
45 0.254 1 0.254 irs 
46 0.245 1 0.245 irs 
47 0.079 1 0.079 irs 
48 0.042 1 0.042 irs 
49 0.179 1 0.179 irs 
50 0.176 1 0.176 irs 
51 0.088 1 0.088 irs 
52 0.199 0.276 0.719 irs 
53 0.132 1 0.132 irs 
54 0.143 0.5 0.286 irs 
55 0.312 1 0.312 irs 
S6 0.292 0.294 0.994 irs 
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57 0.035 0.1 0.352 irs 
58 0.04 0.5 0.08 irs 
59 0.098 0.5 0.196 irs 
60 0.125 0.333 0.374 irs 
61 0.08 0.5 0.16 irs 
62 0.078 0.125 0.625 irs 
63 0.078 1 0.078 irs 
64 0.131 0.5 0.261 irs 
65 0.165 0.5 0.331 irs 
66 0.056 0.5 0.113 irs 
67 0.175 0.5 0.35 irs 
68 0.141 1 0.141 irs 
69 0.103 0.5 0.206 irs 
70 0.427 0.5 0.855 irs 
71 0.141 1 0.141 irs 
72 0.091 1 0.091 irs 
73 0.397 0.407 0.975 irs 
74 0.07 0.333 0.209 irs 
75 0.12 1 0.12 irs 
76 0.053 0.5 0.105 irs 
77 0.079 1 0.079 irs 
78 0.036 0.5 0.072 irs 
79 0.107 0.111 0.967 irs 
80 0.068 1 0.068 irs 
81 0.334 0.353 0.946 irs 
82 0.158 0.158 0.999 
83 0.391 0.401 0.976 drs 
84 0.213 0.333 0.639 irs 
85 0.059 1 0.059 irs 
86 0.487 1 0.487 irs 
87 0.101 1 0.101 irs 
88 0.852 1 0.852 irs 
89 0.068 1 0.068 irs 
90 0.022 1 0.022 irs 
91 1 1 1 
92 0.185 1 0.185 irs 
93 0.692 0.896 0.772 irs 
94 0.066 1 0.066 irs 
95 1 1 1 
96 0.864 1 0.864 irs 
97 0.191 1 0.191 irs 
98 0.185 1 0.185 irs 
99 0.038 1 0.038 irs 
100 0.558 1 0.558 irs 
101 0.349 0.5 0.699 irs 
102 0.12 0.333 0.361 irs 
103 0.063 0.25 0.251 irs 
104 0.058 0.333 0.174 irs 
105 0.892 0.896 0.995 drs 
106 0.098 0.5 0.196 irs 
107 0.318 0.333 0.955 irs 
108 0.013 1 0.013 irs 
109 0.05 0.5 0.099 irs 
110 0.195 0.5 0.391 irs 
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Appendix 14: Results for models SFAI-6 
Serial # SFAI SFA2 SFA3 SFA4 SFA5 SFA6 
1 0.603 0.276 0.602 0.273 0.572 0.240 
2 0.426 0.117 0.488 0.093 0.421 0.137 
3 0.611 0.225 0.626 0.207 0.606 0.230 
4 0.721 0.934 0.720 0.935 0.713 0.999 
5 0.678 0.730 0.686 0.730 0.574 0.395 
6 0.709 0.859 0.712 0.867 0.627 0.453 
7 0.666 0.605 0.675 0.574 0.683 0.723 
8 0.547 0.224 0.555 0.144 0.522 0.228 
9 0.732 0.842 0.716 0.753 0.736 0.999 
10 0.700 0.670 0.701 0.393 0.711 0.647 
11 0.360 0.118 0.424 0.087 0.326 0.146 
12 0.676 0.434 0.680 0.360 0.688 0.508 
13 0.581 0.243 0.615 0.191 0.587 0.250 
14 0.637 0.258 0.650 0.252 0.661 0.323 
15 0.711 0.806 0.714 0.716 0.715 0.901 
16 0.725 0.825 0.723 0.856 0.733 0.999 
17 0.679 0.579 0.686 0.546 0.682 0.582 
18 0.774 0.989 0.763 0.999 0.772 0.999 
19 0.698 0.659 0.698 0.608 0.697 0.625 
20 0.224 0.058 0.268 0.038 0.179 0.048 
21 0.666 0.671 0.670 0.557 0.664 0.731 
22 0.391 0.136 0.443 0.100 0.362 0.146 
23 0.623 0.363 0.629 0.294 0.628 0.351 
24 0.608 0.288 0.586 0.205 0.563 0.255 
25 0.549 0.268 0.581 0.256 0.553 0.325 
26 0.627 0.242 0.627 0.208 0.620 0.313 
27 0.423 0.368 0.483 0.298 0.408 0.413 
28 0.305 0.055 0.372 0.049 0.293 0.059 
29 0.685 0.686 0.680 0.816 0.685 0.999 
30 0.588 0.241 0.601 0.226 0.573 0.273 
31 0.649 0.692 0.656 0.620 0.617 0.761 
32 0.143 0.043 0.244 0.039 0.141 0.037 
33 0.155 0.033 0.223 0.032 0.142 0.039 
34 0.453 0.113 0.496 0.093 0.446 0.118 
35 0.338 0.055 0.324 0.026 0.231 0.043 
36 0.571 0.131 0.598 0.119 0.566 0.196 
37 0.667 0.417 0.674 0.338 0.679 0.465 
38 0.662 0.387 0.673 0.324 0.657 0.404 
39 0.461 0.123 0.524 0.120 0.457 0.131 
40 0.725 0.701 0.720 0.542 0.720 0.612 
41 0.648 0.532 0.643 0.323 0.642 0.464 
42 0.685 0.623 0.692 0.613 0.701 0.851 
43 0.556 0.207 0.581 0.185 0.559 0.213 
44 0.447 0.107 0.472 0.089 0.412 0.115 
45 0.542 0.192 0.559 0.172 0.520 0.208 
46 0.620 0.231 0.640 0.235 0.620 0.251 
47 0.336 0.072 0.367 0.055 0.289 0.067 
48 0.227 0.037 0.348 0.047 0.287 0.066 
49 0.438 0.089 0.499 0.092 0.426 0.115 
50 0.402 0.066 0.456 0.060 0.357 0.075 
51 0.335 0.063 0.414 0.065 0.337 0.081 
52 0.420 0.165 0.485 0.137 0.399 0.211 
53 0.413 0.094 0.476 0.096 0.394 0.108 
54 0.327 0.070 0.404 0.058 0.301 0.076 
55 0.557 0.185 0.598 0.204 0.568 0.254 
56 0.571 0.315 0.589 0.367 0.561 0.438 
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57 0.2l3 0.026 0.293 0.031 0.195 0.034 
58 0.214 0.044 0.273 0.036 0.173 0.040 
59 0.349 0.091 0.417 0.085 0.321 0.098 
60 0.421 0.158 0.487 0.161 0.429 0.200 
61 0.434 0.134 0.486 0.113 0.415 0.127 
62 0.449 0.206 0.497 0.199 0.442 0.260 
63 0.402 0.076 0.463 0.073 0.416 0.091 
64 0.491 0.303 0.541 0.266 0.488 0.285 
65 0.462 0.172 0.524 0.176 0.442 0.186 
66 0.348 0.091 0.431 0.086 0.314 0.081 
67 0.404 0.094 0.485 0.084 0.388 0.090 
68 0.256 0.251 0.336 0.224 0.233 0.228 
69 0.391 0.131 0.464 0.129 0.413 0.169 
70 0.628 0.463 0.637 0.423 0.608 0.467 
71 0.446 0.125 0.477 0.107 0.411 0.125 
72 0.314 0.239 0.393 0.115 0.310 0.111 
73 0.595 0.399 0.611 0.388 0.595 0.493 
74 0.233 0.049 0.326 0.048 0.222 0.058 
75 0.480 0.109 0.525 0.100 0.487 0.119 
76 0.289 0.055 0.366 0.050 0.301 0.067 
77 0.349 0.087 0.419 0.083 0.354 0.100 
78 0.221 0.033 0.306 0.030 0.234 0.041 
79 0.546 0.173 0.577 0.182 0.543 0.255 
80 0.313 0.066 0.391 0.065 0.308 0.076 
81 0.539 0.280 0.563 0.253 0.538 0.345 
82 0.589 0.186 0.596 0.164 0.573 0.235 
83 0.589 0.178 0.598 0.190 0.585 0.228 
84 0.463 0.177 0.527 0.183 0.497 0.260 
85 0.283 0.054 0.338 0.045 0.264 0.058 
86 0.617 0.251 0.639 0.266 0.638 0.379 
87 0.376 0.085 0.409 0.068 0.329 0.081 
88 0.599 0.165 0.608 0.109 0.599 0.219 
89 0.338 0.098 0.383 0.068 0.318 0.078 
90 0.155 0.018 0.230 0.015 0.159 0.019 
91 0.725 0.475 0.720 0.438 0.724 0.499 
92 0.512 0.190 0.552 0.163 0.483 0.212 
93 0.622 0.558 0.637 0.405 0.615 0.387 
94 0.373 0.074 0.366 0.044 0.285 0.050 
95 0.706 0.387 0.705 0.348 0.709 0.432 
96 0.532 0.546 0.562 0.244 0.522 0.224 
97 0.371 0.236 0.444 0.229 0.361 0.273 
98 0.535 0.151 0.569 0.134 0.512 0.143 
99 0.159 0.053 0.227 0.046 0.131 0.062 
100 0.646 0.330 0.646 0.304 0.609 0.326 
101 0.671 0.691 0.684 0.644 0.682 0.723 
102 0.455 0.122 0.518 0.117 0.411 0.105 
103 0.322 0.104 0.425 0.123 0.326 0.132 
104 0.222 0.046 0.307 0.044 0.196 0.049 
105 0.734 0.756 0.732 0.709 0.730 0.710 
106 0.349 0.091 0.440 0.098 0.358 0.119 
107 0.621 0.567 0.641 0.557 0.632 0.666 
108 0.118 0.011 0.182 0.009 0.090 0.008 
109 0.351 0.069 0.398 0.052 0.322 0.064 
110 0.482 0.155 0.540 0.141 0.504 0.184 
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Appendix 15: Facility survey form for health centres 
Name of health centre: 
Ward: 
Upazila: 
District: 
Personnel 
Indicate the number and type of staff working at this health centre 
Name Designation July 200 I salary June 2002 salary Period of 
employment 
during July 2001 
- June 2002 
Basic Allowances Basic Allowances 
Vehicles 
Indicate the number of and type of functioning vehicles at this health centre 
Type of mean Quantity Was it functioning in 200 I 
of transport (specify in which months it was functioning if 
it was functioning only in parts of the year) 
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Buildings 
Building No. Room No. Who works in this room Square feet 
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Furniture 
Indicate the number of functioning items available in each of the rooms of the facility (including waiting 
areas) 
Capital furniture R R R R R R R R R R R R R R 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Chair 
Clock 
Cupboard 
Delivery bed 
Drip stand 
Examination bed 
Hand washing basin 
Labour table 
Benches 
Mattress 
Metal file cabinet 
Screen 
Secretarial table 
Table (wood) 
Other (specify) 
R 
15 
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Capital equipment 
Indicate the number of functioning items available in each of the rooms of the facility (including waiting 
areas) 
Capital equipment R R R R R R R R R R R R R R 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Airway tube 
Autoclave machine 
Breast pump 
Catheter (rubber) 
Centrifuge 
Cold Box 
Drip stand 
Forceps 
Height measuring scale 
Incinerator 
Instrument tray 
Kidney tray 
Microscope 
Needle holder 
Other (specify) 
Refrigerator 
Rubbish bin 
Scissors 
Sterilizer/stove 4 burner 
Stethoscope 
Suction machine 
Surgical blade 
Test tube 
Vaccine carrier 
Weighing scale 
Wheelchair 
Other (specify) 
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Drugs 
Drug name State the total State the total State the amount State the State the amount of 
used at this used at of each drug that amount of each drug that you 
site between satellite sites you had in stock each drug that had at the end of 
July 2000 - between July at the beginning you were June 2001 
June 2001 2000- June of the July 2000 supplied with 
2001 (if during 
applicable) 2000/2001 
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Medical supplies 
Name of medical State the total State the total State the State the State the 
supply used at this site used at satellite amount of amount of amount of 
sites each medical each medical each medical 
supply that supply that supply that 
you had in you were you had at the 
stock at the supplied with end of the 
beginning of during 2001 2001 
the January 
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Table 14: Expenditure on utilities, operating and maintenance between July 2000 - June 2001 
# Item Total 
1. Means of transport 
Petrol 
Lubricant 
Maintenance 
Repairs 
Insurance 
Tire spare parts 
Others ... list: 
Total 
2. Building 
Electricity 
Water 
Facility rent (if relevant) 
Maintenance 
Telephone 
Charcoal 
Kerosene 
Cleaning 
Others ... list: 
Total 
3. Equipment 
Spare parts 
Repairs 
Others .. .list: 
Total 
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Record review 
What was the total number of visits to the health centre for the following services in 2001? 
Type of visit Patients Period covered 
if missing data 
Female Male Total 
Age <1 1-4 +4 < 1 1-4 +4 <1 1-4 +4 
Dysentery 
Diarrhoea 
Diarrhoea / no 
dehydration 
Diarrhoea / some 
dehydration 
Diarrhoea / severe 
dehydration 
Diphtheria 
Jaundice / Hepatitis 
Measles 
Meningitis 
Neonatal tetanus 
Pertussis (whooping 
cough) 
ARI 
Pneumonia 
Severe pneumonia 
Very severe pneumonia 
Total of all cases seen 
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Appendix 16: Data for model DEAl 
Serial # Total cost visits <1 visits 1-4 visits +4 
1 7,651 167 744 6261 
2 8,136 110 674 4023 
3 6,317 292 909 5073 
4 9,032 182 665 4259 
5 5,983 156 580 2742 
6 12,959 83 810 8368 
7 12,048 1682 2158 10073 
8 8,758 242 608 5596 
9 14,642 306 1495 9904 
10 6,877 344 778 2770 
11 8,230 431 879 5318 
12 4,707 429 1380 6914 
13 9,023 988 2145 10925 
14 11,192 883 1055 6982 
IS 10,381 686 2474 13536 
16 13,438 535 1993 14032 
17 4,686 247 1171 6365 
18 7,322 627 1938 9385 
19 12,347 1268 2790 20048 
20 12,030 3121 4464 6919 
21 11,017 878 1923 6286 
22 10,021 2637 3183 9996 
23 11,464 1411 3641 32010 
24 6,357 343 2000 12586 
25 7,075 159 1217 5399 
26 8,050 947 1815 6154 
27 5,941 327 1012 5095 
28 6,049 719 999 7586 
29 11,961 693 1537 4855 
30 7,702 716 2865 11489 
31 6,867 699 1416 9700 
32 7,067 273 1223 4772 
33 7,157 491 3574 18425 
34 7,117 450 1644 9426 
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Appendix 17: Data for model DEA2 
Serial # staff costs ($) drug costs ($) total visits 
2905 3556 7172 
2 2711 3660 4807 
3 3340 1315 6274 
4 3854 3900 5106 
5 2558 2314 3478 
6 5871 6058 9261 
7 4771 6380 13913 
8 3588 4010 6446 
9 5508 7775 11705 
10 3389 3311 3892 
11 3359 3768 6628 
12 1376 2060 8723 
13 2991 4278 14058 
14 5039 269 8920 
15 5077 2329 16696 
16 6357 910 16560 
17 2207 2113 7783 
18 4342 1667 11950 
19 6273 1139 24106 
20 5454 2214 14504 
21 4444 3681 9087 
22 5445 2268 15816 
23 5974 2020 37062 
24 5799 1806 14929 
25 3869 2191 6775 
26 4503 3363 8916 
27 2777 1975 6434 
28 2261 2439 9304 
29 6441 2780 7085 
30 3694 2859 15070 
31 3768 3181 11815 
32 3701 1755 6268 
33 3429 2524 22490 
34 3608 2347 11520 
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Appendix 18: Data for model DEA3 
Serial # staff costs ($) drug costs ($) visits <1 visits 1-4 visits +4 
2905 3556 167 744 6261 
2 2711 3660 110 674 4023 
3 3340 1315 292 909 5073 
4 3854 3900 182 665 4259 
5 2558 2314 156 580 2742 
6 5871 6058 83 810 8368 
7 4771 6380 1682 2158 10073 
8 3588 4010 242 608 5596 
9 5508 7775 306 1495 9904 
10 3389 3311 344 778 2770 
11 3359 3768 431 879 5318 
12 1376 2060 429 1380 6914 
13 2991 4278 988 2145 10925 
14 5039 269 883 1055 6982 
15 5077 2329 686 2474 13536 
16 6357 910 535 1993 14032 
17 2207 2113 247 1171 6365 
18 4342 1667 627 1938 9385 
19 6273 1139 1268 2790 20048 
20 5454 2214 3121 4464 6919 
21 4444 3681 878 1923 6286 
22 5445 2268 2637 3183 9996 
23 5974 2020 1411 3641 32010 
24 5799 1806 343 2000 12586 
25 3869 2191 159 1217 5399 
26 4503 3363 947 1815 6154 
27 2777 1975 327 1012 5095 
28 2261 2439 719 999 7586 
29 6441 2780 693 1537 4855 
30 3694 2859 716 2865 11489 
31 3768 3181 699 1416 9700 
32 3701 1755 273 1223 4772 
33 3429 2524 491 3574 18425 
34 3608 2347 450 1644 9426 
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Appendix 19: Results for model DEAl 
Serial # Overall efficiency Technical efficiency Scale efficiency Type of returns to scale 
0.309 0.571 0.541 irs 
2 0.185 0.5 0.37 irs 
3 0.366 0.667 0.548 irs 
4 0.18 0.444 0.404 irs 
5 0.253 0.8 0.316 irs 
6 0.24 0.365 0.657 irs 
7 0.597 0.639 0.935 irs 
8 0.24 0.5 0.481 irs 
9 0.255 0.341 0.747 irs 
10 0.311 0.667 0.466 irs 
11 0.312 0.501 0.624 irs 
12 0.796 1 0.796 irs 
13 0.629 0.685 0.918 irs 
14 0.374 0.476 0.787 irs 
15 0.57 0.61 0.934 irs 
16 0.385 0.453 0.85 irs 
17 0.631 1 0.631 irs 
18 0.64 0.725 0.883 irs 
19 0.681 0.705 0.966 irs 
20 1 1 
21 0.418 0.488 0.856 irs 
22 
23 1 
24 0.764 0.913 0.836 irs 
25 0.341 0.571 0.596 irs 
26 0.576 0.677 0.851 irs 
27 0.473 0.8 0.591 irs 
28 0.626 0.806 0.777 irs 
29 0.331 0.429 0.771 irs 
30 0.861 0.912 0.944 irs 
31 0.7 0.862 0.812 irs 
32 0.362 0.571 0.633 irs 
33 1 
34 0.548 0.666 0.824 irs 
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Appendix 20: Results of model DEAl 
Serial # Overall efficiency Technical efficiency Scale efficiency Type of returns to scale 
0.376 0.549 0.685 irs 
2 0.27 0.548 0.493 irs 
3 0.3 0.927 0.324 irs 
4 0.202 0.472 0.428 irs 
5 0.207 0.767 0.27 irs 
6 0.241 0.311 0.774 irs 
7 0.445 0.451 0.987 irs 
8 0.274 0.474 0.578 irs 
9 0.324 0.331 0.98 irs 
10 0.175 0.55 0.318 irs 
11 0.301 0.505 0.596 irs 
12 0.967 0.967 irs 
13 0.717 0.726 0.987 irs 
14 1 1 1 
15 0.521 0.696 0.748 irs 
16 0.809 0.829 0.975 irs 
17 0.538 0.856 0.628 irs 
18 0.441 0.786 0.561 irs 
19 
20 0.425 0.651 0.652 irs 
21 0.312 0.471 0.662 irs 
22 0.463 0.665 0.696 irs 
23 1 
24 0.444 0.691 0.642 irs 
25 0.273 0.669 0.408 irs 
26 0.302 0.493 0.612 irs 
27 0.354 0.82 0.432 irs 
28 0.627 0.783 0.801 irs 
29 0.175 0.461 0.38 irs 
30 0.622 0.692 0.899 irs 
31 0.478 0.592 0.808 irs 
32 0.268 0.767 0.349 irs 
33 
34 0.493 0.717 0.687 irs 
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Appendix 21: Results of model DEA3 
Serial # Overall efficiency Technical efficiency Scale efficiency Type of returns to scale 
0.401 0.549 0.73 irs 
2 0.276 0.548 0.504 irs 
3 0.381 0.927 0.411 irs 
4 0.209 0.472 0.442 irs 
5 0.231 0.767 0.302 irs 
6 0.265 0.32 0.828 irs 
7 0.756 0.768 0.984 drs 
8 0.291 0.474 0.614 irs 
9 0.335 0.347 0.966 irs 
10 0.248 0.55 0.45 irs 
11 0.365 0.505 0.722 irs 
12 1 
l3 0.884 0.909 0.972 drs 
14 1 1 
15 0.627 0.741 0.846 irs 
16 0.838 0.873 0.96 irs 
17 0.547 0.856 0.639 irs 
18 0.619 0.845 0.732 irs 
19 1 1 
20 1 1 
21 0.473 0.534 0.885 irs 
22 0.938 0.946 0.991 irs 
23 1 
24 0.563 0.718 0.784 irs 
25 0.348 0.669 0.521 irs 
26 0.468 0.558 0.839 irs 
27 0.412 0.82 0.503 irs 
28 0.84 0.846 0.993 irs 
29 0.297 0.494 0.6 irs 
30 0.78 0.801 0.974 irs 
31 0.57 0.614 0.928 irs 
32 0.399 0.767 0.521 irs 
33 
34 0.528 0.729 0.725 irs 
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